Order ID,Generic Name,Brand Name,Company Name,Disease Medical Use,Invoice date,Company code,ship to country,Sold-to party Country Full Name,Delivery Plant,External Agent,Sales quantity,Price TC /Kg,Revenue,External commissions,Months
FY-2015-001,Aripiprazole,Abilify,Generic,Psychosis; depression,09-11-2015,5704,Mexico,Mexico,8370,Not assigned,450, $204.0 ," $91,800.0 ", $-   ,Nov
IN-2015-002,Oxycodone,OxyContin,Generic,Pain,30-06-2015,5704,Thailand,Thailand,8370,Not assigned,374, $472.0 ," $1,76,528.0 ", $-   ,Jun
IN-2015-003,Oxycodone,OxyContin,Generic,Pain,05-12-2015,5704,Vietnam,Japan,8370,Assigned,138, $472.0 ," $65,136.0 "," $4,186.0 ",Dec
IN-2015-004,Oxycodone,OxyContin,Generic,Pain,09-05-2015,5704,Australia,Australia,8370,Not assigned,227, $472.0 ," $1,07,144.0 ", $-   ,May
IN-2015-005,Oxycodone,OxyContin,Generic,Pain,09-07-2015,5704,Singapore,Singapore,8370,Not assigned,394, $472.0 ," $1,85,968.0 ", $-   ,Jul
IN-2015-006,Oxycodone,OxyContin,Generic,Pain,25-02-2015,5704,Singapore,Singapore,8370,Not assigned,261, $472.0 ," $1,23,192.0 ", $-   ,Feb
IN-2015-007,Oxycodone,OxyContin,Generic,Pain,09-04-2015,5704,Thailand,Thailand,8370,Assigned,129, $472.0 ," $60,888.0 ", $817.0 ,Apr
IN-2015-008,Oxycodone,OxyContin,Generic,Pain,30-03-2015,5704,Thailand,Thailand,8370,Assigned,310, $472.0 ," $1,46,320.0 "," $5,063.3 ",Mar
IN-2015-009,Oxycodone,OxyContin,Generic,Pain,09-02-2015,5704,Thailand,Thailand,8370,Assigned,111, $472.0 ," $52,392.0 "," $1,184.0 ",Feb
IN-2015-010,Oxycodone,OxyContin,Generic,Pain,21-04-2015,5704,Egypt,Egypt,8370,Not assigned,109, $472.0 ," $51,448.0 ", $-   ,Apr
CA-2015-011,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-11-2015,5887,India,India,8095,Not assigned,46, $500.0 ," $23,000.0 ", $-   ,Nov
CA-2015-012,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-09-2015,5887,India,India,8095,Not assigned,376, $500.0 ," $1,88,000.0 ", $-   ,Sep
CA-2015-013,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-07-2015,5887,India,India,8095,Not assigned,135, $500.0 ," $67,500.0 ", $-   ,Jul
CA-2015-014,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-07-2015,5887,India,India,8095,Not assigned,379, $500.0 ," $1,89,500.0 ", $-   ,Jul
CA-2015-015,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-10-2015,5887,India,India,8095,Not assigned,104, $500.0 ," $52,000.0 ", $-   ,Oct
CA-2015-016,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-02-2015,5887,India,India,8095,Assigned,468, $500.0 ," $2,34,000.0 "," $10,296.0 ",Feb
CA-2015-017,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-05-2015,5887,Thailand,Thailand,8095,Not assigned,365, $500.0 ," $1,82,500.0 ", $-   ,May
CA-2015-018,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-06-2015,5887,Thailand,Thailand,8095,Not assigned,119, $500.0 ," $59,500.0 ", $-   ,Jun
CA-2015-019,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-05-2015,5887,Thailand,Thailand,8095,Not assigned,127, $500.0 ," $63,500.0 ", $-   ,May
CA-2015-020,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-07-2015,5887,India,India,8095,Not assigned,254, $500.0 ," $1,27,000.0 ", $-   ,Jul
CA-2015-021,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-12-2015,5887,India,India,8095,Not assigned,171, $500.0 ," $85,500.0 ", $-   ,Dec
CA-2015-022,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-02-2015,5887,South Africa,South Africa,8095,Assigned,250, $500.0 ," $1,25,000.0 "," $7,833.3 ",Feb
CA-2015-023,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-07-2015,5887,India,India,8095,Not assigned,240, $500.0 ," $1,20,000.0 ", $-   ,Jul
CA-2015-024,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-11-2015,5887,India,India,8095,Not assigned,365, $500.0 ," $1,82,500.0 ", $-   ,Nov
CA-2015-025,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-02-2015,5887,Nepal,Nepal,8095,Assigned,88, $500.0 ," $44,000.0 "," $1,760.0 ",Feb
CA-2015-026,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-04-2015,5887,India,India,8095,Not assigned,416, $500.0 ," $2,08,000.0 ", $-   ,Apr
CA-2015-027,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-07-2015,5887,India,India,8095,Not assigned,227, $500.0 ," $1,13,500.0 ", $-   ,Jul
CA-2015-028,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-09-2015,5887,Nepal,Nepal,8095,Assigned,18, $500.0 ," $9,000.0 ", $576.0 ,Sep
CA-2015-029,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-04-2015,5887,India,India,8095,Not assigned,491, $500.0 ," $2,45,500.0 ", $-   ,Apr
CA-2015-030,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-01-2015,5887,India,India,8095,Not assigned,465, $500.0 ," $2,32,500.0 ", $-   ,Jan
CA-2015-031,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-03-2015,5887,India,India,8095,Not assigned,167, $500.0 ," $83,500.0 ", $-   ,Mar
CA-2015-032,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-11-2015,5887,India,India,8095,Not assigned,485, $500.0 ," $2,42,500.0 ", $-   ,Nov
CA-2015-033,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-08-2015,5887,Sudan,Utd.Arab Emir.,8095,Assigned,22, $500.0 ," $11,000.0 ", $381.3 ,Aug
CA-2015-034,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-05-2015,5887,Sudan,Utd.Arab Emir.,8095,Assigned,306, $500.0 ," $1,53,000.0 "," $8,976.0 ",May
TA-2015-035,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,15-07-2015,5704,India,India,8370,Not assigned,232, $453.0 ," $1,05,096.0 ", $-   ,Jul
CA-2015-036,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-10-2015,5887,Egypt,Egypt,8095,Not assigned,77, $500.0 ," $38,500.0 ", $-   ,Oct
CA-2015-037,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-06-2015,5887,India,India,8095,Not assigned,191, $500.0 ," $95,500.0 ", $-   ,Jun
CA-2015-038,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-08-2015,5887,Cambodia,Cambodia,8095,Not assigned,295, $500.0 ," $1,47,500.0 ", $-   ,Aug
CA-2015-039,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-06-2015,5887,India,India,8095,Not assigned,180, $500.0 ," $90,000.0 ", $-   ,Jun
CA-2015-040,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-08-2015,5887,India,India,8095,Not assigned,352, $500.0 ," $1,76,000.0 ", $-   ,Aug
CA-2015-041,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-07-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,259, $500.0 ," $1,29,500.0 ", $-   ,Jul
CA-2015-042,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-02-2015,5887,India,India,8095,Not assigned,211, $500.0 ," $1,05,500.0 ", $-   ,Feb
CA-2015-043,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-10-2015,5887,Malaysia,Malaysia,8095,Not assigned,175, $500.0 ," $87,500.0 ", $-   ,Oct
CA-2015-044,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-12-2015,5887,Malaysia,Malaysia,8095,Not assigned,76, $500.0 ," $38,000.0 ", $-   ,Dec
CA-2015-045,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-04-2015,5887,India,India,8095,Not assigned,261, $500.0 ," $1,30,500.0 ", $-   ,Apr
CA-2015-046,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-09-2015,5887,Netherlands,Netherlands,8095,Assigned,165, $500.0 ," $82,500.0 "," $3,960.0 ",Sep
CA-2015-047,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-03-2015,5887,Thailand,Thailand,8095,Assigned,189, $500.0 ," $94,500.0 "," $5,670.0 ",Mar
CA-2015-048,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-03-2015,5887,India,India,8095,Assigned,220, $500.0 ," $1,10,000.0 "," $3,153.3 ",Mar
CA-2015-049,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-07-2015,5887,Egypt,Egypt,8095,Not assigned,3, $500.0 ," $1,500.0 ", $-   ,Jul
CA-2015-050,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-01-2015,5887,Egypt,Egypt,8095,Not assigned,277, $500.0 ," $1,38,500.0 ", $-   ,Jan
CA-2015-051,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-06-2015,5887,India,India,8095,Assigned,128, $500.0 ," $64,000.0 "," $1,408.0 ",Jun
CA-2015-052,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-11-2015,5887,India,India,8095,Assigned,264, $500.0 ," $1,32,000.0 "," $6,512.0 ",Nov
CA-2015-053,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-06-2015,5887,India,India,8095,Assigned,391, $500.0 ," $1,95,500.0 "," $12,903.0 ",Jun
CA-2015-054,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-10-2015,5887,India,India,8095,Assigned,157, $500.0 ," $78,500.0 "," $4,657.7 ",Oct
CA-2015-055,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-07-2015,5887,India,India,8095,Assigned,205, $500.0 ," $1,02,500.0 "," $2,391.7 ",Jul
CA-2015-056,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-08-2015,5887,India,India,8095,Not assigned,95, $500.0 ," $47,500.0 ", $-   ,Aug
CA-2015-057,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-09-2015,5887,India,India,8095,Not assigned,379, $500.0 ," $1,89,500.0 ", $-   ,Sep
CA-2015-058,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-02-2015,5887,India,India,8095,Assigned,139, $500.0 ," $69,500.0 "," $2,826.3 ",Feb
CA-2015-059,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-01-2015,5887,Cambodia,Cambodia,8095,Not assigned,6, $500.0 ," $3,000.0 ", $-   ,Jan
CA-2015-060,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-09-2015,5887,Singapore,Singapore,8095,Not assigned,398, $500.0 ," $1,99,000.0 ", $-   ,Sep
CA-2015-061,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-12-2015,5887,India,India,8095,Not assigned,60, $500.0 ," $30,000.0 ", $-   ,Dec
CA-2015-062,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-03-2015,5887,South Korea,South Korea,8095,Not assigned,111, $500.0 ," $55,500.0 ", $-   ,Mar
CA-2015-063,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-08-2015,5887,Thailand,Thailand,8095,Assigned,60, $500.0 ," $30,000.0 ", $920.0 ,Aug
CA-2015-064,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-08-2015,5887,Singapore,Singapore,8095,Not assigned,419, $500.0 ," $2,09,500.0 ", $-   ,Aug
CA-2015-065,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-04-2015,5887,India,India,8095,Not assigned,404, $500.0 ," $2,02,000.0 ", $-   ,Apr
CA-2015-066,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-08-2015,5887,Vietnam,Netherlands,8095,Assigned,416, $500.0 ," $2,08,000.0 "," $6,517.3 ",Aug
CA-2015-067,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-02-2015,5887,Vietnam,Netherlands,8095,Assigned,247, $500.0 ," $1,23,500.0 "," $5,598.7 ",Feb
CA-2015-068,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-11-2015,5887,India,India,8095,Not assigned,459, $500.0 ," $2,29,500.0 ", $-   ,Nov
CA-2015-069,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-05-2015,5887,India,India,8095,Not assigned,431, $500.0 ," $2,15,500.0 ", $-   ,May
CA-2015-070,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-07-2015,5887,India,India,8095,Not assigned,497, $500.0 ," $2,48,500.0 ", $-   ,Jul
CA-2015-071,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-03-2015,5887,India,India,8095,Not assigned,472, $500.0 ," $2,36,000.0 ", $-   ,Mar
CA-2015-072,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-09-2015,5887,Singapore,Singapore,8095,Not assigned,459, $500.0 ," $2,29,500.0 ", $-   ,Sep
CA-2015-073,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-10-2015,5887,India,India,8095,Not assigned,119, $500.0 ," $59,500.0 ", $-   ,Oct
CA-2015-074,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-05-2015,5887,India,India,8095,Not assigned,113, $500.0 ," $56,500.0 ", $-   ,May
CA-2015-075,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-12-2015,5887,South Korea,South Korea,8095,Not assigned,181, $500.0 ," $90,500.0 ", $-   ,Dec
CA-2015-076,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-12-2015,5887,South Korea,South Korea,8095,Not assigned,279, $500.0 ," $1,39,500.0 ", $-   ,Dec
CA-2015-077,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-04-2015,5887,Thailand,Philippines,8095,Not assigned,122, $500.0 ," $61,000.0 ", $-   ,Apr
CA-2015-078,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-12-2015,5887,Thailand,Philippines,8095,Not assigned,28, $500.0 ," $14,000.0 ", $-   ,Dec
CA-2015-079,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-09-2015,5887,India,India,8095,Not assigned,284, $500.0 ," $1,42,000.0 ", $-   ,Sep
CA-2015-080,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-06-2015,5887,India,India,8095,Not assigned,470, $500.0 ," $2,35,000.0 ", $-   ,Jun
CA-2015-081,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-01-2015,5887,India,India,8095,Not assigned,244, $500.0 ," $1,22,000.0 ", $-   ,Jan
CA-2015-082,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-06-2015,5887,India,India,8095,Not assigned,321, $500.0 ," $1,60,500.0 ", $-   ,Jun
CA-2015-083,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-04-2015,5887,India,India,8095,Not assigned,118, $500.0 ," $59,000.0 ", $-   ,Apr
CA-2015-084,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-06-2015,5887,India,India,8095,Not assigned,435, $500.0 ," $2,17,500.0 ", $-   ,Jun
CA-2015-085,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-05-2015,5887,India,India,8095,Not assigned,208, $500.0 ," $1,04,000.0 ", $-   ,May
CA-2015-086,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-06-2015,5887,Thailand,Philippines,8095,Not assigned,244, $500.0 ," $1,22,000.0 ", $-   ,Jun
CA-2015-087,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-03-2015,5887,India,India,8095,Not assigned,312, $500.0 ," $1,56,000.0 ", $-   ,Mar
CA-2015-088,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-05-2015,5887,Yemen,Yemen,8095,Not assigned,214, $500.0 ," $1,07,000.0 ", $-   ,May
CA-2015-089,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-03-2015,5887,Sudan,South Korea,8095,Not assigned,458, $500.0 ," $2,29,000.0 ", $-   ,Mar
CA-2015-090,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-12-2015,5887,India,India,8095,Assigned,348, $500.0 ," $1,74,000.0 "," $1,392.0 ",Dec
CA-2015-091,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-06-2015,5887,India,India,8095,Not assigned,32, $500.0 ," $16,000.0 ", $-   ,Jun
CA-2015-092,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-09-2015,5887,India,India,8095,Not assigned,293, $500.0 ," $1,46,500.0 ", $-   ,Sep
CA-2015-093,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-11-2015,5887,India,India,8095,Not assigned,499, $500.0 ," $2,49,500.0 ", $-   ,Nov
CA-2015-094,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-07-2015,5887,India,India,8095,Not assigned,203, $500.0 ," $1,01,500.0 ", $-   ,Jul
CA-2015-095,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-07-2015,5887,India,India,8095,Not assigned,496, $500.0 ," $2,48,000.0 ", $-   ,Jul
CA-2015-096,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-04-2015,5887,India,India,8095,Not assigned,351, $500.0 ," $1,75,500.0 ", $-   ,Apr
CA-2015-097,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-01-2015,5887,India,India,8095,Assigned,305, $500.0 ," $1,52,500.0 "," $9,150.0 ",Jan
CA-2015-098,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-03-2015,5887,India,India,8095,Not assigned,136, $500.0 ," $68,000.0 ", $-   ,Mar
CA-2015-099,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-02-2015,5887,India,India,8095,Not assigned,343, $500.0 ," $1,71,500.0 ", $-   ,Feb
CA-2015-100,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-08-2015,5887,India,India,8095,Not assigned,75, $500.0 ," $37,500.0 ", $-   ,Aug
CA-2015-101,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-04-2015,5887,India,India,8095,Not assigned,58, $500.0 ," $29,000.0 ", $-   ,Apr
CA-2015-102,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-02-2015,5887,Sudan,South Korea,8095,Not assigned,360, $500.0 ," $1,80,000.0 ", $-   ,Feb
CA-2015-103,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-07-2015,5887,India,India,8095,Not assigned,213, $500.0 ," $1,06,500.0 ", $-   ,Jul
CA-2015-104,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-04-2015,5887,India,India,8095,Not assigned,296, $500.0 ," $1,48,000.0 ", $-   ,Apr
CA-2015-105,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-03-2015,5887,Sudan,South Korea,8095,Not assigned,127, $500.0 ," $63,500.0 ", $-   ,Mar
CA-2015-106,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-09-2015,5887,Uganda,Netherlands,8095,Assigned,239, $500.0 ," $1,19,500.0 "," $4,620.7 ",Sep
CA-2015-107,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-11-2015,5887,India,India,8095,Not assigned,291, $500.0 ," $1,45,500.0 ", $-   ,Nov
CA-2015-108,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-07-2015,5887,India,India,8095,Not assigned,429, $500.0 ," $2,14,500.0 ", $-   ,Jul
CA-2015-109,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-04-2015,5887,Uganda,Netherlands,8095,Assigned,103, $500.0 ," $51,500.0 "," $2,197.3 ",Apr
CA-2015-110,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-08-2015,5887,India,India,8095,Assigned,237, $500.0 ," $1,18,500.0 "," $1,580.0 ",Aug
CA-2015-111,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-06-2015,5887,India,India,8095,Not assigned,279, $500.0 ," $1,39,500.0 ", $-   ,Jun
CA-2015-112,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-02-2015,5887,India,India,8095,Not assigned,221, $500.0 ," $1,10,500.0 ", $-   ,Feb
AR-2015-113,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,04-11-2015,5653,India,India,7933,Not assigned,137, $231.0 ," $31,647.0 ", $-   ,Nov
CA-2015-114,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-11-2015,5887,Thailand,Thailand,8095,Assigned,3, $500.0 ," $1,500.0 ", $66.0 ,Nov
CA-2015-115,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-10-2015,5887,India,India,8095,Not assigned,109, $500.0 ," $54,500.0 ", $-   ,Oct
CA-2015-116,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-06-2015,5887,India,India,8095,Not assigned,201, $500.0 ," $1,00,500.0 ", $-   ,Jun
CA-2015-117,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-12-2015,5887,India,India,8095,Not assigned,42, $500.0 ," $21,000.0 ", $-   ,Dec
CA-2015-118,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-08-2015,5887,India,India,8095,Not assigned,485, $500.0 ," $2,42,500.0 ", $-   ,Aug
CA-2015-119,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-07-2015,5887,India,India,8095,Not assigned,220, $500.0 ," $1,10,000.0 ", $-   ,Jul
CA-2015-120,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-06-2015,5887,India,India,8095,Not assigned,42, $500.0 ," $21,000.0 ", $-   ,Jun
CA-2015-121,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-11-2015,5887,India,India,8095,Not assigned,230, $500.0 ," $1,15,000.0 ", $-   ,Nov
CA-2015-122,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-06-2015,5887,India,India,8095,Not assigned,175, $500.0 ," $87,500.0 ", $-   ,Jun
CA-2015-123,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-10-2015,5887,India,India,8095,Not assigned,199, $500.0 ," $99,500.0 ", $-   ,Oct
CA-2015-124,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-01-2015,5887,India,India,8095,Not assigned,189, $500.0 ," $94,500.0 ", $-   ,Jan
CA-2015-125,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-08-2015,5887,India,India,8095,Assigned,213, $500.0 ," $1,06,500.0 "," $3,408.0 ",Aug
CA-2015-126,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-07-2015,5887,India,India,8095,Not assigned,83, $500.0 ," $41,500.0 ", $-   ,Jul
CA-2015-127,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-03-2015,5887,India,India,8095,Assigned,474, $500.0 ," $2,37,000.0 "," $7,900.0 ",Mar
CA-2015-128,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-09-2015,5887,India,India,8095,Assigned,92, $500.0 ," $46,000.0 "," $2,668.0 ",Sep
CA-2015-129,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-10-2015,5887,India,India,8095,Not assigned,49, $500.0 ," $24,500.0 ", $-   ,Oct
CA-2015-130,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-03-2015,5887,India,India,8095,Not assigned,470, $500.0 ," $2,35,000.0 ", $-   ,Mar
CA-2015-131,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-10-2015,5887,India,India,8095,Not assigned,433, $500.0 ," $2,16,500.0 ", $-   ,Oct
CA-2015-132,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-08-2015,5887,India,India,8095,Assigned,101, $500.0 ," $50,500.0 "," $2,222.0 ",Aug
AR-2015-133,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,13-10-2015,5653,India,India,7933,Not assigned,272, $231.0 ," $62,832.0 ", $-   ,Oct
CA-2015-134,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-08-2015,5887,India,India,8095,Not assigned,15, $500.0 ," $7,500.0 ", $-   ,Aug
CA-2015-135,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-10-2015,5887,India,India,8095,Not assigned,136, $500.0 ," $68,000.0 ", $-   ,Oct
CA-2015-136,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-07-2015,5887,India,India,8095,Not assigned,209, $500.0 ," $1,04,500.0 ", $-   ,Jul
AR-2015-137,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,14-10-2015,5653,India,India,7933,Not assigned,64, $231.0 ," $14,784.0 ", $-   ,Oct
CA-2015-138,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-10-2015,5887,Cambodia,Cambodia,8095,Not assigned,250, $500.0 ," $1,25,000.0 ", $-   ,Oct
CA-2015-139,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-01-2015,5887,Indonesia,Indonesia,8095,Not assigned,441, $500.0 ," $2,20,500.0 ", $-   ,Jan
CA-2015-140,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-06-2015,5887,Indonesia,Indonesia,8095,Not assigned,185, $500.0 ," $92,500.0 ", $-   ,Jun
CA-2015-141,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-11-2015,5887,India,India,8095,Not assigned,203, $500.0 ," $1,01,500.0 ", $-   ,Nov
CA-2015-142,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-11-2015,5887,Thailand,Thailand,8095,Assigned,279, $500.0 ," $1,39,500.0 "," $5,301.0 ",Nov
CA-2015-143,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-03-2015,5887,India,India,8095,Not assigned,348, $500.0 ," $1,74,000.0 ", $-   ,Mar
CA-2015-144,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-10-2015,5887,India,India,8095,Not assigned,406, $500.0 ," $2,03,000.0 ", $-   ,Oct
CA-2015-145,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-12-2015,5887,India,India,8095,Assigned,293, $500.0 ," $1,46,500.0 "," $7,813.3 ",Dec
CA-2015-146,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-09-2015,5887,India,India,8095,Not assigned,499, $500.0 ," $2,49,500.0 ", $-   ,Sep
CA-2015-147,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-08-2015,5887,India,India,8095,Not assigned,341, $500.0 ," $1,70,500.0 ", $-   ,Aug
CA-2015-148,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-12-2015,5887,India,India,8095,Not assigned,252, $500.0 ," $1,26,000.0 ", $-   ,Dec
CA-2015-149,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-02-2015,5887,India,India,8095,Not assigned,153, $500.0 ," $76,500.0 ", $-   ,Feb
CA-2015-150,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-08-2015,5887,India,India,8095,Not assigned,302, $500.0 ," $1,51,000.0 ", $-   ,Aug
CA-2015-151,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-11-2015,5887,Nepal,Nepal,8095,Assigned,73, $500.0 ," $36,500.0 "," $2,384.7 ",Nov
CA-2015-152,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-01-2015,5887,Nepal,Nepal,8095,Assigned,421, $500.0 ," $2,10,500.0 "," $13,331.7 ",Jan
CA-2015-153,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-10-2015,5887,India,India,8095,Assigned,469, $500.0 ," $2,34,500.0 "," $14,070.0 ",Oct
CA-2015-154,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-10-2015,5887,India,India,8095,Assigned,117, $500.0 ," $58,500.0 "," $1,677.0 ",Oct
CA-2015-155,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-07-2015,5887,India,India,8095,Assigned,45, $500.0 ," $22,500.0 "," $1,395.0 ",Jul
CA-2015-156,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-03-2015,5887,India,India,8095,Assigned,317, $500.0 ," $1,58,500.0 "," $7,185.3 ",Mar
CA-2015-157,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-07-2015,5887,India,India,8095,Assigned,487, $500.0 ," $2,43,500.0 "," $8,116.7 ",Jul
CA-2015-158,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-07-2015,5887,India,India,8095,Assigned,263, $500.0 ," $1,31,500.0 "," $3,331.3 ",Jul
CA-2015-159,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-08-2015,5887,India,India,8095,Assigned,125, $500.0 ," $62,500.0 "," $1,541.7 ",Aug
CA-2015-160,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-03-2015,5887,India,India,8095,Assigned,197, $500.0 ," $98,500.0 "," $6,041.3 ",Mar
CA-2015-161,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-04-2015,5887,India,India,8095,Assigned,267, $500.0 ," $1,33,500.0 "," $1,869.0 ",Apr
CA-2015-162,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-02-2015,5887,India,India,8095,Assigned,212, $500.0 ," $1,06,000.0 ", $989.3 ,Feb
CA-2015-163,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-10-2015,5887,India,India,8095,Assigned,7, $500.0 ," $3,500.0 ", $126.0 ,Oct
CA-2015-164,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-05-2015,5887,India,India,8095,Assigned,352, $500.0 ," $1,76,000.0 "," $1,877.3 ",May
CA-2015-165,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-06-2015,5887,India,India,8095,Assigned,466, $500.0 ," $2,33,000.0 "," $8,543.3 ",Jun
CA-2015-166,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-09-2015,5887,Philippines,Philippines,8095,Assigned,423, $500.0 ," $2,11,500.0 "," $1,551.0 ",Sep
CA-2015-167,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-05-2015,5887,India,India,8095,Not assigned,123, $500.0 ," $61,500.0 ", $-   ,May
CA-2015-168,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-10-2015,5887,India,India,8095,Not assigned,247, $500.0 ," $1,23,500.0 ", $-   ,Oct
CA-2015-169,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-09-2015,5887,Indonesia,Indonesia,8095,Assigned,205, $500.0 ," $1,02,500.0 "," $1,366.7 ",Sep
CA-2015-170,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-12-2015,5887,Nigeria,Nigeria,8095,Not assigned,292, $500.0 ," $1,46,000.0 ", $-   ,Dec
CA-2015-171,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-12-2015,5887,Nepal,Nepal,8095,Assigned,282, $500.0 ," $1,41,000.0 "," $6,580.0 ",Dec
CA-2015-172,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-01-2015,5887,Philippines,Philippines,8095,Assigned,1, $500.0 , $500.0 , $13.3 ,Jan
CA-2015-173,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-02-2015,5887,Philippines,Philippines,8095,Assigned,423, $500.0 ," $2,11,500.0 "," $12,831.0 ",Feb
CA-2015-174,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-09-2015,5887,Taiwan,China,8095,Not assigned,309, $500.0 ," $1,54,500.0 ", $-   ,Sep
CA-2015-175,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-02-2015,5887,India,India,8095,Not assigned,274, $500.0 ," $1,37,000.0 ", $-   ,Feb
CA-2015-176,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-04-2015,5887,India,India,8095,Not assigned,156, $500.0 ," $78,000.0 ", $-   ,Apr
CA-2015-177,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-03-2015,5887,India,India,8095,Assigned,390, $500.0 ," $1,95,000.0 "," $6,500.0 ",Mar
CA-2015-178,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-12-2015,5887,India,India,8095,Not assigned,226, $500.0 ," $1,13,000.0 ", $-   ,Dec
CA-2015-179,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-10-2015,5887,India,India,8095,Assigned,204, $500.0 ," $1,02,000.0 "," $1,632.0 ",Oct
CA-2015-180,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-03-2015,5887,Egypt,Egypt,8095,Not assigned,113, $500.0 ," $56,500.0 ", $-   ,Mar
CA-2015-181,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-07-2015,5887,India,India,8095,Not assigned,61, $500.0 ," $30,500.0 ", $-   ,Jul
CA-2015-182,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-12-2015,5887,Vietnam,Japan,8095,Assigned,240, $500.0 ," $1,20,000.0 "," $7,120.0 ",Dec
CA-2015-183,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-01-2015,5887,Australia,Australia,8095,Not assigned,184, $500.0 ," $92,000.0 ", $-   ,Jan
CA-2015-184,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-04-2015,5887,India,India,8095,Assigned,91, $500.0 ," $45,500.0 "," $1,880.7 ",Apr
CA-2015-185,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-03-2015,5887,India,India,8095,Not assigned,424, $500.0 ," $2,12,000.0 ", $-   ,Mar
CA-2015-186,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-11-2015,5887,India,India,8095,Assigned,19, $500.0 ," $9,500.0 ", $570.0 ,Nov
CA-2015-187,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-05-2015,5887,India,India,8095,Assigned,349, $500.0 ," $1,74,500.0 "," $9,888.3 ",May
CA-2015-188,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-08-2015,5887,India,India,8095,Assigned,309, $500.0 ," $1,54,500.0 "," $5,356.0 ",Aug
CA-2015-189,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-09-2015,5887,Indonesia,Indonesia,8095,Not assigned,55, $500.0 ," $27,500.0 ", $-   ,Sep
CA-2015-190,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-09-2015,5887,Syria,Lebanon,8095,Assigned,197, $500.0 ," $98,500.0 "," $1,182.0 ",Sep
CA-2015-191,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-05-2015,5887,Syria,Lebanon,8095,Assigned,1, $500.0 , $500.0 , $21.7 ,May
CA-2015-192,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-02-2015,5887,Thailand,Thailand,8095,Assigned,441, $500.0 ," $2,20,500.0 "," $2,352.0 ",Feb
CA-2015-193,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-07-2015,5887,Indonesia,Indonesia,8095,Assigned,177, $500.0 ," $88,500.0 "," $2,124.0 ",Jul
CA-2015-194,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-06-2015,5887,Thailand,Thailand,8095,Assigned,236, $500.0 ," $1,18,000.0 "," $7,080.0 ",Jun
CA-2015-195,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-01-2015,5887,Vietnam,Japan,8095,Assigned,325, $500.0 ," $1,62,500.0 "," $9,100.0 ",Jan
CA-2015-196,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-07-2015,5887,Indonesia,Indonesia,8095,Assigned,136, $500.0 ," $68,000.0 ", $634.7 ,Jul
CA-2015-197,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-07-2015,5887,Thailand,Thailand,8095,Assigned,232, $500.0 ," $1,16,000.0 "," $6,960.0 ",Jul
CA-2015-198,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-05-2015,5887,Malaysia,Malaysia,8095,Not assigned,143, $500.0 ," $71,500.0 ", $-   ,May
CA-2015-199,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-04-2015,5887,Egypt,Egypt,8095,Not assigned,290, $500.0 ," $1,45,000.0 ", $-   ,Apr
CA-2015-200,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-12-2015,5887,Thailand,Thailand,8095,Assigned,363, $500.0 ," $1,81,500.0 "," $3,025.0 ",Dec
CA-2015-201,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-07-2015,5887,Thailand,Thailand,8095,Assigned,236, $500.0 ," $1,18,000.0 "," $3,382.7 ",Jul
CA-2015-202,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-11-2015,5887,India,India,8095,Assigned,372, $500.0 ," $1,86,000.0 "," $5,828.0 ",Nov
AR-2015-203,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,16-10-2015,5653,India,India,7933,Not assigned,426, $231.0 ," $98,406.0 ", $-   ,Oct
IN-2015-204,Bevacizumab,Avastin,Genentech/Roche,Cancer,05-10-2015,5685,India,India,8209,Not assigned,325, $243.0 ," $78,975.0 ", $-   ,Oct
IN-2015-205,Bevacizumab,Avastin,Genentech/Roche,Cancer,06-04-2015,5685,India,India,8209,Not assigned,265, $243.0 ," $64,395.0 ", $-   ,Apr
IN-2015-206,Bevacizumab,Avastin,Genentech/Roche,Cancer,03-04-2015,5685,India,India,8209,Not assigned,285, $243.0 ," $69,255.0 ", $-   ,Apr
IN-2015-207,Bevacizumab,Avastin,Genentech/Roche,Cancer,17-05-2015,5685,India,India,8209,Not assigned,97, $243.0 ," $23,571.0 ", $-   ,May
IN-2015-208,Bevacizumab,Avastin,Genentech/Roche,Cancer,22-05-2015,5685,India,India,8209,Not assigned,380, $243.0 ," $92,340.0 ", $-   ,May
RA-2015-209,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,01-05-2015,5819,India,India,8119,Assigned,104, $364.0 ," $37,856.0 ", $520.0 ,May
IN-2015-210,Bevacizumab,Avastin,Genentech/Roche,Cancer,18-06-2015,5685,India,India,8209,Assigned,48, $243.0 ," $11,664.0 "," $1,360.0 ",Jun
IN-2015-211,Bevacizumab,Avastin,Genentech/Roche,Cancer,16-11-2015,5685,India,India,8209,Not assigned,321, $243.0 ," $78,003.0 ", $-   ,Nov
IN-2015-212,Bevacizumab,Avastin,Genentech/Roche,Cancer,02-09-2015,5685,India,India,8209,Not assigned,396, $243.0 ," $96,228.0 ", $-   ,Sep
IN-2015-213,Bevacizumab,Avastin,Genentech/Roche,Cancer,31-12-2015,5685,India,India,8209,Not assigned,500, $243.0 ," $1,21,500.0 ", $-   ,Dec
IN-2015-214,Bevacizumab,Avastin,Genentech/Roche,Cancer,19-11-2015,5685,Vietnam,Netherlands,8209,Assigned,169, $243.0 ," $41,067.0 "," $2,591.3 ",Nov
IN-2015-215,Bevacizumab,Avastin,Genentech/Roche,Cancer,22-10-2015,5685,Kenya,Kenya,8209,Assigned,311, $243.0 ," $75,573.0 "," $5,287.0 ",Oct
IN-2015-216,Bevacizumab,Avastin,Genentech/Roche,Cancer,24-01-2015,5685,Egypt,Egypt,8209,Not assigned,398, $243.0 ," $96,714.0 ", $-   ,Jan
IN-2015-217,Bevacizumab,Avastin,Genentech/Roche,Cancer,11-11-2015,5685,Lebanon,Lebanon,8209,Not assigned,84, $243.0 ," $20,412.0 ", $-   ,Nov
IN-2015-218,Bevacizumab,Avastin,Genentech/Roche,Cancer,07-02-2015,5685,Lebanon,Lebanon,8209,Not assigned,334, $243.0 ," $81,162.0 ", $-   ,Feb
IN-2015-219,Bevacizumab,Avastin,Genentech/Roche,Cancer,21-09-2015,5685,Lebanon,Lebanon,8209,Not assigned,63, $243.0 ," $15,309.0 ", $-   ,Sep
IN-2015-220,Bevacizumab,Avastin,Genentech/Roche,Cancer,06-06-2015,5685,Indonesia,Indonesia,8209,Not assigned,116, $243.0 ," $28,188.0 ", $-   ,Jun
IN-2015-221,Bevacizumab,Avastin,Genentech/Roche,Cancer,18-08-2015,5685,Indonesia,Indonesia,8209,Not assigned,418, $243.0 ," $1,01,574.0 ", $-   ,Aug
IN-2015-222,Bevacizumab,Avastin,Genentech/Roche,Cancer,06-05-2015,5685,Thailand,Thailand,8209,Assigned,467, $243.0 ," $1,13,481.0 "," $4,514.3 ",May
IN-2015-223,Bevacizumab,Avastin,Genentech/Roche,Cancer,26-07-2015,5685,Thailand,Thailand,8209,Assigned,30, $243.0 ," $7,290.0 ", $430.0 ,Jul
IN-2015-224,Bevacizumab,Avastin,Genentech/Roche,Cancer,13-05-2015,5685,Thailand,Thailand,8209,Assigned,453, $243.0 ," $1,10,079.0 "," $5,587.0 ",May
IN-2015-225,Bevacizumab,Avastin,Genentech/Roche,Cancer,25-02-2015,5685,Thailand,Thailand,8209,Assigned,58, $243.0 ," $14,094.0 ", $502.7 ,Feb
IN-2015-226,Bevacizumab,Avastin,Genentech/Roche,Cancer,23-01-2015,5685,Kenya,Kenya,8209,Assigned,124, $243.0 ," $30,132.0 ", $537.3 ,Jan
IN-2015-227,Bevacizumab,Avastin,Genentech/Roche,Cancer,28-05-2015,5685,Egypt,Egypt,8209,Not assigned,468, $243.0 ," $1,13,724.0 ", $-   ,May
IN-2015-228,Bevacizumab,Avastin,Genentech/Roche,Cancer,11-08-2015,5685,Tanzania,Netherlands,8209,Assigned,454, $243.0 ," $1,10,322.0 "," $14,376.7 ",Aug
IN-2015-229,Bevacizumab,Avastin,Genentech/Roche,Cancer,17-10-2015,5685,Syria,Lebanon,8209,Assigned,125, $243.0 ," $30,375.0 ", $500.0 ,Oct
IN-2015-230,Bevacizumab,Avastin,Genentech/Roche,Cancer,12-05-2015,5685,Thailand,Thailand,8209,Assigned,480, $243.0 ," $1,16,640.0 "," $14,560.0 ",May
IN-2015-231,Bevacizumab,Avastin,Genentech/Roche,Cancer,25-02-2015,5685,Netherlands,Netherlands,8209,Not assigned,422, $243.0 ," $1,02,546.0 ", $-   ,Feb
NE-2015-232,Glatiramer,Copaxone,Generic,Multiple sclerosis,11-02-2015,5704,India,India,8370,Not assigned,90, $451.0 ," $40,590.0 ", $-   ,Feb
NE-2015-233,Glatiramer,Copaxone,Generic,Multiple sclerosis,17-07-2015,5704,India,India,8370,Not assigned,372, $451.0 ," $1,67,772.0 ", $-   ,Jul
NE-2015-234,Glatiramer,Copaxone,Generic,Multiple sclerosis,20-09-2015,5704,India,India,8370,Not assigned,492, $451.0 ," $2,21,892.0 ", $-   ,Sep
NE-2015-235,Glatiramer,Copaxone,Generic,Multiple sclerosis,05-06-2015,5704,India,India,8370,Not assigned,166, $451.0 ," $74,866.0 ", $-   ,Jun
NE-2015-236,Glatiramer,Copaxone,Generic,Multiple sclerosis,27-01-2015,5704,India,India,8370,Not assigned,216, $451.0 ," $97,416.0 ", $-   ,Jan
NE-2015-237,Glatiramer,Copaxone,Generic,Multiple sclerosis,16-09-2015,5704,India,India,8370,Not assigned,203, $451.0 ," $91,553.0 ", $-   ,Sep
NE-2015-238,Glatiramer,Copaxone,Generic,Multiple sclerosis,22-09-2015,5704,India,India,8370,Assigned,33, $451.0 ," $14,883.0 ", $968.0 ,Sep
NE-2015-239,Glatiramer,Copaxone,Generic,Multiple sclerosis,17-07-2015,5704,Kenya,Kenya,8370,Assigned,43, $451.0 ," $19,393.0 ", $903.0 ,Jul
NE-2015-240,Glatiramer,Copaxone,Generic,Multiple sclerosis,27-04-2015,5704,Kenya,Kenya,8370,Assigned,346, $451.0 ," $1,56,046.0 "," $3,575.3 ",Apr
NE-2015-241,Glatiramer,Copaxone,Generic,Multiple sclerosis,19-08-2015,5704,Sri Lanka,Sri Lanka,8370,Assigned,258, $451.0 ," $1,16,358.0 "," $6,106.0 ",Aug
NE-2015-242,Glatiramer,Copaxone,Generic,Multiple sclerosis,03-12-2015,5704,Malaysia,Malaysia,8370,Assigned,36, $451.0 ," $16,236.0 ", $456.0 ,Dec
NE-2015-243,Glatiramer,Copaxone,Generic,Multiple sclerosis,05-08-2015,5704,Netherlands,Netherlands,8370,Assigned,104, $451.0 ," $46,904.0 "," $3,189.3 ",Aug
NE-2015-244,Glatiramer,Copaxone,Generic,Multiple sclerosis,28-01-2015,5704,Netherlands,Netherlands,8370,Assigned,453, $451.0 ," $2,04,303.0 "," $12,835.0 ",Jan
NE-2015-245,Glatiramer,Copaxone,Generic,Multiple sclerosis,26-03-2015,5704,Malaysia,Malaysia,8370,Assigned,494, $451.0 ," $2,22,794.0 "," $13,338.0 ",Mar
NE-2015-246,Glatiramer,Copaxone,Generic,Multiple sclerosis,04-10-2015,5704,Tanzania,Netherlands,8370,Assigned,101, $451.0 ," $45,551.0 "," $3,097.3 ",Oct
NE-2015-247,Glatiramer,Copaxone,Generic,Multiple sclerosis,23-01-2015,5704,Syria,Lebanon,8370,Assigned,285, $451.0 ," $1,28,535.0 "," $1,235.0 ",Jan
NE-2015-248,Glatiramer,Copaxone,Generic,Multiple sclerosis,16-09-2015,5704,Netherlands,Netherlands,8370,Not assigned,290, $451.0 ," $1,30,790.0 ", $-   ,Sep
NE-2015-249,Glatiramer,Copaxone,Generic,Multiple sclerosis,16-03-2015,5704,Netherlands,Netherlands,8370,Not assigned,386, $451.0 ," $1,74,086.0 ", $-   ,Mar
VA-2015-250,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,30-01-2015,5938,Egypt,Egypt,8068,Not assigned,55, $310.0 ," $17,050.0 ", $-   ,Jan
VA-2015-251,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,02-01-2015,5938,Egypt,Egypt,8068,Not assigned,275, $310.0 ," $85,250.0 ", $-   ,Jan
RA-2015-252,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,24-11-2015,5819,India,India,8119,Not assigned,485, $364.0 ," $1,76,540.0 ", $-   ,Nov
RA-2015-253,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,02-05-2015,5819,India,India,8119,Not assigned,248, $364.0 ," $90,272.0 ", $-   ,May
RA-2015-254,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,23-04-2015,5819,India,India,8119,Assigned,115, $364.0 ," $41,860.0 "," $3,450.0 ",Apr
RA-2015-255,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,06-03-2015,5819,India,India,8119,Not assigned,466, $364.0 ," $1,69,624.0 ", $-   ,Mar
RA-2015-256,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,16-10-2015,5819,India,India,8119,Not assigned,228, $364.0 ," $82,992.0 ", $-   ,Oct
RA-2015-257,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,06-07-2015,5819,India,India,8119,Not assigned,275, $364.0 ," $1,00,100.0 ", $-   ,Jul
RA-2015-258,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,28-06-2015,5819,India,India,8119,Assigned,57, $364.0 ," $20,748.0 "," $1,406.0 ",Jun
RA-2015-259,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,15-06-2015,5819,Thailand,Thailand,8119,Not assigned,147, $364.0 ," $53,508.0 ", $-   ,Jun
RA-2015-260,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,08-06-2015,5819,Thailand,Thailand,8119,Assigned,489, $364.0 ," $1,77,996.0 "," $8,150.0 ",Jun
RA-2015-261,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,26-10-2015,5819,Thailand,Thailand,8119,Not assigned,79, $364.0 ," $28,756.0 ", $-   ,Oct
RA-2015-262,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,06-09-2015,5819,Thailand,Thailand,8119,Not assigned,31, $364.0 ," $11,284.0 ", $-   ,Sep
RA-2015-263,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,26-03-2015,5819,Thailand,Thailand,8119,Assigned,381, $364.0 ," $1,38,684.0 "," $6,604.0 ",Mar
RA-2015-264,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,24-01-2015,5819,Thailand,Thailand,8119,Assigned,212, $364.0 ," $77,168.0 "," $5,441.3 ",Jan
RA-2015-265,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,13-02-2015,5819,Thailand,Thailand,8119,Assigned,288, $364.0 ," $1,04,832.0 "," $3,072.0 ",Feb
RA-2015-266,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,29-07-2015,5819,China,China,8119,Not assigned,291, $364.0 ," $1,05,924.0 ", $-   ,Jul
CA-2015-267,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-09-2015,5887,India,India,8095,Not assigned,417, $500.0 ," $2,08,500.0 ", $-   ,Sep
AR-2015-268,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,31-10-2015,5653,Egypt,Egypt,7933,Not assigned,413, $231.0 ," $95,403.0 ", $-   ,Oct
AR-2015-269,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,13-12-2015,5653,Syria,Lebanon,7933,Assigned,373, $231.0 ," $86,163.0 "," $8,952.0 ",Dec
AR-2015-270,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,31-12-2015,5653,Kenya,Kenya,7933,Assigned,163, $231.0 ," $37,653.0 "," $1,249.7 ",Dec
AR-2015-271,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,01-06-2015,5653,Vietnam,Netherlands,7933,Assigned,34, $231.0 ," $7,854.0 ", $634.7 ,Jun
AR-2015-272,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,24-09-2015,5653,Vietnam,Netherlands,7933,Assigned,188, $231.0 ," $43,428.0 "," $5,890.7 ",Sep
AR-2015-273,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,21-08-2015,5653,Vietnam,Netherlands,7933,Assigned,489, $231.0 ," $1,12,959.0 "," $8,802.0 ",Aug
AR-2015-274,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,02-03-2015,5653,Thailand,Thailand,7933,Not assigned,495, $231.0 ," $1,14,345.0 ", $-   ,Mar
AR-2015-275,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,05-03-2015,5653,Thailand,Thailand,7933,Not assigned,161, $231.0 ," $37,191.0 ", $-   ,Mar
AR-2015-276,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,02-08-2015,5653,Thailand,Thailand,7933,Not assigned,461, $231.0 ," $1,06,491.0 ", $-   ,Aug
AR-2015-277,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,29-10-2015,5653,Thailand,Thailand,7933,Not assigned,399, $231.0 ," $92,169.0 ", $-   ,Oct
AR-2015-278,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,31-01-2015,5653,Cambodia,Cambodia,7933,Assigned,354, $231.0 ," $81,774.0 "," $10,974.0 ",Jan
AR-2015-279,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,25-02-2015,5653,Vietnam,Japan,7933,Assigned,443, $231.0 ," $1,02,333.0 "," $2,805.7 ",Feb
AR-2015-280,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,30-07-2015,5653,Vietnam,Japan,7933,Assigned,333, $231.0 ," $76,923.0 "," $3,108.0 ",Jul
AR-2015-281,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,06-11-2015,5653,Vietnam,Japan,7933,Assigned,206, $231.0 ," $47,586.0 "," $2,952.7 ",Nov
AR-2015-282,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,01-04-2015,5653,Vietnam,Netherlands,7933,Assigned,356, $231.0 ," $82,236.0 "," $5,696.0 ",Apr
AR-2015-283,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,10-12-2015,5653,Philippines,Philippines,7933,Not assigned,85, $231.0 ," $19,635.0 ", $-   ,Dec
AR-2015-284,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,15-12-2015,5653,Philippines,Philippines,7933,Not assigned,119, $231.0 ," $27,489.0 ", $-   ,Dec
AR-2015-285,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,21-10-2015,5653,Syria,Lebanon,7933,Assigned,287, $231.0 ," $66,297.0 "," $6,409.7 ",Oct
AR-2015-286,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,25-10-2015,5653,Vietnam,Netherlands,7933,Assigned,271, $231.0 ," $62,601.0 "," $4,245.7 ",Oct
AR-2015-287,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,07-02-2015,5653,Japan,Singapore,7933,Not assigned,186, $231.0 ," $42,966.0 ", $-   ,Feb
DE-2015-288,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,17-02-2015,5754,India,India,7904,Not assigned,306, $314.0 ," $96,084.0 ", $-   ,Feb
DE-2015-289,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,23-03-2015,5754,India,India,7904,Not assigned,334, $314.0 ," $1,04,876.0 ", $-   ,Mar
DE-2015-290,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,15-02-2015,5754,India,India,7904,Not assigned,22, $314.0 ," $6,908.0 ", $-   ,Feb
DE-2015-291,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,31-08-2015,5754,India,India,7904,Not assigned,496, $314.0 ," $1,55,744.0 ", $-   ,Aug
DE-2015-292,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,10-06-2015,5754,India,India,7904,Not assigned,201, $314.0 ," $63,114.0 ", $-   ,Jun
DE-2015-293,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,16-04-2015,5754,India,India,7904,Not assigned,386, $314.0 ," $1,21,204.0 ", $-   ,Apr
DE-2015-294,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,11-06-2015,5754,Egypt,Egypt,7904,Not assigned,466, $314.0 ," $1,46,324.0 ", $-   ,Jun
DE-2015-295,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,19-11-2015,5754,Bangladesh,Bangladesh,7904,Assigned,454, $314.0 ," $1,42,556.0 "," $12,863.3 ",Nov
DE-2015-296,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,30-09-2015,5754,Bangladesh,Bangladesh,7904,Assigned,325, $314.0 ," $1,02,050.0 "," $8,450.0 ",Sep
DE-2015-297,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,07-04-2015,5754,Vietnam,Netherlands,7904,Assigned,216, $314.0 ," $67,824.0 "," $7,056.0 ",Apr
DE-2015-298,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,26-10-2015,5754,Pakistan,Pakistan,7904,Not assigned,70, $314.0 ," $21,980.0 ", $-   ,Oct
DE-2015-299,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,22-09-2015,5754,Pakistan,Pakistan,7904,Not assigned,252, $314.0 ," $79,128.0 ", $-   ,Sep
DE-2015-300,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,22-01-2015,5754,Vietnam,Netherlands,7904,Assigned,424, $314.0 ," $1,33,136.0 "," $6,501.3 ",Jan
DE-2015-301,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,18-02-2015,5754,Hong Kong,Hong Kong,7904,Not assigned,82, $314.0 ," $25,748.0 ", $-   ,Feb
DE-2015-302,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,10-03-2015,5754,Hong Kong,Hong Kong,7904,Not assigned,236, $314.0 ," $74,104.0 ", $-   ,Mar
DE-2015-303,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,20-07-2015,5754,Hong Kong,Hong Kong,7904,Not assigned,436, $314.0 ," $1,36,904.0 ", $-   ,Jul
DE-2015-304,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,16-08-2015,5754,Vietnam,Netherlands,7904,Assigned,346, $314.0 ," $1,08,644.0 "," $8,880.7 ",Aug
DE-2015-305,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,06-07-2015,5754,Vietnam,Japan,7904,Assigned,132, $314.0 ," $41,448.0 "," $4,356.0 ",Jul
DE-2015-306,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,07-05-2015,5754,Vietnam,Japan,7904,Assigned,406, $314.0 ," $1,27,484.0 "," $4,736.7 ",May
DE-2015-307,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,02-05-2015,5754,Vietnam,Netherlands,7904,Assigned,414, $314.0 ," $1,29,996.0 "," $1,794.0 ",May
DE-2015-308,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,30-11-2015,5754,Egypt,Egypt,7904,Not assigned,289, $314.0 ," $90,746.0 ", $-   ,Nov
TA-2015-309,Filgrastim,Neulasta,Amgen,Neutropenia,07-04-2015,5737,Bangladesh,Bangladesh,8270,Assigned,314, $266.0 ," $83,524.0 "," $8,896.7 ",Apr
EL-2015-310,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,19-06-2015,5737,Vietnam,Netherlands,8270,Assigned,252, $250.0 ," $63,000.0 "," $6,804.0 ",Jun
EL-2015-311,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,05-04-2015,5737,Vietnam,Netherlands,8270,Assigned,192, $250.0 ," $48,000.0 "," $4,480.0 ",Apr
EL-2015-312,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,25-10-2015,5737,Pakistan,Pakistan,8270,Assigned,117, $250.0 ," $29,250.0 "," $3,237.0 ",Oct
EL-2015-313,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,29-05-2015,5737,Vietnam,Netherlands,8270,Assigned,287, $250.0 ," $71,750.0 "," $3,826.7 ",May
UM-2015-314,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,13-09-2015,5704,India,India,8370,Not assigned,485, $366.0 ," $1,77,510.0 ", $-   ,Sep
UM-2015-315,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,08-03-2015,5704,India,India,8370,Not assigned,385, $366.0 ," $1,40,910.0 ", $-   ,Mar
UM-2015-316,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,30-10-2015,5704,India,India,8370,Not assigned,98, $366.0 ," $35,868.0 ", $-   ,Oct
UM-2015-317,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,19-12-2015,5704,India,India,8370,Not assigned,206, $366.0 ," $75,396.0 ", $-   ,Dec
UM-2015-318,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,07-03-2015,5704,India,India,8370,Not assigned,88, $366.0 ," $32,208.0 ", $-   ,Mar
UM-2015-319,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,18-04-2015,5704,India,India,8370,Not assigned,3, $366.0 ," $1,098.0 ", $-   ,Apr
UM-2015-320,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,13-07-2015,5704,India,India,8370,Not assigned,438, $366.0 ," $1,60,308.0 ", $-   ,Jul
UM-2015-321,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,06-11-2015,5704,India,India,8370,Not assigned,253, $366.0 ," $92,598.0 ", $-   ,Nov
UM-2015-322,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,21-04-2015,5704,India,India,8370,Not assigned,383, $366.0 ," $1,40,178.0 ", $-   ,Apr
UM-2015-323,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,13-10-2015,5704,India,India,8370,Assigned,223, $366.0 ," $81,618.0 "," $3,568.0 ",Oct
UM-2015-324,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,11-06-2015,5704,India,India,8370,Not assigned,237, $366.0 ," $86,742.0 ", $-   ,Jun
UM-2015-325,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,14-06-2015,5704,Egypt,Egypt,8370,Assigned,153, $366.0 ," $55,998.0 "," $5,100.0 ",Jun
UM-2015-326,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,17-08-2015,5704,Pakistan,Pakistan,8370,Assigned,348, $366.0 ," $1,27,368.0 "," $1,972.0 ",Aug
UM-2015-327,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,07-09-2015,5704,Vietnam,Japan,8370,Assigned,4, $366.0 ," $1,464.0 ", $100.0 ,Sep
UM-2015-328,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,07-04-2015,5704,Pakistan,Pakistan,8370,Assigned,367, $366.0 ," $1,34,322.0 "," $8,318.7 ",Apr
UM-2015-329,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,25-07-2015,5704,Pakistan,Pakistan,8370,Assigned,47, $366.0 ," $17,202.0 "," $1,441.3 ",Jul
UM-2015-330,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,01-10-2015,5704,USA,Mexico,8370,Not assigned,261, $366.0 ," $95,526.0 ", $-   ,Oct
UM-2015-331,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,05-05-2015,5704,USA,Mexico,8370,Not assigned,49, $366.0 ," $17,934.0 ", $-   ,May
UM-2015-332,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,20-07-2015,5704,Hong Kong,China,8370,Not assigned,34, $366.0 ," $12,444.0 ", $-   ,Jul
UM-2015-333,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,29-08-2015,5704,Colombia,Mexico,8370,Not assigned,299, $366.0 ," $1,09,434.0 ", $-   ,Aug
UM-2015-334,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,13-04-2015,5704,USA,Mexico,8370,Not assigned,414, $366.0 ," $1,51,524.0 ", $-   ,Apr
UM-2015-335,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,07-05-2015,5704,Peru,Mexico,8370,Not assigned,288, $366.0 ," $1,05,408.0 ", $-   ,May
UM-2015-336,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,12-11-2015,5704,India,India,8370,Not assigned,6, $366.0 ," $2,196.0 ", $-   ,Nov
UM-2015-337,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,25-09-2015,5704,India,India,8370,Not assigned,399, $366.0 ," $1,46,034.0 ", $-   ,Sep
UM-2015-338,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,29-12-2015,5704,India,India,8370,Not assigned,147, $366.0 ," $53,802.0 ", $-   ,Dec
UM-2015-339,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,31-08-2015,5704,India,India,8370,Not assigned,350, $366.0 ," $1,28,100.0 ", $-   ,Aug
UM-2015-340,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,31-08-2015,5704,India,India,8370,Not assigned,72, $366.0 ," $26,352.0 ", $-   ,Aug
UM-2015-341,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,16-08-2015,5704,India,India,8370,Not assigned,289, $366.0 ," $1,05,774.0 ", $-   ,Aug
UM-2015-342,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,18-06-2015,5704,India,India,8370,Not assigned,74, $366.0 ," $27,084.0 ", $-   ,Jun
UM-2015-343,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,16-03-2015,5704,India,India,8370,Not assigned,202, $366.0 ," $73,932.0 ", $-   ,Mar
UM-2015-344,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,26-07-2015,5704,India,India,8370,Not assigned,491, $366.0 ," $1,79,706.0 ", $-   ,Jul
UM-2015-345,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,21-09-2015,5704,India,India,8370,Not assigned,269, $366.0 ," $98,454.0 ", $-   ,Sep
UM-2015-346,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,03-02-2015,5704,India,India,8370,Not assigned,228, $366.0 ," $83,448.0 ", $-   ,Feb
UM-2015-347,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,03-03-2015,5704,India,India,8370,Not assigned,335, $366.0 ," $1,22,610.0 ", $-   ,Mar
UM-2015-348,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,04-01-2015,5704,India,India,8370,Not assigned,207, $366.0 ," $75,762.0 ", $-   ,Jan
UM-2015-349,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,27-03-2015,5704,India,India,8370,Not assigned,226, $366.0 ," $82,716.0 ", $-   ,Mar
UM-2015-350,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,14-05-2015,5704,India,India,8370,Not assigned,151, $366.0 ," $55,266.0 ", $-   ,May
UM-2015-351,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,17-04-2015,5704,India,India,8370,Not assigned,170, $366.0 ," $62,220.0 ", $-   ,Apr
UM-2015-352,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,19-07-2015,5704,India,India,8370,Not assigned,33, $366.0 ," $12,078.0 ", $-   ,Jul
UM-2015-353,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,22-04-2015,5704,India,India,8370,Not assigned,192, $366.0 ," $70,272.0 ", $-   ,Apr
UM-2015-354,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,17-12-2015,5704,India,India,8370,Not assigned,291, $366.0 ," $1,06,506.0 ", $-   ,Dec
UM-2015-355,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,20-02-2015,5704,India,India,8370,Not assigned,395, $366.0 ," $1,44,570.0 ", $-   ,Feb
UM-2015-356,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,08-04-2015,5704,India,India,8370,Not assigned,52, $366.0 ," $19,032.0 ", $-   ,Apr
UM-2015-357,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,31-01-2015,5704,India,India,8370,Not assigned,312, $366.0 ," $1,14,192.0 ", $-   ,Jan
UM-2015-358,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,26-06-2015,5704,India,India,8370,Not assigned,13, $366.0 ," $4,758.0 ", $-   ,Jun
UM-2015-359,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,17-11-2015,5704,India,India,8370,Not assigned,67, $366.0 ," $24,522.0 ", $-   ,Nov
UM-2015-360,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,20-06-2015,5704,India,India,8370,Not assigned,224, $366.0 ," $81,984.0 ", $-   ,Jun
UM-2015-361,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,05-02-2015,5704,India,India,8370,Not assigned,148, $366.0 ," $54,168.0 ", $-   ,Feb
UM-2015-362,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,14-01-2015,5704,India,India,8370,Not assigned,3, $366.0 ," $1,098.0 ", $-   ,Jan
UM-2015-363,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,02-01-2015,5704,India,India,8370,Not assigned,320, $366.0 ," $1,17,120.0 ", $-   ,Jan
UM-2015-364,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,31-01-2015,5704,India,India,8370,Not assigned,172, $366.0 ," $62,952.0 ", $-   ,Jan
UM-2015-365,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,04-04-2015,5704,India,India,8370,Not assigned,331, $366.0 ," $1,21,146.0 ", $-   ,Apr
UM-2015-366,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,01-03-2015,5704,India,India,8370,Not assigned,386, $366.0 ," $1,41,276.0 ", $-   ,Mar
UM-2015-367,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,13-01-2015,5704,India,India,8370,Not assigned,173, $366.0 ," $63,318.0 ", $-   ,Jan
UM-2015-368,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,09-03-2015,5704,India,India,8370,Not assigned,445, $366.0 ," $1,62,870.0 ", $-   ,Mar
UM-2015-369,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,24-07-2015,5704,India,India,8370,Not assigned,47, $366.0 ," $17,202.0 ", $-   ,Jul
UM-2015-370,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,17-08-2015,5704,India,India,8370,Not assigned,208, $366.0 ," $76,128.0 ", $-   ,Aug
UM-2015-371,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,21-11-2015,5704,India,India,8370,Not assigned,499, $366.0 ," $1,82,634.0 ", $-   ,Nov
US-2015-372,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,02-09-2015,5653,Kenya,Kenya,7933,Assigned,78, $231.0 ," $18,018.0 "," $1,118.0 ",Sep
US-2015-373,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,13-03-2015,5653,Pakistan,Pakistan,7933,Assigned,250, $231.0 ," $57,750.0 "," $7,250.0 ",Mar
US-2015-374,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,21-10-2015,5653,Egypt,Egypt,7933,Not assigned,119, $231.0 ," $27,489.0 ", $-   ,Oct
US-2015-375,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,23-09-2015,5653,Kenya,Kenya,7933,Not assigned,71, $231.0 ," $16,401.0 ", $-   ,Sep
US-2015-376,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,21-10-2015,5653,Saudi Arabia,Saudi Arabia,7933,Not assigned,6, $231.0 ," $1,386.0 ", $-   ,Oct
TA-2015-377,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,02-07-2015,5704,India,India,8370,Not assigned,422, $453.0 ," $1,91,166.0 ", $-   ,Jul
TA-2015-378,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,20-09-2015,5704,India,India,8370,Not assigned,375, $453.0 ," $1,69,875.0 ", $-   ,Sep
TA-2015-379,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,03-01-2015,5704,India,India,8370,Not assigned,45, $453.0 ," $20,385.0 ", $-   ,Jan
TA-2015-380,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,12-08-2015,5704,India,India,8370,Not assigned,143, $453.0 ," $64,779.0 ", $-   ,Aug
TA-2015-381,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,19-11-2015,5704,India,India,8370,Not assigned,237, $453.0 ," $1,07,361.0 ", $-   ,Nov
TA-2015-382,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,18-03-2015,5704,India,India,8370,Not assigned,314, $453.0 ," $1,42,242.0 ", $-   ,Mar
IA-2015-383,Sitagliptin,Januvia,"Merck & Co., Inc.",Diabetes mellitus type 2,19-01-2015,5938,Thailand,Thailand,8318,Assigned,109, $386.0 ," $42,074.0 ", $872.0 ,Jan
FY-2015-384,Aripiprazole,Abilify,Generic,Psychosis; depression,12-05-2015,5704,Mexico,Mexico,8370,Not assigned,166, $204.0 ," $33,864.0 ", $-   ,May
FY-2015-385,Aripiprazole,Abilify,Generic,Psychosis; depression,26-12-2015,5704,Mexico,Mexico,8370,Not assigned,67, $204.0 ," $13,668.0 ", $-   ,Dec
IN-2015-386,Oxycodone,OxyContin,Generic,Pain,22-05-2015,5704,Thailand,Thailand,8370,Not assigned,496, $472.0 ," $2,34,112.0 ", $-   ,May
IN-2015-387,Oxycodone,OxyContin,Generic,Pain,23-07-2015,5704,Thailand,Thailand,8370,Assigned,315, $472.0 ," $1,48,680.0 "," $5,355.0 ",Jul
IN-2015-388,Oxycodone,OxyContin,Generic,Pain,17-04-2015,5704,Thailand,Thailand,8370,Assigned,117, $472.0 ," $55,224.0 "," $2,535.0 ",Apr
IN-2015-389,Oxycodone,OxyContin,Generic,Pain,13-02-2015,5704,Malaysia,Malaysia,8370,Assigned,326, $472.0 ," $1,53,872.0 "," $10,432.0 ",Feb
IN-2015-390,Oxycodone,OxyContin,Generic,Pain,26-06-2015,5704,Thailand,Thailand,8370,Not assigned,461, $472.0 ," $2,17,592.0 ", $-   ,Jun
IN-2015-391,Oxycodone,OxyContin,Generic,Pain,24-05-2015,5704,Thailand,Thailand,8370,Not assigned,233, $472.0 ," $1,09,976.0 ", $-   ,May
IN-2015-392,Oxycodone,OxyContin,Generic,Pain,07-07-2015,5704,Thailand,Thailand,8370,Assigned,283, $472.0 ," $1,33,576.0 "," $1,320.7 ",Jul
IN-2015-393,Oxycodone,OxyContin,Generic,Pain,29-01-2015,5704,Thailand,Thailand,8370,Assigned,283, $472.0 ," $1,33,576.0 "," $3,018.7 ",Jan
IN-2015-394,Oxycodone,OxyContin,Generic,Pain,29-01-2015,5704,Thailand,Thailand,8370,Assigned,35, $472.0 ," $16,520.0 "," $1,143.3 ",Jan
IN-2015-395,Oxycodone,OxyContin,Generic,Pain,22-08-2015,5704,Egypt,Egypt,8370,Not assigned,4, $472.0 ," $1,888.0 ", $-   ,Aug
IN-2015-396,Oxycodone,OxyContin,Generic,Pain,22-10-2015,5704,Egypt,Egypt,8370,Not assigned,180, $472.0 ," $84,960.0 ", $-   ,Oct
IN-2015-397,Oxycodone,OxyContin,Generic,Pain,10-01-2015,5704,Singapore,Singapore,8370,Not assigned,476, $472.0 ," $2,24,672.0 ", $-   ,Jan
IN-2015-398,Oxycodone,OxyContin,Generic,Pain,06-06-2015,5704,Thailand,Thailand,8370,Assigned,99, $472.0 ," $46,728.0 "," $1,881.0 ",Jun
IN-2015-399,Oxycodone,OxyContin,Generic,Pain,14-10-2015,5704,Thailand,Thailand,8370,Assigned,286, $472.0 ," $1,34,992.0 "," $8,580.0 ",Oct
IN-2015-400,Oxycodone,OxyContin,Generic,Pain,26-07-2015,5704,Thailand,Thailand,8370,Assigned,318, $472.0 ," $1,50,096.0 "," $2,756.0 ",Jul
IN-2015-401,Oxycodone,OxyContin,Generic,Pain,21-07-2015,5704,Egypt,Egypt,8370,Not assigned,312, $472.0 ," $1,47,264.0 ", $-   ,Jul
IN-2015-402,Oxycodone,OxyContin,Generic,Pain,01-03-2015,5704,Egypt,Egypt,8370,Not assigned,324, $472.0 ," $1,52,928.0 ", $-   ,Mar
IN-2015-403,Oxycodone,OxyContin,Generic,Pain,17-01-2015,5704,Thailand,Thailand,8370,Assigned,462, $472.0 ," $2,18,064.0 "," $14,476.0 ",Jan
IN-2015-404,Oxycodone,OxyContin,Generic,Pain,19-04-2015,5704,Thailand,Thailand,8370,Assigned,138, $472.0 ," $65,136.0 "," $3,450.0 ",Apr
IN-2015-405,Oxycodone,OxyContin,Generic,Pain,18-11-2015,5704,Thailand,Thailand,8370,Assigned,264, $472.0 ," $1,24,608.0 "," $6,512.0 ",Nov
CA-2015-406,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-09-2015,5887,India,India,8095,Not assigned,18, $500.0 ," $9,000.0 ", $-   ,Sep
CA-2015-407,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-11-2015,5887,India,India,8095,Not assigned,260, $500.0 ," $1,30,000.0 ", $-   ,Nov
CA-2015-408,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-05-2015,5887,India,India,8095,Not assigned,100, $500.0 ," $50,000.0 ", $-   ,May
CA-2015-409,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-09-2015,5887,India,India,8095,Not assigned,172, $500.0 ," $86,000.0 ", $-   ,Sep
CA-2015-410,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-07-2015,5887,India,India,8095,Not assigned,351, $500.0 ," $1,75,500.0 ", $-   ,Jul
CA-2015-411,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-05-2015,5887,India,India,8095,Not assigned,191, $500.0 ," $95,500.0 ", $-   ,May
CA-2015-412,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-06-2015,5887,India,India,8095,Not assigned,181, $500.0 ," $90,500.0 ", $-   ,Jun
CA-2015-413,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-05-2015,5887,India,India,8095,Not assigned,230, $500.0 ," $1,15,000.0 ", $-   ,May
CA-2015-414,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-10-2015,5887,India,India,8095,Not assigned,433, $500.0 ," $2,16,500.0 ", $-   ,Oct
CA-2015-415,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-05-2015,5887,India,India,8095,Not assigned,436, $500.0 ," $2,18,000.0 ", $-   ,May
CA-2015-416,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-03-2015,5887,India,India,8095,Not assigned,328, $500.0 ," $1,64,000.0 ", $-   ,Mar
CA-2015-417,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-12-2015,5887,India,India,8095,Assigned,12, $500.0 ," $6,000.0 ", $388.0 ,Dec
CA-2015-418,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-07-2015,5887,India,India,8095,Not assigned,117, $500.0 ," $58,500.0 ", $-   ,Jul
CA-2015-419,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-04-2015,5887,India,India,8095,Not assigned,132, $500.0 ," $66,000.0 ", $-   ,Apr
CA-2015-420,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-09-2015,5887,India,India,8095,Not assigned,50, $500.0 ," $25,000.0 ", $-   ,Sep
CA-2015-421,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-06-2015,5887,India,India,8095,Not assigned,214, $500.0 ," $1,07,000.0 ", $-   ,Jun
CA-2015-422,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-05-2015,5887,India,India,8095,Assigned,337, $500.0 ," $1,68,500.0 "," $4,156.3 ",May
CA-2015-423,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-01-2015,5887,India,India,8095,Assigned,335, $500.0 ," $1,67,500.0 "," $2,791.7 ",Jan
CA-2015-424,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-05-2015,5887,India,India,8095,Assigned,160, $500.0 ," $80,000.0 "," $1,813.3 ",May
CA-2015-425,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-10-2015,5887,India,India,8095,Assigned,296, $500.0 ," $1,48,000.0 "," $6,314.7 ",Oct
CA-2015-426,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-12-2015,5887,Malaysia,Malaysia,8095,Not assigned,108, $500.0 ," $54,000.0 ", $-   ,Dec
CA-2015-427,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-02-2015,5887,Malaysia,Malaysia,8095,Not assigned,475, $500.0 ," $2,37,500.0 ", $-   ,Feb
CA-2015-428,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-09-2015,5887,India,India,8095,Not assigned,18, $500.0 ," $9,000.0 ", $-   ,Sep
CA-2015-429,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-04-2015,5887,India,India,8095,Not assigned,475, $500.0 ," $2,37,500.0 ", $-   ,Apr
CA-2015-430,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-04-2015,5887,India,India,8095,Not assigned,320, $500.0 ," $1,60,000.0 ", $-   ,Apr
CA-2015-431,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-08-2015,5887,Thailand,Thailand,8095,Assigned,108, $500.0 ," $54,000.0 "," $1,728.0 ",Aug
CA-2015-432,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-05-2015,5887,Egypt,Egypt,8095,Not assigned,413, $500.0 ," $2,06,500.0 ", $-   ,May
CA-2015-433,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-04-2015,5887,Egypt,Egypt,8095,Not assigned,144, $500.0 ," $72,000.0 ", $-   ,Apr
CA-2015-434,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-07-2015,5887,Egypt,Egypt,8095,Not assigned,428, $500.0 ," $2,14,000.0 ", $-   ,Jul
CA-2015-435,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-01-2015,5887,Egypt,Egypt,8095,Not assigned,260, $500.0 ," $1,30,000.0 ", $-   ,Jan
CA-2015-436,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-03-2015,5887,India,India,8095,Not assigned,133, $500.0 ," $66,500.0 ", $-   ,Mar
CA-2015-437,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-10-2015,5887,Lebanon,Lebanon,8095,Not assigned,194, $500.0 ," $97,000.0 ", $-   ,Oct
CA-2015-438,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-02-2015,5887,Lebanon,Lebanon,8095,Not assigned,51, $500.0 ," $25,500.0 ", $-   ,Feb
CA-2015-439,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-06-2015,5887,Lebanon,Lebanon,8095,Not assigned,20, $500.0 ," $10,000.0 ", $-   ,Jun
CA-2015-440,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-06-2015,5887,India,India,8095,Assigned,285, $500.0 ," $1,42,500.0 "," $5,985.0 ",Jun
CA-2015-441,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-04-2015,5887,India,India,8095,Not assigned,231, $500.0 ," $1,15,500.0 ", $-   ,Apr
CA-2015-442,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-12-2015,5887,India,India,8095,Not assigned,19, $500.0 ," $9,500.0 ", $-   ,Dec
CA-2015-443,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-04-2015,5887,India,India,8095,Not assigned,74, $500.0 ," $37,000.0 ", $-   ,Apr
CA-2015-444,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-05-2015,5887,India,India,8095,Assigned,108, $500.0 ," $54,000.0 "," $1,548.0 ",May
CA-2015-445,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-04-2015,5887,India,India,8095,Not assigned,57, $500.0 ," $28,500.0 ", $-   ,Apr
CA-2015-446,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-02-2015,5887,India,India,8095,Not assigned,247, $500.0 ," $1,23,500.0 ", $-   ,Feb
CA-2015-447,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-01-2015,5887,Vietnam,Japan,8095,Assigned,339, $500.0 ," $1,69,500.0 "," $11,300.0 ",Jan
CA-2015-448,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-06-2015,5887,India,India,8095,Not assigned,205, $500.0 ," $1,02,500.0 ", $-   ,Jun
CA-2015-449,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-02-2015,5887,India,India,8095,Not assigned,355, $500.0 ," $1,77,500.0 ", $-   ,Feb
CA-2015-450,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-08-2015,5887,India,India,8095,Not assigned,253, $500.0 ," $1,26,500.0 ", $-   ,Aug
CA-2015-451,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-06-2015,5887,India,India,8095,Not assigned,81, $500.0 ," $40,500.0 ", $-   ,Jun
CA-2015-452,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-12-2015,5887,India,India,8095,Not assigned,68, $500.0 ," $34,000.0 ", $-   ,Dec
CA-2015-453,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-03-2015,5887,India,India,8095,Not assigned,450, $500.0 ," $2,25,000.0 ", $-   ,Mar
CA-2015-454,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-02-2015,5887,India,India,8095,Not assigned,353, $500.0 ," $1,76,500.0 ", $-   ,Feb
CA-2015-455,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-01-2015,5887,India,India,8095,Not assigned,248, $500.0 ," $1,24,000.0 ", $-   ,Jan
CA-2015-456,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-07-2015,5887,Netherlands,Netherlands,8095,Not assigned,151, $500.0 ," $75,500.0 ", $-   ,Jul
CA-2015-457,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-03-2015,5887,Thailand,Thailand,8095,Assigned,405, $500.0 ," $2,02,500.0 "," $6,615.0 ",Mar
CA-2015-458,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-04-2015,5887,Sudan,Utd.Arab Emir.,8095,Assigned,233, $500.0 ," $1,16,500.0 "," $7,766.7 ",Apr
CA-2015-459,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-06-2015,5887,India,India,8095,Not assigned,377, $500.0 ," $1,88,500.0 ", $-   ,Jun
CA-2015-460,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-07-2015,5887,Sudan,Utd.Arab Emir.,8095,Assigned,111, $500.0 ," $55,500.0 "," $3,404.0 ",Jul
CA-2015-461,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-07-2015,5887,India,India,8095,Not assigned,382, $500.0 ," $1,91,000.0 ", $-   ,Jul
CA-2015-462,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-06-2015,5887,Philippines,Philippines,8095,Assigned,347, $500.0 ," $1,73,500.0 "," $10,757.0 ",Jun
CA-2015-463,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-12-2015,5887,India,India,8095,Not assigned,315, $500.0 ," $1,57,500.0 ", $-   ,Dec
CA-2015-464,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-02-2015,5887,Thailand,Philippines,8095,Not assigned,217, $500.0 ," $1,08,500.0 ", $-   ,Feb
CA-2015-465,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-08-2015,5887,Thailand,Philippines,8095,Not assigned,249, $500.0 ," $1,24,500.0 ", $-   ,Aug
CA-2015-466,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-05-2015,5887,Thailand,Philippines,8095,Not assigned,355, $500.0 ," $1,77,500.0 ", $-   ,May
CA-2015-467,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-06-2015,5887,India,India,8095,Not assigned,167, $500.0 ," $83,500.0 ", $-   ,Jun
CA-2015-468,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-05-2015,5887,India,India,8095,Assigned,158, $500.0 ," $79,000.0 "," $3,054.7 ",May
CA-2015-469,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-09-2015,5887,India,India,8095,Not assigned,275, $500.0 ," $1,37,500.0 ", $-   ,Sep
CA-2015-470,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-05-2015,5887,India,India,8095,Not assigned,477, $500.0 ," $2,38,500.0 ", $-   ,May
CA-2015-471,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-09-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,99, $500.0 ," $49,500.0 ", $-   ,Sep
CA-2015-472,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-08-2015,5887,Thailand,Thailand,8095,Assigned,355, $500.0 ," $1,77,500.0 "," $1,183.3 ",Aug
CA-2015-473,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-05-2015,5887,India,India,8095,Assigned,375, $500.0 ," $1,87,500.0 "," $2,500.0 ",May
CA-2015-474,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-02-2015,5887,India,India,8095,Not assigned,269, $500.0 ," $1,34,500.0 ", $-   ,Feb
CA-2015-475,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-06-2015,5887,India,India,8095,Not assigned,238, $500.0 ," $1,19,000.0 ", $-   ,Jun
CA-2015-476,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-02-2015,5887,India,India,8095,Assigned,211, $500.0 ," $1,05,500.0 "," $2,039.7 ",Feb
CA-2015-477,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-03-2015,5887,India,India,8095,Assigned,146, $500.0 ," $73,000.0 "," $4,088.0 ",Mar
CA-2015-478,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-01-2015,5887,Thailand,Thailand,8095,Assigned,373, $500.0 ," $1,86,500.0 "," $11,190.0 ",Jan
CA-2015-479,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-03-2015,5887,India,India,8095,Assigned,225, $500.0 ," $1,12,500.0 "," $6,975.0 ",Mar
CA-2015-480,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-11-2015,5887,India,India,8095,Not assigned,139, $500.0 ," $69,500.0 ", $-   ,Nov
CA-2015-481,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-12-2015,5887,Egypt,Egypt,8095,Not assigned,166, $500.0 ," $83,000.0 ", $-   ,Dec
DE-2015-482,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,11-02-2015,5754,India,India,7904,Assigned,354, $314.0 ," $1,11,156.0 "," $2,714.0 ",Feb
CA-2015-483,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-01-2015,5887,India,India,8095,Not assigned,467, $500.0 ," $2,33,500.0 ", $-   ,Jan
CA-2015-484,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-07-2015,5887,India,India,8095,Not assigned,228, $500.0 ," $1,14,000.0 ", $-   ,Jul
CA-2015-485,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-08-2015,5887,India,India,8095,Not assigned,248, $500.0 ," $1,24,000.0 ", $-   ,Aug
CA-2015-486,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-06-2015,5887,Cambodia,Cambodia,8095,Not assigned,369, $500.0 ," $1,84,500.0 ", $-   ,Jun
CA-2015-487,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-04-2015,5887,India,India,8095,Not assigned,483, $500.0 ," $2,41,500.0 ", $-   ,Apr
CA-2015-488,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-06-2015,5887,India,India,8095,Not assigned,260, $500.0 ," $1,30,000.0 ", $-   ,Jun
CA-2015-489,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-04-2015,5887,India,India,8095,Not assigned,73, $500.0 ," $36,500.0 ", $-   ,Apr
CA-2015-490,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-10-2015,5887,India,India,8095,Not assigned,139, $500.0 ," $69,500.0 ", $-   ,Oct
CA-2015-491,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-03-2015,5887,India,India,8095,Not assigned,410, $500.0 ," $2,05,000.0 ", $-   ,Mar
CA-2015-492,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-05-2015,5887,India,India,8095,Not assigned,318, $500.0 ," $1,59,000.0 ", $-   ,May
CA-2015-493,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-03-2015,5887,India,India,8095,Not assigned,107, $500.0 ," $53,500.0 ", $-   ,Mar
CA-2015-494,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-05-2015,5887,Malaysia,Malaysia,8095,Not assigned,422, $500.0 ," $2,11,000.0 ", $-   ,May
CA-2015-495,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-03-2015,5887,Malaysia,Malaysia,8095,Not assigned,167, $500.0 ," $83,500.0 ", $-   ,Mar
CA-2015-496,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-12-2015,5887,India,India,8095,Not assigned,468, $500.0 ," $2,34,000.0 ", $-   ,Dec
CA-2015-497,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-09-2015,5887,India,India,8095,Assigned,413, $500.0 ," $2,06,500.0 "," $4,818.3 ",Sep
CA-2015-498,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-09-2015,5887,India,India,8095,Not assigned,11, $500.0 ," $5,500.0 ", $-   ,Sep
CA-2015-499,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-07-2015,5887,India,India,8095,Not assigned,471, $500.0 ," $2,35,500.0 ", $-   ,Jul
CA-2015-500,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-08-2015,5887,Malaysia,Malaysia,8095,Assigned,450, $500.0 ," $2,25,000.0 "," $10,800.0 ",Aug
CA-2015-501,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-08-2015,5887,Sri Lanka,Sri Lanka,8095,Assigned,261, $500.0 ," $1,30,500.0 "," $7,917.0 ",Aug
CA-2015-502,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-09-2015,5887,Thailand,Thailand,8095,Assigned,440, $500.0 ," $2,20,000.0 "," $10,853.3 ",Sep
CA-2015-503,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-04-2015,5887,Kenya,Kenya,8095,Assigned,183, $500.0 ," $91,500.0 ", $854.0 ,Apr
CA-2015-504,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-03-2015,5887,India,India,8095,Assigned,386, $500.0 ," $1,93,000.0 "," $11,966.0 ",Mar
CA-2015-505,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-08-2015,5887,India,India,8095,Not assigned,6, $500.0 ," $3,000.0 ", $-   ,Aug
CA-2015-506,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-12-2015,5887,India,India,8095,Not assigned,75, $500.0 ," $37,500.0 ", $-   ,Dec
CA-2015-507,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-06-2015,5887,India,India,8095,Assigned,429, $500.0 ," $2,14,500.0 "," $3,003.0 ",Jun
CA-2015-508,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-05-2015,5887,India,India,8095,Not assigned,270, $500.0 ," $1,35,000.0 ", $-   ,May
CA-2015-509,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-06-2015,5887,India,India,8095,Not assigned,476, $500.0 ," $2,38,000.0 ", $-   ,Jun
CA-2015-510,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-06-2015,5887,India,India,8095,Not assigned,48, $500.0 ," $24,000.0 ", $-   ,Jun
CA-2015-511,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-01-2015,5887,India,India,8095,Not assigned,133, $500.0 ," $66,500.0 ", $-   ,Jan
CA-2015-512,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-01-2015,5887,Netherlands,Netherlands,8095,Assigned,280, $500.0 ," $1,40,000.0 "," $9,146.7 ",Jan
CA-2015-513,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-04-2015,5887,India,India,8095,Not assigned,52, $500.0 ," $26,000.0 ", $-   ,Apr
CA-2015-514,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-04-2015,5887,India,India,8095,Not assigned,32, $500.0 ," $16,000.0 ", $-   ,Apr
CA-2015-515,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-09-2015,5887,India,India,8095,Not assigned,148, $500.0 ," $74,000.0 ", $-   ,Sep
CA-2015-516,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-07-2015,5887,India,India,8095,Not assigned,220, $500.0 ," $1,10,000.0 ", $-   ,Jul
CA-2015-517,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-01-2015,5887,India,India,8095,Not assigned,180, $500.0 ," $90,000.0 ", $-   ,Jan
CA-2015-518,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-10-2015,5887,Egypt,Egypt,8095,Assigned,359, $500.0 ," $1,79,500.0 "," $6,342.3 ",Oct
CA-2015-519,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-08-2015,5887,Nepal,Nepal,8095,Assigned,267, $500.0 ," $1,33,500.0 "," $6,052.0 ",Aug
CA-2015-520,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-11-2015,5887,Nepal,Nepal,8095,Assigned,148, $500.0 ," $74,000.0 "," $1,874.7 ",Nov
CA-2015-521,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-04-2015,5887,Nepal,Nepal,8095,Assigned,417, $500.0 ," $2,08,500.0 "," $5,838.0 ",Apr
CA-2015-522,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-03-2015,5887,India,India,8095,Not assigned,334, $500.0 ," $1,67,000.0 ", $-   ,Mar
CA-2015-523,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-10-2015,5887,India,India,8095,Not assigned,12, $500.0 ," $6,000.0 ", $-   ,Oct
CA-2015-524,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-10-2015,5887,Nepal,Nepal,8095,Assigned,397, $500.0 ," $1,98,500.0 "," $8,866.3 ",Oct
CA-2015-525,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-01-2015,5887,Nepal,Nepal,8095,Assigned,122, $500.0 ," $61,000.0 "," $3,497.3 ",Jan
CA-2015-526,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-04-2015,5887,Indonesia,Indonesia,8095,Assigned,27, $500.0 ," $13,500.0 ", $405.0 ,Apr
TA-2015-527,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,30-11-2015,5704,India,India,8370,Not assigned,327, $453.0 ," $1,48,131.0 ", $-   ,Nov
CA-2015-528,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-10-2015,5887,India,India,8095,Not assigned,430, $500.0 ," $2,15,000.0 ", $-   ,Oct
CA-2015-529,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-03-2015,5887,Indonesia,Indonesia,8095,Assigned,190, $500.0 ," $95,000.0 "," $4,813.3 ",Mar
CA-2015-530,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-03-2015,5887,Indonesia,Indonesia,8095,Assigned,426, $500.0 ," $2,13,000.0 "," $11,360.0 ",Mar
CA-2015-531,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-09-2015,5887,India,India,8095,Not assigned,239, $500.0 ," $1,19,500.0 ", $-   ,Sep
CA-2015-532,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-10-2015,5887,India,India,8095,Not assigned,341, $500.0 ," $1,70,500.0 ", $-   ,Oct
CA-2015-533,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-11-2015,5887,Indonesia,Indonesia,8095,Assigned,77, $500.0 ," $38,500.0 "," $1,771.0 ",Nov
CA-2015-534,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-04-2015,5887,India,India,8095,Assigned,367, $500.0 ," $1,83,500.0 "," $6,606.0 ",Apr
CA-2015-535,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-10-2015,5887,India,India,8095,Assigned,237, $500.0 ," $1,18,500.0 "," $1,343.0 ",Oct
CA-2015-536,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-03-2015,5887,India,India,8095,Not assigned,53, $500.0 ," $26,500.0 ", $-   ,Mar
CA-2015-537,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-02-2015,5887,India,India,8095,Not assigned,397, $500.0 ," $1,98,500.0 ", $-   ,Feb
CA-2015-538,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-08-2015,5887,India,India,8095,Assigned,255, $500.0 ," $1,27,500.0 "," $2,125.0 ",Aug
CA-2015-539,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-06-2015,5887,India,India,8095,Not assigned,420, $500.0 ," $2,10,000.0 ", $-   ,Jun
CA-2015-540,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-11-2015,5887,India,India,8095,Assigned,236, $500.0 ," $1,18,000.0 "," $3,461.3 ",Nov
CA-2015-541,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-06-2015,5887,Oman,Oman,8095,Not assigned,495, $500.0 ," $2,47,500.0 ", $-   ,Jun
CA-2015-542,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-05-2015,5887,India,India,8095,Not assigned,191, $500.0 ," $95,500.0 ", $-   ,May
CA-2015-543,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-03-2015,5887,India,India,8095,Not assigned,313, $500.0 ," $1,56,500.0 ", $-   ,Mar
CA-2015-544,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-11-2015,5887,Oman,Oman,8095,Not assigned,232, $500.0 ," $1,16,000.0 ", $-   ,Nov
CA-2015-545,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-12-2015,5887,India,India,8095,Not assigned,106, $500.0 ," $53,000.0 ", $-   ,Dec
CA-2015-546,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-11-2015,5887,India,India,8095,Not assigned,208, $500.0 ," $1,04,000.0 ", $-   ,Nov
CA-2015-547,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-02-2015,5887,Thailand,Thailand,8095,Assigned,83, $500.0 ," $41,500.0 "," $1,770.7 ",Feb
CA-2015-548,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-08-2015,5887,India,India,8095,Not assigned,393, $500.0 ," $1,96,500.0 ", $-   ,Aug
CA-2015-549,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-02-2015,5887,Philippines,Philippines,8095,Assigned,233, $500.0 ," $1,16,500.0 "," $5,436.7 ",Feb
CA-2015-550,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-03-2015,5887,India,India,8095,Not assigned,256, $500.0 ," $1,28,000.0 ", $-   ,Mar
CA-2015-551,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-07-2015,5887,India,India,8095,Not assigned,478, $500.0 ," $2,39,000.0 ", $-   ,Jul
CA-2015-552,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-09-2015,5887,India,India,8095,Not assigned,304, $500.0 ," $1,52,000.0 ", $-   ,Sep
CA-2015-553,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-04-2015,5887,India,India,8095,Not assigned,335, $500.0 ," $1,67,500.0 ", $-   ,Apr
CA-2015-554,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-10-2015,5887,India,India,8095,Not assigned,392, $500.0 ," $1,96,000.0 ", $-   ,Oct
CA-2015-555,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-10-2015,5887,India,India,8095,Not assigned,250, $500.0 ," $1,25,000.0 ", $-   ,Oct
CA-2015-556,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-03-2015,5887,India,India,8095,Not assigned,465, $500.0 ," $2,32,500.0 ", $-   ,Mar
CA-2015-557,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-07-2015,5887,India,India,8095,Not assigned,178, $500.0 ," $89,000.0 ", $-   ,Jul
CA-2015-558,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-10-2015,5887,Egypt,Egypt,8095,Assigned,488, $500.0 ," $2,44,000.0 "," $10,898.7 ",Oct
CA-2015-559,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-07-2015,5887,Egypt,Egypt,8095,Assigned,324, $500.0 ," $1,62,000.0 "," $4,644.0 ",Jul
CA-2015-560,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-05-2015,5887,Indonesia,Indonesia,8095,Assigned,298, $500.0 ," $1,49,000.0 "," $1,291.3 ",May
CA-2015-561,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-09-2015,5887,India,India,8095,Not assigned,358, $500.0 ," $1,79,000.0 ", $-   ,Sep
CA-2015-562,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-10-2015,5887,India,India,8095,Assigned,480, $500.0 ," $2,40,000.0 "," $2,720.0 ",Oct
CA-2015-563,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-08-2015,5887,India,India,8095,Not assigned,315, $500.0 ," $1,57,500.0 ", $-   ,Aug
CA-2015-564,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-01-2015,5887,Indonesia,Indonesia,8095,Assigned,77, $500.0 ," $38,500.0 "," $2,002.0 ",Jan
CA-2015-565,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-06-2015,5887,India,India,8095,Assigned,136, $500.0 ," $68,000.0 "," $4,170.7 ",Jun
CA-2015-566,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-06-2015,5887,India,India,8095,Not assigned,345, $500.0 ," $1,72,500.0 ", $-   ,Jun
CA-2015-567,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-06-2015,5887,India,India,8095,Assigned,1, $500.0 , $500.0 , $29.7 ,Jun
CA-2015-568,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-10-2015,5887,India,India,8095,Not assigned,176, $500.0 ," $88,000.0 ", $-   ,Oct
CA-2015-569,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-08-2015,5887,India,India,8095,Not assigned,289, $500.0 ," $1,44,500.0 ", $-   ,Aug
CA-2015-570,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-03-2015,5887,India,India,8095,Not assigned,134, $500.0 ," $67,000.0 ", $-   ,Mar
CA-2015-571,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-10-2015,5887,India,India,8095,Not assigned,312, $500.0 ," $1,56,000.0 ", $-   ,Oct
CA-2015-572,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-05-2015,5887,India,India,8095,Not assigned,278, $500.0 ," $1,39,000.0 ", $-   ,May
CA-2015-573,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-05-2015,5887,India,India,8095,Not assigned,364, $500.0 ," $1,82,000.0 ", $-   ,May
CA-2015-574,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-08-2015,5887,India,India,8095,Not assigned,36, $500.0 ," $18,000.0 ", $-   ,Aug
CA-2015-575,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-03-2015,5887,India,India,8095,Not assigned,442, $500.0 ," $2,21,000.0 ", $-   ,Mar
CA-2015-576,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-11-2015,5887,India,India,8095,Not assigned,51, $500.0 ," $25,500.0 ", $-   ,Nov
CA-2015-577,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-10-2015,5887,India,India,8095,Not assigned,152, $500.0 ," $76,000.0 ", $-   ,Oct
CA-2015-578,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-11-2015,5887,India,India,8095,Not assigned,376, $500.0 ," $1,88,000.0 ", $-   ,Nov
CA-2015-579,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-04-2015,5887,India,India,8095,Not assigned,131, $500.0 ," $65,500.0 ", $-   ,Apr
CA-2015-580,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-08-2015,5887,India,India,8095,Not assigned,457, $500.0 ," $2,28,500.0 ", $-   ,Aug
CA-2015-581,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-05-2015,5887,India,India,8095,Not assigned,495, $500.0 ," $2,47,500.0 ", $-   ,May
CA-2015-582,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-12-2015,5887,India,India,8095,Not assigned,53, $500.0 ," $26,500.0 ", $-   ,Dec
CA-2015-583,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-02-2015,5887,India,India,8095,Assigned,105, $500.0 ," $52,500.0 "," $3,360.0 ",Feb
AR-2015-584,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,16-06-2015,5653,India,India,7933,Not assigned,6, $231.0 ," $1,386.0 ", $-   ,Jun
AR-2015-585,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,04-07-2015,5653,India,India,7933,Not assigned,408, $231.0 ," $94,248.0 ", $-   ,Jul
CA-2015-586,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-04-2015,5887,India,India,8095,Not assigned,369, $500.0 ," $1,84,500.0 ", $-   ,Apr
CA-2015-587,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-12-2015,5887,India,India,8095,Not assigned,95, $500.0 ," $47,500.0 ", $-   ,Dec
CA-2015-588,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-11-2015,5887,India,India,8095,Not assigned,463, $500.0 ," $2,31,500.0 ", $-   ,Nov
CA-2015-589,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-07-2015,5887,India,India,8095,Not assigned,83, $500.0 ," $41,500.0 ", $-   ,Jul
CA-2015-590,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-12-2015,5887,India,India,8095,Not assigned,468, $500.0 ," $2,34,000.0 ", $-   ,Dec
CA-2015-591,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-02-2015,5887,India,India,8095,Not assigned,16, $500.0 ," $8,000.0 ", $-   ,Feb
CA-2015-592,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-09-2015,5887,India,India,8095,Not assigned,360, $500.0 ," $1,80,000.0 ", $-   ,Sep
CA-2015-593,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-02-2015,5887,India,India,8095,Not assigned,115, $500.0 ," $57,500.0 ", $-   ,Feb
CA-2015-594,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-01-2015,5887,Indonesia,Indonesia,8095,Assigned,299, $500.0 ," $1,49,500.0 "," $8,870.3 ",Jan
CA-2015-595,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-10-2015,5887,India,India,8095,Not assigned,422, $500.0 ," $2,11,000.0 ", $-   ,Oct
CA-2015-596,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-01-2015,5887,India,India,8095,Not assigned,46, $500.0 ," $23,000.0 ", $-   ,Jan
CA-2015-597,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-06-2015,5887,India,India,8095,Not assigned,98, $500.0 ," $49,000.0 ", $-   ,Jun
CA-2015-598,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-04-2015,5887,India,India,8095,Not assigned,289, $500.0 ," $1,44,500.0 ", $-   ,Apr
CA-2015-599,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-11-2015,5887,India,India,8095,Not assigned,389, $500.0 ," $1,94,500.0 ", $-   ,Nov
CA-2015-600,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-07-2015,5887,Indonesia,Indonesia,8095,Assigned,34, $500.0 ," $17,000.0 ", $748.0 ,Jul
CA-2015-601,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-08-2015,5887,Nepal,Nepal,8095,Assigned,388, $500.0 ," $1,94,000.0 "," $10,864.0 ",Aug
CA-2015-602,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-12-2015,5887,Nepal,Nepal,8095,Assigned,88, $500.0 ," $44,000.0 ", $704.0 ,Dec
CA-2015-603,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-03-2015,5887,Indonesia,Indonesia,8095,Assigned,421, $500.0 ," $2,10,500.0 "," $11,647.7 ",Mar
CA-2015-604,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-03-2015,5887,Indonesia,Indonesia,8095,Assigned,425, $500.0 ," $2,12,500.0 "," $1,416.7 ",Mar
CA-2015-605,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-04-2015,5887,India,India,8095,Assigned,443, $500.0 ," $2,21,500.0 "," $11,665.7 ",Apr
CA-2015-606,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-01-2015,5887,India,India,8095,Not assigned,73, $500.0 ," $36,500.0 ", $-   ,Jan
CA-2015-607,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-06-2015,5887,India,India,8095,Not assigned,48, $500.0 ," $24,000.0 ", $-   ,Jun
CA-2015-608,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-07-2015,5887,India,India,8095,Not assigned,180, $500.0 ," $90,000.0 ", $-   ,Jul
CA-2015-609,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-01-2015,5887,India,India,8095,Not assigned,178, $500.0 ," $89,000.0 ", $-   ,Jan
CA-2015-610,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-04-2015,5887,India,India,8095,Not assigned,499, $500.0 ," $2,49,500.0 ", $-   ,Apr
CA-2015-611,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-06-2015,5887,India,India,8095,Not assigned,348, $500.0 ," $1,74,000.0 ", $-   ,Jun
CA-2015-612,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-11-2015,5887,India,India,8095,Not assigned,300, $500.0 ," $1,50,000.0 ", $-   ,Nov
CA-2015-613,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-09-2015,5887,India,India,8095,Not assigned,127, $500.0 ," $63,500.0 ", $-   ,Sep
CA-2015-614,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-12-2015,5887,India,India,8095,Not assigned,186, $500.0 ," $93,000.0 ", $-   ,Dec
CA-2015-615,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-06-2015,5887,India,India,8095,Not assigned,150, $500.0 ," $75,000.0 ", $-   ,Jun
CA-2015-616,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-06-2015,5887,India,India,8095,Not assigned,293, $500.0 ," $1,46,500.0 ", $-   ,Jun
CA-2015-617,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-06-2015,5887,India,India,8095,Not assigned,226, $500.0 ," $1,13,000.0 ", $-   ,Jun
CA-2015-618,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-10-2015,5887,India,India,8095,Not assigned,87, $500.0 ," $43,500.0 ", $-   ,Oct
CA-2015-619,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-08-2015,5887,India,India,8095,Not assigned,346, $500.0 ," $1,73,000.0 ", $-   ,Aug
CA-2015-620,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-12-2015,5887,India,India,8095,Not assigned,235, $500.0 ," $1,17,500.0 ", $-   ,Dec
CA-2015-621,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-06-2015,5887,India,India,8095,Assigned,323, $500.0 ," $1,61,500.0 "," $1,184.3 ",Jun
CA-2015-622,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-11-2015,5887,India,India,8095,Not assigned,176, $500.0 ," $88,000.0 ", $-   ,Nov
CA-2015-623,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-11-2015,5887,India,India,8095,Not assigned,421, $500.0 ," $2,10,500.0 ", $-   ,Nov
CA-2015-624,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-04-2015,5887,India,India,8095,Not assigned,129, $500.0 ," $64,500.0 ", $-   ,Apr
CA-2015-625,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-12-2015,5887,India,India,8095,Not assigned,475, $500.0 ," $2,37,500.0 ", $-   ,Dec
CA-2015-626,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-02-2015,5887,India,India,8095,Not assigned,228, $500.0 ," $1,14,000.0 ", $-   ,Feb
CA-2015-627,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-08-2015,5887,India,India,8095,Not assigned,432, $500.0 ," $2,16,000.0 ", $-   ,Aug
CA-2015-628,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-06-2015,5887,India,India,8095,Not assigned,127, $500.0 ," $63,500.0 ", $-   ,Jun
CA-2015-629,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-01-2015,5887,India,India,8095,Not assigned,2, $500.0 ," $1,000.0 ", $-   ,Jan
CA-2015-630,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-06-2015,5887,India,India,8095,Not assigned,263, $500.0 ," $1,31,500.0 ", $-   ,Jun
CA-2015-631,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-11-2015,5887,India,India,8095,Not assigned,448, $500.0 ," $2,24,000.0 ", $-   ,Nov
CA-2015-632,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-05-2015,5887,India,India,8095,Not assigned,83, $500.0 ," $41,500.0 ", $-   ,May
CA-2015-633,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-05-2015,5887,India,India,8095,Not assigned,388, $500.0 ," $1,94,000.0 ", $-   ,May
CA-2015-634,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-03-2015,5887,India,India,8095,Not assigned,432, $500.0 ," $2,16,000.0 ", $-   ,Mar
CA-2015-635,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-12-2015,5887,India,India,8095,Not assigned,205, $500.0 ," $1,02,500.0 ", $-   ,Dec
CA-2015-636,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-10-2015,5887,India,India,8095,Not assigned,445, $500.0 ," $2,22,500.0 ", $-   ,Oct
CA-2015-637,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-05-2015,5887,India,India,8095,Assigned,121, $500.0 ," $60,500.0 "," $3,751.0 ",May
CA-2015-638,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-01-2015,5887,India,India,8095,Not assigned,97, $500.0 ," $48,500.0 ", $-   ,Jan
CA-2015-639,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-10-2015,5887,India,India,8095,Not assigned,283, $500.0 ," $1,41,500.0 ", $-   ,Oct
CA-2015-640,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-04-2015,5887,India,India,8095,Assigned,440, $500.0 ," $2,20,000.0 "," $2,053.3 ",Apr
CA-2015-641,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-03-2015,5887,India,India,8095,Assigned,120, $500.0 ," $60,000.0 "," $1,200.0 ",Mar
CA-2015-642,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-11-2015,5887,India,India,8095,Assigned,401, $500.0 ," $2,00,500.0 "," $10,827.0 ",Nov
CA-2015-643,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-03-2015,5887,India,India,8095,Assigned,366, $500.0 ," $1,83,000.0 "," $10,980.0 ",Mar
CA-2015-644,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-03-2015,5887,India,India,8095,Assigned,15, $500.0 ," $7,500.0 ", $460.0 ,Mar
CA-2015-645,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-03-2015,5887,India,India,8095,Not assigned,61, $500.0 ," $30,500.0 ", $-   ,Mar
CA-2015-646,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-10-2015,5887,India,India,8095,Assigned,480, $500.0 ," $2,40,000.0 "," $12,480.0 ",Oct
CA-2015-647,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-03-2015,5887,Kenya,Kenya,8095,Assigned,287, $500.0 ," $1,43,500.0 "," $5,166.0 ",Mar
CA-2015-648,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-06-2015,5887,Vietnam,Netherlands,8095,Assigned,308, $500.0 ," $1,54,000.0 "," $2,464.0 ",Jun
CA-2015-649,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-04-2015,5887,Vietnam,Japan,8095,Assigned,232, $500.0 ," $1,16,000.0 "," $6,960.0 ",Apr
CA-2015-650,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-09-2015,5887,Vietnam,Netherlands,8095,Assigned,270, $500.0 ," $1,35,000.0 "," $6,570.0 ",Sep
CA-2015-651,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-01-2015,5887,India,India,8095,Not assigned,191, $500.0 ," $95,500.0 ", $-   ,Jan
CA-2015-652,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-11-2015,5887,India,India,8095,Not assigned,490, $500.0 ," $2,45,000.0 ", $-   ,Nov
CA-2015-653,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-06-2015,5887,Malaysia,Malaysia,8095,Not assigned,132, $500.0 ," $66,000.0 ", $-   ,Jun
CA-2015-654,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-04-2015,5887,India,India,8095,Not assigned,467, $500.0 ," $2,33,500.0 ", $-   ,Apr
CA-2015-655,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-06-2015,5887,Singapore,Singapore,8095,Not assigned,395, $500.0 ," $1,97,500.0 ", $-   ,Jun
CA-2015-656,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-02-2015,5887,Thailand,Thailand,8095,Assigned,289, $500.0 ," $1,44,500.0 "," $2,793.7 ",Feb
CA-2015-657,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-03-2015,5887,Thailand,Thailand,8095,Assigned,496, $500.0 ," $2,48,000.0 "," $2,149.3 ",Mar
CA-2015-658,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-06-2015,5887,Thailand,Thailand,8095,Assigned,243, $500.0 ," $1,21,500.0 "," $2,835.0 ",Jun
CA-2015-659,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-01-2015,5887,Hong Kong,China,8095,Not assigned,255, $500.0 ," $1,27,500.0 ", $-   ,Jan
CA-2015-660,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-03-2015,5887,Taiwan,China,8095,Not assigned,191, $500.0 ," $95,500.0 ", $-   ,Mar
CA-2015-661,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-09-2015,5887,India,India,8095,Assigned,411, $500.0 ," $2,05,500.0 "," $6,576.0 ",Sep
CA-2015-662,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-01-2015,5887,Taiwan,China,8095,Not assigned,312, $500.0 ," $1,56,000.0 ", $-   ,Jan
CA-2015-663,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-01-2015,5887,India,India,8095,Not assigned,442, $500.0 ," $2,21,000.0 ", $-   ,Jan
CA-2015-664,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-04-2015,5887,India,India,8095,Not assigned,427, $500.0 ," $2,13,500.0 ", $-   ,Apr
CA-2015-665,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-07-2015,5887,India,India,8095,Not assigned,39, $500.0 ," $19,500.0 ", $-   ,Jul
CA-2015-666,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-04-2015,5887,India,India,8095,Not assigned,375, $500.0 ," $1,87,500.0 ", $-   ,Apr
CA-2015-667,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-01-2015,5887,India,India,8095,Not assigned,497, $500.0 ," $2,48,500.0 ", $-   ,Jan
CA-2015-668,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-02-2015,5887,India,India,8095,Not assigned,62, $500.0 ," $31,000.0 ", $-   ,Feb
CA-2015-669,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-02-2015,5887,India,India,8095,Not assigned,55, $500.0 ," $27,500.0 ", $-   ,Feb
CA-2015-670,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-05-2015,5887,South Korea,South Korea,8095,Not assigned,496, $500.0 ," $2,48,000.0 ", $-   ,May
CA-2015-671,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-12-2015,5887,India,India,8095,Not assigned,484, $500.0 ," $2,42,000.0 ", $-   ,Dec
CA-2015-672,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-12-2015,5887,India,India,8095,Assigned,219, $500.0 ," $1,09,500.0 "," $5,548.0 ",Dec
CA-2015-673,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-04-2015,5887,India,India,8095,Not assigned,43, $500.0 ," $21,500.0 ", $-   ,Apr
CA-2015-674,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-05-2015,5887,India,India,8095,Not assigned,365, $500.0 ," $1,82,500.0 ", $-   ,May
CA-2015-675,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-05-2015,5887,India,India,8095,Not assigned,278, $500.0 ," $1,39,000.0 ", $-   ,May
CA-2015-676,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-06-2015,5887,India,India,8095,Not assigned,143, $500.0 ," $71,500.0 ", $-   ,Jun
CA-2015-677,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-06-2015,5887,Syria,Lebanon,8095,Assigned,8, $500.0 ," $4,000.0 ", $256.0 ,Jun
CA-2015-678,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-07-2015,5887,Kenya,Kenya,8095,Assigned,184, $500.0 ," $92,000.0 "," $5,029.3 ",Jul
CA-2015-679,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-02-2015,5887,Kenya,Kenya,8095,Assigned,142, $500.0 ," $71,000.0 "," $3,786.7 ",Feb
CA-2015-680,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-01-2015,5887,Kenya,Kenya,8095,Assigned,51, $500.0 ," $25,500.0 ", $170.0 ,Jan
CA-2015-681,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-03-2015,5887,India,India,8095,Not assigned,191, $500.0 ," $95,500.0 ", $-   ,Mar
CA-2015-682,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-06-2015,5887,South Africa,South Africa,8095,Assigned,282, $500.0 ," $1,41,000.0 "," $6,956.0 ",Jun
CA-2015-683,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-03-2015,5887,India,India,8095,Not assigned,112, $500.0 ," $56,000.0 ", $-   ,Mar
CA-2015-684,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-09-2015,5887,Netherlands,Netherlands,8095,Assigned,49, $500.0 ," $24,500.0 ", $588.0 ,Sep
CA-2015-685,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-06-2015,5887,Indonesia,Indonesia,8095,Assigned,94, $500.0 ," $47,000.0 ", $783.3 ,Jun
CA-2015-686,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-11-2015,5887,Malaysia,Malaysia,8095,Assigned,454, $500.0 ," $2,27,000.0 "," $1,513.3 ",Nov
CA-2015-687,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-09-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,311, $500.0 ," $1,55,500.0 ", $-   ,Sep
CA-2015-688,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-05-2015,5887,India,India,8095,Assigned,104, $500.0 ," $52,000.0 "," $1,525.3 ",May
CA-2015-689,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-11-2015,5887,India,India,8095,Not assigned,286, $500.0 ," $1,43,000.0 ", $-   ,Nov
CA-2015-690,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-01-2015,5887,India,India,8095,Not assigned,122, $500.0 ," $61,000.0 ", $-   ,Jan
CA-2015-691,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-03-2015,5887,India,India,8095,Not assigned,420, $500.0 ," $2,10,000.0 ", $-   ,Mar
CA-2015-692,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-05-2015,5887,India,India,8095,Assigned,265, $500.0 ," $1,32,500.0 "," $7,508.3 ",May
CA-2015-693,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-05-2015,5887,Thailand,Thailand,8095,Assigned,264, $500.0 ," $1,32,000.0 "," $3,872.0 ",May
CA-2015-694,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-01-2015,5887,India,India,8095,Assigned,448, $500.0 ," $2,24,000.0 "," $4,032.0 ",Jan
CA-2015-695,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-10-2015,5887,India,India,8095,Assigned,455, $500.0 ," $2,27,500.0 "," $4,853.3 ",Oct
CA-2015-696,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-12-2015,5887,India,India,8095,Assigned,189, $500.0 ," $94,500.0 "," $1,197.0 ",Dec
CA-2015-697,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-07-2015,5887,Egypt,Egypt,8095,Not assigned,291, $500.0 ," $1,45,500.0 ", $-   ,Jul
CA-2015-698,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-08-2015,5887,India,India,8095,Assigned,110, $500.0 ," $55,000.0 ", $843.3 ,Aug
CA-2015-699,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-07-2015,5887,India,India,8095,Assigned,323, $500.0 ," $1,61,500.0 "," $9,905.3 ",Jul
CA-2015-700,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-07-2015,5887,India,India,8095,Not assigned,387, $500.0 ," $1,93,500.0 ", $-   ,Jul
CA-2015-701,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-08-2015,5887,South Korea,South Korea,8095,Not assigned,211, $500.0 ," $1,05,500.0 ", $-   ,Aug
CA-2015-702,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-06-2015,5887,South Korea,South Korea,8095,Not assigned,198, $500.0 ," $99,000.0 ", $-   ,Jun
CA-2015-703,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-06-2015,5887,South Korea,South Korea,8095,Not assigned,393, $500.0 ," $1,96,500.0 ", $-   ,Jun
CA-2015-704,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-06-2015,5887,Egypt,Egypt,8095,Not assigned,156, $500.0 ," $78,000.0 ", $-   ,Jun
CA-2015-705,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-09-2015,5887,Hong Kong,China,8095,Not assigned,402, $500.0 ," $2,01,000.0 ", $-   ,Sep
CA-2015-706,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-01-2015,5887,India,India,8095,Not assigned,391, $500.0 ," $1,95,500.0 ", $-   ,Jan
IN-2015-707,Bevacizumab,Avastin,Genentech/Roche,Cancer,08-04-2015,5685,India,India,8209,Not assigned,464, $243.0 ," $1,12,752.0 ", $-   ,Apr
CA-2015-708,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-03-2015,5887,India,India,8095,Assigned,498, $500.0 ," $2,49,000.0 "," $3,984.0 ",Mar
CA-2015-709,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-02-2015,5887,India,India,8095,Assigned,332, $500.0 ," $1,66,000.0 "," $1,106.7 ",Feb
CA-2015-710,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-09-2015,5887,India,India,8095,Not assigned,43, $500.0 ," $21,500.0 ", $-   ,Sep
CA-2015-711,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-02-2015,5887,India,India,8095,Not assigned,249, $500.0 ," $1,24,500.0 ", $-   ,Feb
CA-2015-712,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-03-2015,5887,India,India,8095,Not assigned,305, $500.0 ," $1,52,500.0 ", $-   ,Mar
CA-2015-713,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-09-2015,5887,India,India,8095,Assigned,428, $500.0 ," $2,14,000.0 "," $13,410.7 ",Sep
CA-2015-714,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-05-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,344, $500.0 ," $1,72,000.0 ", $-   ,May
CA-2015-715,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-09-2015,5887,India,India,8095,Not assigned,422, $500.0 ," $2,11,000.0 ", $-   ,Sep
CA-2015-716,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-02-2015,5887,India,India,8095,Not assigned,356, $500.0 ," $1,78,000.0 ", $-   ,Feb
CA-2015-717,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-08-2015,5887,India,India,8095,Assigned,474, $500.0 ," $2,37,000.0 "," $1,896.0 ",Aug
CA-2015-718,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-02-2015,5887,India,India,8095,Assigned,228, $500.0 ," $1,14,000.0 "," $2,280.0 ",Feb
CA-2015-719,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-06-2015,5887,Kenya,Kenya,8095,Assigned,5, $500.0 ," $2,500.0 ", $68.3 ,Jun
CA-2015-720,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-04-2015,5887,Malaysia,Malaysia,8095,Not assigned,227, $500.0 ," $1,13,500.0 ", $-   ,Apr
CA-2015-721,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-08-2015,5887,Kenya,Kenya,8095,Assigned,339, $500.0 ," $1,69,500.0 "," $5,650.0 ",Aug
CA-2015-722,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-11-2015,5887,Thailand,Thailand,8095,Not assigned,436, $500.0 ," $2,18,000.0 ", $-   ,Nov
CA-2015-723,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-03-2015,5887,India,India,8095,Assigned,416, $500.0 ," $2,08,000.0 "," $12,480.0 ",Mar
CA-2015-724,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-04-2015,5887,India,India,8095,Not assigned,419, $500.0 ," $2,09,500.0 ", $-   ,Apr
CA-2015-725,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-02-2015,5887,Vietnam,Japan,8095,Assigned,231, $500.0 ," $1,15,500.0 "," $4,081.0 ",Feb
CA-2015-726,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-04-2015,5887,India,India,8095,Not assigned,390, $500.0 ," $1,95,000.0 ", $-   ,Apr
CA-2015-727,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-12-2015,5887,India,India,8095,Not assigned,123, $500.0 ," $61,500.0 ", $-   ,Dec
CA-2015-728,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-01-2015,5887,India,India,8095,Not assigned,317, $500.0 ," $1,58,500.0 ", $-   ,Jan
CA-2015-729,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-05-2015,5887,India,India,8095,Not assigned,431, $500.0 ," $2,15,500.0 ", $-   ,May
CA-2015-730,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-08-2015,5887,India,India,8095,Not assigned,424, $500.0 ," $2,12,000.0 ", $-   ,Aug
CA-2015-731,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-11-2015,5887,India,India,8095,Not assigned,83, $500.0 ," $41,500.0 ", $-   ,Nov
CA-2015-732,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-09-2015,5887,Germany,Germany,8095,Not assigned,375, $500.0 ," $1,87,500.0 ", $-   ,Sep
CA-2015-733,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-11-2015,5887,Singapore,Singapore,8095,Not assigned,486, $500.0 ," $2,43,000.0 ", $-   ,Nov
CA-2015-734,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-02-2015,5887,Indonesia,Indonesia,8095,Not assigned,94, $500.0 ," $47,000.0 ", $-   ,Feb
CA-2015-735,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-08-2015,5887,Indonesia,Indonesia,8095,Not assigned,220, $500.0 ," $1,10,000.0 ", $-   ,Aug
CA-2015-736,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-10-2015,5887,Taiwan,China,8095,Not assigned,436, $500.0 ," $2,18,000.0 ", $-   ,Oct
CA-2015-737,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-09-2015,5887,India,India,8095,Not assigned,262, $500.0 ," $1,31,000.0 ", $-   ,Sep
CA-2015-738,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-05-2015,5887,India,India,8095,Not assigned,388, $500.0 ," $1,94,000.0 ", $-   ,May
CA-2015-739,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-11-2015,5887,India,India,8095,Not assigned,416, $500.0 ," $2,08,000.0 ", $-   ,Nov
CA-2015-740,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-12-2015,5887,India,India,8095,Not assigned,54, $500.0 ," $27,000.0 ", $-   ,Dec
CA-2015-741,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-07-2015,5887,India,India,8095,Not assigned,84, $500.0 ," $42,000.0 ", $-   ,Jul
CA-2015-742,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-08-2015,5887,India,India,8095,Not assigned,413, $500.0 ," $2,06,500.0 ", $-   ,Aug
CA-2015-743,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-11-2015,5887,India,India,8095,Not assigned,461, $500.0 ," $2,30,500.0 ", $-   ,Nov
CA-2015-744,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-11-2015,5887,India,India,8095,Not assigned,379, $500.0 ," $1,89,500.0 ", $-   ,Nov
CA-2015-745,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-03-2015,5887,India,India,8095,Not assigned,369, $500.0 ," $1,84,500.0 ", $-   ,Mar
CA-2015-746,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-12-2015,5887,India,India,8095,Not assigned,303, $500.0 ," $1,51,500.0 ", $-   ,Dec
CA-2015-747,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-10-2015,5887,India,India,8095,Not assigned,390, $500.0 ," $1,95,000.0 ", $-   ,Oct
CA-2015-748,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-04-2015,5887,India,India,8095,Not assigned,109, $500.0 ," $54,500.0 ", $-   ,Apr
CA-2015-749,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-03-2015,5887,India,India,8095,Not assigned,472, $500.0 ," $2,36,000.0 ", $-   ,Mar
CA-2015-750,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-06-2015,5887,India,India,8095,Not assigned,239, $500.0 ," $1,19,500.0 ", $-   ,Jun
CA-2015-751,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-02-2015,5887,India,India,8095,Not assigned,66, $500.0 ," $33,000.0 ", $-   ,Feb
CA-2015-752,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-04-2015,5887,India,India,8095,Not assigned,477, $500.0 ," $2,38,500.0 ", $-   ,Apr
CA-2015-753,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-06-2015,5887,India,India,8095,Not assigned,209, $500.0 ," $1,04,500.0 ", $-   ,Jun
CA-2015-754,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-06-2015,5887,India,India,8095,Not assigned,295, $500.0 ," $1,47,500.0 ", $-   ,Jun
CA-2015-755,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-05-2015,5887,India,India,8095,Not assigned,388, $500.0 ," $1,94,000.0 ", $-   ,May
CA-2015-756,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-11-2015,5887,India,India,8095,Not assigned,184, $500.0 ," $92,000.0 ", $-   ,Nov
CA-2015-757,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-01-2015,5887,India,India,8095,Not assigned,89, $500.0 ," $44,500.0 ", $-   ,Jan
CA-2015-758,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-10-2015,5887,India,India,8095,Not assigned,181, $500.0 ," $90,500.0 ", $-   ,Oct
CA-2015-759,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-12-2015,5887,India,India,8095,Not assigned,157, $500.0 ," $78,500.0 ", $-   ,Dec
CA-2015-760,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-02-2015,5887,India,India,8095,Not assigned,114, $500.0 ," $57,000.0 ", $-   ,Feb
AR-2015-761,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,14-01-2015,5653,India,India,7933,Assigned,382, $231.0 ," $88,242.0 "," $1,910.0 ",Jan
CA-2015-762,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-09-2015,5887,India,India,8095,Not assigned,373, $500.0 ," $1,86,500.0 ", $-   ,Sep
CA-2015-763,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-04-2015,5887,Sri Lanka,Sri Lanka,8095,Assigned,389, $500.0 ," $1,94,500.0 "," $7,520.7 ",Apr
CA-2015-764,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-02-2015,5887,Indonesia,Indonesia,8095,Not assigned,437, $500.0 ," $2,18,500.0 ", $-   ,Feb
CA-2015-765,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-04-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,178, $500.0 ," $89,000.0 ", $-   ,Apr
CA-2015-766,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-02-2015,5887,India,India,8095,Not assigned,388, $500.0 ," $1,94,000.0 ", $-   ,Feb
CA-2015-767,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-11-2015,5887,India,India,8095,Not assigned,436, $500.0 ," $2,18,000.0 ", $-   ,Nov
CA-2015-768,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-10-2015,5887,Egypt,Egypt,8095,Not assigned,148, $500.0 ," $74,000.0 ", $-   ,Oct
CA-2015-769,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-11-2015,5887,India,India,8095,Assigned,177, $500.0 ," $88,500.0 "," $1,475.0 ",Nov
CA-2015-770,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-12-2015,5887,India,India,8095,Not assigned,407, $500.0 ," $2,03,500.0 ", $-   ,Dec
CA-2015-771,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-10-2015,5887,India,India,8095,Not assigned,489, $500.0 ," $2,44,500.0 ", $-   ,Oct
CA-2015-772,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-08-2015,5887,India,India,8095,Assigned,427, $500.0 ," $2,13,500.0 "," $2,846.7 ",Aug
CA-2015-773,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-03-2015,5887,India,India,8095,Not assigned,354, $500.0 ," $1,77,000.0 ", $-   ,Mar
CA-2015-774,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-12-2015,5887,India,India,8095,Not assigned,268, $500.0 ," $1,34,000.0 ", $-   ,Dec
CA-2015-775,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-12-2015,5887,India,India,8095,Not assigned,21, $500.0 ," $10,500.0 ", $-   ,Dec
CA-2015-776,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-02-2015,5887,India,India,8095,Assigned,493, $500.0 ," $2,46,500.0 "," $11,010.3 ",Feb
CA-2015-777,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-02-2015,5887,India,India,8095,Not assigned,397, $500.0 ," $1,98,500.0 ", $-   ,Feb
CA-2015-778,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-10-2015,5887,Ethiopia,Ethiopia,8095,Assigned,123, $500.0 ," $61,500.0 "," $3,813.0 ",Oct
CA-2015-779,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-09-2015,5887,Ethiopia,Ethiopia,8095,Assigned,89, $500.0 ," $44,500.0 ", $385.7 ,Sep
CA-2015-780,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-02-2015,5887,India,India,8095,Assigned,129, $500.0 ," $64,500.0 "," $1,505.0 ",Feb
CA-2015-781,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-01-2015,5887,Egypt,Egypt,8095,Not assigned,411, $500.0 ," $2,05,500.0 ", $-   ,Jan
CA-2015-782,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-08-2015,5887,Thailand,Thailand,8095,Assigned,318, $500.0 ," $1,59,000.0 "," $2,120.0 ",Aug
CA-2015-783,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-07-2015,5887,India,India,8095,Assigned,261, $500.0 ," $1,30,500.0 "," $3,828.0 ",Jul
CA-2015-784,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-10-2015,5887,India,India,8095,Not assigned,383, $500.0 ," $1,91,500.0 ", $-   ,Oct
CA-2015-785,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-04-2015,5887,India,India,8095,Assigned,108, $500.0 ," $54,000.0 "," $3,024.0 ",Apr
CA-2015-786,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-04-2015,5887,India,India,8095,Not assigned,317, $500.0 ," $1,58,500.0 ", $-   ,Apr
CA-2015-787,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-02-2015,5887,India,India,8095,Not assigned,372, $500.0 ," $1,86,000.0 ", $-   ,Feb
CA-2015-788,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-07-2015,5887,India,India,8095,Assigned,31, $500.0 ," $15,500.0 ", $206.7 ,Jul
CA-2015-789,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-08-2015,5887,India,India,8095,Not assigned,348, $500.0 ," $1,74,000.0 ", $-   ,Aug
CA-2015-790,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-02-2015,5887,India,India,8095,Not assigned,218, $500.0 ," $1,09,000.0 ", $-   ,Feb
CA-2015-791,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-10-2015,5887,India,India,8095,Not assigned,342, $500.0 ," $1,71,000.0 ", $-   ,Oct
CA-2015-792,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-04-2015,5887,India,India,8095,Not assigned,136, $500.0 ," $68,000.0 ", $-   ,Apr
CA-2015-793,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-08-2015,5887,India,India,8095,Not assigned,365, $500.0 ," $1,82,500.0 ", $-   ,Aug
CA-2015-794,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-10-2015,5887,Philippines,Philippines,8095,Assigned,43, $500.0 ," $21,500.0 "," $1,232.7 ",Oct
CA-2015-795,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-10-2015,5887,Philippines,Philippines,8095,Assigned,136, $500.0 ," $68,000.0 "," $2,720.0 ",Oct
CA-2015-796,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-06-2015,5887,India,India,8095,Not assigned,237, $500.0 ," $1,18,500.0 ", $-   ,Jun
AR-2015-797,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,11-06-2015,5653,India,India,7933,Assigned,305, $231.0 ," $70,455.0 "," $5,896.7 ",Jun
CA-2015-798,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-07-2015,5887,India,India,8095,Assigned,448, $500.0 ," $2,24,000.0 "," $9,856.0 ",Jul
CA-2015-799,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-08-2015,5887,Singapore,Singapore,8095,Not assigned,392, $500.0 ," $1,96,000.0 ", $-   ,Aug
CA-2015-800,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-06-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,2, $500.0 ," $1,000.0 ", $-   ,Jun
CA-2015-801,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-03-2015,5887,Egypt,Egypt,8095,Assigned,63, $500.0 ," $31,500.0 ", $672.0 ,Mar
CA-2015-802,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-04-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,16, $500.0 ," $8,000.0 ", $-   ,Apr
CA-2015-803,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-10-2015,5887,India,India,8095,Not assigned,496, $500.0 ," $2,48,000.0 ", $-   ,Oct
CA-2015-804,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-07-2015,5887,India,India,8095,Assigned,410, $500.0 ," $2,05,000.0 "," $8,610.0 ",Jul
CA-2015-805,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-04-2015,5887,India,India,8095,Assigned,114, $500.0 ," $57,000.0 ", $722.0 ,Apr
CA-2015-806,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-04-2015,5887,India,India,8095,Not assigned,233, $500.0 ," $1,16,500.0 ", $-   ,Apr
CA-2015-807,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-07-2015,5887,India,India,8095,Assigned,391, $500.0 ," $1,95,500.0 "," $9,253.7 ",Jul
CA-2015-808,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-03-2015,5887,India,India,8095,Assigned,461, $500.0 ," $2,30,500.0 "," $2,919.7 ",Mar
CA-2015-809,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-03-2015,5887,India,India,8095,Not assigned,229, $500.0 ," $1,14,500.0 ", $-   ,Mar
CA-2015-810,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-07-2015,5887,India,India,8095,Not assigned,409, $500.0 ," $2,04,500.0 ", $-   ,Jul
CA-2015-811,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-08-2015,5887,Nepal,Nepal,8095,Assigned,274, $500.0 ," $1,37,000.0 "," $7,032.7 ",Aug
CA-2015-812,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-12-2015,5887,Egypt,Egypt,8095,Not assigned,169, $500.0 ," $84,500.0 ", $-   ,Dec
CA-2015-813,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-04-2015,5887,Nepal,Nepal,8095,Not assigned,327, $500.0 ," $1,63,500.0 ", $-   ,Apr
CA-2015-814,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-12-2015,5887,Nepal,Nepal,8095,Not assigned,271, $500.0 ," $1,35,500.0 ", $-   ,Dec
CA-2015-815,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-06-2015,5887,Egypt,Egypt,8095,Not assigned,393, $500.0 ," $1,96,500.0 ", $-   ,Jun
CA-2015-816,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-03-2015,5887,South Korea,South Korea,8095,Assigned,439, $500.0 ," $2,19,500.0 "," $4,682.7 ",Mar
CA-2015-817,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-03-2015,5887,South Korea,South Korea,8095,Assigned,440, $500.0 ," $2,20,000.0 "," $1,760.0 ",Mar
CA-2015-818,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-11-2015,5887,Cambodia,Cambodia,8095,Assigned,65, $500.0 ," $32,500.0 "," $1,625.0 ",Nov
CA-2015-819,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-09-2015,5887,Thailand,Thailand,8095,Assigned,41, $500.0 ," $20,500.0 "," $1,134.3 ",Sep
CA-2015-820,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-09-2015,5887,India,India,8095,Assigned,425, $500.0 ," $2,12,500.0 "," $2,125.0 ",Sep
CA-2015-821,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-04-2015,5887,India,India,8095,Not assigned,343, $500.0 ," $1,71,500.0 ", $-   ,Apr
CA-2015-822,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-04-2015,5887,India,India,8095,Not assigned,88, $500.0 ," $44,000.0 ", $-   ,Apr
CA-2015-823,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-02-2015,5887,India,India,8095,Not assigned,73, $500.0 ," $36,500.0 ", $-   ,Feb
CA-2015-824,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-08-2015,5887,India,India,8095,Not assigned,241, $500.0 ," $1,20,500.0 ", $-   ,Aug
CA-2015-825,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-02-2015,5887,India,India,8095,Not assigned,101, $500.0 ," $50,500.0 ", $-   ,Feb
CA-2015-826,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-07-2015,5887,South Korea,South Korea,8095,Assigned,40, $500.0 ," $20,000.0 "," $1,226.7 ",Jul
CA-2015-827,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-01-2015,5887,Egypt,Egypt,8095,Not assigned,36, $500.0 ," $18,000.0 ", $-   ,Jan
CA-2015-828,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-10-2015,5887,Egypt,Egypt,8095,Not assigned,294, $500.0 ," $1,47,000.0 ", $-   ,Oct
CA-2015-829,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-02-2015,5887,India,India,8095,Assigned,223, $500.0 ," $1,11,500.0 "," $5,426.3 ",Feb
CA-2015-830,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-12-2015,5887,India,India,8095,Not assigned,176, $500.0 ," $88,000.0 ", $-   ,Dec
CA-2015-831,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-02-2015,5887,India,India,8095,Not assigned,104, $500.0 ," $52,000.0 ", $-   ,Feb
CA-2015-832,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-08-2015,5887,India,India,8095,Assigned,339, $500.0 ," $1,69,500.0 "," $2,712.0 ",Aug
CA-2015-833,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-03-2015,5887,Indonesia,Indonesia,8095,Assigned,336, $500.0 ," $1,68,000.0 "," $10,864.0 ",Mar
CA-2015-834,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-03-2015,5887,Thailand,Thailand,8095,Not assigned,218, $500.0 ," $1,09,000.0 ", $-   ,Mar
CA-2015-835,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-09-2015,5887,Malaysia,Malaysia,8095,Assigned,202, $500.0 ," $1,01,000.0 "," $3,905.3 ",Sep
CA-2015-836,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-06-2015,5887,Singapore,Singapore,8095,Not assigned,326, $500.0 ," $1,63,000.0 ", $-   ,Jun
CA-2015-837,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-02-2015,5887,Thailand,Thailand,8095,Assigned,198, $500.0 ," $99,000.0 ", $726.0 ,Feb
CA-2015-838,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-09-2015,5887,India,India,8095,Not assigned,299, $500.0 ," $1,49,500.0 ", $-   ,Sep
CA-2015-839,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-10-2015,5887,India,India,8095,Not assigned,482, $500.0 ," $2,41,000.0 ", $-   ,Oct
CA-2015-840,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-02-2015,5887,India,India,8095,Assigned,230, $500.0 ," $1,15,000.0 "," $7,666.7 ",Feb
CA-2015-841,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-06-2015,5887,India,India,8095,Not assigned,9, $500.0 ," $4,500.0 ", $-   ,Jun
CA-2015-842,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-09-2015,5887,Egypt,Egypt,8095,Not assigned,200, $500.0 ," $1,00,000.0 ", $-   ,Sep
CA-2015-843,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-11-2015,5887,Egypt,Egypt,8095,Not assigned,438, $500.0 ," $2,19,000.0 ", $-   ,Nov
CA-2015-844,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-02-2015,5887,India,India,8095,Not assigned,314, $500.0 ," $1,57,000.0 ", $-   ,Feb
CA-2015-845,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-06-2015,5887,India,India,8095,Not assigned,457, $500.0 ," $2,28,500.0 ", $-   ,Jun
CA-2015-846,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-10-2015,5887,India,India,8095,Not assigned,91, $500.0 ," $45,500.0 ", $-   ,Oct
CA-2015-847,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-10-2015,5887,Thailand,Thailand,8095,Assigned,234, $500.0 ," $1,17,000.0 "," $6,474.0 ",Oct
CA-2015-848,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-05-2015,5887,India,India,8095,Assigned,199, $500.0 ," $99,500.0 "," $6,036.3 ",May
CA-2015-849,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-06-2015,5887,Nepal,Nepal,8095,Assigned,378, $500.0 ," $1,89,000.0 "," $2,772.0 ",Jun
CA-2015-850,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-10-2015,5887,Thailand,Thailand,8095,Assigned,486, $500.0 ," $2,43,000.0 "," $3,726.0 ",Oct
CA-2015-851,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-03-2015,5887,Nepal,Nepal,8095,Assigned,481, $500.0 ," $2,40,500.0 "," $14,590.3 ",Mar
CA-2015-852,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-08-2015,5887,Singapore,Singapore,8095,Not assigned,436, $500.0 ," $2,18,000.0 ", $-   ,Aug
CA-2015-853,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-07-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,10, $500.0 ," $5,000.0 ", $-   ,Jul
CA-2015-854,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-10-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,106, $500.0 ," $53,000.0 ", $-   ,Oct
CA-2015-855,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-03-2015,5887,Indonesia,Indonesia,8095,Not assigned,227, $500.0 ," $1,13,500.0 ", $-   ,Mar
CA-2015-856,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-09-2015,5887,Kenya,Kenya,8095,Assigned,42, $500.0 ," $21,000.0 ", $140.0 ,Sep
CA-2015-857,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-08-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,295, $500.0 ," $1,47,500.0 ", $-   ,Aug
CA-2015-858,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-03-2015,5887,Thailand,Thailand,8095,Not assigned,122, $500.0 ," $61,000.0 ", $-   ,Mar
CA-2015-859,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-01-2015,5887,South Korea,South Korea,8095,Assigned,72, $500.0 ," $36,000.0 "," $1,704.0 ",Jan
CA-2015-860,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-05-2015,5887,Indonesia,Indonesia,8095,Assigned,333, $500.0 ," $1,66,500.0 "," $6,438.0 ",May
CA-2015-861,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-07-2015,5887,Malaysia,Malaysia,8095,Assigned,388, $500.0 ," $1,94,000.0 "," $10,346.7 ",Jul
CA-2015-862,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-05-2015,5887,Indonesia,Indonesia,8095,Not assigned,209, $500.0 ," $1,04,500.0 ", $-   ,May
CA-2015-863,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-03-2015,5887,Indonesia,Indonesia,8095,Not assigned,398, $500.0 ," $1,99,000.0 ", $-   ,Mar
CA-2015-864,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-12-2015,5887,Indonesia,Indonesia,8095,Not assigned,375, $500.0 ," $1,87,500.0 ", $-   ,Dec
CA-2015-865,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-05-2015,5887,Malaysia,Malaysia,8095,Assigned,118, $500.0 ," $59,000.0 "," $2,124.0 ",May
CA-2015-866,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-04-2015,5887,Malaysia,Malaysia,8095,Assigned,171, $500.0 ," $85,500.0 "," $1,311.0 ",Apr
CA-2015-867,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-08-2015,5887,South Korea,South Korea,8095,Assigned,341, $500.0 ," $1,70,500.0 "," $4,205.7 ",Aug
CA-2015-868,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-01-2015,5887,Sudan,Sudan,8095,Not assigned,471, $500.0 ," $2,35,500.0 ", $-   ,Jan
CA-2015-869,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-02-2015,5887,Sudan,Sudan,8095,Not assigned,420, $500.0 ," $2,10,000.0 ", $-   ,Feb
CA-2015-870,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-01-2015,5887,Indonesia,Indonesia,8095,Assigned,256, $500.0 ," $1,28,000.0 "," $7,594.7 ",Jan
CA-2015-871,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-12-2015,5887,India,India,8095,Not assigned,366, $500.0 ," $1,83,000.0 ", $-   ,Dec
CA-2015-872,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-02-2015,5887,India,India,8095,Assigned,209, $500.0 ," $1,04,500.0 "," $1,114.7 ",Feb
CA-2015-873,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-01-2015,5887,Kenya,Kenya,8095,Assigned,391, $500.0 ," $1,95,500.0 "," $11,730.0 ",Jan
CA-2015-874,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-03-2015,5887,South Africa,South Africa,8095,Assigned,305, $500.0 ," $1,52,500.0 "," $2,846.7 ",Mar
CA-2015-875,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-03-2015,5887,South Korea,South Korea,8095,Assigned,380, $500.0 ," $1,90,000.0 "," $9,753.3 ",Mar
CA-2015-876,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-10-2015,5887,Philippines,Philippines,8095,Assigned,301, $500.0 ," $1,50,500.0 "," $5,819.3 ",Oct
CA-2015-877,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-05-2015,5887,Cambodia,Cambodia,8095,Not assigned,297, $500.0 ," $1,48,500.0 ", $-   ,May
CA-2015-878,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-03-2015,5887,India,India,8095,Assigned,486, $500.0 ," $2,43,000.0 "," $7,938.0 ",Mar
CA-2015-879,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-07-2015,5887,Thailand,Thailand,8095,Not assigned,88, $500.0 ," $44,000.0 ", $-   ,Jul
CA-2015-880,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-07-2015,5887,Vietnam,Japan,8095,Assigned,212, $500.0 ," $1,06,000.0 "," $2,897.3 ",Jul
CA-2015-881,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-04-2015,5887,Thailand,Thailand,8095,Assigned,121, $500.0 ," $60,500.0 "," $3,025.0 ",Apr
CA-2015-882,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-12-2015,5887,Thailand,Thailand,8095,Assigned,349, $500.0 ," $1,74,500.0 "," $9,190.3 ",Dec
CA-2015-883,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-02-2015,5887,India,India,8095,Not assigned,50, $500.0 ," $25,000.0 ", $-   ,Feb
CA-2015-884,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-11-2015,5887,India,India,8095,Not assigned,254, $500.0 ," $1,27,000.0 ", $-   ,Nov
CA-2015-885,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-11-2015,5887,India,India,8095,Not assigned,343, $500.0 ," $1,71,500.0 ", $-   ,Nov
CA-2015-886,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-09-2015,5887,India,India,8095,Not assigned,412, $500.0 ," $2,06,000.0 ", $-   ,Sep
CA-2015-887,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-10-2015,5887,India,India,8095,Not assigned,423, $500.0 ," $2,11,500.0 ", $-   ,Oct
CA-2015-888,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-11-2015,5887,South Korea,South Korea,8095,Not assigned,253, $500.0 ," $1,26,500.0 ", $-   ,Nov
CA-2015-889,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-01-2015,5887,India,India,8095,Not assigned,405, $500.0 ," $2,02,500.0 ", $-   ,Jan
CA-2015-890,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-04-2015,5887,India,India,8095,Not assigned,422, $500.0 ," $2,11,000.0 ", $-   ,Apr
CA-2015-891,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-12-2015,5887,India,India,8095,Not assigned,181, $500.0 ," $90,500.0 ", $-   ,Dec
CA-2015-892,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-03-2015,5887,India,India,8095,Not assigned,215, $500.0 ," $1,07,500.0 ", $-   ,Mar
CA-2015-893,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-08-2015,5887,India,India,8095,Not assigned,461, $500.0 ," $2,30,500.0 ", $-   ,Aug
CA-2015-894,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-03-2015,5887,India,India,8095,Not assigned,9, $500.0 ," $4,500.0 ", $-   ,Mar
CA-2015-895,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-05-2015,5887,Indonesia,Indonesia,8095,Not assigned,108, $500.0 ," $54,000.0 ", $-   ,May
CA-2015-896,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-05-2015,5887,Indonesia,Indonesia,8095,Not assigned,288, $500.0 ," $1,44,000.0 ", $-   ,May
CA-2015-897,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-02-2015,5887,India,India,8095,Assigned,259, $500.0 ," $1,29,500.0 "," $3,367.0 ",Feb
CA-2015-898,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-02-2015,5887,India,India,8095,Not assigned,381, $500.0 ," $1,90,500.0 ", $-   ,Feb
CA-2015-899,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-03-2015,5887,Singapore,Singapore,8095,Not assigned,352, $500.0 ," $1,76,000.0 ", $-   ,Mar
CA-2015-900,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-10-2015,5887,India,India,8095,Assigned,448, $500.0 ," $2,24,000.0 "," $11,200.0 ",Oct
CA-2015-901,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-04-2015,5887,India,India,8095,Assigned,329, $500.0 ," $1,64,500.0 "," $3,838.3 ",Apr
CA-2015-902,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-06-2015,5887,Egypt,Egypt,8095,Not assigned,442, $500.0 ," $2,21,000.0 ", $-   ,Jun
CA-2015-903,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-10-2015,5887,India,India,8095,Not assigned,64, $500.0 ," $32,000.0 ", $-   ,Oct
CA-2015-904,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-09-2015,5887,Sri Lanka,Sri Lanka,8095,Assigned,170, $500.0 ," $85,000.0 "," $4,533.3 ",Sep
CA-2015-905,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-12-2015,5887,Egypt,Egypt,8095,Not assigned,462, $500.0 ," $2,31,000.0 ", $-   ,Dec
CA-2015-906,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-09-2015,5887,Egypt,Egypt,8095,Not assigned,186, $500.0 ," $93,000.0 ", $-   ,Sep
CA-2015-907,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-01-2015,5887,Egypt,Egypt,8095,Not assigned,163, $500.0 ," $81,500.0 ", $-   ,Jan
CA-2015-908,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-04-2015,5887,Lebanon,Lebanon,8095,Not assigned,80, $500.0 ," $40,000.0 ", $-   ,Apr
CA-2015-909,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-11-2015,5887,Lebanon,Lebanon,8095,Not assigned,212, $500.0 ," $1,06,000.0 ", $-   ,Nov
CA-2015-910,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-06-2015,5887,Lebanon,Lebanon,8095,Not assigned,384, $500.0 ," $1,92,000.0 ", $-   ,Jun
CA-2015-911,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-05-2015,5887,India,India,8095,Not assigned,465, $500.0 ," $2,32,500.0 ", $-   ,May
CA-2015-912,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-01-2015,5887,Kenya,Kenya,8095,Assigned,208, $500.0 ," $1,04,000.0 "," $2,496.0 ",Jan
CA-2015-913,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-12-2015,5887,Kenya,Kenya,8095,Assigned,68, $500.0 ," $34,000.0 ", $816.0 ,Dec
CA-2015-914,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-04-2015,5887,Egypt,Egypt,8095,Not assigned,385, $500.0 ," $1,92,500.0 ", $-   ,Apr
CA-2015-915,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-10-2015,5887,Egypt,Egypt,8095,Not assigned,379, $500.0 ," $1,89,500.0 ", $-   ,Oct
CA-2015-916,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-05-2015,5887,Thailand,Thailand,8095,Assigned,425, $500.0 ," $2,12,500.0 "," $6,941.7 ",May
CA-2015-917,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-09-2015,5887,Thailand,Thailand,8095,Assigned,83, $500.0 ," $41,500.0 "," $2,296.3 ",Sep
CA-2015-918,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-11-2015,5887,Thailand,Thailand,8095,Assigned,53, $500.0 ," $26,500.0 "," $1,537.0 ",Nov
CA-2015-919,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-06-2015,5887,Thailand,Thailand,8095,Assigned,400, $500.0 ," $2,00,000.0 "," $9,600.0 ",Jun
CA-2015-920,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-04-2015,5887,Taiwan,China,8095,Not assigned,452, $500.0 ," $2,26,000.0 ", $-   ,Apr
CA-2015-921,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-04-2015,5887,Singapore,Singapore,8095,Not assigned,285, $500.0 ," $1,42,500.0 ", $-   ,Apr
CA-2015-922,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-10-2015,5887,Egypt,Egypt,8095,Not assigned,32, $500.0 ," $16,000.0 ", $-   ,Oct
CA-2015-923,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-08-2015,5887,Taiwan,China,8095,Not assigned,445, $500.0 ," $2,22,500.0 ", $-   ,Aug
CA-2015-924,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-01-2015,5887,India,India,8095,Assigned,328, $500.0 ," $1,64,000.0 "," $9,949.3 ",Jan
CA-2015-925,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-11-2015,5887,India,India,8095,Not assigned,427, $500.0 ," $2,13,500.0 ", $-   ,Nov
CA-2015-926,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-07-2015,5887,India,India,8095,Not assigned,320, $500.0 ," $1,60,000.0 ", $-   ,Jul
CA-2015-927,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-03-2015,5887,India,India,8095,Assigned,198, $500.0 ," $99,000.0 "," $1,782.0 ",Mar
CA-2015-928,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-03-2015,5887,India,India,8095,Not assigned,105, $500.0 ," $52,500.0 ", $-   ,Mar
CA-2015-929,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-09-2015,5887,Thailand,Thailand,8095,Assigned,277, $500.0 ," $1,38,500.0 "," $4,339.7 ",Sep
CA-2015-930,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-03-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,407, $500.0 ," $2,03,500.0 ", $-   ,Mar
CA-2015-931,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-01-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,303, $500.0 ," $1,51,500.0 ", $-   ,Jan
CA-2015-932,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-01-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,10, $500.0 ," $5,000.0 ", $-   ,Jan
CA-2015-933,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-11-2015,5887,Indonesia,Indonesia,8095,Assigned,3, $500.0 ," $1,500.0 ", $42.0 ,Nov
CA-2015-934,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-11-2015,5887,Indonesia,Indonesia,8095,Assigned,487, $500.0 ," $2,43,500.0 "," $12,499.7 ",Nov
CA-2015-935,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-06-2015,5887,India,India,8095,Assigned,372, $500.0 ," $1,86,000.0 "," $8,184.0 ",Jun
CA-2015-936,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-11-2015,5887,India,India,8095,Assigned,73, $500.0 ," $36,500.0 "," $2,360.3 ",Nov
CA-2015-937,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-07-2015,5887,Thailand,Thailand,8095,Assigned,470, $500.0 ," $2,35,000.0 "," $3,760.0 ",Jul
CA-2015-938,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-07-2015,5887,Thailand,Thailand,8095,Assigned,479, $500.0 ," $2,39,500.0 "," $14,370.0 ",Jul
CA-2015-939,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-01-2015,5887,South Korea,South Korea,8095,Not assigned,375, $500.0 ," $1,87,500.0 ", $-   ,Jan
CA-2015-940,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-08-2015,5887,India,India,8095,Not assigned,225, $500.0 ," $1,12,500.0 ", $-   ,Aug
CA-2015-941,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-06-2015,5887,Malaysia,Malaysia,8095,Not assigned,358, $500.0 ," $1,79,000.0 ", $-   ,Jun
CA-2015-942,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-03-2015,5887,Kenya,Kenya,8095,Assigned,116, $500.0 ," $58,000.0 ", $657.3 ,Mar
CA-2015-943,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-05-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,116, $500.0 ," $58,000.0 ", $-   ,May
CA-2015-944,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-05-2015,5887,Indonesia,Indonesia,8095,Assigned,433, $500.0 ," $2,16,500.0 "," $3,897.0 ",May
CA-2015-945,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-05-2015,5887,Taiwan,China,8095,Not assigned,94, $500.0 ," $47,000.0 ", $-   ,May
CA-2015-946,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-08-2015,5887,India,India,8095,Assigned,41, $500.0 ," $20,500.0 ", $218.7 ,Aug
CA-2015-947,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-09-2015,5887,Vietnam,Japan,8095,Assigned,64, $500.0 ," $32,000.0 "," $1,024.0 ",Sep
CA-2015-948,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-04-2015,5887,Vietnam,Japan,8095,Assigned,264, $500.0 ," $1,32,000.0 "," $1,936.0 ",Apr
CA-2015-949,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-01-2015,5887,Vietnam,Japan,8095,Assigned,113, $500.0 ," $56,500.0 "," $2,335.3 ",Jan
CA-2015-950,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-07-2015,5887,India,India,8095,Not assigned,169, $500.0 ," $84,500.0 ", $-   ,Jul
CA-2015-951,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-01-2015,5887,India,India,8095,Not assigned,386, $500.0 ," $1,93,000.0 ", $-   ,Jan
CA-2015-952,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-12-2015,5887,India,India,8095,Assigned,279, $500.0 ," $1,39,500.0 "," $4,464.0 ",Dec
CA-2015-953,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-07-2015,5887,India,India,8095,Assigned,266, $500.0 ," $1,33,000.0 "," $1,507.3 ",Jul
CA-2015-954,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-11-2015,5887,France,France,8095,Not assigned,436, $500.0 ," $2,18,000.0 ", $-   ,Nov
CA-2015-955,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-06-2015,5887,India,India,8095,Not assigned,279, $500.0 ," $1,39,500.0 ", $-   ,Jun
CA-2015-956,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-07-2015,5887,Thailand,Thailand,8095,Assigned,492, $500.0 ," $2,46,000.0 "," $10,168.0 ",Jul
CA-2015-957,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-10-2015,5887,France,France,8095,Not assigned,359, $500.0 ," $1,79,500.0 ", $-   ,Oct
CA-2015-958,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-02-2015,5887,Singapore,Singapore,8095,Not assigned,142, $500.0 ," $71,000.0 ", $-   ,Feb
CA-2015-959,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-03-2015,5887,India,India,8095,Not assigned,186, $500.0 ," $93,000.0 ", $-   ,Mar
CA-2015-960,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-03-2015,5887,India,India,8095,Not assigned,384, $500.0 ," $1,92,000.0 ", $-   ,Mar
CA-2015-961,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-12-2015,5887,India,India,8095,Not assigned,243, $500.0 ," $1,21,500.0 ", $-   ,Dec
CA-2015-962,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-08-2015,5887,Indonesia,Indonesia,8095,Assigned,50, $500.0 ," $25,000.0 "," $1,100.0 ",Aug
CA-2015-963,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-06-2015,5887,Indonesia,Indonesia,8095,Assigned,386, $500.0 ," $1,93,000.0 "," $7,720.0 ",Jun
CA-2015-964,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-04-2015,5887,Indonesia,Indonesia,8095,Assigned,345, $500.0 ," $1,72,500.0 "," $4,140.0 ",Apr
CA-2015-965,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-06-2015,5887,Indonesia,Indonesia,8095,Assigned,211, $500.0 ," $1,05,500.0 "," $2,532.0 ",Jun
CA-2015-966,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-07-2015,5887,Thailand,Thailand,8095,Assigned,354, $500.0 ," $1,77,000.0 "," $3,540.0 ",Jul
CA-2015-967,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-11-2015,5887,India,India,8095,Not assigned,464, $500.0 ," $2,32,000.0 ", $-   ,Nov
CA-2015-968,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-06-2015,5887,India,India,8095,Assigned,52, $500.0 ," $26,000.0 ", $312.0 ,Jun
CA-2015-969,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-12-2015,5887,Malaysia,Malaysia,8095,Assigned,262, $500.0 ," $1,31,000.0 "," $1,834.0 ",Dec
CA-2015-970,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-09-2015,5887,India,India,8095,Not assigned,255, $500.0 ," $1,27,500.0 ", $-   ,Sep
CA-2015-971,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-01-2015,5887,Nepal,Nepal,8095,Assigned,354, $500.0 ," $1,77,000.0 "," $2,360.0 ",Jan
CA-2015-972,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-12-2015,5887,India,India,8095,Not assigned,205, $500.0 ," $1,02,500.0 ", $-   ,Dec
CA-2015-973,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-04-2015,5887,India,India,8095,Not assigned,388, $500.0 ," $1,94,000.0 ", $-   ,Apr
CA-2015-974,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-01-2015,5887,Indonesia,Indonesia,8095,Assigned,263, $500.0 ," $1,31,500.0 "," $3,156.0 ",Jan
CA-2015-975,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-06-2015,5887,Syria,Lebanon,8095,Assigned,235, $500.0 ," $1,17,500.0 "," $1,331.7 ",Jun
CA-2015-976,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-07-2015,5887,Thailand,Thailand,8095,Not assigned,103, $500.0 ," $51,500.0 ", $-   ,Jul
CA-2015-977,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-05-2015,5887,India,India,8095,Not assigned,86, $500.0 ," $43,000.0 ", $-   ,May
CA-2015-978,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-11-2015,5887,India,India,8095,Not assigned,28, $500.0 ," $14,000.0 ", $-   ,Nov
CA-2015-979,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-04-2015,5887,India,India,8095,Not assigned,53, $500.0 ," $26,500.0 ", $-   ,Apr
CA-2015-980,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-08-2015,5887,India,India,8095,Assigned,276, $500.0 ," $1,38,000.0 "," $8,556.0 ",Aug
CA-2015-981,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-02-2015,5887,Vietnam,Japan,8095,Assigned,284, $500.0 ," $1,42,000.0 "," $5,490.7 ",Feb
CA-2015-982,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-10-2015,5887,Vietnam,Netherlands,8095,Assigned,40, $500.0 ," $20,000.0 ", $866.7 ,Oct
CA-2015-983,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-04-2015,5887,India,India,8095,Not assigned,441, $500.0 ," $2,20,500.0 ", $-   ,Apr
CA-2015-984,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-12-2015,5887,India,India,8095,Not assigned,149, $500.0 ," $74,500.0 ", $-   ,Dec
CA-2015-985,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-01-2015,5887,India,India,8095,Not assigned,361, $500.0 ," $1,80,500.0 ", $-   ,Jan
CA-2015-986,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-02-2015,5887,Syria,Lebanon,8095,Assigned,5, $500.0 ," $2,500.0 ", $143.3 ,Feb
CA-2015-987,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-09-2015,5887,Oman,Oman,8095,Not assigned,451, $500.0 ," $2,25,500.0 ", $-   ,Sep
DE-2015-988,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,24-11-2015,5754,India,India,7904,Assigned,8, $314.0 ," $2,512.0 ", $229.3 ,Nov
CA-2015-989,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-09-2015,5887,India,India,8095,Not assigned,347, $500.0 ," $1,73,500.0 ", $-   ,Sep
CA-2015-990,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-08-2015,5887,Oman,Oman,8095,Not assigned,233, $500.0 ," $1,16,500.0 ", $-   ,Aug
CA-2015-991,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-07-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,448, $500.0 ," $2,24,000.0 ", $-   ,Jul
CA-2015-992,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-01-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,116, $500.0 ," $58,000.0 ", $-   ,Jan
CA-2015-993,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-05-2015,5887,India,India,8095,Not assigned,121, $500.0 ," $60,500.0 ", $-   ,May
CA-2015-994,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-04-2015,5887,India,India,8095,Not assigned,289, $500.0 ," $1,44,500.0 ", $-   ,Apr
CA-2015-995,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-07-2015,5887,Philippines,Philippines,8095,Assigned,255, $500.0 ," $1,27,500.0 "," $8,330.0 ",Jul
CA-2015-996,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-12-2015,5887,Ethiopia,Ethiopia,8095,Assigned,379, $500.0 ," $1,89,500.0 "," $9,096.0 ",Dec
CA-2015-997,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-11-2015,5887,Philippines,Philippines,8095,Assigned,440, $500.0 ," $2,20,000.0 "," $3,666.7 ",Nov
CA-2015-998,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-08-2015,5887,Philippines,Philippines,8095,Assigned,103, $500.0 ," $51,500.0 "," $3,330.3 ",Aug
CA-2015-999,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-11-2015,5887,South Korea,South Korea,8095,Assigned,170, $500.0 ," $85,000.0 "," $2,040.0 ",Nov
CA-2015-1000,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-08-2015,5887,Hong Kong,China,8095,Not assigned,45, $500.0 ," $22,500.0 ", $-   ,Aug
CA-2015-1001,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-09-2015,5887,India,India,8095,Not assigned,225, $500.0 ," $1,12,500.0 ", $-   ,Sep
CA-2015-1002,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-08-2015,5887,India,India,8095,Assigned,465, $500.0 ," $2,32,500.0 "," $9,610.0 ",Aug
CA-2015-1003,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-11-2015,5887,India,India,8095,Assigned,193, $500.0 ," $96,500.0 "," $4,503.3 ",Nov
CA-2015-1004,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-12-2015,5887,India,India,8095,Assigned,397, $500.0 ," $1,98,500.0 "," $2,514.3 ",Dec
CA-2015-1005,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-11-2015,5887,India,India,8095,Not assigned,370, $500.0 ," $1,85,000.0 ", $-   ,Nov
CA-2015-1006,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-02-2015,5887,India,India,8095,Assigned,460, $500.0 ," $2,30,000.0 "," $5,826.7 ",Feb
CA-2015-1007,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-08-2015,5887,India,India,8095,Not assigned,33, $500.0 ," $16,500.0 ", $-   ,Aug
CA-2015-1008,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-08-2015,5887,India,India,8095,Not assigned,366, $500.0 ," $1,83,000.0 ", $-   ,Aug
CA-2015-1009,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-09-2015,5887,India,India,8095,Assigned,480, $500.0 ," $2,40,000.0 "," $6,560.0 ",Sep
CA-2015-1010,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-11-2015,5887,India,India,8095,Assigned,435, $500.0 ," $2,17,500.0 "," $6,380.0 ",Nov
CA-2015-1011,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-12-2015,5887,Vietnam,Japan,8095,Assigned,272, $500.0 ," $1,36,000.0 "," $2,810.7 ",Dec
CA-2015-1012,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-03-2015,5887,India,India,8095,Assigned,155, $500.0 ," $77,500.0 "," $1,808.3 ",Mar
CA-2015-1013,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-06-2015,5887,India,India,8095,Not assigned,112, $500.0 ," $56,000.0 ", $-   ,Jun
CA-2015-1014,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-03-2015,5887,India,India,8095,Not assigned,68, $500.0 ," $34,000.0 ", $-   ,Mar
CA-2015-1015,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-08-2015,5887,India,India,8095,Assigned,388, $500.0 ," $1,94,000.0 "," $12,674.7 ",Aug
CA-2015-1016,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-06-2015,5887,India,India,8095,Assigned,379, $500.0 ," $1,89,500.0 "," $12,254.3 ",Jun
CA-2015-1017,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-09-2015,5887,Indonesia,Indonesia,8095,Assigned,414, $500.0 ," $2,07,000.0 "," $6,624.0 ",Sep
CA-2015-1018,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-04-2015,5887,Vietnam,Japan,8095,Assigned,419, $500.0 ," $2,09,500.0 "," $4,050.3 ",Apr
CA-2015-1019,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-12-2015,5887,Germany,Netherlands,8095,Not assigned,244, $500.0 ," $1,22,000.0 ", $-   ,Dec
CA-2015-1020,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-10-2015,5887,Netherlands,Netherlands,8095,Not assigned,30, $500.0 ," $15,000.0 ", $-   ,Oct
CA-2015-1021,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-03-2015,5887,India,India,8095,Assigned,111, $500.0 ," $55,500.0 "," $1,850.0 ",Mar
CA-2015-1022,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-02-2015,5887,India,India,8095,Assigned,259, $500.0 ," $1,29,500.0 "," $4,057.7 ",Feb
CA-2015-1023,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-07-2015,5887,Syria,Lebanon,8095,Assigned,463, $500.0 ," $2,31,500.0 "," $14,970.3 ",Jul
CA-2015-1024,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-09-2015,5887,Egypt,Egypt,8095,Not assigned,206, $500.0 ," $1,03,000.0 ", $-   ,Sep
CA-2015-1025,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-06-2015,5887,Morocco,Netherlands,8095,Not assigned,457, $500.0 ," $2,28,500.0 ", $-   ,Jun
CA-2015-1026,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-09-2015,5887,Thailand,Thailand,8095,Assigned,495, $500.0 ," $2,47,500.0 "," $12,540.0 ",Sep
CA-2015-1027,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-08-2015,5887,Taiwan,China,8095,Not assigned,290, $500.0 ," $1,45,000.0 ", $-   ,Aug
IN-2015-1028,Bevacizumab,Avastin,Genentech/Roche,Cancer,01-06-2015,5685,India,India,8209,Not assigned,284, $243.0 ," $69,012.0 ", $-   ,Jun
IN-2015-1029,Bevacizumab,Avastin,Genentech/Roche,Cancer,03-04-2015,5685,India,India,8209,Not assigned,460, $243.0 ," $1,11,780.0 ", $-   ,Apr
IN-2015-1030,Bevacizumab,Avastin,Genentech/Roche,Cancer,18-06-2015,5685,India,India,8209,Assigned,327, $243.0 ," $79,461.0 "," $2,289.0 ",Jun
IN-2015-1031,Bevacizumab,Avastin,Genentech/Roche,Cancer,29-07-2015,5685,India,India,8209,Assigned,289, $243.0 ," $70,227.0 "," $2,697.3 ",Jul
IN-2015-1032,Bevacizumab,Avastin,Genentech/Roche,Cancer,26-10-2015,5685,India,India,8209,Assigned,61, $243.0 ," $14,823.0 "," $1,830.0 ",Oct
IN-2015-1033,Bevacizumab,Avastin,Genentech/Roche,Cancer,06-11-2015,5685,India,India,8209,Assigned,332, $243.0 ," $80,676.0 "," $9,517.3 ",Nov
IN-2015-1034,Bevacizumab,Avastin,Genentech/Roche,Cancer,01-04-2015,5685,India,India,8209,Not assigned,398, $243.0 ," $96,714.0 ", $-   ,Apr
IN-2015-1035,Bevacizumab,Avastin,Genentech/Roche,Cancer,29-04-2015,5685,India,India,8209,Assigned,263, $243.0 ," $63,909.0 "," $5,698.3 ",Apr
IN-2015-1036,Bevacizumab,Avastin,Genentech/Roche,Cancer,19-07-2015,5685,India,India,8209,Assigned,203, $243.0 ," $49,329.0 "," $2,706.7 ",Jul
IN-2015-1037,Bevacizumab,Avastin,Genentech/Roche,Cancer,03-08-2015,5685,India,India,8209,Not assigned,452, $243.0 ," $1,09,836.0 ", $-   ,Aug
IN-2015-1038,Bevacizumab,Avastin,Genentech/Roche,Cancer,23-01-2015,5685,India,India,8209,Assigned,475, $243.0 ," $1,15,425.0 "," $10,450.0 ",Jan
IN-2015-1039,Bevacizumab,Avastin,Genentech/Roche,Cancer,26-12-2015,5685,India,India,8209,Not assigned,87, $243.0 ," $21,141.0 ", $-   ,Dec
IN-2015-1040,Bevacizumab,Avastin,Genentech/Roche,Cancer,18-02-2015,5685,India,India,8209,Not assigned,397, $243.0 ," $96,471.0 ", $-   ,Feb
IN-2015-1041,Bevacizumab,Avastin,Genentech/Roche,Cancer,28-06-2015,5685,India,India,8209,Assigned,290, $243.0 ," $70,470.0 "," $7,926.7 ",Jun
IN-2015-1042,Bevacizumab,Avastin,Genentech/Roche,Cancer,06-05-2015,5685,India,India,8209,Assigned,434, $243.0 ," $1,05,462.0 "," $2,025.3 ",May
IN-2015-1043,Bevacizumab,Avastin,Genentech/Roche,Cancer,12-12-2015,5685,India,India,8209,Not assigned,399, $243.0 ," $96,957.0 ", $-   ,Dec
IN-2015-1044,Bevacizumab,Avastin,Genentech/Roche,Cancer,10-03-2015,5685,India,India,8209,Not assigned,35, $243.0 ," $8,505.0 ", $-   ,Mar
IN-2015-1045,Bevacizumab,Avastin,Genentech/Roche,Cancer,14-03-2015,5685,India,India,8209,Not assigned,337, $243.0 ," $81,891.0 ", $-   ,Mar
IN-2015-1046,Bevacizumab,Avastin,Genentech/Roche,Cancer,05-02-2015,5685,India,India,8209,Not assigned,88, $243.0 ," $21,384.0 ", $-   ,Feb
IN-2015-1047,Bevacizumab,Avastin,Genentech/Roche,Cancer,26-11-2015,5685,India,India,8209,Not assigned,302, $243.0 ," $73,386.0 ", $-   ,Nov
IN-2015-1048,Bevacizumab,Avastin,Genentech/Roche,Cancer,15-11-2015,5685,India,India,8209,Not assigned,241, $243.0 ," $58,563.0 ", $-   ,Nov
IN-2015-1049,Bevacizumab,Avastin,Genentech/Roche,Cancer,06-04-2015,5685,India,India,8209,Not assigned,440, $243.0 ," $1,06,920.0 ", $-   ,Apr
IN-2015-1050,Bevacizumab,Avastin,Genentech/Roche,Cancer,04-09-2015,5685,India,India,8209,Not assigned,373, $243.0 ," $90,639.0 ", $-   ,Sep
IN-2015-1051,Bevacizumab,Avastin,Genentech/Roche,Cancer,20-01-2015,5685,India,India,8209,Not assigned,346, $243.0 ," $84,078.0 ", $-   ,Jan
IN-2015-1052,Bevacizumab,Avastin,Genentech/Roche,Cancer,23-11-2015,5685,India,India,8209,Not assigned,374, $243.0 ," $90,882.0 ", $-   ,Nov
IN-2015-1053,Bevacizumab,Avastin,Genentech/Roche,Cancer,21-07-2015,5685,India,India,8209,Assigned,11, $243.0 ," $2,673.0 ", $311.7 ,Jul
IN-2015-1054,Bevacizumab,Avastin,Genentech/Roche,Cancer,20-12-2015,5685,India,India,8209,Not assigned,182, $243.0 ," $44,226.0 ", $-   ,Dec
IN-2015-1055,Bevacizumab,Avastin,Genentech/Roche,Cancer,04-02-2015,5685,India,India,8209,Assigned,451, $243.0 ," $1,09,593.0 "," $11,726.0 ",Feb
IN-2015-1056,Bevacizumab,Avastin,Genentech/Roche,Cancer,27-05-2015,5685,India,India,8209,Not assigned,57, $243.0 ," $13,851.0 ", $-   ,May
IN-2015-1057,Bevacizumab,Avastin,Genentech/Roche,Cancer,27-09-2015,5685,India,India,8209,Not assigned,371, $243.0 ," $90,153.0 ", $-   ,Sep
IN-2015-1058,Bevacizumab,Avastin,Genentech/Roche,Cancer,12-03-2015,5685,India,India,8209,Not assigned,89, $243.0 ," $21,627.0 ", $-   ,Mar
AR-2015-1059,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,20-12-2015,5653,India,India,7933,Assigned,355, $231.0 ," $82,005.0 "," $6,271.7 ",Dec
IN-2015-1060,Bevacizumab,Avastin,Genentech/Roche,Cancer,29-05-2015,5685,India,India,8209,Not assigned,241, $243.0 ," $58,563.0 ", $-   ,May
IN-2015-1061,Bevacizumab,Avastin,Genentech/Roche,Cancer,01-09-2015,5685,India,India,8209,Not assigned,301, $243.0 ," $73,143.0 ", $-   ,Sep
IN-2015-1062,Bevacizumab,Avastin,Genentech/Roche,Cancer,08-07-2015,5685,India,India,8209,Not assigned,171, $243.0 ," $41,553.0 ", $-   ,Jul
IN-2015-1063,Bevacizumab,Avastin,Genentech/Roche,Cancer,11-06-2015,5685,India,India,8209,Assigned,485, $243.0 ," $1,17,855.0 "," $4,526.7 ",Jun
IN-2015-1064,Bevacizumab,Avastin,Genentech/Roche,Cancer,01-12-2015,5685,India,India,8209,Not assigned,436, $243.0 ," $1,05,948.0 ", $-   ,Dec
IN-2015-1065,Bevacizumab,Avastin,Genentech/Roche,Cancer,24-05-2015,5685,India,India,8209,Not assigned,29, $243.0 ," $7,047.0 ", $-   ,May
IN-2015-1066,Bevacizumab,Avastin,Genentech/Roche,Cancer,20-12-2015,5685,India,India,8209,Not assigned,76, $243.0 ," $18,468.0 ", $-   ,Dec
IN-2015-1067,Bevacizumab,Avastin,Genentech/Roche,Cancer,12-11-2015,5685,India,India,8209,Not assigned,488, $243.0 ," $1,18,584.0 ", $-   ,Nov
IN-2015-1068,Bevacizumab,Avastin,Genentech/Roche,Cancer,04-11-2015,5685,India,India,8209,Not assigned,429, $243.0 ," $1,04,247.0 ", $-   ,Nov
IN-2015-1069,Bevacizumab,Avastin,Genentech/Roche,Cancer,25-08-2015,5685,India,India,8209,Not assigned,124, $243.0 ," $30,132.0 ", $-   ,Aug
IN-2015-1070,Bevacizumab,Avastin,Genentech/Roche,Cancer,13-02-2015,5685,India,India,8209,Not assigned,494, $243.0 ," $1,20,042.0 ", $-   ,Feb
IN-2015-1071,Bevacizumab,Avastin,Genentech/Roche,Cancer,06-09-2015,5685,India,India,8209,Not assigned,193, $243.0 ," $46,899.0 ", $-   ,Sep
IN-2015-1072,Bevacizumab,Avastin,Genentech/Roche,Cancer,15-10-2015,5685,India,India,8209,Assigned,248, $243.0 ," $60,264.0 "," $3,389.3 ",Oct
IN-2015-1073,Bevacizumab,Avastin,Genentech/Roche,Cancer,07-08-2015,5685,India,India,8209,Not assigned,348, $243.0 ," $84,564.0 ", $-   ,Aug
IN-2015-1074,Bevacizumab,Avastin,Genentech/Roche,Cancer,12-12-2015,5685,India,India,8209,Not assigned,267, $243.0 ," $64,881.0 ", $-   ,Dec
IN-2015-1075,Bevacizumab,Avastin,Genentech/Roche,Cancer,09-04-2015,5685,India,India,8209,Assigned,161, $243.0 ," $39,123.0 "," $4,830.0 ",Apr
IN-2015-1076,Bevacizumab,Avastin,Genentech/Roche,Cancer,24-01-2015,5685,India,India,8209,Assigned,338, $243.0 ," $82,134.0 "," $11,154.0 ",Jan
IN-2015-1077,Bevacizumab,Avastin,Genentech/Roche,Cancer,28-08-2015,5685,India,India,8209,Not assigned,405, $243.0 ," $98,415.0 ", $-   ,Aug
IN-2015-1078,Bevacizumab,Avastin,Genentech/Roche,Cancer,04-02-2015,5685,India,India,8209,Assigned,347, $243.0 ," $84,321.0 "," $1,735.0 ",Feb
IN-2015-1079,Bevacizumab,Avastin,Genentech/Roche,Cancer,18-01-2015,5685,India,India,8209,Not assigned,302, $243.0 ," $73,386.0 ", $-   ,Jan
AR-2015-1080,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,05-04-2015,5653,India,India,7933,Assigned,269, $231.0 ," $62,139.0 "," $3,138.3 ",Apr
IN-2015-1081,Bevacizumab,Avastin,Genentech/Roche,Cancer,17-06-2015,5685,India,India,8209,Assigned,415, $243.0 ," $1,00,845.0 "," $11,066.7 ",Jun
IN-2015-1082,Bevacizumab,Avastin,Genentech/Roche,Cancer,14-04-2015,5685,India,India,8209,Not assigned,272, $243.0 ," $66,096.0 ", $-   ,Apr
IN-2015-1083,Bevacizumab,Avastin,Genentech/Roche,Cancer,07-07-2015,5685,India,India,8209,Not assigned,474, $243.0 ," $1,15,182.0 ", $-   ,Jul
IN-2015-1084,Bevacizumab,Avastin,Genentech/Roche,Cancer,05-09-2015,5685,India,India,8209,Not assigned,4, $243.0 , $972.0 , $-   ,Sep
IN-2015-1085,Bevacizumab,Avastin,Genentech/Roche,Cancer,17-02-2015,5685,Egypt,Egypt,8209,Assigned,338, $243.0 ," $82,134.0 "," $2,704.0 ",Feb
IN-2015-1086,Bevacizumab,Avastin,Genentech/Roche,Cancer,21-11-2015,5685,Egypt,Egypt,8209,Assigned,452, $243.0 ," $1,09,836.0 "," $5,725.3 ",Nov
IN-2015-1087,Bevacizumab,Avastin,Genentech/Roche,Cancer,03-08-2015,5685,Kenya,Kenya,8209,Assigned,429, $243.0 ," $1,04,247.0 "," $13,871.0 ",Aug
IN-2015-1088,Bevacizumab,Avastin,Genentech/Roche,Cancer,05-12-2015,5685,Kenya,Kenya,8209,Assigned,354, $243.0 ," $86,022.0 "," $6,608.0 ",Dec
IN-2015-1089,Bevacizumab,Avastin,Genentech/Roche,Cancer,07-04-2015,5685,Kenya,Kenya,8209,Assigned,7, $243.0 ," $1,701.0 ", $102.7 ,Apr
IN-2015-1090,Bevacizumab,Avastin,Genentech/Roche,Cancer,20-09-2015,5685,Sudan,Utd.Arab Emir.,8209,Assigned,379, $243.0 ," $92,097.0 "," $3,411.0 ",Sep
IN-2015-1091,Bevacizumab,Avastin,Genentech/Roche,Cancer,20-08-2015,5685,Sudan,Utd.Arab Emir.,8209,Assigned,67, $243.0 ," $16,281.0 "," $1,965.3 ",Aug
IN-2015-1092,Bevacizumab,Avastin,Genentech/Roche,Cancer,13-05-2015,5685,Sudan,Utd.Arab Emir.,8209,Assigned,18, $243.0 ," $4,374.0 ", $360.0 ,May
IN-2015-1093,Bevacizumab,Avastin,Genentech/Roche,Cancer,27-01-2015,5685,Nepal,Nepal,8209,Assigned,28, $243.0 ," $6,804.0 ", $634.7 ,Jan
IN-2015-1094,Bevacizumab,Avastin,Genentech/Roche,Cancer,25-05-2015,5685,South Korea,South Korea,8209,Assigned,473, $243.0 ," $1,14,939.0 "," $10,248.3 ",May
IN-2015-1095,Bevacizumab,Avastin,Genentech/Roche,Cancer,06-09-2015,5685,Egypt,Egypt,8209,Not assigned,129, $243.0 ," $31,347.0 ", $-   ,Sep
IN-2015-1096,Bevacizumab,Avastin,Genentech/Roche,Cancer,23-03-2015,5685,Nigeria,Nigeria,8209,Not assigned,222, $243.0 ," $53,946.0 ", $-   ,Mar
IN-2015-1097,Bevacizumab,Avastin,Genentech/Roche,Cancer,11-04-2015,5685,Sudan,Utd.Arab Emir.,8209,Assigned,7, $243.0 ," $1,701.0 ", $119.0 ,Apr
IN-2015-1098,Bevacizumab,Avastin,Genentech/Roche,Cancer,03-08-2015,5685,Utd.Arab Emir.,Utd.Arab Emir.,8209,Not assigned,293, $243.0 ," $71,199.0 ", $-   ,Aug
IN-2015-1099,Bevacizumab,Avastin,Genentech/Roche,Cancer,25-11-2015,5685,Cambodia,Cambodia,8209,Not assigned,311, $243.0 ," $75,573.0 ", $-   ,Nov
IN-2015-1100,Bevacizumab,Avastin,Genentech/Roche,Cancer,28-01-2015,5685,Cambodia,Cambodia,8209,Not assigned,322, $243.0 ," $78,246.0 ", $-   ,Jan
IN-2015-1101,Bevacizumab,Avastin,Genentech/Roche,Cancer,30-09-2015,5685,Thailand,Thailand,8209,Assigned,278, $243.0 ," $67,554.0 "," $4,077.3 ",Sep
IN-2015-1102,Bevacizumab,Avastin,Genentech/Roche,Cancer,30-11-2015,5685,Thailand,Thailand,8209,Assigned,416, $243.0 ," $1,01,088.0 "," $13,173.3 ",Nov
IN-2015-1103,Bevacizumab,Avastin,Genentech/Roche,Cancer,26-07-2015,5685,Thailand,Thailand,8209,Assigned,111, $243.0 ," $26,973.0 ", $481.0 ,Jul
IN-2015-1104,Bevacizumab,Avastin,Genentech/Roche,Cancer,07-10-2015,5685,Thailand,Thailand,8209,Assigned,418, $243.0 ," $1,01,574.0 "," $11,286.0 ",Oct
IN-2015-1105,Bevacizumab,Avastin,Genentech/Roche,Cancer,08-04-2015,5685,Uganda,Netherlands,8209,Assigned,16, $243.0 ," $3,888.0 ", $517.3 ,Apr
IN-2015-1106,Bevacizumab,Avastin,Genentech/Roche,Cancer,05-03-2015,5685,Indonesia,Indonesia,8209,Not assigned,54, $243.0 ," $13,122.0 ", $-   ,Mar
IN-2015-1107,Bevacizumab,Avastin,Genentech/Roche,Cancer,15-03-2015,5685,Indonesia,Indonesia,8209,Not assigned,176, $243.0 ," $42,768.0 ", $-   ,Mar
IN-2015-1108,Bevacizumab,Avastin,Genentech/Roche,Cancer,03-12-2015,5685,Singapore,Singapore,8209,Not assigned,335, $243.0 ," $81,405.0 ", $-   ,Dec
IN-2015-1109,Bevacizumab,Avastin,Genentech/Roche,Cancer,27-02-2015,5685,Thailand,Thailand,8209,Assigned,408, $243.0 ," $99,144.0 "," $8,568.0 ",Feb
IN-2015-1110,Bevacizumab,Avastin,Genentech/Roche,Cancer,09-01-2015,5685,Syria,Lebanon,8209,Assigned,490, $243.0 ," $1,19,070.0 "," $4,410.0 ",Jan
IN-2015-1111,Bevacizumab,Avastin,Genentech/Roche,Cancer,12-01-2015,5685,Egypt,Egypt,8209,Not assigned,486, $243.0 ," $1,18,098.0 ", $-   ,Jan
IN-2015-1112,Bevacizumab,Avastin,Genentech/Roche,Cancer,21-07-2015,5685,Yemen,Yemen,8209,Not assigned,186, $243.0 ," $45,198.0 ", $-   ,Jul
IN-2015-1113,Bevacizumab,Avastin,Genentech/Roche,Cancer,13-08-2015,5685,Yemen,Yemen,8209,Not assigned,371, $243.0 ," $90,153.0 ", $-   ,Aug
IN-2015-1114,Bevacizumab,Avastin,Genentech/Roche,Cancer,07-05-2015,5685,Nepal,Nepal,8209,Assigned,389, $243.0 ," $94,527.0 "," $7,261.3 ",May
IN-2015-1115,Bevacizumab,Avastin,Genentech/Roche,Cancer,03-09-2015,5685,Nepal,Nepal,8209,Assigned,155, $243.0 ," $37,665.0 "," $5,166.7 ",Sep
IN-2015-1116,Bevacizumab,Avastin,Genentech/Roche,Cancer,28-01-2015,5685,Nepal,Nepal,8209,Assigned,10, $243.0 ," $2,430.0 ", $296.7 ,Jan
IN-2015-1117,Bevacizumab,Avastin,Genentech/Roche,Cancer,18-02-2015,5685,Nepal,Nepal,8209,Assigned,370, $243.0 ," $89,910.0 "," $6,166.7 ",Feb
IN-2015-1118,Bevacizumab,Avastin,Genentech/Roche,Cancer,29-05-2015,5685,Nepal,Nepal,8209,Assigned,105, $243.0 ," $25,515.0 "," $2,660.0 ",May
IN-2015-1119,Bevacizumab,Avastin,Genentech/Roche,Cancer,07-01-2015,5685,Nepal,Nepal,8209,Assigned,486, $243.0 ," $1,18,098.0 "," $5,670.0 ",Jan
IN-2015-1120,Bevacizumab,Avastin,Genentech/Roche,Cancer,09-04-2015,5685,Nepal,Nepal,8209,Assigned,103, $243.0 ," $25,029.0 "," $3,124.3 ",Apr
IN-2015-1121,Bevacizumab,Avastin,Genentech/Roche,Cancer,21-05-2015,5685,Egypt,Egypt,8209,Not assigned,252, $243.0 ," $61,236.0 ", $-   ,May
IN-2015-1122,Bevacizumab,Avastin,Genentech/Roche,Cancer,15-08-2015,5685,Kenya,Kenya,8209,Assigned,118, $243.0 ," $28,674.0 "," $1,298.0 ",Aug
IN-2015-1123,Bevacizumab,Avastin,Genentech/Roche,Cancer,17-11-2015,5685,Cambodia,Cambodia,8209,Not assigned,166, $243.0 ," $40,338.0 ", $-   ,Nov
IN-2015-1124,Bevacizumab,Avastin,Genentech/Roche,Cancer,13-12-2015,5685,Egypt,Egypt,8209,Not assigned,176, $243.0 ," $42,768.0 ", $-   ,Dec
IN-2015-1125,Bevacizumab,Avastin,Genentech/Roche,Cancer,28-05-2015,5685,Indonesia,Indonesia,8209,Assigned,103, $243.0 ," $25,029.0 "," $2,334.7 ",May
IN-2015-1126,Bevacizumab,Avastin,Genentech/Roche,Cancer,14-09-2015,5685,Indonesia,Indonesia,8209,Assigned,140, $243.0 ," $34,020.0 "," $3,080.0 ",Sep
IN-2015-1127,Bevacizumab,Avastin,Genentech/Roche,Cancer,14-12-2015,5685,Malaysia,Malaysia,8209,Not assigned,67, $243.0 ," $16,281.0 ", $-   ,Dec
IN-2015-1128,Bevacizumab,Avastin,Genentech/Roche,Cancer,27-09-2015,5685,Netherlands,Netherlands,8209,Assigned,388, $243.0 ," $94,284.0 "," $7,113.3 ",Sep
IN-2015-1129,Bevacizumab,Avastin,Genentech/Roche,Cancer,07-03-2015,5685,Netherlands,Netherlands,8209,Assigned,488, $243.0 ," $1,18,584.0 "," $3,578.7 ",Mar
IN-2015-1130,Bevacizumab,Avastin,Genentech/Roche,Cancer,19-05-2015,5685,Malaysia,Malaysia,8209,Assigned,337, $243.0 ," $81,891.0 "," $5,729.0 ",May
IN-2015-1131,Bevacizumab,Avastin,Genentech/Roche,Cancer,04-05-2015,5685,Malaysia,Malaysia,8209,Not assigned,237, $243.0 ," $57,591.0 ", $-   ,May
IN-2015-1132,Bevacizumab,Avastin,Genentech/Roche,Cancer,07-06-2015,5685,Kenya,Kenya,8209,Assigned,375, $243.0 ," $91,125.0 "," $8,000.0 ",Jun
IN-2015-1133,Bevacizumab,Avastin,Genentech/Roche,Cancer,05-10-2015,5685,Uganda,Netherlands,8209,Assigned,158, $243.0 ," $38,394.0 "," $5,266.7 ",Oct
IN-2015-1134,Bevacizumab,Avastin,Genentech/Roche,Cancer,09-02-2015,5685,Ethiopia,Ethiopia,8209,Assigned,147, $243.0 ," $35,721.0 "," $1,813.0 ",Feb
IN-2015-1135,Bevacizumab,Avastin,Genentech/Roche,Cancer,18-05-2015,5685,Thailand,Thailand,8209,Assigned,295, $243.0 ," $71,685.0 "," $6,588.3 ",May
IN-2015-1136,Bevacizumab,Avastin,Genentech/Roche,Cancer,22-01-2015,5685,Iran,Iran,8209,Not assigned,13, $243.0 ," $3,159.0 ", $-   ,Jan
IN-2015-1137,Bevacizumab,Avastin,Genentech/Roche,Cancer,15-01-2015,5685,Egypt,Egypt,8209,Not assigned,361, $243.0 ," $87,723.0 ", $-   ,Jan
IN-2015-1138,Bevacizumab,Avastin,Genentech/Roche,Cancer,09-06-2015,5685,Egypt,Egypt,8209,Not assigned,407, $243.0 ," $98,901.0 ", $-   ,Jun
IN-2015-1139,Bevacizumab,Avastin,Genentech/Roche,Cancer,22-01-2015,5685,Nepal,Nepal,8209,Assigned,249, $243.0 ," $60,507.0 "," $4,731.0 ",Jan
IN-2015-1140,Bevacizumab,Avastin,Genentech/Roche,Cancer,07-03-2015,5685,Nepal,Nepal,8209,Not assigned,487, $243.0 ," $1,18,341.0 ", $-   ,Mar
IN-2015-1141,Bevacizumab,Avastin,Genentech/Roche,Cancer,19-09-2015,5685,Cambodia,Cambodia,8209,Assigned,463, $243.0 ," $1,12,509.0 "," $7,871.0 ",Sep
IN-2015-1142,Bevacizumab,Avastin,Genentech/Roche,Cancer,22-03-2015,5685,Vietnam,Netherlands,8209,Assigned,203, $243.0 ," $49,329.0 "," $3,451.0 ",Mar
IN-2015-1143,Bevacizumab,Avastin,Genentech/Roche,Cancer,13-04-2015,5685,Vietnam,Netherlands,8209,Assigned,50, $243.0 ," $12,150.0 ", $950.0 ,Apr
IN-2015-1144,Bevacizumab,Avastin,Genentech/Roche,Cancer,20-09-2015,5685,Egypt,Egypt,8209,Not assigned,330, $243.0 ," $80,190.0 ", $-   ,Sep
IN-2015-1145,Bevacizumab,Avastin,Genentech/Roche,Cancer,20-07-2015,5685,Indonesia,Indonesia,8209,Not assigned,418, $243.0 ," $1,01,574.0 ", $-   ,Jul
IN-2015-1146,Bevacizumab,Avastin,Genentech/Roche,Cancer,20-05-2015,5685,Indonesia,Indonesia,8209,Not assigned,112, $243.0 ," $27,216.0 ", $-   ,May
IN-2015-1147,Bevacizumab,Avastin,Genentech/Roche,Cancer,24-10-2015,5685,Thailand,Thailand,8209,Assigned,332, $243.0 ," $80,676.0 "," $5,865.3 ",Oct
IN-2015-1148,Bevacizumab,Avastin,Genentech/Roche,Cancer,08-05-2015,5685,Thailand,Thailand,8209,Assigned,379, $243.0 ," $92,097.0 "," $8,338.0 ",May
IN-2015-1149,Bevacizumab,Avastin,Genentech/Roche,Cancer,30-09-2015,5685,Thailand,Thailand,8209,Assigned,46, $243.0 ," $11,178.0 ", $214.7 ,Sep
IN-2015-1150,Bevacizumab,Avastin,Genentech/Roche,Cancer,22-06-2015,5685,Egypt,Egypt,8209,Not assigned,60, $243.0 ," $14,580.0 ", $-   ,Jun
IN-2015-1151,Bevacizumab,Avastin,Genentech/Roche,Cancer,09-01-2015,5685,Egypt,Egypt,8209,Not assigned,394, $243.0 ," $95,742.0 ", $-   ,Jan
IN-2015-1152,Bevacizumab,Avastin,Genentech/Roche,Cancer,11-07-2015,5685,Egypt,Egypt,8209,Not assigned,94, $243.0 ," $22,842.0 ", $-   ,Jul
IN-2015-1153,Bevacizumab,Avastin,Genentech/Roche,Cancer,16-05-2015,5685,Cambodia,Cambodia,8209,Not assigned,181, $243.0 ," $43,983.0 ", $-   ,May
IN-2015-1154,Bevacizumab,Avastin,Genentech/Roche,Cancer,26-08-2015,5685,Thailand,Thailand,8209,Assigned,317, $243.0 ," $77,031.0 "," $5,389.0 ",Aug
IN-2015-1155,Bevacizumab,Avastin,Genentech/Roche,Cancer,15-10-2015,5685,Vietnam,Japan,8209,Assigned,166, $243.0 ," $40,338.0 "," $4,316.0 ",Oct
IN-2015-1156,Bevacizumab,Avastin,Genentech/Roche,Cancer,19-03-2015,5685,Vietnam,Japan,8209,Assigned,18, $243.0 ," $4,374.0 ", $168.0 ,Mar
IN-2015-1157,Bevacizumab,Avastin,Genentech/Roche,Cancer,28-01-2015,5685,Taiwan,China,8209,Not assigned,8, $243.0 ," $1,944.0 ", $-   ,Jan
IN-2015-1158,Bevacizumab,Avastin,Genentech/Roche,Cancer,25-02-2015,5685,Hungary,Netherlands,8209,Not assigned,237, $243.0 ," $57,591.0 ", $-   ,Feb
IN-2015-1159,Bevacizumab,Avastin,Genentech/Roche,Cancer,31-03-2015,5685,Netherlands,Netherlands,8209,Not assigned,178, $243.0 ," $43,254.0 ", $-   ,Mar
NE-2015-1160,Glatiramer,Copaxone,Generic,Multiple sclerosis,03-03-2015,5704,India,India,8370,Assigned,307, $451.0 ," $1,38,457.0 "," $4,093.3 ",Mar
NE-2015-1161,Glatiramer,Copaxone,Generic,Multiple sclerosis,03-05-2015,5704,India,India,8370,Not assigned,273, $451.0 ," $1,23,123.0 ", $-   ,May
NE-2015-1162,Glatiramer,Copaxone,Generic,Multiple sclerosis,19-06-2015,5704,India,India,8370,Not assigned,478, $451.0 ," $2,15,578.0 ", $-   ,Jun
NE-2015-1163,Glatiramer,Copaxone,Generic,Multiple sclerosis,05-04-2015,5704,India,India,8370,Assigned,323, $451.0 ," $1,45,673.0 "," $7,106.0 ",Apr
NE-2015-1164,Glatiramer,Copaxone,Generic,Multiple sclerosis,06-08-2015,5704,India,India,8370,Assigned,293, $451.0 ," $1,32,143.0 "," $2,930.0 ",Aug
NE-2015-1165,Glatiramer,Copaxone,Generic,Multiple sclerosis,28-05-2015,5704,India,India,8370,Assigned,488, $451.0 ," $2,20,088.0 "," $8,784.0 ",May
NE-2015-1166,Glatiramer,Copaxone,Generic,Multiple sclerosis,29-01-2015,5704,India,India,8370,Assigned,283, $451.0 ," $1,27,633.0 "," $3,962.0 ",Jan
NE-2015-1167,Glatiramer,Copaxone,Generic,Multiple sclerosis,26-11-2015,5704,India,India,8370,Assigned,391, $451.0 ," $1,76,341.0 "," $9,253.7 ",Nov
NE-2015-1168,Glatiramer,Copaxone,Generic,Multiple sclerosis,27-09-2015,5704,India,India,8370,Assigned,60, $451.0 ," $27,060.0 "," $2,000.0 ",Sep
NE-2015-1169,Glatiramer,Copaxone,Generic,Multiple sclerosis,04-12-2015,5704,India,India,8370,Not assigned,121, $451.0 ," $54,571.0 ", $-   ,Dec
NE-2015-1170,Glatiramer,Copaxone,Generic,Multiple sclerosis,05-10-2015,5704,India,India,8370,Not assigned,332, $451.0 ," $1,49,732.0 ", $-   ,Oct
NE-2015-1171,Glatiramer,Copaxone,Generic,Multiple sclerosis,07-05-2015,5704,India,India,8370,Not assigned,319, $451.0 ," $1,43,869.0 ", $-   ,May
NE-2015-1172,Glatiramer,Copaxone,Generic,Multiple sclerosis,28-03-2015,5704,India,India,8370,Not assigned,478, $451.0 ," $2,15,578.0 ", $-   ,Mar
NE-2015-1173,Glatiramer,Copaxone,Generic,Multiple sclerosis,11-07-2015,5704,India,India,8370,Not assigned,410, $451.0 ," $1,84,910.0 ", $-   ,Jul
NE-2015-1174,Glatiramer,Copaxone,Generic,Multiple sclerosis,09-12-2015,5704,India,India,8370,Not assigned,460, $451.0 ," $2,07,460.0 ", $-   ,Dec
NE-2015-1175,Glatiramer,Copaxone,Generic,Multiple sclerosis,29-11-2015,5704,India,India,8370,Not assigned,65, $451.0 ," $29,315.0 ", $-   ,Nov
NE-2015-1176,Glatiramer,Copaxone,Generic,Multiple sclerosis,14-05-2015,5704,India,India,8370,Not assigned,298, $451.0 ," $1,34,398.0 ", $-   ,May
NE-2015-1177,Glatiramer,Copaxone,Generic,Multiple sclerosis,15-01-2015,5704,India,India,8370,Not assigned,309, $451.0 ," $1,39,359.0 ", $-   ,Jan
NE-2015-1178,Glatiramer,Copaxone,Generic,Multiple sclerosis,16-09-2015,5704,India,India,8370,Not assigned,98, $451.0 ," $44,198.0 ", $-   ,Sep
NE-2015-1179,Glatiramer,Copaxone,Generic,Multiple sclerosis,27-04-2015,5704,India,India,8370,Not assigned,227, $451.0 ," $1,02,377.0 ", $-   ,Apr
NE-2015-1180,Glatiramer,Copaxone,Generic,Multiple sclerosis,18-04-2015,5704,India,India,8370,Not assigned,109, $451.0 ," $49,159.0 ", $-   ,Apr
NE-2015-1181,Glatiramer,Copaxone,Generic,Multiple sclerosis,28-10-2015,5704,India,India,8370,Assigned,429, $451.0 ," $1,93,479.0 "," $10,296.0 ",Oct
NE-2015-1182,Glatiramer,Copaxone,Generic,Multiple sclerosis,18-11-2015,5704,India,India,8370,Not assigned,467, $451.0 ," $2,10,617.0 ", $-   ,Nov
NE-2015-1183,Glatiramer,Copaxone,Generic,Multiple sclerosis,20-07-2015,5704,India,India,8370,Not assigned,90, $451.0 ," $40,590.0 ", $-   ,Jul
NE-2015-1184,Glatiramer,Copaxone,Generic,Multiple sclerosis,14-11-2015,5704,India,India,8370,Assigned,23, $451.0 ," $10,373.0 ", $207.0 ,Nov
NE-2015-1185,Glatiramer,Copaxone,Generic,Multiple sclerosis,11-04-2015,5704,India,India,8370,Assigned,111, $451.0 ," $50,061.0 "," $2,664.0 ",Apr
NE-2015-1186,Glatiramer,Copaxone,Generic,Multiple sclerosis,20-05-2015,5704,India,India,8370,Not assigned,437, $451.0 ," $1,97,087.0 ", $-   ,May
NE-2015-1187,Glatiramer,Copaxone,Generic,Multiple sclerosis,05-12-2015,5704,India,India,8370,Assigned,468, $451.0 ," $2,11,068.0 "," $7,800.0 ",Dec
NE-2015-1188,Glatiramer,Copaxone,Generic,Multiple sclerosis,09-07-2015,5704,India,India,8370,Assigned,87, $451.0 ," $39,237.0 ", $464.0 ,Jul
NE-2015-1189,Glatiramer,Copaxone,Generic,Multiple sclerosis,24-11-2015,5704,India,India,8370,Not assigned,259, $451.0 ," $1,16,809.0 ", $-   ,Nov
NE-2015-1190,Glatiramer,Copaxone,Generic,Multiple sclerosis,02-10-2015,5704,India,India,8370,Not assigned,131, $451.0 ," $59,081.0 ", $-   ,Oct
NE-2015-1191,Glatiramer,Copaxone,Generic,Multiple sclerosis,30-07-2015,5704,India,India,8370,Assigned,259, $451.0 ," $1,16,809.0 "," $5,266.3 ",Jul
NE-2015-1192,Glatiramer,Copaxone,Generic,Multiple sclerosis,11-11-2015,5704,India,India,8370,Assigned,288, $451.0 ," $1,29,888.0 "," $7,104.0 ",Nov
NE-2015-1193,Glatiramer,Copaxone,Generic,Multiple sclerosis,23-02-2015,5704,India,India,8370,Not assigned,201, $451.0 ," $90,651.0 ", $-   ,Feb
NE-2015-1194,Glatiramer,Copaxone,Generic,Multiple sclerosis,12-05-2015,5704,India,India,8370,Not assigned,274, $451.0 ," $1,23,574.0 ", $-   ,May
NE-2015-1195,Glatiramer,Copaxone,Generic,Multiple sclerosis,24-09-2015,5704,India,India,8370,Not assigned,474, $451.0 ," $2,13,774.0 ", $-   ,Sep
NE-2015-1196,Glatiramer,Copaxone,Generic,Multiple sclerosis,26-10-2015,5704,India,India,8370,Not assigned,143, $451.0 ," $64,493.0 ", $-   ,Oct
NE-2015-1197,Glatiramer,Copaxone,Generic,Multiple sclerosis,20-12-2015,5704,India,India,8370,Assigned,353, $451.0 ," $1,59,203.0 "," $1,176.7 ",Dec
NE-2015-1198,Glatiramer,Copaxone,Generic,Multiple sclerosis,07-01-2015,5704,India,India,8370,Not assigned,484, $451.0 ," $2,18,284.0 ", $-   ,Jan
NE-2015-1199,Glatiramer,Copaxone,Generic,Multiple sclerosis,12-05-2015,5704,India,India,8370,Assigned,355, $451.0 ," $1,60,105.0 "," $7,691.7 ",May
NE-2015-1200,Glatiramer,Copaxone,Generic,Multiple sclerosis,05-01-2015,5704,India,India,8370,Not assigned,296, $451.0 ," $1,33,496.0 ", $-   ,Jan
NE-2015-1201,Glatiramer,Copaxone,Generic,Multiple sclerosis,17-09-2015,5704,India,India,8370,Not assigned,291, $451.0 ," $1,31,241.0 ", $-   ,Sep
NE-2015-1202,Glatiramer,Copaxone,Generic,Multiple sclerosis,29-01-2015,5704,India,India,8370,Not assigned,8, $451.0 ," $3,608.0 ", $-   ,Jan
NE-2015-1203,Glatiramer,Copaxone,Generic,Multiple sclerosis,17-06-2015,5704,India,India,8370,Assigned,314, $451.0 ," $1,41,614.0 "," $1,151.3 ",Jun
NE-2015-1204,Glatiramer,Copaxone,Generic,Multiple sclerosis,13-04-2015,5704,India,India,8370,Not assigned,253, $451.0 ," $1,14,103.0 ", $-   ,Apr
NE-2015-1205,Glatiramer,Copaxone,Generic,Multiple sclerosis,23-10-2015,5704,India,India,8370,Not assigned,209, $451.0 ," $94,259.0 ", $-   ,Oct
NE-2015-1206,Glatiramer,Copaxone,Generic,Multiple sclerosis,28-12-2015,5704,India,India,8370,Not assigned,8, $451.0 ," $3,608.0 ", $-   ,Dec
NE-2015-1207,Glatiramer,Copaxone,Generic,Multiple sclerosis,08-12-2015,5704,India,India,8370,Not assigned,107, $451.0 ," $48,257.0 ", $-   ,Dec
NE-2015-1208,Glatiramer,Copaxone,Generic,Multiple sclerosis,24-01-2015,5704,India,India,8370,Assigned,462, $451.0 ," $2,08,362.0 "," $4,466.0 ",Jan
NE-2015-1209,Glatiramer,Copaxone,Generic,Multiple sclerosis,22-04-2015,5704,India,India,8370,Not assigned,361, $451.0 ," $1,62,811.0 ", $-   ,Apr
NE-2015-1210,Glatiramer,Copaxone,Generic,Multiple sclerosis,11-05-2015,5704,India,India,8370,Not assigned,38, $451.0 ," $17,138.0 ", $-   ,May
NE-2015-1211,Glatiramer,Copaxone,Generic,Multiple sclerosis,28-08-2015,5704,India,India,8370,Not assigned,397, $451.0 ," $1,79,047.0 ", $-   ,Aug
NE-2015-1212,Glatiramer,Copaxone,Generic,Multiple sclerosis,17-07-2015,5704,India,India,8370,Not assigned,101, $451.0 ," $45,551.0 ", $-   ,Jul
NE-2015-1213,Glatiramer,Copaxone,Generic,Multiple sclerosis,01-08-2015,5704,Kenya,Kenya,8370,Assigned,156, $451.0 ," $70,356.0 "," $4,264.0 ",Aug
NE-2015-1214,Glatiramer,Copaxone,Generic,Multiple sclerosis,09-11-2015,5704,Kenya,Kenya,8370,Assigned,118, $451.0 ," $53,218.0 "," $1,573.3 ",Nov
NE-2015-1215,Glatiramer,Copaxone,Generic,Multiple sclerosis,25-03-2015,5704,Sudan,Utd.Arab Emir.,8370,Assigned,92, $451.0 ," $41,492.0 "," $1,901.3 ",Mar
NE-2015-1216,Glatiramer,Copaxone,Generic,Multiple sclerosis,27-09-2015,5704,Sudan,Utd.Arab Emir.,8370,Assigned,450, $451.0 ," $2,02,950.0 "," $10,800.0 ",Sep
NE-2015-1217,Glatiramer,Copaxone,Generic,Multiple sclerosis,13-09-2015,5704,Sudan,Utd.Arab Emir.,8370,Assigned,62, $451.0 ," $27,962.0 ", $826.7 ,Sep
NE-2015-1218,Glatiramer,Copaxone,Generic,Multiple sclerosis,15-08-2015,5704,Sudan,Utd.Arab Emir.,8370,Assigned,97, $451.0 ," $43,747.0 ", $711.3 ,Aug
NE-2015-1219,Glatiramer,Copaxone,Generic,Multiple sclerosis,24-05-2015,5704,Malaysia,Malaysia,8370,Assigned,180, $451.0 ," $81,180.0 "," $5,520.0 ",May
NE-2015-1220,Glatiramer,Copaxone,Generic,Multiple sclerosis,21-11-2015,5704,Nepal,Nepal,8370,Assigned,178, $451.0 ," $80,278.0 "," $3,797.3 ",Nov
NE-2015-1221,Glatiramer,Copaxone,Generic,Multiple sclerosis,15-01-2015,5704,Nepal,Nepal,8370,Assigned,421, $451.0 ," $1,89,871.0 "," $5,613.3 ",Jan
NE-2015-1222,Glatiramer,Copaxone,Generic,Multiple sclerosis,01-08-2015,5704,Nigeria,Nigeria,8370,Not assigned,464, $451.0 ," $2,09,264.0 ", $-   ,Aug
NE-2015-1223,Glatiramer,Copaxone,Generic,Multiple sclerosis,26-06-2015,5704,Utd.Arab Emir.,Utd.Arab Emir.,8370,Not assigned,462, $451.0 ," $2,08,362.0 ", $-   ,Jun
NE-2015-1224,Glatiramer,Copaxone,Generic,Multiple sclerosis,15-10-2015,5704,Cambodia,Cambodia,8370,Not assigned,79, $451.0 ," $35,629.0 ", $-   ,Oct
NE-2015-1225,Glatiramer,Copaxone,Generic,Multiple sclerosis,28-10-2015,5704,Malaysia,Malaysia,8370,Assigned,47, $451.0 ," $21,197.0 ", $391.7 ,Oct
NE-2015-1226,Glatiramer,Copaxone,Generic,Multiple sclerosis,30-05-2015,5704,Malaysia,Malaysia,8370,Assigned,118, $451.0 ," $53,218.0 "," $3,461.3 ",May
NE-2015-1227,Glatiramer,Copaxone,Generic,Multiple sclerosis,17-08-2015,5704,Vietnam,Japan,8370,Assigned,82, $451.0 ," $36,982.0 "," $2,651.3 ",Aug
NE-2015-1228,Glatiramer,Copaxone,Generic,Multiple sclerosis,03-07-2015,5704,Oman,Oman,8370,Not assigned,482, $451.0 ," $2,17,382.0 ", $-   ,Jul
NE-2015-1229,Glatiramer,Copaxone,Generic,Multiple sclerosis,13-01-2015,5704,Oman,Oman,8370,Not assigned,218, $451.0 ," $98,318.0 ", $-   ,Jan
NE-2015-1230,Glatiramer,Copaxone,Generic,Multiple sclerosis,05-01-2015,5704,Sudan,South Korea,8370,Not assigned,327, $451.0 ," $1,47,477.0 ", $-   ,Jan
NE-2015-1231,Glatiramer,Copaxone,Generic,Multiple sclerosis,25-07-2015,5704,Uganda,Netherlands,8370,Assigned,148, $451.0 ," $66,748.0 "," $4,489.3 ",Jul
NE-2015-1232,Glatiramer,Copaxone,Generic,Multiple sclerosis,17-03-2015,5704,Uganda,Netherlands,8370,Assigned,153, $451.0 ," $69,003.0 "," $4,845.0 ",Mar
NE-2015-1233,Glatiramer,Copaxone,Generic,Multiple sclerosis,21-02-2015,5704,Thailand,Philippines,8370,Not assigned,197, $451.0 ," $88,847.0 ", $-   ,Feb
NE-2015-1234,Glatiramer,Copaxone,Generic,Multiple sclerosis,30-06-2015,5704,Philippines,Philippines,8370,Assigned,59, $451.0 ," $26,609.0 "," $1,553.7 ",Jun
NE-2015-1235,Glatiramer,Copaxone,Generic,Multiple sclerosis,14-09-2015,5704,Syria,Lebanon,8370,Assigned,399, $451.0 ," $1,79,949.0 "," $1,330.0 ",Sep
NE-2015-1236,Glatiramer,Copaxone,Generic,Multiple sclerosis,07-04-2015,5704,Egypt,Egypt,8370,Not assigned,129, $451.0 ," $58,179.0 ", $-   ,Apr
NE-2015-1237,Glatiramer,Copaxone,Generic,Multiple sclerosis,24-11-2015,5704,Thailand,Thailand,8370,Assigned,366, $451.0 ," $1,65,066.0 "," $2,684.0 ",Nov
NE-2015-1238,Glatiramer,Copaxone,Generic,Multiple sclerosis,14-07-2015,5704,Thailand,Thailand,8370,Assigned,46, $451.0 ," $20,746.0 ", $245.3 ,Jul
NE-2015-1239,Glatiramer,Copaxone,Generic,Multiple sclerosis,01-10-2015,5704,Nepal,Nepal,8370,Assigned,299, $451.0 ," $1,34,849.0 "," $9,468.3 ",Oct
NE-2015-1240,Glatiramer,Copaxone,Generic,Multiple sclerosis,13-09-2015,5704,Nepal,Nepal,8370,Assigned,283, $451.0 ," $1,27,633.0 "," $5,565.7 ",Sep
NE-2015-1241,Glatiramer,Copaxone,Generic,Multiple sclerosis,22-01-2015,5704,Nepal,Nepal,8370,Assigned,27, $451.0 ," $12,177.0 ", $189.0 ,Jan
NE-2015-1242,Glatiramer,Copaxone,Generic,Multiple sclerosis,03-08-2015,5704,Nepal,Nepal,8370,Assigned,410, $451.0 ," $1,84,910.0 "," $12,983.3 ",Aug
NE-2015-1243,Glatiramer,Copaxone,Generic,Multiple sclerosis,03-03-2015,5704,Nepal,Nepal,8370,Assigned,22, $451.0 ," $9,922.0 ", $95.3 ,Mar
NE-2015-1244,Glatiramer,Copaxone,Generic,Multiple sclerosis,22-10-2015,5704,Nepal,Nepal,8370,Assigned,42, $451.0 ," $18,942.0 "," $1,302.0 ",Oct
NE-2015-1245,Glatiramer,Copaxone,Generic,Multiple sclerosis,22-12-2015,5704,Egypt,Egypt,8370,Not assigned,176, $451.0 ," $79,376.0 ", $-   ,Dec
NE-2015-1246,Glatiramer,Copaxone,Generic,Multiple sclerosis,06-04-2015,5704,Thailand,Thailand,8370,Assigned,68, $451.0 ," $30,668.0 "," $2,221.3 ",Apr
NE-2015-1247,Glatiramer,Copaxone,Generic,Multiple sclerosis,23-09-2015,5704,Netherlands,Netherlands,8370,Assigned,265, $451.0 ," $1,19,515.0 "," $3,356.7 ",Sep
NE-2015-1248,Glatiramer,Copaxone,Generic,Multiple sclerosis,27-08-2015,5704,Malaysia,Malaysia,8370,Assigned,463, $451.0 ," $2,08,813.0 "," $13,890.0 ",Aug
NE-2015-1249,Glatiramer,Copaxone,Generic,Multiple sclerosis,13-05-2015,5704,Kenya,Kenya,8370,Assigned,216, $451.0 ," $97,416.0 "," $4,248.0 ",May
NE-2015-1250,Glatiramer,Copaxone,Generic,Multiple sclerosis,08-03-2015,5704,Netherlands,Netherlands,8370,Assigned,124, $451.0 ," $55,924.0 "," $3,430.7 ",Mar
NE-2015-1251,Glatiramer,Copaxone,Generic,Multiple sclerosis,04-11-2015,5704,Netherlands,Netherlands,8370,Assigned,450, $451.0 ," $2,02,950.0 "," $2,700.0 ",Nov
NE-2015-1252,Glatiramer,Copaxone,Generic,Multiple sclerosis,23-05-2015,5704,Kenya,Kenya,8370,Assigned,57, $451.0 ," $25,707.0 ", $361.0 ,May
NE-2015-1253,Glatiramer,Copaxone,Generic,Multiple sclerosis,17-09-2015,5704,Malaysia,Malaysia,8370,Assigned,409, $451.0 ," $1,84,459.0 "," $3,272.0 ",Sep
NE-2015-1254,Glatiramer,Copaxone,Generic,Multiple sclerosis,26-12-2015,5704,Malaysia,Malaysia,8370,Assigned,456, $451.0 ," $2,05,656.0 "," $3,344.0 ",Dec
NE-2015-1255,Glatiramer,Copaxone,Generic,Multiple sclerosis,30-05-2015,5704,Kenya,Kenya,8370,Assigned,264, $451.0 ," $1,19,064.0 ", $968.0 ,May
NE-2015-1256,Glatiramer,Copaxone,Generic,Multiple sclerosis,09-01-2015,5704,India,India,8370,Not assigned,151, $451.0 ," $68,101.0 ", $-   ,Jan
NE-2015-1257,Glatiramer,Copaxone,Generic,Multiple sclerosis,11-01-2015,5704,Philippines,Philippines,8370,Not assigned,453, $451.0 ," $2,04,303.0 ", $-   ,Jan
NE-2015-1258,Glatiramer,Copaxone,Generic,Multiple sclerosis,09-11-2015,5704,Philippines,Philippines,8370,Not assigned,308, $451.0 ," $1,38,908.0 ", $-   ,Nov
NE-2015-1259,Glatiramer,Copaxone,Generic,Multiple sclerosis,10-06-2015,5704,Uganda,Netherlands,8370,Assigned,53, $451.0 ," $23,903.0 "," $1,484.0 ",Jun
NE-2015-1260,Glatiramer,Copaxone,Generic,Multiple sclerosis,18-04-2015,5704,Ethiopia,Ethiopia,8370,Assigned,96, $451.0 ," $43,296.0 "," $2,784.0 ",Apr
NE-2015-1261,Glatiramer,Copaxone,Generic,Multiple sclerosis,09-08-2015,5704,Iran,Iran,8370,Not assigned,282, $451.0 ," $1,27,182.0 ", $-   ,Aug
NE-2015-1262,Glatiramer,Copaxone,Generic,Multiple sclerosis,20-09-2015,5704,Philippines,Philippines,8370,Assigned,80, $451.0 ," $36,080.0 "," $2,346.7 ",Sep
NE-2015-1263,Glatiramer,Copaxone,Generic,Multiple sclerosis,25-12-2015,5704,Philippines,Philippines,8370,Assigned,136, $451.0 ," $61,336.0 ", $906.7 ,Dec
NE-2015-1264,Glatiramer,Copaxone,Generic,Multiple sclerosis,27-09-2015,5704,Egypt,Egypt,8370,Not assigned,22, $451.0 ," $9,922.0 ", $-   ,Sep
NE-2015-1265,Glatiramer,Copaxone,Generic,Multiple sclerosis,04-11-2015,5704,Egypt,Egypt,8370,Not assigned,137, $451.0 ," $61,787.0 ", $-   ,Nov
NE-2015-1266,Glatiramer,Copaxone,Generic,Multiple sclerosis,17-10-2015,5704,Nepal,Nepal,8370,Assigned,379, $451.0 ," $1,70,929.0 "," $1,895.0 ",Oct
NE-2015-1267,Glatiramer,Copaxone,Generic,Multiple sclerosis,05-09-2015,5704,Singapore,Singapore,8370,Not assigned,394, $451.0 ," $1,77,694.0 ", $-   ,Sep
NE-2015-1268,Glatiramer,Copaxone,Generic,Multiple sclerosis,19-03-2015,5704,Thailand,Thailand,8370,Assigned,261, $451.0 ," $1,17,711.0 "," $7,395.0 ",Mar
NE-2015-1269,Glatiramer,Copaxone,Generic,Multiple sclerosis,02-02-2015,5704,Thailand,Thailand,8370,Assigned,96, $451.0 ," $43,296.0 "," $2,848.0 ",Feb
NE-2015-1270,Glatiramer,Copaxone,Generic,Multiple sclerosis,09-10-2015,5704,Oman,Oman,8370,Not assigned,53, $451.0 ," $23,903.0 ", $-   ,Oct
NE-2015-1271,Glatiramer,Copaxone,Generic,Multiple sclerosis,26-05-2015,5704,Egypt,Egypt,8370,Not assigned,421, $451.0 ," $1,89,871.0 ", $-   ,May
NE-2015-1272,Glatiramer,Copaxone,Generic,Multiple sclerosis,03-07-2015,5704,Egypt,Egypt,8370,Not assigned,133, $451.0 ," $59,983.0 ", $-   ,Jul
NE-2015-1273,Glatiramer,Copaxone,Generic,Multiple sclerosis,25-07-2015,5704,Malaysia,Malaysia,8370,Assigned,219, $451.0 ," $98,769.0 "," $2,701.0 ",Jul
NE-2015-1274,Glatiramer,Copaxone,Generic,Multiple sclerosis,09-09-2015,5704,Thailand,Philippines,8370,Not assigned,137, $451.0 ," $61,787.0 ", $-   ,Sep
NE-2015-1275,Glatiramer,Copaxone,Generic,Multiple sclerosis,11-01-2015,5704,Thailand,Thailand,8370,Assigned,289, $451.0 ," $1,30,339.0 "," $4,431.3 ",Jan
NE-2015-1276,Glatiramer,Copaxone,Generic,Multiple sclerosis,13-06-2015,5704,Netherlands,Netherlands,8370,Not assigned,231, $451.0 ," $1,04,181.0 ", $-   ,Jun
NE-2015-1277,Glatiramer,Copaxone,Generic,Multiple sclerosis,19-11-2015,5704,Spain,Netherlands,8370,Not assigned,168, $451.0 ," $75,768.0 ", $-   ,Nov
NE-2015-1278,Glatiramer,Copaxone,Generic,Multiple sclerosis,01-06-2015,5704,Netherlands,Netherlands,8370,Not assigned,58, $451.0 ," $26,158.0 ", $-   ,Jun
NE-2015-1279,Glatiramer,Copaxone,Generic,Multiple sclerosis,29-09-2015,5704,Netherlands,Netherlands,8370,Not assigned,61, $451.0 ," $27,511.0 ", $-   ,Sep
NE-2015-1280,Glatiramer,Copaxone,Generic,Multiple sclerosis,11-05-2015,5704,Netherlands,Netherlands,8370,Not assigned,326, $451.0 ," $1,47,026.0 ", $-   ,May
NE-2015-1281,Glatiramer,Copaxone,Generic,Multiple sclerosis,14-03-2015,5704,Netherlands,Netherlands,8370,Not assigned,169, $451.0 ," $76,219.0 ", $-   ,Mar
VA-2015-1282,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,29-08-2015,5938,India,India,8068,Not assigned,482, $310.0 ," $1,49,420.0 ", $-   ,Aug
VA-2015-1283,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,31-08-2015,5938,India,India,8068,Not assigned,84, $310.0 ," $26,040.0 ", $-   ,Aug
VA-2015-1284,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,14-05-2015,5938,India,India,8068,Not assigned,141, $310.0 ," $43,710.0 ", $-   ,May
VA-2015-1285,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,30-06-2015,5938,India,India,8068,Not assigned,213, $310.0 ," $66,030.0 ", $-   ,Jun
VA-2015-1286,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,25-08-2015,5938,India,India,8068,Not assigned,420, $310.0 ," $1,30,200.0 ", $-   ,Aug
VA-2015-1287,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,31-12-2015,5938,India,India,8068,Not assigned,463, $310.0 ," $1,43,530.0 ", $-   ,Dec
VA-2015-1288,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,14-10-2015,5938,India,India,8068,Not assigned,417, $310.0 ," $1,29,270.0 ", $-   ,Oct
VA-2015-1289,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,11-03-2015,5938,India,India,8068,Not assigned,422, $310.0 ," $1,30,820.0 ", $-   ,Mar
VA-2015-1290,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,13-02-2015,5938,India,India,8068,Not assigned,112, $310.0 ," $34,720.0 ", $-   ,Feb
VA-2015-1291,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,16-05-2015,5938,India,India,8068,Not assigned,8, $310.0 ," $2,480.0 ", $-   ,May
VA-2015-1292,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,12-05-2015,5938,India,India,8068,Not assigned,325, $310.0 ," $1,00,750.0 ", $-   ,May
VA-2015-1293,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,16-04-2015,5938,India,India,8068,Not assigned,216, $310.0 ," $66,960.0 ", $-   ,Apr
VA-2015-1294,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,02-02-2015,5938,India,India,8068,Not assigned,179, $310.0 ," $55,490.0 ", $-   ,Feb
VA-2015-1295,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,16-04-2015,5938,Egypt,Egypt,8068,Not assigned,13, $310.0 ," $4,030.0 ", $-   ,Apr
VA-2015-1296,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,16-12-2015,5938,Egypt,Egypt,8068,Not assigned,133, $310.0 ," $41,230.0 ", $-   ,Dec
VA-2015-1297,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,19-08-2015,5938,Egypt,Egypt,8068,Not assigned,231, $310.0 ," $71,610.0 ", $-   ,Aug
VA-2015-1298,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,15-08-2015,5938,Egypt,Egypt,8068,Not assigned,424, $310.0 ," $1,31,440.0 ", $-   ,Aug
VA-2015-1299,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,05-04-2015,5938,Bangladesh,Bangladesh,8068,Assigned,221, $310.0 ," $68,510.0 "," $4,641.0 ",Apr
VA-2015-1300,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,03-03-2015,5938,Egypt,Egypt,8068,Not assigned,482, $310.0 ," $1,49,420.0 ", $-   ,Mar
VA-2015-1301,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,04-11-2015,5938,Egypt,Egypt,8068,Not assigned,183, $310.0 ," $56,730.0 ", $-   ,Nov
VA-2015-1302,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,28-02-2015,5938,Syria,Lebanon,8068,Assigned,191, $310.0 ," $59,210.0 "," $4,966.0 ",Feb
VA-2015-1303,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,09-07-2015,5938,Netherlands,Netherlands,8068,Not assigned,439, $310.0 ," $1,36,090.0 ", $-   ,Jul
VA-2015-1304,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,24-10-2015,5938,Morocco,Netherlands,8068,Not assigned,280, $310.0 ," $86,800.0 ", $-   ,Oct
RA-2015-1305,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,14-09-2015,5819,India,India,8119,Assigned,64, $364.0 ," $23,296.0 "," $2,090.7 ",Sep
RA-2015-1306,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,16-06-2015,5819,India,India,8119,Assigned,206, $364.0 ," $74,984.0 "," $2,128.7 ",Jun
RA-2015-1307,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,14-07-2015,5819,India,India,8119,Not assigned,430, $364.0 ," $1,56,520.0 ", $-   ,Jul
RA-2015-1308,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,09-02-2015,5819,India,India,8119,Not assigned,110, $364.0 ," $40,040.0 ", $-   ,Feb
RA-2015-1309,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,27-10-2015,5819,India,India,8119,Not assigned,228, $364.0 ," $82,992.0 ", $-   ,Oct
RA-2015-1310,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,04-09-2015,5819,India,India,8119,Not assigned,365, $364.0 ," $1,32,860.0 ", $-   ,Sep
RA-2015-1311,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,04-07-2015,5819,India,India,8119,Not assigned,87, $364.0 ," $31,668.0 ", $-   ,Jul
RA-2015-1312,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,03-03-2015,5819,India,India,8119,Not assigned,121, $364.0 ," $44,044.0 ", $-   ,Mar
RA-2015-1313,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,09-05-2015,5819,India,India,8119,Not assigned,430, $364.0 ," $1,56,520.0 ", $-   ,May
RA-2015-1314,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,07-01-2015,5819,India,India,8119,Assigned,306, $364.0 ," $1,11,384.0 "," $6,324.0 ",Jan
RA-2015-1315,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,11-07-2015,5819,India,India,8119,Not assigned,166, $364.0 ," $60,424.0 ", $-   ,Jul
CA-2015-1316,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-07-2015,5887,India,India,8095,Assigned,244, $500.0 ," $1,22,000.0 "," $7,076.0 ",Jul
RA-2015-1317,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,25-05-2015,5819,India,India,8119,Assigned,107, $364.0 ," $38,948.0 "," $2,532.3 ",May
RA-2015-1318,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,01-04-2015,5819,India,India,8119,Not assigned,306, $364.0 ," $1,11,384.0 ", $-   ,Apr
RA-2015-1319,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,01-12-2015,5819,India,India,8119,Assigned,63, $364.0 ," $22,932.0 ", $882.0 ,Dec
RA-2015-1320,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,14-07-2015,5819,India,India,8119,Not assigned,271, $364.0 ," $98,644.0 ", $-   ,Jul
RA-2015-1321,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,21-10-2015,5819,India,India,8119,Assigned,251, $364.0 ," $91,364.0 "," $1,171.3 ",Oct
RA-2015-1322,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,10-02-2015,5819,India,India,8119,Not assigned,418, $364.0 ," $1,52,152.0 ", $-   ,Feb
RA-2015-1323,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,10-04-2015,5819,India,India,8119,Not assigned,173, $364.0 ," $62,972.0 ", $-   ,Apr
RA-2015-1324,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,25-08-2015,5819,India,India,8119,Not assigned,486, $364.0 ," $1,76,904.0 ", $-   ,Aug
RA-2015-1325,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,17-03-2015,5819,India,India,8119,Assigned,285, $364.0 ," $1,03,740.0 "," $4,085.0 ",Mar
RA-2015-1326,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,27-01-2015,5819,India,India,8119,Not assigned,138, $364.0 ," $50,232.0 ", $-   ,Jan
RA-2015-1327,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,28-04-2015,5819,India,India,8119,Not assigned,121, $364.0 ," $44,044.0 ", $-   ,Apr
RA-2015-1328,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,22-10-2015,5819,India,India,8119,Assigned,258, $364.0 ," $93,912.0 "," $7,310.0 ",Oct
RA-2015-1329,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,02-09-2015,5819,India,India,8119,Not assigned,101, $364.0 ," $36,764.0 ", $-   ,Sep
RA-2015-1330,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,06-07-2015,5819,India,India,8119,Not assigned,308, $364.0 ," $1,12,112.0 ", $-   ,Jul
RA-2015-1331,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,30-12-2015,5819,India,India,8119,Not assigned,370, $364.0 ," $1,34,680.0 ", $-   ,Dec
RA-2015-1332,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,07-07-2015,5819,India,India,8119,Not assigned,267, $364.0 ," $97,188.0 ", $-   ,Jul
RA-2015-1333,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,04-11-2015,5819,India,India,8119,Not assigned,428, $364.0 ," $1,55,792.0 ", $-   ,Nov
RA-2015-1334,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,06-06-2015,5819,India,India,8119,Not assigned,209, $364.0 ," $76,076.0 ", $-   ,Jun
RA-2015-1335,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,29-10-2015,5819,India,India,8119,Not assigned,389, $364.0 ," $1,41,596.0 ", $-   ,Oct
RA-2015-1336,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,16-09-2015,5819,India,India,8119,Assigned,27, $364.0 ," $9,828.0 ", $216.0 ,Sep
RA-2015-1337,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,15-03-2015,5819,India,India,8119,Not assigned,328, $364.0 ," $1,19,392.0 ", $-   ,Mar
IN-2015-1338,Bevacizumab,Avastin,Genentech/Roche,Cancer,17-04-2015,5685,India,India,8209,Assigned,280, $243.0 ," $68,040.0 "," $5,786.7 ",Apr
RA-2015-1339,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,29-05-2015,5819,India,India,8119,Not assigned,22, $364.0 ," $8,008.0 ", $-   ,May
RA-2015-1340,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,09-04-2015,5819,Thailand,Thailand,8119,Assigned,178, $364.0 ," $64,792.0 "," $3,500.7 ",Apr
RA-2015-1341,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,14-01-2015,5819,Egypt,Egypt,8119,Assigned,105, $364.0 ," $38,220.0 ", $770.0 ,Jan
RA-2015-1342,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,03-06-2015,5819,Thailand,Thailand,8119,Assigned,305, $364.0 ," $1,11,020.0 "," $10,166.7 ",Jun
RA-2015-1343,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,03-10-2015,5819,Thailand,Thailand,8119,Assigned,444, $364.0 ," $1,61,616.0 "," $5,772.0 ",Oct
RA-2015-1344,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,18-04-2015,5819,Thailand,Thailand,8119,Assigned,431, $364.0 ," $1,56,884.0 "," $3,879.0 ",Apr
RA-2015-1345,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,18-08-2015,5819,Thailand,Thailand,8119,Assigned,233, $364.0 ," $84,812.0 "," $5,359.0 ",Aug
RA-2015-1346,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,23-11-2015,5819,Thailand,Thailand,8119,Not assigned,173, $364.0 ," $62,972.0 ", $-   ,Nov
RA-2015-1347,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,08-11-2015,5819,Thailand,Thailand,8119,Assigned,276, $364.0 ," $1,00,464.0 "," $1,380.0 ",Nov
RA-2015-1348,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,02-02-2015,5819,Thailand,Thailand,8119,Not assigned,367, $364.0 ," $1,33,588.0 ", $-   ,Feb
RA-2015-1349,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,26-04-2015,5819,Thailand,Thailand,8119,Assigned,201, $364.0 ," $73,164.0 "," $3,484.0 ",Apr
RA-2015-1350,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,18-04-2015,5819,Thailand,Thailand,8119,Assigned,493, $364.0 ," $1,79,452.0 "," $7,723.7 ",Apr
RA-2015-1351,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,31-10-2015,5819,Thailand,Thailand,8119,Assigned,448, $364.0 ," $1,63,072.0 "," $1,493.3 ",Oct
RA-2015-1352,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,29-11-2015,5819,Thailand,Thailand,8119,Assigned,43, $364.0 ," $15,652.0 "," $1,275.7 ",Nov
RA-2015-1353,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,12-04-2015,5819,Thailand,Thailand,8119,Assigned,406, $364.0 ," $1,47,784.0 "," $12,992.0 ",Apr
LA-2015-1354,Emtricitabine/tenofovir/efavirenz,Atripla,"Gilead Sciences, Inc.",HIV infection,18-03-2015,5566,Nigeria,Nigeria,8128,Not assigned,264, $269.0 ," $71,016.0 ", $-   ,Mar
AR-2015-1355,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,20-06-2015,5653,India,India,7933,Not assigned,284, $231.0 ," $65,604.0 ", $-   ,Jun
AR-2015-1356,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,16-11-2015,5653,India,India,7933,Not assigned,229, $231.0 ," $52,899.0 ", $-   ,Nov
AR-2015-1357,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,26-01-2015,5653,India,India,7933,Not assigned,389, $231.0 ," $89,859.0 ", $-   ,Jan
AR-2015-1358,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,25-11-2015,5653,India,India,7933,Not assigned,150, $231.0 ," $34,650.0 ", $-   ,Nov
AR-2015-1359,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,25-04-2015,5653,India,India,7933,Assigned,307, $231.0 ," $70,917.0 "," $1,944.3 ",Apr
AR-2015-1360,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,03-06-2015,5653,India,India,7933,Not assigned,253, $231.0 ," $58,443.0 ", $-   ,Jun
AR-2015-1361,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,27-10-2015,5653,India,India,7933,Not assigned,486, $231.0 ," $1,12,266.0 ", $-   ,Oct
AR-2015-1362,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,26-10-2015,5653,India,India,7933,Assigned,327, $231.0 ," $75,537.0 "," $4,687.0 ",Oct
AR-2015-1363,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,03-02-2015,5653,India,India,7933,Not assigned,286, $231.0 ," $66,066.0 ", $-   ,Feb
AR-2015-1364,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,04-12-2015,5653,India,India,7933,Not assigned,302, $231.0 ," $69,762.0 ", $-   ,Dec
AR-2015-1365,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,07-03-2015,5653,India,India,7933,Not assigned,399, $231.0 ," $92,169.0 ", $-   ,Mar
AR-2015-1366,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,24-05-2015,5653,India,India,7933,Not assigned,17, $231.0 ," $3,927.0 ", $-   ,May
AR-2015-1367,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,29-10-2015,5653,India,India,7933,Not assigned,92, $231.0 ," $21,252.0 ", $-   ,Oct
AR-2015-1368,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,18-07-2015,5653,India,India,7933,Not assigned,373, $231.0 ," $86,163.0 ", $-   ,Jul
AR-2015-1369,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,07-03-2015,5653,India,India,7933,Assigned,89, $231.0 ," $20,559.0 "," $2,492.0 ",Mar
AR-2015-1370,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,15-04-2015,5653,India,India,7933,Assigned,75, $231.0 ," $17,325.0 "," $1,775.0 ",Apr
AR-2015-1371,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,22-05-2015,5653,India,India,7933,Assigned,109, $231.0 ," $25,179.0 "," $1,271.7 ",May
AR-2015-1372,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,27-02-2015,5653,India,India,7933,Assigned,106, $231.0 ," $24,486.0 "," $2,756.0 ",Feb
AR-2015-1373,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,04-10-2015,5653,India,India,7933,Assigned,65, $231.0 ," $15,015.0 "," $1,603.3 ",Oct
AR-2015-1374,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,30-10-2015,5653,India,India,7933,Assigned,433, $231.0 ," $1,00,023.0 "," $1,732.0 ",Oct
AR-2015-1375,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,06-02-2015,5653,India,India,7933,Not assigned,140, $231.0 ," $32,340.0 ", $-   ,Feb
AR-2015-1376,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,01-03-2015,5653,India,India,7933,Assigned,496, $231.0 ," $1,14,576.0 "," $8,597.3 ",Mar
AR-2015-1377,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,14-08-2015,5653,India,India,7933,Assigned,476, $231.0 ," $1,09,956.0 "," $2,856.0 ",Aug
AR-2015-1378,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,14-05-2015,5653,India,India,7933,Assigned,187, $231.0 ," $43,197.0 "," $5,734.7 ",May
AR-2015-1379,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,01-05-2015,5653,India,India,7933,Not assigned,48, $231.0 ," $11,088.0 ", $-   ,May
AR-2015-1380,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,17-02-2015,5653,India,India,7933,Not assigned,238, $231.0 ," $54,978.0 ", $-   ,Feb
AR-2015-1381,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,02-03-2015,5653,India,India,7933,Not assigned,498, $231.0 ," $1,15,038.0 ", $-   ,Mar
AR-2015-1382,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,14-11-2015,5653,India,India,7933,Assigned,13, $231.0 ," $3,003.0 ", $247.0 ,Nov
AR-2015-1383,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,27-06-2015,5653,India,India,7933,Assigned,376, $231.0 ," $86,856.0 "," $9,650.7 ",Jun
AR-2015-1384,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,17-02-2015,5653,India,India,7933,Not assigned,324, $231.0 ," $74,844.0 ", $-   ,Feb
AR-2015-1385,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,17-10-2015,5653,India,India,7933,Not assigned,491, $231.0 ," $1,13,421.0 ", $-   ,Oct
CA-2015-1386,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-05-2015,5887,India,India,8095,Not assigned,471, $500.0 ," $2,35,500.0 ", $-   ,May
CA-2015-1387,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-07-2015,5887,India,India,8095,Not assigned,400, $500.0 ," $2,00,000.0 ", $-   ,Jul
AR-2015-1388,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,20-01-2015,5653,India,India,7933,Not assigned,474, $231.0 ," $1,09,494.0 ", $-   ,Jan
RA-2015-1389,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,17-06-2015,5819,India,India,8119,Assigned,425, $364.0 ," $1,54,700.0 "," $4,533.3 ",Jun
AR-2015-1390,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,26-11-2015,5653,India,India,7933,Not assigned,369, $231.0 ," $85,239.0 ", $-   ,Nov
AR-2015-1391,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,23-12-2015,5653,India,India,7933,Not assigned,461, $231.0 ," $1,06,491.0 ", $-   ,Dec
CA-2015-1392,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-10-2015,5887,India,India,8095,Assigned,480, $500.0 ," $2,40,000.0 "," $7,360.0 ",Oct
AR-2015-1393,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,27-08-2015,5653,India,India,7933,Not assigned,211, $231.0 ," $48,741.0 ", $-   ,Aug
AR-2015-1394,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,07-05-2015,5653,India,India,7933,Assigned,100, $231.0 ," $23,100.0 "," $3,266.7 ",May
AR-2015-1395,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,01-12-2015,5653,India,India,7933,Assigned,335, $231.0 ," $77,385.0 "," $8,821.7 ",Dec
CA-2015-1396,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-02-2015,5887,India,India,8095,Not assigned,187, $500.0 ," $93,500.0 ", $-   ,Feb
US-2015-1397,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,27-02-2015,5653,South Africa,India,7933,Not assigned,412, $231.0 ," $95,172.0 ", $-   ,Feb
AR-2015-1398,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,05-12-2015,5653,India,India,7933,Not assigned,496, $231.0 ," $1,14,576.0 ", $-   ,Dec
AR-2015-1399,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,02-06-2015,5653,India,India,7933,Not assigned,308, $231.0 ," $71,148.0 ", $-   ,Jun
AR-2015-1400,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,19-12-2015,5653,India,India,7933,Not assigned,179, $231.0 ," $41,349.0 ", $-   ,Dec
AR-2015-1401,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,18-03-2015,5653,India,India,7933,Not assigned,262, $231.0 ," $60,522.0 ", $-   ,Mar
AR-2015-1402,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,18-05-2015,5653,India,India,7933,Not assigned,276, $231.0 ," $63,756.0 ", $-   ,May
AR-2015-1403,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,01-02-2015,5653,India,India,7933,Not assigned,197, $231.0 ," $45,507.0 ", $-   ,Feb
AR-2015-1404,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,12-12-2015,5653,India,India,7933,Not assigned,139, $231.0 ," $32,109.0 ", $-   ,Dec
CA-2015-1405,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-11-2015,5887,India,India,8095,Not assigned,447, $500.0 ," $2,23,500.0 ", $-   ,Nov
AR-2015-1406,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,10-12-2015,5653,India,India,7933,Not assigned,117, $231.0 ," $27,027.0 ", $-   ,Dec
AR-2015-1407,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,10-10-2015,5653,India,India,7933,Not assigned,282, $231.0 ," $65,142.0 ", $-   ,Oct
AR-2015-1408,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,22-11-2015,5653,India,India,7933,Not assigned,292, $231.0 ," $67,452.0 ", $-   ,Nov
AR-2015-1409,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,19-05-2015,5653,India,India,7933,Not assigned,379, $231.0 ," $87,549.0 ", $-   ,May
AR-2015-1410,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,20-05-2015,5653,India,India,7933,Not assigned,438, $231.0 ," $1,01,178.0 ", $-   ,May
AR-2015-1411,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,30-09-2015,5653,Egypt,Egypt,7933,Not assigned,307, $231.0 ," $70,917.0 ", $-   ,Sep
AR-2015-1412,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,09-10-2015,5653,Egypt,Egypt,7933,Not assigned,443, $231.0 ," $1,02,333.0 ", $-   ,Oct
AR-2015-1413,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,03-06-2015,5653,Sudan,Utd.Arab Emir.,7933,Assigned,448, $231.0 ," $1,03,488.0 "," $13,589.3 ",Jun
AR-2015-1414,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,05-12-2015,5653,Sudan,Utd.Arab Emir.,7933,Assigned,385, $231.0 ," $88,935.0 "," $4,363.3 ",Dec
AR-2015-1415,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,14-02-2015,5653,Sudan,Utd.Arab Emir.,7933,Assigned,150, $231.0 ," $34,650.0 "," $3,400.0 ",Feb
AR-2015-1416,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,10-11-2015,5653,Sudan,Utd.Arab Emir.,7933,Assigned,239, $231.0 ," $55,209.0 ", $796.7 ,Nov
AR-2015-1417,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,23-11-2015,5653,Sudan,Utd.Arab Emir.,7933,Assigned,479, $231.0 ," $1,10,649.0 "," $12,134.7 ",Nov
AR-2015-1418,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,11-10-2015,5653,Vietnam,Japan,7933,Assigned,42, $231.0 ," $9,702.0 ", $924.0 ,Oct
AR-2015-1419,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,07-08-2015,5653,Vietnam,Netherlands,7933,Assigned,279, $231.0 ," $64,449.0 "," $5,487.0 ",Aug
AR-2015-1420,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,10-02-2015,5653,Vietnam,Netherlands,7933,Assigned,486, $231.0 ," $1,12,266.0 "," $13,608.0 ",Feb
AR-2015-1421,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,12-01-2015,5653,Thailand,Thailand,7933,Not assigned,407, $231.0 ," $94,017.0 ", $-   ,Jan
AR-2015-1422,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,27-01-2015,5653,Thailand,Thailand,7933,Not assigned,137, $231.0 ," $31,647.0 ", $-   ,Jan
AR-2015-1423,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,15-02-2015,5653,Thailand,Thailand,7933,Not assigned,249, $231.0 ," $57,519.0 ", $-   ,Feb
AR-2015-1424,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,29-07-2015,5653,Thailand,Thailand,7933,Not assigned,372, $231.0 ," $85,932.0 ", $-   ,Jul
AR-2015-1425,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,20-06-2015,5653,Nigeria,Nigeria,7933,Not assigned,334, $231.0 ," $77,154.0 ", $-   ,Jun
AR-2015-1426,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,29-07-2015,5653,Vietnam,Japan,7933,Assigned,398, $231.0 ," $91,938.0 "," $10,878.7 ",Jul
AR-2015-1427,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,30-06-2015,5653,Singapore,Singapore,7933,Not assigned,497, $231.0 ," $1,14,807.0 ", $-   ,Jun
AR-2015-1428,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,07-08-2015,5653,Thailand,Thailand,7933,Assigned,292, $231.0 ," $67,452.0 "," $6,424.0 ",Aug
AR-2015-1429,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,26-02-2015,5653,Bangladesh,Bangladesh,7933,Assigned,460, $231.0 ," $1,06,260.0 "," $5,520.0 ",Feb
AR-2015-1430,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,19-02-2015,5653,Egypt,Egypt,7933,Not assigned,419, $231.0 ," $96,789.0 ", $-   ,Feb
AR-2015-1431,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,05-05-2015,5653,Egypt,Egypt,7933,Not assigned,136, $231.0 ," $31,416.0 ", $-   ,May
AR-2015-1432,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,28-07-2015,5653,Thailand,Thailand,7933,Not assigned,186, $231.0 ," $42,966.0 ", $-   ,Jul
AR-2015-1433,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,17-05-2015,5653,Thailand,Thailand,7933,Not assigned,367, $231.0 ," $84,777.0 ", $-   ,May
AR-2015-1434,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,17-09-2015,5653,Thailand,Thailand,7933,Not assigned,437, $231.0 ," $1,00,947.0 ", $-   ,Sep
AR-2015-1435,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,15-11-2015,5653,Malaysia,Malaysia,7933,Not assigned,440, $231.0 ," $1,01,640.0 ", $-   ,Nov
AR-2015-1436,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,14-03-2015,5653,Vietnam,Japan,7933,Assigned,471, $231.0 ," $1,08,801.0 "," $1,884.0 ",Mar
AR-2015-1437,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,08-10-2015,5653,Vietnam,Japan,7933,Assigned,217, $231.0 ," $50,127.0 "," $4,050.7 ",Oct
AR-2015-1438,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,05-07-2015,5653,Cambodia,Cambodia,7933,Not assigned,319, $231.0 ," $73,689.0 ", $-   ,Jul
AR-2015-1439,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,16-09-2015,5653,Cambodia,Cambodia,7933,Not assigned,483, $231.0 ," $1,11,573.0 ", $-   ,Sep
AR-2015-1440,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,13-09-2015,5653,Thailand,Thailand,7933,Not assigned,267, $231.0 ," $61,677.0 ", $-   ,Sep
AR-2015-1441,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,30-11-2015,5653,Thailand,Thailand,7933,Not assigned,288, $231.0 ," $66,528.0 ", $-   ,Nov
AR-2015-1442,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,06-11-2015,5653,Thailand,Thailand,7933,Not assigned,413, $231.0 ," $95,403.0 ", $-   ,Nov
AR-2015-1443,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,25-10-2015,5653,Thailand,Thailand,7933,Not assigned,318, $231.0 ," $73,458.0 ", $-   ,Oct
AR-2015-1444,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,11-10-2015,5653,Thailand,Thailand,7933,Not assigned,235, $231.0 ," $54,285.0 ", $-   ,Oct
AR-2015-1445,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,20-11-2015,5653,Thailand,Thailand,7933,Not assigned,63, $231.0 ," $14,553.0 ", $-   ,Nov
AR-2015-1446,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,02-10-2015,5653,Thailand,Thailand,7933,Not assigned,26, $231.0 ," $6,006.0 ", $-   ,Oct
AR-2015-1447,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,06-03-2015,5653,Thailand,Thailand,7933,Not assigned,299, $231.0 ," $69,069.0 ", $-   ,Mar
AR-2015-1448,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,05-01-2015,5653,Thailand,Thailand,7933,Not assigned,27, $231.0 ," $6,237.0 ", $-   ,Jan
AR-2015-1449,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,06-03-2015,5653,Thailand,Thailand,7933,Not assigned,443, $231.0 ," $1,02,333.0 ", $-   ,Mar
AR-2015-1450,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,16-08-2015,5653,Thailand,Thailand,7933,Not assigned,284, $231.0 ," $65,604.0 ", $-   ,Aug
AR-2015-1451,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,11-02-2015,5653,Thailand,Thailand,7933,Not assigned,252, $231.0 ," $58,212.0 ", $-   ,Feb
AR-2015-1452,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,06-09-2015,5653,Thailand,Thailand,7933,Not assigned,256, $231.0 ," $59,136.0 ", $-   ,Sep
AR-2015-1453,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,25-04-2015,5653,Thailand,Thailand,7933,Not assigned,109, $231.0 ," $25,179.0 ", $-   ,Apr
AR-2015-1454,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,18-05-2015,5653,Thailand,Thailand,7933,Not assigned,218, $231.0 ," $50,358.0 ", $-   ,May
AR-2015-1455,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,04-09-2015,5653,Australia,Australia,7933,Not assigned,197, $231.0 ," $45,507.0 ", $-   ,Sep
AR-2015-1456,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,22-07-2015,5653,Australia,Australia,7933,Not assigned,65, $231.0 ," $15,015.0 ", $-   ,Jul
AR-2015-1457,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,26-05-2015,5653,Egypt,Egypt,7933,Not assigned,404, $231.0 ," $93,324.0 ", $-   ,May
AR-2015-1458,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,22-10-2015,5653,Egypt,Egypt,7933,Not assigned,17, $231.0 ," $3,927.0 ", $-   ,Oct
AR-2015-1459,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,30-03-2015,5653,Egypt,Egypt,7933,Not assigned,39, $231.0 ," $9,009.0 ", $-   ,Mar
AR-2015-1460,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,17-02-2015,5653,Japan,Singapore,7933,Not assigned,469, $231.0 ," $1,08,339.0 ", $-   ,Feb
AR-2015-1461,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,07-11-2015,5653,Japan,Singapore,7933,Not assigned,266, $231.0 ," $61,446.0 ", $-   ,Nov
AR-2015-1462,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,25-09-2015,5653,Japan,Singapore,7933,Not assigned,166, $231.0 ," $38,346.0 ", $-   ,Sep
AR-2015-1463,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,23-10-2015,5653,Japan,Singapore,7933,Not assigned,331, $231.0 ," $76,461.0 ", $-   ,Oct
AR-2015-1464,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,26-04-2015,5653,Japan,Singapore,7933,Not assigned,53, $231.0 ," $12,243.0 ", $-   ,Apr
AR-2015-1465,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,02-02-2015,5653,Yemen,Yemen,7933,Not assigned,295, $231.0 ," $68,145.0 ", $-   ,Feb
AR-2015-1466,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,18-11-2015,5653,Yemen,Yemen,7933,Not assigned,138, $231.0 ," $31,878.0 ", $-   ,Nov
AR-2015-1467,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,01-02-2015,5653,Philippines,Philippines,7933,Assigned,41, $231.0 ," $9,471.0 ", $300.7 ,Feb
AR-2015-1468,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,21-02-2015,5653,Philippines,Philippines,7933,Assigned,176, $231.0 ," $40,656.0 "," $5,573.3 ",Feb
AR-2015-1469,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,07-05-2015,5653,Kenya,Kenya,7933,Assigned,232, $231.0 ," $53,592.0 "," $6,805.3 ",May
AR-2015-1470,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,10-07-2015,5653,Malaysia,Malaysia,7933,Assigned,113, $231.0 ," $26,103.0 "," $3,465.3 ",Jul
AR-2015-1471,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,21-09-2015,5653,Malaysia,Malaysia,7933,Assigned,197, $231.0 ," $45,507.0 "," $6,501.0 ",Sep
AR-2015-1472,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,07-02-2015,5653,Vietnam,Netherlands,7933,Assigned,471, $231.0 ," $1,08,801.0 "," $7,065.0 ",Feb
AR-2015-1473,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,01-01-2015,5653,Indonesia,Indonesia,7933,Assigned,404, $231.0 ," $93,324.0 "," $10,908.0 ",Jan
AR-2015-1474,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,26-03-2015,5653,Indonesia,Indonesia,7933,Assigned,169, $231.0 ," $39,039.0 "," $4,056.0 ",Mar
AR-2015-1475,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,25-06-2015,5653,Vietnam,Netherlands,7933,Assigned,56, $231.0 ," $12,936.0 "," $1,549.3 ",Jun
AR-2015-1476,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,07-08-2015,5653,Vietnam,Vietnam,7933,Assigned,128, $231.0 ," $29,568.0 "," $3,797.3 ",Aug
AR-2015-1477,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,08-03-2015,5653,Thailand,Thailand,7933,Assigned,205, $231.0 ," $47,355.0 "," $2,460.0 ",Mar
AR-2015-1478,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,30-11-2015,5653,Thailand,Thailand,7933,Assigned,282, $231.0 ," $65,142.0 "," $8,554.0 ",Nov
AR-2015-1479,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,29-05-2015,5653,Thailand,Thailand,7933,Assigned,496, $231.0 ," $1,14,576.0 "," $9,589.3 ",May
AR-2015-1480,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,10-10-2015,5653,Malaysia,Malaysia,7933,Not assigned,424, $231.0 ," $97,944.0 ", $-   ,Oct
AR-2015-1481,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,16-08-2015,5653,Thailand,Thailand,7933,Not assigned,488, $231.0 ," $1,12,728.0 ", $-   ,Aug
AR-2015-1482,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,09-09-2015,5653,Vietnam,Japan,7933,Assigned,120, $231.0 ," $27,720.0 "," $2,520.0 ",Sep
AR-2015-1483,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,08-12-2015,5653,Thailand,Thailand,7933,Not assigned,266, $231.0 ," $61,446.0 ", $-   ,Dec
AR-2015-1484,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,18-02-2015,5653,Thailand,Thailand,7933,Not assigned,99, $231.0 ," $22,869.0 ", $-   ,Feb
AR-2015-1485,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,15-01-2015,5653,Vietnam,Netherlands,7933,Assigned,437, $231.0 ," $1,00,947.0 "," $5,098.3 ",Jan
AR-2015-1486,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,19-07-2015,5653,Vietnam,Netherlands,7933,Assigned,282, $231.0 ," $65,142.0 "," $1,598.0 ",Jul
AR-2015-1487,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,22-07-2015,5653,Thailand,Thailand,7933,Not assigned,148, $231.0 ," $34,188.0 ", $-   ,Jul
AR-2015-1488,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,16-06-2015,5653,Thailand,Thailand,7933,Not assigned,488, $231.0 ," $1,12,728.0 ", $-   ,Jun
AR-2015-1489,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,25-02-2015,5653,Egypt,Egypt,7933,Not assigned,113, $231.0 ," $26,103.0 ", $-   ,Feb
DE-2015-1490,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,03-11-2015,5754,India,India,7904,Not assigned,187, $314.0 ," $58,718.0 ", $-   ,Nov
DE-2015-1491,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,17-05-2015,5754,India,India,7904,Not assigned,217, $314.0 ," $68,138.0 ", $-   ,May
DE-2015-1492,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,21-08-2015,5754,India,India,7904,Not assigned,326, $314.0 ," $1,02,364.0 ", $-   ,Aug
DE-2015-1493,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,16-02-2015,5754,India,India,7904,Not assigned,156, $314.0 ," $48,984.0 ", $-   ,Feb
DE-2015-1494,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,22-11-2015,5754,India,India,7904,Not assigned,98, $314.0 ," $30,772.0 ", $-   ,Nov
DE-2015-1495,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,25-11-2015,5754,India,India,7904,Not assigned,125, $314.0 ," $39,250.0 ", $-   ,Nov
DE-2015-1496,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,21-05-2015,5754,India,India,7904,Not assigned,27, $314.0 ," $8,478.0 ", $-   ,May
DE-2015-1497,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,07-06-2015,5754,India,India,7904,Assigned,191, $314.0 ," $59,974.0 "," $4,520.3 ",Jun
DE-2015-1498,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,29-03-2015,5754,India,India,7904,Assigned,18, $314.0 ," $5,652.0 ", $534.0 ,Mar
IN-2015-1499,Bevacizumab,Avastin,Genentech/Roche,Cancer,03-03-2015,5685,India,India,8209,Assigned,267, $243.0 ," $64,881.0 "," $6,052.0 ",Mar
DE-2015-1500,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,29-05-2015,5754,India,India,7904,Assigned,378, $314.0 ," $1,18,692.0 "," $8,694.0 ",May
DE-2015-1501,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,18-10-2015,5754,India,India,7904,Assigned,318, $314.0 ," $99,852.0 "," $6,996.0 ",Oct
DE-2015-1502,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,12-08-2015,5754,India,India,7904,Not assigned,419, $314.0 ," $1,31,566.0 ", $-   ,Aug
DE-2015-1503,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,20-02-2015,5754,India,India,7904,Assigned,458, $314.0 ," $1,43,812.0 "," $5,648.7 ",Feb
DE-2015-1504,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,04-05-2015,5754,India,India,7904,Assigned,31, $314.0 ," $9,734.0 ", $940.3 ,May
DE-2015-1505,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,18-11-2015,5754,India,India,7904,Assigned,25, $314.0 ," $7,850.0 ", $566.7 ,Nov
CA-2015-1506,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-04-2015,5887,India,India,8095,Assigned,433, $500.0 ," $2,16,500.0 "," $13,856.0 ",Apr
DE-2015-1507,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,29-05-2015,5754,India,India,7904,Assigned,142, $314.0 ," $44,588.0 "," $3,266.0 ",May
DE-2015-1508,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,14-04-2015,5754,India,India,7904,Not assigned,383, $314.0 ," $1,20,262.0 ", $-   ,Apr
DE-2015-1509,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,02-08-2015,5754,India,India,7904,Not assigned,131, $314.0 ," $41,134.0 ", $-   ,Aug
DE-2015-1510,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,22-10-2015,5754,India,India,7904,Not assigned,1, $314.0 , $314.0 , $-   ,Oct
DE-2015-1511,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,20-02-2015,5754,India,India,7904,Not assigned,135, $314.0 ," $42,390.0 ", $-   ,Feb
DE-2015-1512,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,05-04-2015,5754,India,India,7904,Not assigned,161, $314.0 ," $50,554.0 ", $-   ,Apr
DE-2015-1513,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,18-05-2015,5754,India,India,7904,Not assigned,477, $314.0 ," $1,49,778.0 ", $-   ,May
DE-2015-1514,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,01-04-2015,5754,Pakistan,Pakistan,7904,Not assigned,238, $314.0 ," $74,732.0 ", $-   ,Apr
DE-2015-1515,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,09-07-2015,5754,Pakistan,Pakistan,7904,Not assigned,72, $314.0 ," $22,608.0 ", $-   ,Jul
DE-2015-1516,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,17-06-2015,5754,Egypt,Egypt,7904,Not assigned,378, $314.0 ," $1,18,692.0 ", $-   ,Jun
DE-2015-1517,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,24-03-2015,5754,Egypt,Egypt,7904,Not assigned,166, $314.0 ," $52,124.0 ", $-   ,Mar
DE-2015-1518,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,15-11-2015,5754,Egypt,Egypt,7904,Not assigned,4, $314.0 ," $1,256.0 ", $-   ,Nov
DE-2015-1519,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,06-09-2015,5754,Indonesia,Indonesia,7904,Assigned,456, $314.0 ," $1,43,184.0 "," $6,840.0 ",Sep
DE-2015-1520,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,25-06-2015,5754,Indonesia,Indonesia,7904,Assigned,435, $314.0 ," $1,36,590.0 "," $10,150.0 ",Jun
DE-2015-1521,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,28-08-2015,5754,Egypt,Egypt,7904,Assigned,140, $314.0 ," $43,960.0 "," $2,006.7 ",Aug
DE-2015-1522,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,02-11-2015,5754,Egypt,Egypt,7904,Assigned,494, $314.0 ," $1,55,116.0 "," $4,446.0 ",Nov
DE-2015-1523,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,24-08-2015,5754,Egypt,Egypt,7904,Assigned,314, $314.0 ," $98,596.0 "," $7,745.3 ",Aug
DE-2015-1524,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,20-11-2015,5754,Egypt,Egypt,7904,Assigned,320, $314.0 ," $1,00,480.0 "," $3,413.3 ",Nov
DE-2015-1525,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,11-02-2015,5754,Nepal,Nepal,7904,Assigned,221, $314.0 ," $69,394.0 "," $4,935.7 ",Feb
DE-2015-1526,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,21-04-2015,5754,Nepal,Nepal,7904,Assigned,340, $314.0 ," $1,06,760.0 "," $8,613.3 ",Apr
DE-2015-1527,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,23-10-2015,5754,Egypt,Egypt,7904,Not assigned,478, $314.0 ," $1,50,092.0 ", $-   ,Oct
DE-2015-1528,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,13-08-2015,5754,Egypt,Egypt,7904,Not assigned,493, $314.0 ," $1,54,802.0 ", $-   ,Aug
DE-2015-1529,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,07-07-2015,5754,Vietnam,Vietnam,7904,Assigned,126, $314.0 ," $39,564.0 "," $1,596.0 ",Jul
DE-2015-1530,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,13-10-2015,5754,Singapore,Singapore,7904,Not assigned,113, $314.0 ," $35,482.0 ", $-   ,Oct
DE-2015-1531,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,30-12-2015,5754,Vietnam,Japan,7904,Assigned,377, $314.0 ," $1,18,378.0 "," $5,906.3 ",Dec
DE-2015-1532,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,24-01-2015,5754,Vietnam,Japan,7904,Assigned,148, $314.0 ," $46,472.0 "," $3,601.3 ",Jan
DE-2015-1533,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,18-05-2015,5754,Vietnam,Japan,7904,Assigned,151, $314.0 ," $47,414.0 "," $1,661.0 ",May
DE-2015-1534,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,14-10-2015,5754,Vietnam,Japan,7904,Assigned,464, $314.0 ," $1,45,696.0 "," $14,693.3 ",Oct
DE-2015-1535,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,14-06-2015,5754,Egypt,Egypt,7904,Not assigned,365, $314.0 ," $1,14,610.0 ", $-   ,Jun
DE-2015-1536,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,25-10-2015,5754,Egypt,Egypt,7904,Not assigned,109, $314.0 ," $34,226.0 ", $-   ,Oct
DE-2015-1537,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,25-12-2015,5754,Egypt,Egypt,7904,Not assigned,16, $314.0 ," $5,024.0 ", $-   ,Dec
DE-2015-1538,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,20-05-2015,5754,Vietnam,Japan,7904,Assigned,500, $314.0 ," $1,57,000.0 "," $2,166.7 ",May
DE-2015-1539,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,24-10-2015,5754,Bangladesh,Bangladesh,7904,Assigned,186, $314.0 ," $58,404.0 ", $806.0 ,Oct
DE-2015-1540,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,11-10-2015,5754,Saudi Arabia,Saudi Arabia,7904,Not assigned,284, $314.0 ," $89,176.0 ", $-   ,Oct
DE-2015-1541,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,19-04-2015,5754,Vietnam,Netherlands,7904,Assigned,95, $314.0 ," $29,830.0 "," $1,456.7 ",Apr
DE-2015-1542,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,03-11-2015,5754,Vietnam,Japan,7904,Assigned,68, $314.0 ," $21,352.0 "," $1,700.0 ",Nov
DE-2015-1543,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,10-06-2015,5754,Yemen,Yemen,7904,Not assigned,190, $314.0 ," $59,660.0 ", $-   ,Jun
DE-2015-1544,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,13-12-2015,5754,Yemen,Yemen,7904,Not assigned,415, $314.0 ," $1,30,310.0 ", $-   ,Dec
DE-2015-1545,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,01-08-2015,5754,Nepal,Nepal,7904,Assigned,166, $314.0 ," $52,124.0 "," $2,158.0 ",Aug
DE-2015-1546,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,04-10-2015,5754,Singapore,Singapore,7904,Not assigned,364, $314.0 ," $1,14,296.0 ", $-   ,Oct
DE-2015-1547,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,14-01-2015,5754,Nepal,Nepal,7904,Assigned,291, $314.0 ," $91,374.0 "," $8,342.0 ",Jan
DE-2015-1548,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,27-11-2015,5754,Vietnam,Netherlands,7904,Assigned,497, $314.0 ," $1,56,058.0 "," $10,271.3 ",Nov
DE-2015-1549,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,09-11-2015,5754,Egypt,Egypt,7904,Not assigned,3, $314.0 , $942.0 , $-   ,Nov
DE-2015-1550,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,23-05-2015,5754,Vietnam,Netherlands,7904,Assigned,60, $314.0 ," $18,840.0 "," $1,640.0 ",May
DE-2015-1551,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,25-09-2015,5754,Nepal,Nepal,7904,Assigned,335, $314.0 ," $1,05,190.0 "," $5,918.3 ",Sep
DE-2015-1552,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,04-01-2015,5754,Nepal,Nepal,7904,Assigned,339, $314.0 ," $1,06,446.0 "," $3,051.0 ",Jan
DE-2015-1553,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,26-06-2015,5754,Vietnam,Netherlands,7904,Assigned,275, $314.0 ," $86,350.0 "," $2,016.7 ",Jun
DE-2015-1554,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,09-06-2015,5754,Vietnam,Netherlands,7904,Assigned,136, $314.0 ," $42,704.0 "," $2,130.7 ",Jun
DE-2015-1555,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,16-07-2015,5754,Vietnam,Netherlands,7904,Assigned,382, $314.0 ," $1,19,948.0 "," $5,220.7 ",Jul
DE-2015-1556,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,11-04-2015,5754,Vietnam,Netherlands,7904,Assigned,302, $314.0 ," $94,828.0 "," $6,744.7 ",Apr
DE-2015-1557,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,23-02-2015,5754,Vietnam,Netherlands,7904,Assigned,492, $314.0 ," $1,54,488.0 "," $7,380.0 ",Feb
DE-2015-1558,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,24-07-2015,5754,Malaysia,Malaysia,7904,Not assigned,340, $314.0 ," $1,06,760.0 ", $-   ,Jul
DE-2015-1559,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,27-06-2015,5754,Singapore,Singapore,7904,Not assigned,192, $314.0 ," $60,288.0 ", $-   ,Jun
DE-2015-1560,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,28-05-2015,5754,Indonesia,Indonesia,7904,Assigned,204, $314.0 ," $64,056.0 "," $5,100.0 ",May
DE-2015-1561,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,12-09-2015,5754,Vietnam,Netherlands,7904,Assigned,231, $314.0 ," $72,534.0 "," $3,157.0 ",Sep
DE-2015-1562,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,20-06-2015,5754,Vietnam,Japan,7904,Assigned,442, $314.0 ," $1,38,788.0 "," $14,291.3 ",Jun
DE-2015-1563,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,03-03-2015,5754,Indonesia,Indonesia,7904,Not assigned,453, $314.0 ," $1,42,242.0 ", $-   ,Mar
DE-2015-1564,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,08-08-2015,5754,Indonesia,Indonesia,7904,Not assigned,443, $314.0 ," $1,39,102.0 ", $-   ,Aug
DE-2015-1565,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,06-05-2015,5754,Vietnam,Netherlands,7904,Assigned,292, $314.0 ," $91,688.0 "," $2,336.0 ",May
DE-2015-1566,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,16-03-2015,5754,Hong Kong,Hong Kong,7904,Not assigned,37, $314.0 ," $11,618.0 ", $-   ,Mar
AR-2015-1567,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,21-02-2015,5653,Philippines,Philippines,7933,Assigned,345, $231.0 ," $79,695.0 "," $1,725.0 ",Feb
AR-2015-1568,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,11-01-2015,5653,Vietnam,Japan,7933,Assigned,434, $231.0 ," $1,00,254.0 "," $5,786.7 ",Jan
AR-2015-1569,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,30-11-2015,5653,Bangladesh,Bangladesh,7933,Not assigned,89, $231.0 ," $20,559.0 ", $-   ,Nov
AR-2015-1570,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,12-06-2015,5653,Bangladesh,Bangladesh,7933,Not assigned,390, $231.0 ," $90,090.0 ", $-   ,Jun
AR-2015-1571,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,21-10-2015,5653,Yemen,Yemen,7933,Not assigned,120, $231.0 ," $27,720.0 ", $-   ,Oct
AR-2015-1572,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,01-06-2015,5653,Yemen,Yemen,7933,Not assigned,257, $231.0 ," $59,367.0 ", $-   ,Jun
AR-2015-1573,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,01-04-2015,5653,Bangladesh,Bangladesh,7933,Not assigned,240, $231.0 ," $55,440.0 ", $-   ,Apr
AR-2015-1574,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,05-10-2015,5653,Bangladesh,Bangladesh,7933,Not assigned,10, $231.0 ," $2,310.0 ", $-   ,Oct
TA-2015-1575,Filgrastim,Neulasta,Amgen,Neutropenia,10-05-2015,5737,Malaysia,Malaysia,8270,Not assigned,412, $266.0 ," $1,09,592.0 ", $-   ,May
EL-2015-1576,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,29-12-2015,5737,Malaysia,Malaysia,8270,Assigned,189, $250.0 ," $47,250.0 "," $1,890.0 ",Dec
EL-2015-1577,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,16-05-2015,5737,Vietnam,Japan,8270,Assigned,472, $250.0 ," $1,18,000.0 "," $10,698.7 ",May
EL-2015-1578,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,27-05-2015,5737,Pakistan,Pakistan,8270,Assigned,486, $250.0 ," $1,21,500.0 "," $16,200.0 ",May
EL-2015-1579,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,23-11-2015,5737,Pakistan,Pakistan,8270,Not assigned,234, $250.0 ," $58,500.0 ", $-   ,Nov
EL-2015-1580,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,19-06-2015,5737,Syria,Lebanon,8270,Assigned,133, $250.0 ," $33,250.0 "," $3,059.0 ",Jun
EL-2015-1581,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,20-06-2015,5737,Vietnam,Japan,8270,Assigned,95, $250.0 ," $23,750.0 "," $3,040.0 ",Jun
EL-2015-1582,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,08-12-2015,5737,Malaysia,Malaysia,8270,Assigned,499, $250.0 ," $1,24,750.0 "," $13,639.3 ",Dec
EL-2015-1583,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,14-09-2015,5737,Hong Kong,Philippines,8270,Not assigned,468, $250.0 ," $1,17,000.0 ", $-   ,Sep
UM-2015-1584,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,07-05-2015,5704,India,India,8370,Not assigned,136, $366.0 ," $49,776.0 ", $-   ,May
UM-2015-1585,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,23-04-2015,5704,India,India,8370,Assigned,64, $366.0 ," $23,424.0 "," $1,216.0 ",Apr
UM-2015-1586,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,26-10-2015,5704,India,India,8370,Not assigned,81, $366.0 ," $29,646.0 ", $-   ,Oct
UM-2015-1587,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,22-04-2015,5704,India,India,8370,Assigned,235, $366.0 ," $86,010.0 "," $4,856.7 ",Apr
UM-2015-1588,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,16-06-2015,5704,India,India,8370,Not assigned,239, $366.0 ," $87,474.0 ", $-   ,Jun
UM-2015-1589,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,27-01-2015,5704,India,India,8370,Not assigned,78, $366.0 ," $28,548.0 ", $-   ,Jan
UM-2015-1590,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,25-02-2015,5704,India,India,8370,Assigned,46, $366.0 ," $16,836.0 "," $1,349.3 ",Feb
UM-2015-1591,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,14-10-2015,5704,India,India,8370,Assigned,341, $366.0 ," $1,24,806.0 "," $2,614.3 ",Oct
UM-2015-1592,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,31-10-2015,5704,India,India,8370,Not assigned,413, $366.0 ," $1,51,158.0 ", $-   ,Oct
UM-2015-1593,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,15-12-2015,5704,India,India,8370,Assigned,460, $366.0 ," $1,68,360.0 "," $3,066.7 ",Dec
UM-2015-1594,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,18-07-2015,5704,India,India,8370,Not assigned,46, $366.0 ," $16,836.0 ", $-   ,Jul
UM-2015-1595,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,16-09-2015,5704,India,India,8370,Not assigned,250, $366.0 ," $91,500.0 ", $-   ,Sep
UM-2015-1596,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,15-10-2015,5704,India,India,8370,Not assigned,413, $366.0 ," $1,51,158.0 ", $-   ,Oct
UM-2015-1597,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,06-06-2015,5704,India,India,8370,Assigned,14, $366.0 ," $5,124.0 ", $186.7 ,Jun
UM-2015-1598,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,09-12-2015,5704,India,India,8370,Not assigned,407, $366.0 ," $1,48,962.0 ", $-   ,Dec
UM-2015-1599,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,24-04-2015,5704,India,India,8370,Not assigned,309, $366.0 ," $1,13,094.0 ", $-   ,Apr
UM-2015-1600,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,06-02-2015,5704,India,India,8370,Not assigned,432, $366.0 ," $1,58,112.0 ", $-   ,Feb
UM-2015-1601,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,04-05-2015,5704,India,India,8370,Not assigned,139, $366.0 ," $50,874.0 ", $-   ,May
UM-2015-1602,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,27-01-2015,5704,India,India,8370,Not assigned,339, $366.0 ," $1,24,074.0 ", $-   ,Jan
UM-2015-1603,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,30-03-2015,5704,India,India,8370,Not assigned,189, $366.0 ," $69,174.0 ", $-   ,Mar
UM-2015-1604,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,17-08-2015,5704,India,India,8370,Not assigned,72, $366.0 ," $26,352.0 ", $-   ,Aug
UM-2015-1605,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,11-06-2015,5704,India,India,8370,Not assigned,116, $366.0 ," $42,456.0 ", $-   ,Jun
UM-2015-1606,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,23-03-2015,5704,India,India,8370,Not assigned,276, $366.0 ," $1,01,016.0 ", $-   ,Mar
UM-2015-1607,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,19-03-2015,5704,India,India,8370,Not assigned,97, $366.0 ," $35,502.0 ", $-   ,Mar
UM-2015-1608,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,02-12-2015,5704,India,India,8370,Not assigned,65, $366.0 ," $23,790.0 ", $-   ,Dec
UM-2015-1609,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,28-03-2015,5704,India,India,8370,Not assigned,139, $366.0 ," $50,874.0 ", $-   ,Mar
UM-2015-1610,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,04-03-2015,5704,India,India,8370,Not assigned,153, $366.0 ," $55,998.0 ", $-   ,Mar
UM-2015-1611,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,16-12-2015,5704,India,India,8370,Assigned,373, $366.0 ," $1,36,518.0 "," $8,330.3 ",Dec
UM-2015-1612,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,25-12-2015,5704,India,India,8370,Assigned,405, $366.0 ," $1,48,230.0 "," $6,480.0 ",Dec
UM-2015-1613,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,21-11-2015,5704,India,India,8370,Not assigned,46, $366.0 ," $16,836.0 ", $-   ,Nov
UM-2015-1614,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,10-09-2015,5704,India,India,8370,Not assigned,9, $366.0 ," $3,294.0 ", $-   ,Sep
UM-2015-1615,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,05-03-2015,5704,India,India,8370,Not assigned,270, $366.0 ," $98,820.0 ", $-   ,Mar
UM-2015-1616,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,18-09-2015,5704,India,India,8370,Not assigned,326, $366.0 ," $1,19,316.0 ", $-   ,Sep
UM-2015-1617,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,22-10-2015,5704,India,India,8370,Not assigned,165, $366.0 ," $60,390.0 ", $-   ,Oct
UM-2015-1618,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,12-11-2015,5704,India,India,8370,Not assigned,399, $366.0 ," $1,46,034.0 ", $-   ,Nov
UM-2015-1619,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,01-05-2015,5704,India,India,8370,Not assigned,270, $366.0 ," $98,820.0 ", $-   ,May
UM-2015-1620,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,10-04-2015,5704,India,India,8370,Not assigned,31, $366.0 ," $11,346.0 ", $-   ,Apr
UM-2015-1621,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,12-07-2015,5704,India,India,8370,Assigned,123, $366.0 ," $45,018.0 "," $1,599.0 ",Jul
UM-2015-1622,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,08-06-2015,5704,India,India,8370,Assigned,212, $366.0 ," $77,592.0 "," $1,130.7 ",Jun
UM-2015-1623,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,18-11-2015,5704,India,India,8370,Not assigned,59, $366.0 ," $21,594.0 ", $-   ,Nov
UM-2015-1624,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,19-09-2015,5704,India,India,8370,Not assigned,214, $366.0 ," $78,324.0 ", $-   ,Sep
UM-2015-1625,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,24-05-2015,5704,India,India,8370,Not assigned,487, $366.0 ," $1,78,242.0 ", $-   ,May
UM-2015-1626,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,21-05-2015,5704,India,India,8370,Not assigned,259, $366.0 ," $94,794.0 ", $-   ,May
UM-2015-1627,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,23-09-2015,5704,India,India,8370,Not assigned,92, $366.0 ," $33,672.0 ", $-   ,Sep
UM-2015-1628,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,20-04-2015,5704,India,India,8370,Not assigned,356, $366.0 ," $1,30,296.0 ", $-   ,Apr
UM-2015-1629,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,03-04-2015,5704,India,India,8370,Not assigned,190, $366.0 ," $69,540.0 ", $-   ,Apr
UM-2015-1630,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,03-04-2015,5704,India,India,8370,Not assigned,137, $366.0 ," $50,142.0 ", $-   ,Apr
UM-2015-1631,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,12-10-2015,5704,India,India,8370,Not assigned,152, $366.0 ," $55,632.0 ", $-   ,Oct
UM-2015-1632,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,19-09-2015,5704,India,India,8370,Not assigned,450, $366.0 ," $1,64,700.0 ", $-   ,Sep
UM-2015-1633,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,23-08-2015,5704,India,India,8370,Not assigned,343, $366.0 ," $1,25,538.0 ", $-   ,Aug
UM-2015-1634,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,27-03-2015,5704,India,India,8370,Not assigned,267, $366.0 ," $97,722.0 ", $-   ,Mar
UM-2015-1635,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,19-11-2015,5704,India,India,8370,Not assigned,182, $366.0 ," $66,612.0 ", $-   ,Nov
UM-2015-1636,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,29-07-2015,5704,India,India,8370,Not assigned,74, $366.0 ," $27,084.0 ", $-   ,Jul
UM-2015-1637,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,04-03-2015,5704,India,India,8370,Not assigned,445, $366.0 ," $1,62,870.0 ", $-   ,Mar
UM-2015-1638,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,18-11-2015,5704,India,India,8370,Not assigned,357, $366.0 ," $1,30,662.0 ", $-   ,Nov
UM-2015-1639,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,23-12-2015,5704,India,India,8370,Not assigned,490, $366.0 ," $1,79,340.0 ", $-   ,Dec
UM-2015-1640,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,04-12-2015,5704,India,India,8370,Not assigned,250, $366.0 ," $91,500.0 ", $-   ,Dec
UM-2015-1641,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,27-02-2015,5704,India,India,8370,Not assigned,271, $366.0 ," $99,186.0 ", $-   ,Feb
UM-2015-1642,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,22-07-2015,5704,India,India,8370,Not assigned,355, $366.0 ," $1,29,930.0 ", $-   ,Jul
UM-2015-1643,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,24-02-2015,5704,India,India,8370,Not assigned,392, $366.0 ," $1,43,472.0 ", $-   ,Feb
UM-2015-1644,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,20-04-2015,5704,India,India,8370,Assigned,435, $366.0 ," $1,59,210.0 "," $9,860.0 ",Apr
UM-2015-1645,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,17-06-2015,5704,India,India,8370,Not assigned,379, $366.0 ," $1,38,714.0 ", $-   ,Jun
UM-2015-1646,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,12-09-2015,5704,India,India,8370,Assigned,403, $366.0 ," $1,47,498.0 "," $4,836.0 ",Sep
UM-2015-1647,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,11-10-2015,5704,India,India,8370,Not assigned,441, $366.0 ," $1,61,406.0 ", $-   ,Oct
UM-2015-1648,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,30-07-2015,5704,India,India,8370,Not assigned,300, $366.0 ," $1,09,800.0 ", $-   ,Jul
UM-2015-1649,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,09-04-2015,5704,India,India,8370,Not assigned,408, $366.0 ," $1,49,328.0 ", $-   ,Apr
UM-2015-1650,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,01-01-2015,5704,India,India,8370,Not assigned,378, $366.0 ," $1,38,348.0 ", $-   ,Jan
UM-2015-1651,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,04-01-2015,5704,India,India,8370,Not assigned,290, $366.0 ," $1,06,140.0 ", $-   ,Jan
UM-2015-1652,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,26-07-2015,5704,India,India,8370,Not assigned,242, $366.0 ," $88,572.0 ", $-   ,Jul
UM-2015-1653,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,30-12-2015,5704,India,India,8370,Not assigned,66, $366.0 ," $24,156.0 ", $-   ,Dec
UM-2015-1654,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,07-09-2015,5704,India,India,8370,Not assigned,178, $366.0 ," $65,148.0 ", $-   ,Sep
UM-2015-1655,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,12-04-2015,5704,India,India,8370,Not assigned,191, $366.0 ," $69,906.0 ", $-   ,Apr
UM-2015-1656,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,01-07-2015,5704,India,India,8370,Not assigned,88, $366.0 ," $32,208.0 ", $-   ,Jul
UM-2015-1657,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,26-03-2015,5704,India,India,8370,Not assigned,65, $366.0 ," $23,790.0 ", $-   ,Mar
UM-2015-1658,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,06-08-2015,5704,India,India,8370,Not assigned,66, $366.0 ," $24,156.0 ", $-   ,Aug
UM-2015-1659,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,13-04-2015,5704,India,India,8370,Not assigned,165, $366.0 ," $60,390.0 ", $-   ,Apr
UM-2015-1660,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,30-08-2015,5704,USA,USA,8370,Not assigned,245, $366.0 ," $89,670.0 ", $-   ,Aug
UM-2015-1661,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,08-12-2015,5704,Malaysia,Malaysia,8370,Assigned,34, $366.0 ," $12,444.0 ", $555.3 ,Dec
UM-2015-1662,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,11-04-2015,5704,Indonesia,Indonesia,8370,Not assigned,133, $366.0 ," $48,678.0 ", $-   ,Apr
UM-2015-1663,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,30-11-2015,5704,India,India,8370,Not assigned,62, $366.0 ," $22,692.0 ", $-   ,Nov
UM-2015-1664,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,04-08-2015,5704,India,India,8370,Not assigned,456, $366.0 ," $1,66,896.0 ", $-   ,Aug
UM-2015-1665,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,07-11-2015,5704,USA,USA,8370,Not assigned,208, $366.0 ," $76,128.0 ", $-   ,Nov
UM-2015-1666,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,05-02-2015,5704,Vietnam,Netherlands,8370,Assigned,329, $366.0 ," $1,20,414.0 "," $1,206.3 ",Feb
UM-2015-1667,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,07-10-2015,5704,Argentina,Argentina,8370,Not assigned,366, $366.0 ," $1,33,956.0 ", $-   ,Oct
UM-2015-1668,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,06-08-2015,5704,Kenya,Kenya,8370,Assigned,486, $366.0 ," $1,77,876.0 "," $8,100.0 ",Aug
UM-2015-1669,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,13-11-2015,5704,Argentina,Argentina,8370,Not assigned,457, $366.0 ," $1,67,262.0 ", $-   ,Nov
UM-2015-1670,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,04-01-2015,5704,Pakistan,Pakistan,8370,Assigned,346, $366.0 ," $1,26,636.0 "," $10,956.7 ",Jan
UM-2015-1671,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,25-06-2015,5704,India,India,8370,Not assigned,252, $366.0 ," $92,232.0 ", $-   ,Jun
UM-2015-1672,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,29-09-2015,5704,India,India,8370,Not assigned,131, $366.0 ," $47,946.0 ", $-   ,Sep
UM-2015-1673,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,29-04-2015,5704,India,India,8370,Not assigned,314, $366.0 ," $1,14,924.0 ", $-   ,Apr
UM-2015-1674,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,18-01-2015,5704,Vietnam,Japan,8370,Assigned,417, $366.0 ," $1,52,622.0 "," $3,614.0 ",Jan
UM-2015-1675,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,01-09-2015,5704,India,India,8370,Not assigned,83, $366.0 ," $30,378.0 ", $-   ,Sep
UM-2015-1676,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,27-07-2015,5704,Egypt,Egypt,8370,Assigned,309, $366.0 ," $1,13,094.0 "," $7,416.0 ",Jul
UM-2015-1677,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,16-03-2015,5704,Panama,Mexico,8370,Not assigned,22, $366.0 ," $8,052.0 ", $-   ,Mar
UM-2015-1678,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,17-08-2015,5704,Colombia,Mexico,8370,Not assigned,93, $366.0 ," $34,038.0 ", $-   ,Aug
UM-2015-1679,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,06-05-2015,5704,Argentina,Mexico,8370,Not assigned,76, $366.0 ," $27,816.0 ", $-   ,May
UM-2015-1680,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,06-06-2015,5704,Colombia,Mexico,8370,Not assigned,180, $366.0 ," $65,880.0 ", $-   ,Jun
UM-2015-1681,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,05-07-2015,5704,Peru,Mexico,8370,Not assigned,60, $366.0 ," $21,960.0 ", $-   ,Jul
UM-2015-1682,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,25-09-2015,5704,Netherlands,Netherlands,8370,Not assigned,375, $366.0 ," $1,37,250.0 ", $-   ,Sep
UM-2015-1683,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,01-02-2015,5704,India,India,8370,Not assigned,189, $366.0 ," $69,174.0 ", $-   ,Feb
UM-2015-1684,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,27-02-2015,5704,India,India,8370,Not assigned,207, $366.0 ," $75,762.0 ", $-   ,Feb
UM-2015-1685,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,01-08-2015,5704,India,India,8370,Not assigned,283, $366.0 ," $1,03,578.0 ", $-   ,Aug
UM-2015-1686,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,05-12-2015,5704,India,India,8370,Not assigned,296, $366.0 ," $1,08,336.0 ", $-   ,Dec
UM-2015-1687,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,24-11-2015,5704,India,India,8370,Not assigned,65, $366.0 ," $23,790.0 ", $-   ,Nov
UM-2015-1688,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,30-12-2015,5704,India,India,8370,Not assigned,285, $366.0 ," $1,04,310.0 ", $-   ,Dec
UM-2015-1689,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,07-03-2015,5704,India,India,8370,Not assigned,157, $366.0 ," $57,462.0 ", $-   ,Mar
UM-2015-1690,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,23-08-2015,5704,India,India,8370,Not assigned,173, $366.0 ," $63,318.0 ", $-   ,Aug
UM-2015-1691,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,05-05-2015,5704,India,India,8370,Not assigned,465, $366.0 ," $1,70,190.0 ", $-   ,May
UM-2015-1692,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,08-01-2015,5704,India,India,8370,Not assigned,318, $366.0 ," $1,16,388.0 ", $-   ,Jan
UM-2015-1693,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,03-04-2015,5704,India,India,8370,Not assigned,430, $366.0 ," $1,57,380.0 ", $-   ,Apr
UM-2015-1694,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,02-05-2015,5704,India,India,8370,Not assigned,5, $366.0 ," $1,830.0 ", $-   ,May
UM-2015-1695,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,01-10-2015,5704,India,India,8370,Not assigned,208, $366.0 ," $76,128.0 ", $-   ,Oct
UM-2015-1696,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,18-06-2015,5704,India,India,8370,Not assigned,201, $366.0 ," $73,566.0 ", $-   ,Jun
UM-2015-1697,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,11-12-2015,5704,India,India,8370,Not assigned,195, $366.0 ," $71,370.0 ", $-   ,Dec
UM-2015-1698,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,06-11-2015,5704,India,India,8370,Not assigned,451, $366.0 ," $1,65,066.0 ", $-   ,Nov
UM-2015-1699,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,25-08-2015,5704,India,India,8370,Not assigned,39, $366.0 ," $14,274.0 ", $-   ,Aug
UM-2015-1700,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,24-05-2015,5704,India,India,8370,Not assigned,355, $366.0 ," $1,29,930.0 ", $-   ,May
UM-2015-1701,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,03-08-2015,5704,India,India,8370,Not assigned,287, $366.0 ," $1,05,042.0 ", $-   ,Aug
UM-2015-1702,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,08-08-2015,5704,India,India,8370,Not assigned,132, $366.0 ," $48,312.0 ", $-   ,Aug
UM-2015-1703,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,12-06-2015,5704,India,India,8370,Not assigned,397, $366.0 ," $1,45,302.0 ", $-   ,Jun
UM-2015-1704,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,16-12-2015,5704,India,India,8370,Not assigned,118, $366.0 ," $43,188.0 ", $-   ,Dec
UM-2015-1705,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,11-06-2015,5704,India,India,8370,Not assigned,263, $366.0 ," $96,258.0 ", $-   ,Jun
UM-2015-1706,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,01-06-2015,5704,India,India,8370,Not assigned,425, $366.0 ," $1,55,550.0 ", $-   ,Jun
UM-2015-1707,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,29-09-2015,5704,India,India,8370,Not assigned,76, $366.0 ," $27,816.0 ", $-   ,Sep
UM-2015-1708,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,17-04-2015,5704,India,India,8370,Not assigned,131, $366.0 ," $47,946.0 ", $-   ,Apr
UM-2015-1709,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,27-01-2015,5704,India,India,8370,Not assigned,239, $366.0 ," $87,474.0 ", $-   ,Jan
UM-2015-1710,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,16-03-2015,5704,India,India,8370,Not assigned,389, $366.0 ," $1,42,374.0 ", $-   ,Mar
UM-2015-1711,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,14-04-2015,5704,India,India,8370,Not assigned,425, $366.0 ," $1,55,550.0 ", $-   ,Apr
UM-2015-1712,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,10-10-2015,5704,India,India,8370,Not assigned,106, $366.0 ," $38,796.0 ", $-   ,Oct
UM-2015-1713,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,07-03-2015,5704,India,India,8370,Not assigned,224, $366.0 ," $81,984.0 ", $-   ,Mar
UM-2015-1714,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,02-02-2015,5704,India,India,8370,Not assigned,181, $366.0 ," $66,246.0 ", $-   ,Feb
UM-2015-1715,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,20-04-2015,5704,India,India,8370,Not assigned,349, $366.0 ," $1,27,734.0 ", $-   ,Apr
UM-2015-1716,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,13-11-2015,5704,India,India,8370,Not assigned,324, $366.0 ," $1,18,584.0 ", $-   ,Nov
UM-2015-1717,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,31-01-2015,5704,India,India,8370,Not assigned,365, $366.0 ," $1,33,590.0 ", $-   ,Jan
UM-2015-1718,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,31-05-2015,5704,India,India,8370,Not assigned,103, $366.0 ," $37,698.0 ", $-   ,May
UM-2015-1719,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,20-10-2015,5704,India,India,8370,Not assigned,317, $366.0 ," $1,16,022.0 ", $-   ,Oct
UM-2015-1720,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,06-11-2015,5704,India,India,8370,Not assigned,95, $366.0 ," $34,770.0 ", $-   ,Nov
UM-2015-1721,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,01-03-2015,5704,India,India,8370,Not assigned,332, $366.0 ," $1,21,512.0 ", $-   ,Mar
UM-2015-1722,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,14-07-2015,5704,India,India,8370,Not assigned,142, $366.0 ," $51,972.0 ", $-   ,Jul
UM-2015-1723,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,05-05-2015,5704,India,India,8370,Not assigned,242, $366.0 ," $88,572.0 ", $-   ,May
UM-2015-1724,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,07-10-2015,5704,India,India,8370,Not assigned,160, $366.0 ," $58,560.0 ", $-   ,Oct
UM-2015-1725,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,17-08-2015,5704,India,India,8370,Not assigned,82, $366.0 ," $30,012.0 ", $-   ,Aug
UM-2015-1726,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,18-07-2015,5704,India,India,8370,Not assigned,488, $366.0 ," $1,78,608.0 ", $-   ,Jul
UM-2015-1727,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,14-02-2015,5704,India,India,8370,Not assigned,236, $366.0 ," $86,376.0 ", $-   ,Feb
UM-2015-1728,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,30-03-2015,5704,India,India,8370,Not assigned,30, $366.0 ," $10,980.0 ", $-   ,Mar
UM-2015-1729,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,26-02-2015,5704,India,India,8370,Not assigned,305, $366.0 ," $1,11,630.0 ", $-   ,Feb
UM-2015-1730,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,01-08-2015,5704,India,India,8370,Not assigned,392, $366.0 ," $1,43,472.0 ", $-   ,Aug
UM-2015-1731,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,17-10-2015,5704,India,India,8370,Not assigned,183, $366.0 ," $66,978.0 ", $-   ,Oct
UM-2015-1732,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,06-12-2015,5704,India,India,8370,Not assigned,109, $366.0 ," $39,894.0 ", $-   ,Dec
UM-2015-1733,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,07-07-2015,5704,India,India,8370,Not assigned,56, $366.0 ," $20,496.0 ", $-   ,Jul
UM-2015-1734,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,04-01-2015,5704,India,India,8370,Not assigned,499, $366.0 ," $1,82,634.0 ", $-   ,Jan
UM-2015-1735,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,02-03-2015,5704,India,India,8370,Not assigned,318, $366.0 ," $1,16,388.0 ", $-   ,Mar
UM-2015-1736,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,25-05-2015,5704,India,India,8370,Not assigned,214, $366.0 ," $78,324.0 ", $-   ,May
UM-2015-1737,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,28-03-2015,5704,India,India,8370,Not assigned,418, $366.0 ," $1,52,988.0 ", $-   ,Mar
UM-2015-1738,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,24-12-2015,5704,India,India,8370,Not assigned,471, $366.0 ," $1,72,386.0 ", $-   ,Dec
UM-2015-1739,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,08-08-2015,5704,India,India,8370,Not assigned,19, $366.0 ," $6,954.0 ", $-   ,Aug
UM-2015-1740,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,07-11-2015,5704,India,India,8370,Not assigned,407, $366.0 ," $1,48,962.0 ", $-   ,Nov
UM-2015-1741,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,03-11-2015,5704,India,India,8370,Not assigned,480, $366.0 ," $1,75,680.0 ", $-   ,Nov
UM-2015-1742,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,30-05-2015,5704,India,India,8370,Not assigned,41, $366.0 ," $15,006.0 ", $-   ,May
UM-2015-1743,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,18-07-2015,5704,India,India,8370,Not assigned,82, $366.0 ," $30,012.0 ", $-   ,Jul
UM-2015-1744,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,18-02-2015,5704,India,India,8370,Not assigned,153, $366.0 ," $55,998.0 ", $-   ,Feb
UM-2015-1745,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,12-04-2015,5704,India,India,8370,Not assigned,253, $366.0 ," $92,598.0 ", $-   ,Apr
UM-2015-1746,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,17-07-2015,5704,India,India,8370,Not assigned,49, $366.0 ," $17,934.0 ", $-   ,Jul
UM-2015-1747,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,13-11-2015,5704,India,India,8370,Not assigned,354, $366.0 ," $1,29,564.0 ", $-   ,Nov
UM-2015-1748,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,04-07-2015,5704,India,India,8370,Not assigned,111, $366.0 ," $40,626.0 ", $-   ,Jul
UM-2015-1749,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,29-01-2015,5704,India,India,8370,Not assigned,243, $366.0 ," $88,938.0 ", $-   ,Jan
UM-2015-1750,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,19-02-2015,5704,India,India,8370,Not assigned,143, $366.0 ," $52,338.0 ", $-   ,Feb
UM-2015-1751,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,30-11-2015,5704,India,India,8370,Not assigned,118, $366.0 ," $43,188.0 ", $-   ,Nov
UM-2015-1752,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,20-12-2015,5704,India,India,8370,Not assigned,447, $366.0 ," $1,63,602.0 ", $-   ,Dec
UM-2015-1753,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,20-12-2015,5704,India,India,8370,Not assigned,35, $366.0 ," $12,810.0 ", $-   ,Dec
US-2015-1754,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,10-09-2015,5653,Bangladesh,Bangladesh,7933,Assigned,410, $231.0 ," $94,710.0 "," $4,646.7 ",Sep
US-2015-1755,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,24-11-2015,5653,Bangladesh,Bangladesh,7933,Assigned,18, $231.0 ," $4,158.0 ", $258.0 ,Nov
US-2015-1756,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,10-07-2015,5653,Kenya,Kenya,7933,Assigned,115, $231.0 ," $26,565.0 "," $2,031.7 ",Jul
US-2015-1757,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,11-07-2015,5653,South Africa,South Africa,7933,Assigned,275, $231.0 ," $63,525.0 "," $5,866.7 ",Jul
US-2015-1758,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,04-08-2015,5653,Pakistan,Pakistan,7933,Assigned,331, $231.0 ," $76,461.0 "," $4,854.7 ",Aug
US-2015-1759,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,19-11-2015,5653,Pakistan,Pakistan,7933,Assigned,20, $231.0 ," $4,620.0 ", $386.7 ,Nov
US-2015-1760,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,19-05-2015,5653,Australia,Australia,7933,Not assigned,349, $231.0 ," $80,619.0 ", $-   ,May
US-2015-1761,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,29-04-2015,5653,Bangladesh,Bangladesh,7933,Assigned,372, $231.0 ," $85,932.0 "," $8,308.0 ",Apr
US-2015-1762,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,06-08-2015,5653,Malaysia,Malaysia,7933,Not assigned,329, $231.0 ," $75,999.0 ", $-   ,Aug
US-2015-1763,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,25-01-2015,5653,Japan,Singapore,7933,Not assigned,402, $231.0 ," $92,862.0 ", $-   ,Jan
US-2015-1764,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,29-11-2015,5653,Indonesia,Indonesia,7933,Assigned,359, $231.0 ," $82,929.0 "," $7,658.7 ",Nov
US-2015-1765,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,21-12-2015,5653,Syria,Lebanon,7933,Assigned,215, $231.0 ," $49,665.0 "," $6,593.3 ",Dec
US-2015-1766,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,13-05-2015,5653,Kenya,Kenya,7933,Not assigned,235, $231.0 ," $54,285.0 ", $-   ,May
US-2015-1767,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,24-09-2015,5653,Syria,Lebanon,7933,Assigned,441, $231.0 ," $1,01,871.0 "," $11,907.0 ",Sep
US-2015-1768,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,14-06-2015,5653,Saudi Arabia,Saudi Arabia,7933,Not assigned,8, $231.0 ," $1,848.0 ", $-   ,Jun
TA-2015-1769,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,16-11-2015,5704,India,India,8370,Not assigned,242, $453.0 ," $1,09,626.0 ", $-   ,Nov
TA-2015-1770,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,20-11-2015,5704,India,India,8370,Not assigned,193, $453.0 ," $87,429.0 ", $-   ,Nov
TA-2015-1771,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,27-05-2015,5704,India,India,8370,Not assigned,95, $453.0 ," $43,035.0 ", $-   ,May
TA-2015-1772,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,12-04-2015,5704,India,India,8370,Not assigned,74, $453.0 ," $33,522.0 ", $-   ,Apr
TA-2015-1773,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,14-01-2015,5704,India,India,8370,Not assigned,9, $453.0 ," $4,077.0 ", $-   ,Jan
TA-2015-1774,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,17-07-2015,5704,India,India,8370,Not assigned,438, $453.0 ," $1,98,414.0 ", $-   ,Jul
TA-2015-1775,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,07-01-2015,5704,India,India,8370,Not assigned,455, $453.0 ," $2,06,115.0 ", $-   ,Jan
TA-2015-1776,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,17-11-2015,5704,India,India,8370,Not assigned,136, $453.0 ," $61,608.0 ", $-   ,Nov
TA-2015-1777,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,11-08-2015,5704,India,India,8370,Not assigned,498, $453.0 ," $2,25,594.0 ", $-   ,Aug
TA-2015-1778,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,25-09-2015,5704,India,India,8370,Not assigned,202, $453.0 ," $91,506.0 ", $-   ,Sep
TA-2015-1779,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,04-01-2015,5704,India,India,8370,Not assigned,173, $453.0 ," $78,369.0 ", $-   ,Jan
TA-2015-1780,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,27-04-2015,5704,India,India,8370,Not assigned,239, $453.0 ," $1,08,267.0 ", $-   ,Apr
TA-2015-1781,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,20-06-2015,5704,India,India,8370,Not assigned,445, $453.0 ," $2,01,585.0 ", $-   ,Jun
IA-2015-1782,Sitagliptin,Januvia,"Merck & Co., Inc.",Diabetes mellitus type 2,12-11-2015,5938,India,India,8318,Assigned,206, $386.0 ," $79,516.0 "," $2,678.0 ",Nov
IA-2015-1783,Sitagliptin,Januvia,"Merck & Co., Inc.",Diabetes mellitus type 2,31-07-2015,5938,India,India,8318,Assigned,390, $386.0 ," $1,50,540.0 "," $2,600.0 ",Jul
IA-2015-1784,Sitagliptin,Januvia,"Merck & Co., Inc.",Diabetes mellitus type 2,25-08-2015,5938,India,India,8318,Assigned,173, $386.0 ," $66,778.0 "," $1,845.3 ",Aug
OR-2015-1785,Rosuvastatin,Crestor,"AstraZeneca, Shionogi",Cholesterol,19-06-2015,5574,India,India,8103,Not assigned,211, $499.0 ," $1,05,289.0 ", $-   ,Jun
OR-2015-1786,Rosuvastatin,Crestor,"AstraZeneca, Shionogi",Cholesterol,21-11-2015,5574,India,Spain,8103,Not assigned,466, $499.0 ," $2,32,534.0 ", $-   ,Nov
TA-2015-1787,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,28-07-2015,5704,India,India,8370,Not assigned,15, $453.0 ," $6,795.0 ", $-   ,Jul
TA-2015-1788,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,30-11-2015,5704,India,India,8370,Not assigned,139, $453.0 ," $62,967.0 ", $-   ,Nov
IN-2015-1789,Oxycodone,OxyContin,Generic,Pain,31-01-2015,5704,Thailand,Thailand,8370,Not assigned,359, $472.0 ," $1,69,448.0 ", $-   ,Jan
IN-2015-1790,Oxycodone,OxyContin,Generic,Pain,19-04-2015,5704,Thailand,Thailand,8370,Assigned,343, $472.0 ," $1,61,896.0 "," $1,143.3 ",Apr
IN-2015-1791,Oxycodone,OxyContin,Generic,Pain,26-01-2015,5704,Thailand,Thailand,8370,Assigned,236, $472.0 ," $1,11,392.0 "," $1,258.7 ",Jan
IN-2015-1792,Oxycodone,OxyContin,Generic,Pain,24-09-2015,5704,Thailand,Thailand,8370,Assigned,64, $472.0 ," $30,208.0 ", $661.3 ,Sep
IN-2015-1793,Oxycodone,OxyContin,Generic,Pain,25-04-2015,5704,Thailand,Thailand,8370,Assigned,356, $472.0 ," $1,68,032.0 "," $10,798.7 ",Apr
IN-2015-1794,Oxycodone,OxyContin,Generic,Pain,24-07-2015,5704,Thailand,Thailand,8370,Assigned,54, $472.0 ," $25,488.0 "," $1,638.0 ",Jul
IN-2015-1795,Oxycodone,OxyContin,Generic,Pain,13-01-2015,5704,Egypt,Egypt,8370,Not assigned,374, $472.0 ," $1,76,528.0 ", $-   ,Jan
IN-2015-1796,Oxycodone,OxyContin,Generic,Pain,18-09-2015,5704,Thailand,Thailand,8370,Assigned,224, $472.0 ," $1,05,728.0 "," $6,944.0 ",Sep
CA-2015-1797,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-08-2015,5887,Thailand,Thailand,8095,Not assigned,36, $500.0 ," $18,000.0 ", $-   ,Aug
CA-2015-1798,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-07-2015,5887,India,India,8095,Not assigned,478, $500.0 ," $2,39,000.0 ", $-   ,Jul
CA-2015-1799,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-04-2015,5887,India,India,8095,Not assigned,219, $500.0 ," $1,09,500.0 ", $-   ,Apr
CA-2015-1800,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-02-2015,5887,India,India,8095,Not assigned,226, $500.0 ," $1,13,000.0 ", $-   ,Feb
CA-2015-1801,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-08-2015,5887,India,India,8095,Not assigned,469, $500.0 ," $2,34,500.0 ", $-   ,Aug
CA-2015-1802,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-09-2015,5887,India,India,8095,Not assigned,398, $500.0 ," $1,99,000.0 ", $-   ,Sep
CA-2015-1803,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-02-2015,5887,India,India,8095,Not assigned,496, $500.0 ," $2,48,000.0 ", $-   ,Feb
CA-2015-1804,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-04-2015,5887,India,India,8095,Not assigned,406, $500.0 ," $2,03,000.0 ", $-   ,Apr
CA-2015-1805,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-01-2015,5887,India,India,8095,Not assigned,426, $500.0 ," $2,13,000.0 ", $-   ,Jan
CA-2015-1806,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-12-2015,5887,India,India,8095,Not assigned,62, $500.0 ," $31,000.0 ", $-   ,Dec
CA-2015-1807,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-10-2015,5887,India,India,8095,Not assigned,445, $500.0 ," $2,22,500.0 ", $-   ,Oct
AR-2015-1808,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,28-03-2015,5653,India,India,7933,Assigned,432, $231.0 ," $99,792.0 "," $6,912.0 ",Mar
CA-2015-1809,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-08-2015,5887,India,India,8095,Not assigned,112, $500.0 ," $56,000.0 ", $-   ,Aug
CA-2015-1810,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-01-2015,5887,Thailand,Thailand,8095,Assigned,468, $500.0 ," $2,34,000.0 "," $10,608.0 ",Jan
CA-2015-1811,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-12-2015,5887,Thailand,Thailand,8095,Not assigned,422, $500.0 ," $2,11,000.0 ", $-   ,Dec
CA-2015-1812,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-11-2015,5887,United Kingdom,United Kingdom,8095,Not assigned,205, $500.0 ," $1,02,500.0 ", $-   ,Nov
AR-2015-1813,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,30-03-2015,5653,India,India,7933,Assigned,280, $231.0 ," $64,680.0 "," $3,733.3 ",Mar
CA-2015-1814,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-01-2015,5887,United Kingdom,United Kingdom,8095,Not assigned,499, $500.0 ," $2,49,500.0 ", $-   ,Jan
CA-2015-1815,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-05-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,462, $500.0 ," $2,31,000.0 ", $-   ,May
CA-2015-1816,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-12-2015,5887,Philippines,Philippines,8095,Not assigned,136, $500.0 ," $68,000.0 ", $-   ,Dec
CA-2015-1817,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-05-2015,5887,India,India,8095,Not assigned,81, $500.0 ," $40,500.0 ", $-   ,May
CA-2015-1818,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-03-2015,5887,India,India,8095,Not assigned,317, $500.0 ," $1,58,500.0 ", $-   ,Mar
CA-2015-1819,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-09-2015,5887,India,India,8095,Not assigned,408, $500.0 ," $2,04,000.0 ", $-   ,Sep
CA-2015-1820,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-06-2015,5887,India,India,8095,Assigned,159, $500.0 ," $79,500.0 "," $4,611.0 ",Jun
CA-2015-1821,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-04-2015,5887,India,India,8095,Not assigned,178, $500.0 ," $89,000.0 ", $-   ,Apr
CA-2015-1822,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-04-2015,5887,Philippines,Philippines,8095,Not assigned,374, $500.0 ," $1,87,000.0 ", $-   ,Apr
CA-2015-1823,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-05-2015,5887,India,India,8095,Not assigned,270, $500.0 ," $1,35,000.0 ", $-   ,May
CA-2015-1824,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-11-2015,5887,India,India,8095,Not assigned,8, $500.0 ," $4,000.0 ", $-   ,Nov
CA-2015-1825,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-09-2015,5887,Vietnam,Netherlands,8095,Assigned,406, $500.0 ," $2,03,000.0 "," $11,368.0 ",Sep
CA-2015-1826,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-10-2015,5887,India,India,8095,Not assigned,5, $500.0 ," $2,500.0 ", $-   ,Oct
CA-2015-1827,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-08-2015,5887,India,India,8095,Not assigned,293, $500.0 ," $1,46,500.0 ", $-   ,Aug
CA-2015-1828,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-09-2015,5887,India,India,8095,Not assigned,217, $500.0 ," $1,08,500.0 ", $-   ,Sep
CA-2015-1829,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-01-2015,5887,India,India,8095,Not assigned,156, $500.0 ," $78,000.0 ", $-   ,Jan
CA-2015-1830,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-06-2015,5887,India,India,8095,Not assigned,5, $500.0 ," $2,500.0 ", $-   ,Jun
CA-2015-1831,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-01-2015,5887,India,India,8095,Not assigned,461, $500.0 ," $2,30,500.0 ", $-   ,Jan
CA-2015-1832,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-05-2015,5887,India,India,8095,Not assigned,199, $500.0 ," $99,500.0 ", $-   ,May
CA-2015-1833,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-11-2015,5887,India,India,8095,Not assigned,348, $500.0 ," $1,74,000.0 ", $-   ,Nov
CA-2015-1834,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-12-2015,5887,India,India,8095,Not assigned,149, $500.0 ," $74,500.0 ", $-   ,Dec
CA-2015-1835,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-06-2015,5887,Iran,Iran,8095,Not assigned,421, $500.0 ," $2,10,500.0 ", $-   ,Jun
CA-2015-1836,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-06-2015,5887,India,India,8095,Not assigned,181, $500.0 ," $90,500.0 ", $-   ,Jun
CA-2015-1837,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-11-2015,5887,India,India,8095,Not assigned,429, $500.0 ," $2,14,500.0 ", $-   ,Nov
CA-2015-1838,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-12-2015,5887,India,India,8095,Not assigned,232, $500.0 ," $1,16,000.0 ", $-   ,Dec
CA-2015-1839,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-03-2015,5887,Indonesia,Indonesia,8095,Assigned,92, $500.0 ," $46,000.0 ", $552.0 ,Mar
CA-2015-1840,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-09-2015,5887,India,India,8095,Not assigned,270, $500.0 ," $1,35,000.0 ", $-   ,Sep
CA-2015-1841,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-07-2015,5887,India,India,8095,Not assigned,171, $500.0 ," $85,500.0 ", $-   ,Jul
CA-2015-1842,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-07-2015,5887,India,India,8095,Assigned,129, $500.0 ," $64,500.0 ", $473.0 ,Jul
CA-2015-1843,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-06-2015,5887,India,India,8095,Not assigned,93, $500.0 ," $46,500.0 ", $-   ,Jun
CA-2015-1844,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-07-2015,5887,Kenya,Kenya,8095,Assigned,423, $500.0 ," $2,11,500.0 "," $1,833.0 ",Jul
CA-2015-1845,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-10-2015,5887,Hong Kong,China,8095,Not assigned,64, $500.0 ," $32,000.0 ", $-   ,Oct
CA-2015-1846,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-05-2015,5887,India,India,8095,Not assigned,305, $500.0 ," $1,52,500.0 ", $-   ,May
CA-2015-1847,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-12-2015,5887,India,India,8095,Not assigned,173, $500.0 ," $86,500.0 ", $-   ,Dec
CA-2015-1848,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-03-2015,5887,India,India,8095,Not assigned,428, $500.0 ," $2,14,000.0 ", $-   ,Mar
CA-2015-1849,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-06-2015,5887,India,India,8095,Not assigned,118, $500.0 ," $59,000.0 ", $-   ,Jun
CA-2015-1850,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-09-2015,5887,India,India,8095,Not assigned,367, $500.0 ," $1,83,500.0 ", $-   ,Sep
CA-2015-1851,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-05-2015,5887,India,India,8095,Assigned,358, $500.0 ," $1,79,000.0 "," $6,444.0 ",May
CA-2015-1852,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-11-2015,5887,India,India,8095,Not assigned,85, $500.0 ," $42,500.0 ", $-   ,Nov
CA-2015-1853,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-01-2015,5887,India,India,8095,Not assigned,118, $500.0 ," $59,000.0 ", $-   ,Jan
CA-2015-1854,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-03-2015,5887,India,India,8095,Not assigned,214, $500.0 ," $1,07,000.0 ", $-   ,Mar
CA-2015-1855,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-03-2015,5887,India,India,8095,Assigned,46, $500.0 ," $23,000.0 ", $276.0 ,Mar
CA-2015-1856,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-12-2015,5887,India,India,8095,Assigned,494, $500.0 ," $2,47,000.0 "," $6,257.3 ",Dec
CA-2015-1857,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-01-2015,5887,India,India,8095,Not assigned,304, $500.0 ," $1,52,000.0 ", $-   ,Jan
CA-2015-1858,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-07-2015,5887,India,India,8095,Not assigned,114, $500.0 ," $57,000.0 ", $-   ,Jul
CA-2015-1859,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-12-2015,5887,India,India,8095,Not assigned,320, $500.0 ," $1,60,000.0 ", $-   ,Dec
CA-2015-1860,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-04-2015,5887,Vietnam,Japan,8095,Assigned,467, $500.0 ," $2,33,500.0 "," $11,830.7 ",Apr
CA-2015-1861,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-04-2015,5887,India,India,8095,Not assigned,428, $500.0 ," $2,14,000.0 ", $-   ,Apr
CA-2015-1862,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-08-2015,5887,Kenya,Kenya,8095,Assigned,360, $500.0 ," $1,80,000.0 "," $4,320.0 ",Aug
CA-2015-1863,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-12-2015,5887,India,India,8095,Not assigned,256, $500.0 ," $1,28,000.0 ", $-   ,Dec
CA-2015-1864,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-01-2015,5887,India,India,8095,Not assigned,494, $500.0 ," $2,47,000.0 ", $-   ,Jan
CA-2015-1865,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-10-2015,5887,India,India,8095,Not assigned,276, $500.0 ," $1,38,000.0 ", $-   ,Oct
CA-2015-1866,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-02-2015,5887,India,India,8095,Not assigned,352, $500.0 ," $1,76,000.0 ", $-   ,Feb
CA-2015-1867,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-07-2015,5887,India,India,8095,Not assigned,87, $500.0 ," $43,500.0 ", $-   ,Jul
CA-2015-1868,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-10-2015,5887,India,India,8095,Not assigned,246, $500.0 ," $1,23,000.0 ", $-   ,Oct
CA-2015-1869,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-10-2015,5887,India,India,8095,Not assigned,14, $500.0 ," $7,000.0 ", $-   ,Oct
CA-2015-1870,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-09-2015,5887,India,India,8095,Not assigned,212, $500.0 ," $1,06,000.0 ", $-   ,Sep
CA-2015-1871,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-09-2015,5887,India,India,8095,Not assigned,171, $500.0 ," $85,500.0 ", $-   ,Sep
CA-2015-1872,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-05-2015,5887,India,India,8095,Not assigned,389, $500.0 ," $1,94,500.0 ", $-   ,May
CA-2015-1873,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-09-2015,5887,India,India,8095,Not assigned,474, $500.0 ," $2,37,000.0 ", $-   ,Sep
CA-2015-1874,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-05-2015,5887,Indonesia,Indonesia,8095,Assigned,454, $500.0 ," $2,27,000.0 "," $12,863.3 ",May
CA-2015-1875,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-04-2015,5887,India,India,8095,Not assigned,260, $500.0 ," $1,30,000.0 ", $-   ,Apr
CA-2015-1876,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-04-2015,5887,United Kingdom,United Kingdom,8095,Not assigned,262, $500.0 ," $1,31,000.0 ", $-   ,Apr
CA-2015-1877,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-06-2015,5887,Nigeria,Nigeria,8095,Not assigned,284, $500.0 ," $1,42,000.0 ", $-   ,Jun
CA-2015-1878,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-03-2015,5887,Nigeria,Nigeria,8095,Not assigned,66, $500.0 ," $33,000.0 ", $-   ,Mar
CA-2015-1879,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-03-2015,5887,India,India,8095,Not assigned,256, $500.0 ," $1,28,000.0 ", $-   ,Mar
CA-2015-1880,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-01-2015,5887,India,India,8095,Not assigned,375, $500.0 ," $1,87,500.0 ", $-   ,Jan
CA-2015-1881,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-03-2015,5887,India,India,8095,Not assigned,259, $500.0 ," $1,29,500.0 ", $-   ,Mar
CA-2015-1882,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-12-2015,5887,Indonesia,Indonesia,8095,Assigned,287, $500.0 ," $1,43,500.0 "," $9,566.7 ",Dec
CA-2015-1883,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-11-2015,5887,Indonesia,Indonesia,8095,Assigned,141, $500.0 ," $70,500.0 "," $4,606.0 ",Nov
CA-2015-1884,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-08-2015,5887,India,India,8095,Not assigned,89, $500.0 ," $44,500.0 ", $-   ,Aug
CA-2015-1885,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-12-2015,5887,Malaysia,Malaysia,8095,Not assigned,265, $500.0 ," $1,32,500.0 ", $-   ,Dec
CA-2015-1886,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-02-2015,5887,Nepal,Nepal,8095,Assigned,249, $500.0 ," $1,24,500.0 "," $5,810.0 ",Feb
CA-2015-1887,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-06-2015,5887,Thailand,Thailand,8095,Assigned,150, $500.0 ," $75,000.0 "," $3,600.0 ",Jun
CA-2015-1888,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-07-2015,5887,Thailand,Thailand,8095,Assigned,15, $500.0 ," $7,500.0 ", $365.0 ,Jul
CA-2015-1889,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-01-2015,5887,India,India,8095,Not assigned,227, $500.0 ," $1,13,500.0 ", $-   ,Jan
CA-2015-1890,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-09-2015,5887,Kenya,Kenya,8095,Assigned,270, $500.0 ," $1,35,000.0 "," $8,280.0 ",Sep
CA-2015-1891,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-08-2015,5887,India,India,8095,Not assigned,361, $500.0 ," $1,80,500.0 ", $-   ,Aug
CA-2015-1892,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-06-2015,5887,India,India,8095,Not assigned,300, $500.0 ," $1,50,000.0 ", $-   ,Jun
CA-2015-1893,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-03-2015,5887,Kenya,Kenya,8095,Assigned,153, $500.0 ," $76,500.0 "," $3,366.0 ",Mar
CA-2015-1894,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-06-2015,5887,India,India,8095,Not assigned,79, $500.0 ," $39,500.0 ", $-   ,Jun
CA-2015-1895,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-11-2015,5887,India,India,8095,Not assigned,464, $500.0 ," $2,32,000.0 ", $-   ,Nov
CA-2015-1896,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-03-2015,5887,Singapore,Singapore,8095,Not assigned,313, $500.0 ," $1,56,500.0 ", $-   ,Mar
CA-2015-1897,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-02-2015,5887,Vietnam,Netherlands,8095,Assigned,478, $500.0 ," $2,39,000.0 "," $4,939.3 ",Feb
CA-2015-1898,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-12-2015,5887,India,India,8095,Not assigned,466, $500.0 ," $2,33,000.0 ", $-   ,Dec
CA-2015-1899,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-07-2015,5887,Vietnam,Netherlands,8095,Assigned,398, $500.0 ," $1,99,000.0 "," $2,122.7 ",Jul
CA-2015-1900,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-12-2015,5887,India,India,8095,Not assigned,482, $500.0 ," $2,41,000.0 ", $-   ,Dec
CA-2015-1901,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-04-2015,5887,India,India,8095,Not assigned,374, $500.0 ," $1,87,000.0 ", $-   ,Apr
CA-2015-1902,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-03-2015,5887,Thailand,Thailand,8095,Assigned,4, $500.0 ," $2,000.0 ", $29.3 ,Mar
CA-2015-1903,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-12-2015,5887,Thailand,Thailand,8095,Assigned,50, $500.0 ," $25,000.0 ", $733.3 ,Dec
CA-2015-1904,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-12-2015,5887,India,India,8095,Not assigned,139, $500.0 ," $69,500.0 ", $-   ,Dec
CA-2015-1905,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-06-2015,5887,India,India,8095,Not assigned,105, $500.0 ," $52,500.0 ", $-   ,Jun
CA-2015-1906,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-05-2015,5887,Thailand,Thailand,8095,Assigned,407, $500.0 ," $2,03,500.0 "," $9,361.0 ",May
CA-2015-1907,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-08-2015,5887,India,India,8095,Not assigned,26, $500.0 ," $13,000.0 ", $-   ,Aug
CA-2015-1908,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-12-2015,5887,South Korea,South Korea,8095,Assigned,114, $500.0 ," $57,000.0 "," $1,178.0 ",Dec
CA-2015-1909,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-10-2015,5887,India,India,8095,Assigned,212, $500.0 ," $1,06,000.0 "," $2,614.7 ",Oct
CA-2015-1910,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-08-2015,5887,India,India,8095,Assigned,366, $500.0 ," $1,83,000.0 "," $8,784.0 ",Aug
CA-2015-1911,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-06-2015,5887,India,India,8095,Not assigned,357, $500.0 ," $1,78,500.0 ", $-   ,Jun
CA-2015-1912,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-03-2015,5887,Vietnam,Japan,8095,Assigned,52, $500.0 ," $26,000.0 ", $312.0 ,Mar
CA-2015-1913,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-06-2015,5887,Vietnam,Japan,8095,Assigned,64, $500.0 ," $32,000.0 "," $1,877.3 ",Jun
CA-2015-1914,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-11-2015,5887,Vietnam,Japan,8095,Assigned,359, $500.0 ," $1,79,500.0 "," $5,504.7 ",Nov
CA-2015-1915,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-12-2015,5887,Thailand,Thailand,8095,Assigned,180, $500.0 ," $90,000.0 "," $1,560.0 ",Dec
CA-2015-1916,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-09-2015,5887,Taiwan,China,8095,Not assigned,19, $500.0 ," $9,500.0 ", $-   ,Sep
IN-2015-1917,Bevacizumab,Avastin,Genentech/Roche,Cancer,21-10-2015,5685,India,India,8209,Not assigned,465, $243.0 ," $1,12,995.0 ", $-   ,Oct
AR-2015-1918,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,12-06-2015,5653,India,India,7933,Assigned,113, $231.0 ," $26,103.0 "," $2,825.0 ",Jun
CA-2015-1919,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-03-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,379, $500.0 ," $1,89,500.0 ", $-   ,Mar
CA-2015-1920,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-03-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,452, $500.0 ," $2,26,000.0 ", $-   ,Mar
CA-2015-1921,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-04-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,270, $500.0 ," $1,35,000.0 ", $-   ,Apr
CA-2015-1922,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-01-2015,5887,Indonesia,Indonesia,8095,Assigned,183, $500.0 ," $91,500.0 "," $1,342.0 ",Jan
CA-2015-1923,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-08-2015,5887,Indonesia,Indonesia,8095,Assigned,211, $500.0 ," $1,05,500.0 "," $3,235.3 ",Aug
CA-2015-1924,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-05-2015,5887,Indonesia,Indonesia,8095,Assigned,66, $500.0 ," $33,000.0 ", $660.0 ,May
CA-2015-1925,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-12-2015,5887,Indonesia,Indonesia,8095,Assigned,251, $500.0 ," $1,25,500.0 "," $7,948.3 ",Dec
CA-2015-1926,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-05-2015,5887,Indonesia,Indonesia,8095,Assigned,312, $500.0 ," $1,56,000.0 "," $4,576.0 ",May
CA-2015-1927,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-11-2015,5887,Indonesia,Indonesia,8095,Assigned,83, $500.0 ," $41,500.0 "," $2,683.7 ",Nov
CA-2015-1928,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-11-2015,5887,Thailand,Thailand,8095,Assigned,128, $500.0 ," $64,000.0 "," $1,365.3 ",Nov
CA-2015-1929,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-11-2015,5887,Thailand,Thailand,8095,Assigned,135, $500.0 ," $67,500.0 "," $2,340.0 ",Nov
CA-2015-1930,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-04-2015,5887,Malaysia,Malaysia,8095,Not assigned,283, $500.0 ," $1,41,500.0 ", $-   ,Apr
CA-2015-1931,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-05-2015,5887,Indonesia,Indonesia,8095,Assigned,195, $500.0 ," $97,500.0 "," $5,135.0 ",May
CA-2015-1932,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-07-2015,5887,Hong Kong,Hong Kong,8095,Not assigned,404, $500.0 ," $2,02,000.0 ", $-   ,Jul
CA-2015-1933,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-09-2015,5887,Indonesia,Indonesia,8095,Assigned,315, $500.0 ," $1,57,500.0 "," $6,195.0 ",Sep
CA-2015-1934,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-09-2015,5887,Hong Kong,Hong Kong,8095,Not assigned,432, $500.0 ," $2,16,000.0 ", $-   ,Sep
CA-2015-1935,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-02-2015,5887,Hong Kong,Hong Kong,8095,Not assigned,192, $500.0 ," $96,000.0 ", $-   ,Feb
CA-2015-1936,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-09-2015,5887,Hong Kong,Hong Kong,8095,Not assigned,190, $500.0 ," $95,000.0 ", $-   ,Sep
CA-2015-1937,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-06-2015,5887,Hong Kong,Hong Kong,8095,Not assigned,395, $500.0 ," $1,97,500.0 ", $-   ,Jun
CA-2015-1938,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-03-2015,5887,Hong Kong,Hong Kong,8095,Not assigned,441, $500.0 ," $2,20,500.0 ", $-   ,Mar
CA-2015-1939,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-04-2015,5887,India,India,8095,Not assigned,280, $500.0 ," $1,40,000.0 ", $-   ,Apr
CA-2015-1940,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-11-2015,5887,Thailand,Thailand,8095,Not assigned,3, $500.0 ," $1,500.0 ", $-   ,Nov
CA-2015-1941,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-07-2015,5887,Iran,Iran,8095,Not assigned,294, $500.0 ," $1,47,000.0 ", $-   ,Jul
CA-2015-1942,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-08-2015,5887,Thailand,Thailand,8095,Assigned,297, $500.0 ," $1,48,500.0 "," $9,009.0 ",Aug
CA-2015-1943,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-11-2015,5887,India,India,8095,Not assigned,149, $500.0 ," $74,500.0 ", $-   ,Nov
CA-2015-1944,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-04-2015,5887,Thailand,Thailand,8095,Assigned,460, $500.0 ," $2,30,000.0 "," $4,140.0 ",Apr
CA-2015-1945,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-01-2015,5887,India,India,8095,Not assigned,395, $500.0 ," $1,97,500.0 ", $-   ,Jan
CA-2015-1946,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-11-2015,5887,Indonesia,Indonesia,8095,Assigned,386, $500.0 ," $1,93,000.0 "," $5,661.3 ",Nov
CA-2015-1947,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-07-2015,5887,Indonesia,Indonesia,8095,Assigned,101, $500.0 ," $50,500.0 ", $572.3 ,Jul
CA-2015-1948,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-01-2015,5887,Thailand,Thailand,8095,Assigned,73, $500.0 ," $36,500.0 "," $2,336.0 ",Jan
CA-2015-1949,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-01-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,490, $500.0 ," $2,45,000.0 ", $-   ,Jan
CA-2015-1950,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-09-2015,5887,Turkey,Lebanon,8095,Assigned,101, $500.0 ," $50,500.0 ", $740.7 ,Sep
CA-2015-1951,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-12-2015,5887,Thailand,Thailand,8095,Assigned,497, $500.0 ," $2,48,500.0 "," $13,419.0 ",Dec
CA-2015-1952,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-09-2015,5887,Thailand,Thailand,8095,Assigned,472, $500.0 ," $2,36,000.0 "," $6,608.0 ",Sep
CA-2015-1953,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-12-2015,5887,Thailand,Thailand,8095,Assigned,223, $500.0 ," $1,11,500.0 "," $2,155.7 ",Dec
CA-2015-1954,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-01-2015,5887,India,India,8095,Not assigned,317, $500.0 ," $1,58,500.0 ", $-   ,Jan
CA-2015-1955,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-01-2015,5887,India,India,8095,Assigned,399, $500.0 ," $1,99,500.0 "," $7,448.0 ",Jan
CA-2015-1956,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-11-2015,5887,India,India,8095,Not assigned,350, $500.0 ," $1,75,000.0 ", $-   ,Nov
CA-2015-1957,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-07-2015,5887,India,India,8095,Not assigned,351, $500.0 ," $1,75,500.0 ", $-   ,Jul
CA-2015-1958,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-10-2015,5887,India,India,8095,Not assigned,428, $500.0 ," $2,14,000.0 ", $-   ,Oct
CA-2015-1959,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-04-2015,5887,Egypt,Egypt,8095,Not assigned,405, $500.0 ," $2,02,500.0 ", $-   ,Apr
CA-2015-1960,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-09-2015,5887,Thailand,Thailand,8095,Assigned,275, $500.0 ," $1,37,500.0 "," $9,166.7 ",Sep
CA-2015-1961,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-11-2015,5887,India,India,8095,Not assigned,335, $500.0 ," $1,67,500.0 ", $-   ,Nov
CA-2015-1962,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-02-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,196, $500.0 ," $98,000.0 ", $-   ,Feb
CA-2015-1963,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-09-2015,5887,Thailand,Thailand,8095,Not assigned,445, $500.0 ," $2,22,500.0 ", $-   ,Sep
CA-2015-1964,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-12-2015,5887,Indonesia,Indonesia,8095,Assigned,306, $500.0 ," $1,53,000.0 "," $1,734.0 ",Dec
CA-2015-1965,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-11-2015,5887,Indonesia,Indonesia,8095,Assigned,294, $500.0 ," $1,47,000.0 "," $7,252.0 ",Nov
CA-2015-1966,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-12-2015,5887,India,India,8095,Not assigned,17, $500.0 ," $8,500.0 ", $-   ,Dec
CA-2015-1967,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-12-2015,5887,India,India,8095,Not assigned,318, $500.0 ," $1,59,000.0 ", $-   ,Dec
CA-2015-1968,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-05-2015,5887,India,India,8095,Not assigned,272, $500.0 ," $1,36,000.0 ", $-   ,May
CA-2015-1969,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-12-2015,5887,Thailand,Thailand,8095,Assigned,150, $500.0 ," $75,000.0 "," $2,350.0 ",Dec
CA-2015-1970,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-09-2015,5887,India,India,8095,Not assigned,67, $500.0 ," $33,500.0 ", $-   ,Sep
CA-2015-1971,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-07-2015,5887,India,India,8095,Assigned,479, $500.0 ," $2,39,500.0 "," $11,815.3 ",Jul
CA-2015-1972,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-03-2015,5887,India,India,8095,Assigned,113, $500.0 ," $56,500.0 "," $2,109.3 ",Mar
CA-2015-1973,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-10-2015,5887,India,India,8095,Assigned,141, $500.0 ," $70,500.0 "," $2,961.0 ",Oct
CA-2015-1974,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-03-2015,5887,India,India,8095,Not assigned,226, $500.0 ," $1,13,000.0 ", $-   ,Mar
CA-2015-1975,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-04-2015,5887,India,India,8095,Not assigned,82, $500.0 ," $41,000.0 ", $-   ,Apr
CA-2015-1976,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-06-2015,5887,Thailand,Thailand,8095,Assigned,61, $500.0 ," $30,500.0 "," $1,403.0 ",Jun
CA-2015-1977,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-12-2015,5887,India,India,8095,Not assigned,244, $500.0 ," $1,22,000.0 ", $-   ,Dec
CA-2015-1978,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-04-2015,5887,India,India,8095,Not assigned,74, $500.0 ," $37,000.0 ", $-   ,Apr
CA-2015-1979,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-11-2015,5887,India,India,8095,Not assigned,212, $500.0 ," $1,06,000.0 ", $-   ,Nov
CA-2015-1980,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-01-2015,5887,Thailand,Thailand,8095,Assigned,159, $500.0 ," $79,500.0 "," $2,173.0 ",Jan
CA-2015-1981,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-05-2015,5887,India,India,8095,Assigned,268, $500.0 ," $1,34,000.0 "," $5,002.7 ",May
CA-2015-1982,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-11-2015,5887,India,India,8095,Assigned,281, $500.0 ," $1,40,500.0 "," $8,804.7 ",Nov
CA-2015-1983,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-07-2015,5887,Thailand,Thailand,8095,Assigned,461, $500.0 ," $2,30,500.0 "," $3,380.7 ",Jul
CA-2015-1984,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-06-2015,5887,Thailand,Thailand,8095,Assigned,404, $500.0 ," $2,02,000.0 "," $7,002.7 ",Jun
CA-2015-1985,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-10-2015,5887,India,India,8095,Assigned,128, $500.0 ," $64,000.0 ", $554.7 ,Oct
CA-2015-1986,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-03-2015,5887,Vietnam,Japan,8095,Assigned,424, $500.0 ," $2,12,000.0 "," $2,826.7 ",Mar
CA-2015-1987,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-03-2015,5887,India,India,8095,Not assigned,269, $500.0 ," $1,34,500.0 ", $-   ,Mar
CA-2015-1988,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-01-2015,5887,India,India,8095,Not assigned,70, $500.0 ," $35,000.0 ", $-   ,Jan
CA-2015-1989,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-01-2015,5887,India,India,8095,Not assigned,359, $500.0 ," $1,79,500.0 ", $-   ,Jan
CA-2015-1990,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-06-2015,5887,India,India,8095,Not assigned,334, $500.0 ," $1,67,000.0 ", $-   ,Jun
CA-2015-1991,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-08-2015,5887,Syria,United Kingdom,8095,Not assigned,105, $500.0 ," $52,500.0 ", $-   ,Aug
CA-2015-1992,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-10-2015,5887,Syria,United Kingdom,8095,Not assigned,310, $500.0 ," $1,55,000.0 ", $-   ,Oct
CA-2015-1993,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-10-2015,5887,Thailand,Thailand,8095,Assigned,149, $500.0 ," $74,500.0 "," $4,718.3 ",Oct
CA-2015-1994,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-01-2015,5887,Indonesia,Indonesia,8095,Assigned,403, $500.0 ," $2,01,500.0 "," $13,433.3 ",Jan
CA-2015-1995,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-06-2015,5887,Thailand,Thailand,8095,Assigned,338, $500.0 ," $1,69,000.0 "," $4,394.0 ",Jun
CA-2015-1996,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-09-2015,5887,Hong Kong,Hong Kong,8095,Not assigned,76, $500.0 ," $38,000.0 ", $-   ,Sep
CA-2015-1997,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-05-2015,5887,Hong Kong,Hong Kong,8095,Not assigned,480, $500.0 ," $2,40,000.0 ", $-   ,May
CA-2015-1998,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-07-2015,5887,Vietnam,Japan,8095,Assigned,217, $500.0 ," $1,08,500.0 "," $2,097.7 ",Jul
CA-2015-1999,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-01-2015,5887,Indonesia,Indonesia,8095,Assigned,157, $500.0 ," $78,500.0 "," $1,360.7 ",Jan
CA-2015-2000,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-04-2015,5887,Indonesia,Indonesia,8095,Assigned,41, $500.0 ," $20,500.0 ", $615.0 ,Apr
IN-2015-2001,Bevacizumab,Avastin,Genentech/Roche,Cancer,19-07-2015,5685,India,India,8209,Not assigned,120, $243.0 ," $29,160.0 ", $-   ,Jul
IN-2015-2002,Bevacizumab,Avastin,Genentech/Roche,Cancer,24-07-2015,5685,India,India,8209,Not assigned,232, $243.0 ," $56,376.0 ", $-   ,Jul
CA-2015-2003,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-05-2015,5887,India,India,8095,Not assigned,321, $500.0 ," $1,60,500.0 ", $-   ,May
IN-2015-2004,Bevacizumab,Avastin,Genentech/Roche,Cancer,27-10-2015,5685,India,India,8209,Not assigned,478, $243.0 ," $1,16,154.0 ", $-   ,Oct
IN-2015-2005,Bevacizumab,Avastin,Genentech/Roche,Cancer,24-09-2015,5685,India,India,8209,Not assigned,453, $243.0 ," $1,10,079.0 ", $-   ,Sep
IN-2015-2006,Bevacizumab,Avastin,Genentech/Roche,Cancer,09-04-2015,5685,India,India,8209,Assigned,180, $243.0 ," $43,740.0 "," $1,200.0 ",Apr
IN-2015-2007,Bevacizumab,Avastin,Genentech/Roche,Cancer,07-09-2015,5685,India,India,8209,Not assigned,186, $243.0 ," $45,198.0 ", $-   ,Sep
IN-2015-2008,Bevacizumab,Avastin,Genentech/Roche,Cancer,01-09-2015,5685,India,India,8209,Not assigned,85, $243.0 ," $20,655.0 ", $-   ,Sep
IN-2015-2009,Bevacizumab,Avastin,Genentech/Roche,Cancer,18-01-2015,5685,India,India,8209,Not assigned,482, $243.0 ," $1,17,126.0 ", $-   ,Jan
IN-2015-2010,Bevacizumab,Avastin,Genentech/Roche,Cancer,04-09-2015,5685,India,India,8209,Not assigned,293, $243.0 ," $71,199.0 ", $-   ,Sep
IN-2015-2011,Bevacizumab,Avastin,Genentech/Roche,Cancer,15-08-2015,5685,India,India,8209,Not assigned,165, $243.0 ," $40,095.0 ", $-   ,Aug
IN-2015-2012,Bevacizumab,Avastin,Genentech/Roche,Cancer,30-06-2015,5685,India,India,8209,Not assigned,92, $243.0 ," $22,356.0 ", $-   ,Jun
IN-2015-2013,Bevacizumab,Avastin,Genentech/Roche,Cancer,21-06-2015,5685,India,India,8209,Not assigned,349, $243.0 ," $84,807.0 ", $-   ,Jun
IN-2015-2014,Bevacizumab,Avastin,Genentech/Roche,Cancer,17-02-2015,5685,India,India,8209,Not assigned,447, $243.0 ," $1,08,621.0 ", $-   ,Feb
IN-2015-2015,Bevacizumab,Avastin,Genentech/Roche,Cancer,27-03-2015,5685,India,India,8209,Not assigned,475, $243.0 ," $1,15,425.0 ", $-   ,Mar
IN-2015-2016,Bevacizumab,Avastin,Genentech/Roche,Cancer,09-07-2015,5685,Kenya,Kenya,8209,Assigned,435, $243.0 ," $1,05,705.0 "," $2,320.0 ",Jul
IN-2015-2017,Bevacizumab,Avastin,Genentech/Roche,Cancer,05-11-2015,5685,Utd.Arab Emir.,Utd.Arab Emir.,8209,Not assigned,282, $243.0 ," $68,526.0 ", $-   ,Nov
IN-2015-2018,Bevacizumab,Avastin,Genentech/Roche,Cancer,09-06-2015,5685,Utd.Arab Emir.,Utd.Arab Emir.,8209,Not assigned,332, $243.0 ," $80,676.0 ", $-   ,Jun
IN-2015-2019,Bevacizumab,Avastin,Genentech/Roche,Cancer,03-08-2015,5685,Utd.Arab Emir.,Utd.Arab Emir.,8209,Not assigned,102, $243.0 ," $24,786.0 ", $-   ,Aug
IN-2015-2020,Bevacizumab,Avastin,Genentech/Roche,Cancer,20-01-2015,5685,Sudan,Utd.Arab Emir.,8209,Assigned,371, $243.0 ," $90,153.0 "," $3,957.3 ",Jan
IN-2015-2021,Bevacizumab,Avastin,Genentech/Roche,Cancer,31-08-2015,5685,Netherlands,Netherlands,8209,Assigned,392, $243.0 ," $95,256.0 "," $10,976.0 ",Aug
IN-2015-2022,Bevacizumab,Avastin,Genentech/Roche,Cancer,19-03-2015,5685,Netherlands,Netherlands,8209,Assigned,264, $243.0 ," $64,152.0 "," $6,952.0 ",Mar
IN-2015-2023,Bevacizumab,Avastin,Genentech/Roche,Cancer,21-05-2015,5685,Nepal,Nepal,8209,Assigned,449, $243.0 ," $1,09,107.0 "," $12,572.0 ",May
IN-2015-2024,Bevacizumab,Avastin,Genentech/Roche,Cancer,28-04-2015,5685,Bangladesh,Bangladesh,8209,Assigned,419, $243.0 ," $1,01,817.0 "," $1,396.7 ",Apr
IN-2015-2025,Bevacizumab,Avastin,Genentech/Roche,Cancer,25-06-2015,5685,Thailand,Thailand,8209,Assigned,18, $243.0 ," $4,374.0 ", $258.0 ,Jun
IN-2015-2026,Bevacizumab,Avastin,Genentech/Roche,Cancer,25-02-2015,5685,Thailand,Thailand,8209,Assigned,391, $243.0 ," $95,013.0 "," $2,737.0 ",Feb
IN-2015-2027,Bevacizumab,Avastin,Genentech/Roche,Cancer,18-05-2015,5685,Thailand,Thailand,8209,Assigned,52, $243.0 ," $12,636.0 "," $1,213.3 ",May
IN-2015-2028,Bevacizumab,Avastin,Genentech/Roche,Cancer,25-05-2015,5685,Thailand,Thailand,8209,Assigned,220, $243.0 ," $53,460.0 "," $5,500.0 ",May
IN-2015-2029,Bevacizumab,Avastin,Genentech/Roche,Cancer,21-12-2015,5685,Malaysia,Malaysia,8209,Not assigned,284, $243.0 ," $69,012.0 ", $-   ,Dec
IN-2015-2030,Bevacizumab,Avastin,Genentech/Roche,Cancer,15-07-2015,5685,Nigeria,Nigeria,8209,Not assigned,230, $243.0 ," $55,890.0 ", $-   ,Jul
IN-2015-2031,Bevacizumab,Avastin,Genentech/Roche,Cancer,04-05-2015,5685,Nigeria,Nigeria,8209,Not assigned,51, $243.0 ," $12,393.0 ", $-   ,May
IN-2015-2032,Bevacizumab,Avastin,Genentech/Roche,Cancer,11-06-2015,5685,Uganda,Netherlands,8209,Assigned,164, $243.0 ," $39,852.0 ", $546.7 ,Jun
IN-2015-2033,Bevacizumab,Avastin,Genentech/Roche,Cancer,15-08-2015,5685,Thailand,Thailand,8209,Assigned,33, $243.0 ," $8,019.0 "," $1,012.0 ",Aug
IN-2015-2034,Bevacizumab,Avastin,Genentech/Roche,Cancer,12-12-2015,5685,Kenya,Kenya,8209,Assigned,257, $243.0 ," $62,451.0 "," $2,827.0 ",Dec
IN-2015-2035,Bevacizumab,Avastin,Genentech/Roche,Cancer,26-03-2015,5685,Thailand,Thailand,8209,Assigned,316, $243.0 ," $76,788.0 "," $7,900.0 ",Mar
IN-2015-2036,Bevacizumab,Avastin,Genentech/Roche,Cancer,22-03-2015,5685,Thailand,Thailand,8209,Assigned,30, $243.0 ," $7,290.0 ", $670.0 ,Mar
IN-2015-2037,Bevacizumab,Avastin,Genentech/Roche,Cancer,07-03-2015,5685,Thailand,Thailand,8209,Assigned,455, $243.0 ," $1,10,565.0 "," $8,645.0 ",Mar
IN-2015-2038,Bevacizumab,Avastin,Genentech/Roche,Cancer,22-10-2015,5685,Netherlands,Netherlands,8209,Not assigned,345, $243.0 ," $83,835.0 ", $-   ,Oct
RA-2015-2039,Adalimumab,Humira,AbbVie,Crohn's disease; Rheumatoid arthritis,29-01-2015,5574,Indonesia,Indonesia,7942,Not assigned,460, $349.0 ," $1,60,540.0 ", $-   ,Jan
RA-2015-2040,Adalimumab,Humira,AbbVie,Crohn's disease; Rheumatoid arthritis,15-10-2015,5574,Indonesia,Indonesia,7942,Not assigned,227, $349.0 ," $79,223.0 ", $-   ,Oct
NE-2015-2041,Glatiramer,Copaxone,Generic,Multiple sclerosis,18-10-2015,5704,India,India,8370,Not assigned,271, $451.0 ," $1,22,221.0 ", $-   ,Oct
NE-2015-2042,Glatiramer,Copaxone,Generic,Multiple sclerosis,29-09-2015,5704,India,India,8370,Not assigned,407, $451.0 ," $1,83,557.0 ", $-   ,Sep
NE-2015-2043,Glatiramer,Copaxone,Generic,Multiple sclerosis,24-10-2015,5704,India,India,8370,Not assigned,125, $451.0 ," $56,375.0 ", $-   ,Oct
NE-2015-2044,Glatiramer,Copaxone,Generic,Multiple sclerosis,26-08-2015,5704,India,India,8370,Not assigned,152, $451.0 ," $68,552.0 ", $-   ,Aug
NE-2015-2045,Glatiramer,Copaxone,Generic,Multiple sclerosis,12-11-2015,5704,India,India,8370,Assigned,300, $451.0 ," $1,35,300.0 "," $8,100.0 ",Nov
NE-2015-2046,Glatiramer,Copaxone,Generic,Multiple sclerosis,10-12-2015,5704,India,India,8370,Not assigned,408, $451.0 ," $1,84,008.0 ", $-   ,Dec
NE-2015-2047,Glatiramer,Copaxone,Generic,Multiple sclerosis,20-02-2015,5704,India,India,8370,Not assigned,420, $451.0 ," $1,89,420.0 ", $-   ,Feb
NE-2015-2048,Glatiramer,Copaxone,Generic,Multiple sclerosis,25-01-2015,5704,India,India,8370,Not assigned,254, $451.0 ," $1,14,554.0 ", $-   ,Jan
NE-2015-2049,Glatiramer,Copaxone,Generic,Multiple sclerosis,21-10-2015,5704,India,India,8370,Not assigned,258, $451.0 ," $1,16,358.0 ", $-   ,Oct
NE-2015-2050,Glatiramer,Copaxone,Generic,Multiple sclerosis,14-01-2015,5704,India,India,8370,Not assigned,471, $451.0 ," $2,12,421.0 ", $-   ,Jan
NE-2015-2051,Glatiramer,Copaxone,Generic,Multiple sclerosis,01-10-2015,5704,India,India,8370,Not assigned,283, $451.0 ," $1,27,633.0 ", $-   ,Oct
NE-2015-2052,Glatiramer,Copaxone,Generic,Multiple sclerosis,25-11-2015,5704,India,India,8370,Not assigned,196, $451.0 ," $88,396.0 ", $-   ,Nov
NE-2015-2053,Glatiramer,Copaxone,Generic,Multiple sclerosis,31-10-2015,5704,India,India,8370,Not assigned,78, $451.0 ," $35,178.0 ", $-   ,Oct
NE-2015-2054,Glatiramer,Copaxone,Generic,Multiple sclerosis,02-04-2015,5704,India,India,8370,Not assigned,30, $451.0 ," $13,530.0 ", $-   ,Apr
NE-2015-2055,Glatiramer,Copaxone,Generic,Multiple sclerosis,03-05-2015,5704,India,India,8370,Not assigned,194, $451.0 ," $87,494.0 ", $-   ,May
NE-2015-2056,Glatiramer,Copaxone,Generic,Multiple sclerosis,06-02-2015,5704,India,India,8370,Not assigned,26, $451.0 ," $11,726.0 ", $-   ,Feb
NE-2015-2057,Glatiramer,Copaxone,Generic,Multiple sclerosis,07-12-2015,5704,India,India,8370,Not assigned,353, $451.0 ," $1,59,203.0 ", $-   ,Dec
NE-2015-2058,Glatiramer,Copaxone,Generic,Multiple sclerosis,22-03-2015,5704,India,India,8370,Not assigned,390, $451.0 ," $1,75,890.0 ", $-   ,Mar
NE-2015-2059,Glatiramer,Copaxone,Generic,Multiple sclerosis,30-06-2015,5704,India,India,8370,Not assigned,296, $451.0 ," $1,33,496.0 ", $-   ,Jun
NE-2015-2060,Glatiramer,Copaxone,Generic,Multiple sclerosis,30-09-2015,5704,India,India,8370,Not assigned,225, $451.0 ," $1,01,475.0 ", $-   ,Sep
NE-2015-2061,Glatiramer,Copaxone,Generic,Multiple sclerosis,24-10-2015,5704,Kenya,Kenya,8370,Assigned,111, $451.0 ," $50,061.0 "," $2,923.0 ",Oct
NE-2015-2062,Glatiramer,Copaxone,Generic,Multiple sclerosis,22-11-2015,5704,Utd.Arab Emir.,Utd.Arab Emir.,8370,Not assigned,289, $451.0 ," $1,30,339.0 ", $-   ,Nov
NE-2015-2063,Glatiramer,Copaxone,Generic,Multiple sclerosis,16-07-2015,5704,Utd.Arab Emir.,Utd.Arab Emir.,8370,Not assigned,116, $451.0 ," $52,316.0 ", $-   ,Jul
NE-2015-2064,Glatiramer,Copaxone,Generic,Multiple sclerosis,08-05-2015,5704,Utd.Arab Emir.,Utd.Arab Emir.,8370,Not assigned,342, $451.0 ," $1,54,242.0 ", $-   ,May
NE-2015-2065,Glatiramer,Copaxone,Generic,Multiple sclerosis,14-02-2015,5704,Sudan,Utd.Arab Emir.,8370,Assigned,453, $451.0 ," $2,04,303.0 "," $4,379.0 ",Feb
NE-2015-2066,Glatiramer,Copaxone,Generic,Multiple sclerosis,03-12-2015,5704,Kenya,Kenya,8370,Assigned,373, $451.0 ," $1,68,223.0 "," $5,346.3 ",Dec
NE-2015-2067,Glatiramer,Copaxone,Generic,Multiple sclerosis,22-08-2015,5704,Nepal,Nepal,8370,Assigned,486, $451.0 ," $2,19,186.0 "," $15,552.0 ",Aug
NE-2015-2068,Glatiramer,Copaxone,Generic,Multiple sclerosis,16-05-2015,5704,Malaysia,Malaysia,8370,Not assigned,324, $451.0 ," $1,46,124.0 ", $-   ,May
NE-2015-2069,Glatiramer,Copaxone,Generic,Multiple sclerosis,28-04-2015,5704,Netherlands,Netherlands,8370,Assigned,337, $451.0 ," $1,51,987.0 "," $2,359.0 ",Apr
NE-2015-2070,Glatiramer,Copaxone,Generic,Multiple sclerosis,16-10-2015,5704,Netherlands,Netherlands,8370,Assigned,455, $451.0 ," $2,05,205.0 "," $1,516.7 ",Oct
NE-2015-2071,Glatiramer,Copaxone,Generic,Multiple sclerosis,28-01-2015,5704,Nepal,Nepal,8370,Assigned,138, $451.0 ," $62,238.0 "," $4,002.0 ",Jan
NE-2015-2072,Glatiramer,Copaxone,Generic,Multiple sclerosis,19-08-2015,5704,Malaysia,Malaysia,8370,Assigned,261, $451.0 ," $1,17,711.0 "," $5,742.0 ",Aug
NE-2015-2073,Glatiramer,Copaxone,Generic,Multiple sclerosis,16-04-2015,5704,Nigeria,Nigeria,8370,Not assigned,404, $451.0 ," $1,82,204.0 ", $-   ,Apr
NE-2015-2074,Glatiramer,Copaxone,Generic,Multiple sclerosis,18-10-2015,5704,Nigeria,Nigeria,8370,Not assigned,348, $451.0 ," $1,56,948.0 ", $-   ,Oct
NE-2015-2075,Glatiramer,Copaxone,Generic,Multiple sclerosis,21-04-2015,5704,Uganda,Netherlands,8370,Assigned,452, $451.0 ," $2,03,852.0 "," $4,520.0 ",Apr
NE-2015-2076,Glatiramer,Copaxone,Generic,Multiple sclerosis,08-08-2015,5704,Thailand,Thailand,8370,Assigned,99, $451.0 ," $44,649.0 "," $1,023.0 ",Aug
NE-2015-2077,Glatiramer,Copaxone,Generic,Multiple sclerosis,29-06-2015,5704,Thailand,Thailand,8370,Assigned,380, $451.0 ," $1,71,380.0 "," $7,093.3 ",Jun
NE-2015-2078,Glatiramer,Copaxone,Generic,Multiple sclerosis,04-12-2015,5704,Thailand,Thailand,8370,Assigned,28, $451.0 ," $12,628.0 ", $121.3 ,Dec
NE-2015-2079,Glatiramer,Copaxone,Generic,Multiple sclerosis,26-06-2015,5704,Netherlands,Netherlands,8370,Assigned,298, $451.0 ," $1,34,398.0 "," $2,185.3 ",Jun
NE-2015-2080,Glatiramer,Copaxone,Generic,Multiple sclerosis,30-03-2015,5704,Netherlands,Netherlands,8370,Assigned,333, $451.0 ," $1,50,183.0 "," $3,330.0 ",Mar
NE-2015-2081,Glatiramer,Copaxone,Generic,Multiple sclerosis,14-11-2015,5704,Netherlands,Netherlands,8370,Not assigned,393, $451.0 ," $1,77,243.0 ", $-   ,Nov
VA-2015-2082,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,14-07-2015,5938,Bangladesh,Bangladesh,8068,Assigned,491, $310.0 ," $1,52,210.0 "," $7,692.3 ",Jul
RA-2015-2083,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,17-07-2015,5819,India,India,8119,Not assigned,87, $364.0 ," $31,668.0 ", $-   ,Jul
RA-2015-2084,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,17-06-2015,5819,India,India,8119,Assigned,413, $364.0 ," $1,50,332.0 "," $7,434.0 ",Jun
RA-2015-2085,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,06-03-2015,5819,India,India,8119,Not assigned,119, $364.0 ," $43,316.0 ", $-   ,Mar
RA-2015-2086,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,31-03-2015,5819,India,India,8119,Not assigned,71, $364.0 ," $25,844.0 ", $-   ,Mar
DE-2015-2087,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,26-08-2015,5754,India,India,7904,Assigned,53, $314.0 ," $16,642.0 "," $1,095.3 ",Aug
RA-2015-2088,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,23-04-2015,5819,Thailand,Thailand,8119,Not assigned,231, $364.0 ," $84,084.0 ", $-   ,Apr
RA-2015-2089,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,02-08-2015,5819,Thailand,Thailand,8119,Not assigned,98, $364.0 ," $35,672.0 ", $-   ,Aug
RA-2015-2090,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,16-05-2015,5819,Thailand,Thailand,8119,Assigned,238, $364.0 ," $86,632.0 "," $6,426.0 ",May
RA-2015-2091,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,07-05-2015,5819,Thailand,Thailand,8119,Assigned,270, $364.0 ," $98,280.0 "," $6,120.0 ",May
RA-2015-2092,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,22-07-2015,5819,Thailand,Thailand,8119,Not assigned,127, $364.0 ," $46,228.0 ", $-   ,Jul
RA-2015-2093,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,09-01-2015,5819,Thailand,Thailand,8119,Assigned,407, $364.0 ," $1,48,148.0 "," $6,105.0 ",Jan
RA-2015-2094,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,13-04-2015,5819,Hong Kong,China,8119,Not assigned,284, $364.0 ," $1,03,376.0 ", $-   ,Apr
LA-2015-2095,Emtricitabine/tenofovir/efavirenz,Atripla,"Gilead Sciences, Inc.",HIV infection,27-09-2015,5566,Romania,Netherlands,8128,Not assigned,113, $269.0 ," $30,397.0 ", $-   ,Sep
LA-2015-2096,Emtricitabine/tenofovir/efavirenz,Atripla,"Gilead Sciences, Inc.",HIV infection,15-09-2015,5566,Romania,Netherlands,8128,Not assigned,198, $269.0 ," $53,262.0 ", $-   ,Sep
AR-2015-2097,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,12-06-2015,5653,India,India,7933,Not assigned,58, $231.0 ," $13,398.0 ", $-   ,Jun
AR-2015-2098,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,06-03-2015,5653,India,India,7933,Not assigned,265, $231.0 ," $61,215.0 ", $-   ,Mar
AR-2015-2099,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,06-09-2015,5653,India,India,7933,Not assigned,29, $231.0 ," $6,699.0 ", $-   ,Sep
AR-2015-2100,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,21-02-2015,5653,India,India,7933,Not assigned,6, $231.0 ," $1,386.0 ", $-   ,Feb
CA-2015-2101,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-12-2015,5887,India,India,8095,Not assigned,122, $500.0 ," $61,000.0 ", $-   ,Dec
AR-2015-2102,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,06-09-2015,5653,India,India,7933,Not assigned,187, $231.0 ," $43,197.0 ", $-   ,Sep
AR-2015-2103,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,28-12-2015,5653,India,India,7933,Not assigned,431, $231.0 ," $99,561.0 ", $-   ,Dec
AR-2015-2104,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,03-12-2015,5653,India,India,7933,Not assigned,309, $231.0 ," $71,379.0 ", $-   ,Dec
AR-2015-2105,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,22-02-2015,5653,India,India,7933,Assigned,66, $231.0 ," $15,246.0 "," $1,320.0 ",Feb
AR-2015-2106,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,27-02-2015,5653,India,India,7933,Assigned,114, $231.0 ," $26,334.0 "," $3,610.0 ",Feb
AR-2015-2107,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,03-10-2015,5653,India,India,7933,Assigned,100, $231.0 ," $23,100.0 "," $2,166.7 ",Oct
AR-2015-2108,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,05-08-2015,5653,India,India,7933,Not assigned,197, $231.0 ," $45,507.0 ", $-   ,Aug
AR-2015-2109,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,17-02-2015,5653,Egypt,Egypt,7933,Not assigned,226, $231.0 ," $52,206.0 ", $-   ,Feb
AR-2015-2110,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,03-05-2015,5653,Vietnam,Netherlands,7933,Assigned,157, $231.0 ," $36,267.0 "," $2,878.3 ",May
AR-2015-2111,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,04-10-2015,5653,Vietnam,Netherlands,7933,Assigned,493, $231.0 ," $1,13,883.0 "," $4,930.0 ",Oct
AR-2015-2112,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,08-12-2015,5653,Vietnam,Netherlands,7933,Assigned,487, $231.0 ," $1,12,497.0 "," $12,824.3 ",Dec
AR-2015-2113,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,17-01-2015,5653,Vietnam,Netherlands,7933,Assigned,78, $231.0 ," $18,018.0 "," $1,430.0 ",Jan
AR-2015-2114,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,13-10-2015,5653,Vietnam,Netherlands,7933,Assigned,157, $231.0 ," $36,267.0 "," $1,831.7 ",Oct
AR-2015-2115,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,25-01-2015,5653,Singapore,Singapore,7933,Not assigned,30, $231.0 ," $6,930.0 ", $-   ,Jan
AR-2015-2116,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,18-04-2015,5653,Thailand,Thailand,7933,Not assigned,214, $231.0 ," $49,434.0 ", $-   ,Apr
AR-2015-2117,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,01-08-2015,5653,Thailand,Thailand,7933,Not assigned,278, $231.0 ," $64,218.0 ", $-   ,Aug
AR-2015-2118,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,25-03-2015,5653,Japan,Singapore,7933,Not assigned,494, $231.0 ," $1,14,114.0 ", $-   ,Mar
AR-2015-2119,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,10-07-2015,5653,Malaysia,Malaysia,7933,Not assigned,403, $231.0 ," $93,093.0 ", $-   ,Jul
AR-2015-2120,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,05-06-2015,5653,Vietnam,Japan,7933,Assigned,458, $231.0 ," $1,05,798.0 "," $7,633.3 ",Jun
AR-2015-2121,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,15-01-2015,5653,Vietnam,Japan,7933,Assigned,190, $231.0 ," $43,890.0 "," $2,090.0 ",Jan
AR-2015-2122,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,12-01-2015,5653,Thailand,Thailand,7933,Not assigned,25, $231.0 ," $5,775.0 ", $-   ,Jan
AR-2015-2123,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,30-05-2015,5653,Thailand,Thailand,7933,Not assigned,254, $231.0 ," $58,674.0 ", $-   ,May
AR-2015-2124,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,29-12-2015,5653,Thailand,Thailand,7933,Not assigned,369, $231.0 ," $85,239.0 ", $-   ,Dec
AR-2015-2125,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,19-04-2015,5653,Thailand,Thailand,7933,Not assigned,24, $231.0 ," $5,544.0 ", $-   ,Apr
AR-2015-2126,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,06-01-2015,5653,Malaysia,Malaysia,7933,Not assigned,480, $231.0 ," $1,10,880.0 ", $-   ,Jan
AR-2015-2127,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,26-01-2015,5653,Indonesia,Indonesia,7933,Assigned,26, $231.0 ," $6,006.0 ", $806.0 ,Jan
AR-2015-2128,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,13-08-2015,5653,Kenya,Kenya,7933,Not assigned,87, $231.0 ," $20,097.0 ", $-   ,Aug
AR-2015-2129,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,16-09-2015,5653,Oman,Oman,7933,Not assigned,478, $231.0 ," $1,10,418.0 ", $-   ,Sep
AR-2015-2130,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,11-02-2015,5653,Oman,Oman,7933,Not assigned,471, $231.0 ," $1,08,801.0 ", $-   ,Feb
AR-2015-2131,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,13-02-2015,5653,Malaysia,Malaysia,7933,Assigned,418, $231.0 ," $96,558.0 "," $10,171.3 ",Feb
RA-2015-2132,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,19-12-2015,5819,India,India,8119,Assigned,219, $364.0 ," $79,716.0 "," $4,088.0 ",Dec
DE-2015-2133,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,08-06-2015,5754,India,India,7904,Not assigned,268, $314.0 ," $84,152.0 ", $-   ,Jun
DE-2015-2134,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,06-12-2015,5754,India,India,7904,Not assigned,232, $314.0 ," $72,848.0 ", $-   ,Dec
DE-2015-2135,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,14-11-2015,5754,India,India,7904,Assigned,465, $314.0 ," $1,46,010.0 "," $8,835.0 ",Nov
DE-2015-2136,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,14-08-2015,5754,India,India,7904,Assigned,55, $314.0 ," $17,270.0 ", $311.7 ,Aug
DE-2015-2137,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,04-08-2015,5754,India,India,7904,Not assigned,325, $314.0 ," $1,02,050.0 ", $-   ,Aug
DE-2015-2138,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,14-03-2015,5754,India,India,7904,Not assigned,446, $314.0 ," $1,40,044.0 ", $-   ,Mar
DE-2015-2139,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,20-09-2015,5754,India,India,7904,Not assigned,411, $314.0 ," $1,29,054.0 ", $-   ,Sep
DE-2015-2140,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,19-09-2015,5754,India,India,7904,Not assigned,171, $314.0 ," $53,694.0 ", $-   ,Sep
DE-2015-2141,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,10-04-2015,5754,Vietnam,Japan,7904,Assigned,261, $314.0 ," $81,954.0 "," $4,263.0 ",Apr
DE-2015-2142,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,17-10-2015,5754,Egypt,Egypt,7904,Not assigned,362, $314.0 ," $1,13,668.0 ", $-   ,Oct
DE-2015-2143,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,03-04-2015,5754,Singapore,Singapore,7904,Not assigned,489, $314.0 ," $1,53,546.0 ", $-   ,Apr
DE-2015-2144,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,29-01-2015,5754,Bangladesh,Bangladesh,7904,Not assigned,47, $314.0 ," $14,758.0 ", $-   ,Jan
DE-2015-2145,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,15-05-2015,5754,Vietnam,Netherlands,7904,Assigned,452, $314.0 ," $1,41,928.0 "," $10,094.7 ",May
DE-2015-2146,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,13-12-2015,5754,Vietnam,Vietnam,7904,Assigned,16, $314.0 ," $5,024.0 ", $400.0 ,Dec
DE-2015-2147,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,16-12-2015,5754,Vietnam,Japan,7904,Assigned,20, $314.0 ," $6,280.0 ", $606.7 ,Dec
DE-2015-2148,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,13-07-2015,5754,Indonesia,Indonesia,7904,Assigned,177, $314.0 ," $55,578.0 "," $1,947.0 ",Jul
DE-2015-2149,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,31-05-2015,5754,Indonesia,Indonesia,7904,Assigned,36, $314.0 ," $11,304.0 ", $780.0 ,May
DE-2015-2150,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,11-04-2015,5754,Indonesia,Indonesia,7904,Assigned,492, $314.0 ," $1,54,488.0 "," $4,264.0 ",Apr
DE-2015-2151,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,17-05-2015,5754,Vietnam,Netherlands,7904,Assigned,24, $314.0 ," $7,536.0 ", $432.0 ,May
DE-2015-2152,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,01-03-2015,5754,Vietnam,Netherlands,7904,Assigned,387, $314.0 ," $1,21,518.0 "," $9,546.0 ",Mar
DE-2015-2153,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,26-04-2015,5754,Egypt,Egypt,7904,Assigned,90, $314.0 ," $28,260.0 "," $2,940.0 ",Apr
DE-2015-2154,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,19-07-2015,5754,Malaysia,Malaysia,7904,Assigned,40, $314.0 ," $12,560.0 ", $426.7 ,Jul
DE-2015-2155,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,01-01-2015,5754,Indonesia,Indonesia,7904,Not assigned,124, $314.0 ," $38,936.0 ", $-   ,Jan
TA-2015-2156,Filgrastim,Neulasta,Amgen,Neutropenia,13-01-2015,5737,Pakistan,Pakistan,8270,Not assigned,269, $266.0 ," $71,554.0 ", $-   ,Jan
AR-2015-2157,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,11-08-2015,5653,Pakistan,Pakistan,7933,Not assigned,11, $231.0 ," $2,541.0 ", $-   ,Aug
TA-2015-2158,Filgrastim,Neulasta,Amgen,Neutropenia,20-07-2015,5737,Philippines,Philippines,8270,Not assigned,415, $266.0 ," $1,10,390.0 ", $-   ,Jul
AR-2015-2159,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,31-10-2015,5653,Philippines,Philippines,7933,Not assigned,349, $231.0 ," $80,619.0 ", $-   ,Oct
TA-2015-2160,Filgrastim,Neulasta,Amgen,Neutropenia,23-05-2015,5737,Bangladesh,Bangladesh,8270,Not assigned,158, $266.0 ," $42,028.0 ", $-   ,May
AR-2015-2161,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,14-02-2015,5653,Yemen,Yemen,7933,Not assigned,13, $231.0 ," $3,003.0 ", $-   ,Feb
EL-2015-2162,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,31-10-2015,5737,Vietnam,Japan,8270,Assigned,459, $250.0 ," $1,14,750.0 "," $7,191.0 ",Oct
EL-2015-2163,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,24-11-2015,5737,Bangladesh,Bangladesh,8270,Not assigned,269, $250.0 ," $67,250.0 ", $-   ,Nov
EL-2015-2164,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,23-04-2015,5737,Singapore,Singapore,8270,Not assigned,406, $250.0 ," $1,01,500.0 ", $-   ,Apr
UM-2015-2165,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,27-12-2015,5704,India,India,8370,Not assigned,290, $366.0 ," $1,06,140.0 ", $-   ,Dec
UM-2015-2166,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,08-04-2015,5704,India,India,8370,Not assigned,29, $366.0 ," $10,614.0 ", $-   ,Apr
UM-2015-2167,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,12-09-2015,5704,India,India,8370,Not assigned,476, $366.0 ," $1,74,216.0 ", $-   ,Sep
UM-2015-2168,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,02-08-2015,5704,Pakistan,Pakistan,8370,Not assigned,8, $366.0 ," $2,928.0 ", $-   ,Aug
UM-2015-2169,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,15-02-2015,5704,India,India,8370,Not assigned,340, $366.0 ," $1,24,440.0 ", $-   ,Feb
UM-2015-2170,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,27-09-2015,5704,India,India,8370,Not assigned,500, $366.0 ," $1,83,000.0 ", $-   ,Sep
UM-2015-2171,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,24-08-2015,5704,India,India,8370,Assigned,446, $366.0 ," $1,63,236.0 "," $12,934.0 ",Aug
UM-2015-2172,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,08-08-2015,5704,India,India,8370,Not assigned,407, $366.0 ," $1,48,962.0 ", $-   ,Aug
UM-2015-2173,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,06-08-2015,5704,India,India,8370,Not assigned,395, $366.0 ," $1,44,570.0 ", $-   ,Aug
UM-2015-2174,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,25-07-2015,5704,Vietnam,Japan,8370,Assigned,209, $366.0 ," $76,494.0 "," $3,274.3 ",Jul
UM-2015-2175,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,29-08-2015,5704,Bangladesh,Bangladesh,8370,Assigned,28, $366.0 ," $10,248.0 ", $420.0 ,Aug
UM-2015-2176,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,22-04-2015,5704,Jordan,Jordan,8370,Not assigned,387, $366.0 ," $1,41,642.0 ", $-   ,Apr
UM-2015-2177,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,03-10-2015,5704,Pakistan,Pakistan,8370,Assigned,146, $366.0 ," $53,436.0 "," $4,234.0 ",Oct
UM-2015-2178,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,27-03-2015,5704,Vietnam,Netherlands,8370,Assigned,5, $366.0 ," $1,830.0 ", $161.7 ,Mar
UM-2015-2179,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,07-03-2015,5704,Colombia,Mexico,8370,Not assigned,23, $366.0 ," $8,418.0 ", $-   ,Mar
UM-2015-2180,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,08-09-2015,5704,Colombia,Mexico,8370,Not assigned,334, $366.0 ," $1,22,244.0 ", $-   ,Sep
UM-2015-2181,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,06-07-2015,5704,Peru,Mexico,8370,Not assigned,499, $366.0 ," $1,82,634.0 ", $-   ,Jul
UM-2015-2182,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,12-11-2015,5704,India,India,8370,Not assigned,73, $366.0 ," $26,718.0 ", $-   ,Nov
UM-2015-2183,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,22-02-2015,5704,India,India,8370,Not assigned,205, $366.0 ," $75,030.0 ", $-   ,Feb
UM-2015-2184,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,27-11-2015,5704,India,India,8370,Not assigned,466, $366.0 ," $1,70,556.0 ", $-   ,Nov
UM-2015-2185,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,11-12-2015,5704,India,India,8370,Not assigned,378, $366.0 ," $1,38,348.0 ", $-   ,Dec
UM-2015-2186,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,09-10-2015,5704,India,India,8370,Not assigned,500, $366.0 ," $1,83,000.0 ", $-   ,Oct
UM-2015-2187,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,23-05-2015,5704,India,India,8370,Not assigned,400, $366.0 ," $1,46,400.0 ", $-   ,May
UM-2015-2188,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,13-02-2015,5704,India,India,8370,Not assigned,87, $366.0 ," $31,842.0 ", $-   ,Feb
UM-2015-2189,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,29-04-2015,5704,India,India,8370,Not assigned,177, $366.0 ," $64,782.0 ", $-   ,Apr
UM-2015-2190,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,13-12-2015,5704,India,India,8370,Not assigned,350, $366.0 ," $1,28,100.0 ", $-   ,Dec
UM-2015-2191,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,21-10-2015,5704,India,India,8370,Not assigned,106, $366.0 ," $38,796.0 ", $-   ,Oct
UM-2015-2192,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,06-11-2015,5704,India,India,8370,Not assigned,314, $366.0 ," $1,14,924.0 ", $-   ,Nov
UM-2015-2193,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,02-01-2015,5704,India,India,8370,Not assigned,112, $366.0 ," $40,992.0 ", $-   ,Jan
UM-2015-2194,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,12-10-2015,5704,India,India,8370,Not assigned,333, $366.0 ," $1,21,878.0 ", $-   ,Oct
UM-2015-2195,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,13-11-2015,5704,India,India,8370,Not assigned,94, $366.0 ," $34,404.0 ", $-   ,Nov
UM-2015-2196,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,21-09-2015,5704,India,India,8370,Not assigned,376, $366.0 ," $1,37,616.0 ", $-   ,Sep
UM-2015-2197,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,27-02-2015,5704,India,India,8370,Not assigned,119, $366.0 ," $43,554.0 ", $-   ,Feb
UM-2015-2198,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,23-12-2015,5704,India,India,8370,Not assigned,31, $366.0 ," $11,346.0 ", $-   ,Dec
UM-2015-2199,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,26-10-2015,5704,India,India,8370,Not assigned,67, $366.0 ," $24,522.0 ", $-   ,Oct
UM-2015-2200,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,26-01-2015,5704,India,India,8370,Not assigned,7, $366.0 ," $2,562.0 ", $-   ,Jan
UM-2015-2201,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,25-05-2015,5704,India,India,8370,Not assigned,402, $366.0 ," $1,47,132.0 ", $-   ,May
UM-2015-2202,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,05-01-2015,5704,India,India,8370,Not assigned,140, $366.0 ," $51,240.0 ", $-   ,Jan
UM-2015-2203,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,26-11-2015,5704,India,India,8370,Not assigned,114, $366.0 ," $41,724.0 ", $-   ,Nov
UM-2015-2204,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,09-07-2015,5704,India,India,8370,Not assigned,492, $366.0 ," $1,80,072.0 ", $-   ,Jul
US-2015-2205,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,13-03-2015,5653,Australia,Australia,7933,Not assigned,335, $231.0 ," $77,385.0 ", $-   ,Mar
US-2015-2206,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,02-09-2015,5653,Bangladesh,Bangladesh,7933,Assigned,105, $231.0 ," $24,255.0 "," $2,205.0 ",Sep
US-2015-2207,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,06-12-2015,5653,Bangladesh,Bangladesh,7933,Assigned,251, $231.0 ," $57,981.0 "," $7,195.3 ",Dec
US-2015-2208,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,21-04-2015,5653,Bangladesh,Bangladesh,7933,Assigned,177, $231.0 ," $40,887.0 "," $4,425.0 ",Apr
US-2015-2209,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,23-12-2015,5653,Indonesia,Indonesia,7933,Assigned,305, $231.0 ," $70,455.0 "," $1,118.3 ",Dec
US-2015-2210,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,06-03-2015,5653,Syria,Lebanon,7933,Assigned,470, $231.0 ," $1,08,570.0 "," $13,943.3 ",Mar
US-2015-2211,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,27-08-2015,5653,Pakistan,Pakistan,7933,Assigned,109, $231.0 ," $25,179.0 "," $2,870.3 ",Aug
US-2015-2212,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,15-06-2015,5653,Indonesia,Indonesia,7933,Assigned,213, $231.0 ," $49,203.0 "," $1,704.0 ",Jun
US-2015-2213,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,10-01-2015,5653,Benin,United Kingdom,7933,Not assigned,359, $231.0 ," $82,929.0 ", $-   ,Jan
US-2015-2214,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,04-08-2015,5653,Lebanon,Lebanon,7933,Assigned,346, $231.0 ," $79,926.0 "," $10,264.7 ",Aug
US-2015-2215,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,18-08-2015,5653,South Africa,South Africa,7933,Assigned,128, $231.0 ," $29,568.0 "," $1,194.7 ",Aug
TA-2015-2216,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,12-11-2015,5704,India,India,8370,Not assigned,336, $453.0 ," $1,52,208.0 ", $-   ,Nov
TA-2015-2217,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,07-06-2015,5704,India,India,8370,Not assigned,216, $453.0 ," $97,848.0 ", $-   ,Jun
TA-2015-2218,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,26-06-2015,5704,India,India,8370,Not assigned,112, $453.0 ," $50,736.0 ", $-   ,Jun
IA-2015-2219,Sitagliptin,Januvia,"Merck & Co., Inc.",Diabetes mellitus type 2,09-03-2015,5938,India,India,8318,Not assigned,195, $386.0 ," $75,270.0 ", $-   ,Mar
IA-2015-2220,Sitagliptin,Januvia,"Merck & Co., Inc.",Diabetes mellitus type 2,15-09-2015,5938,Thailand,Thailand,8318,Assigned,471, $386.0 ," $1,81,806.0 "," $7,850.0 ",Sep
IA-2015-2221,Sitagliptin,Januvia,"Merck & Co., Inc.",Diabetes mellitus type 2,06-12-2015,5938,Thailand,Thailand,8318,Assigned,158, $386.0 ," $60,988.0 "," $3,476.0 ",Dec
UM-2015-2222,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,07-10-2015,5704,India,India,8370,Not assigned,234, $366.0 ," $85,644.0 ", $-   ,Oct
FY-2015-2223,Aripiprazole,Abilify,Generic,Psychosis; depression,07-07-2015,5704,India,India,8370,Not assigned,102, $204.0 ," $20,808.0 ", $-   ,Jul
AR-2015-2224,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,14-01-2015,5653,Pakistan,Pakistan,7933,Assigned,429, $231.0 ," $99,099.0 "," $14,300.0 ",Jan
AR-2015-2225,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,31-08-2015,5653,Pakistan,Pakistan,7933,Assigned,254, $231.0 ," $58,674.0 "," $1,185.3 ",Aug
AR-2015-2226,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,01-09-2015,5653,India,India,7933,Assigned,228, $231.0 ," $52,668.0 "," $4,484.0 ",Sep
AR-2015-2227,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,07-02-2015,5653,Pakistan,Pakistan,7933,Assigned,141, $231.0 ," $32,571.0 "," $4,700.0 ",Feb
AR-2015-2228,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,20-09-2015,5653,Pakistan,Pakistan,7933,Assigned,11, $231.0 ," $2,541.0 ", $194.3 ,Sep
CA-2015-2229,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-04-2015,5887,India,India,8095,Not assigned,105, $500.0 ," $52,500.0 ", $-   ,Apr
AR-2015-2230,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,19-05-2015,5653,India,India,7933,Assigned,27, $231.0 ," $6,237.0 ", $432.0 ,May
AR-2015-2231,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,30-01-2015,5653,Pakistan,Pakistan,7933,Assigned,410, $231.0 ," $94,710.0 "," $10,386.7 ",Jan
AR-2015-2232,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,21-06-2015,5653,Pakistan,Pakistan,7933,Assigned,131, $231.0 ," $30,261.0 "," $2,532.7 ",Jun
AR-2015-2233,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,10-09-2015,5653,India,India,7933,Assigned,200, $231.0 ," $46,200.0 "," $3,133.3 ",Sep
CA-2015-2234,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-09-2015,5887,India,India,8095,Not assigned,42, $500.0 ," $21,000.0 ", $-   ,Sep
AR-2015-2235,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,16-01-2015,5653,India,India,7933,Assigned,359, $231.0 ," $82,929.0 "," $5,026.0 ",Jan
DE-2015-2236,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,31-05-2015,5754,Pakistan,Pakistan,7904,Not assigned,342, $314.0 ," $1,07,388.0 ", $-   ,May
DE-2015-2237,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,11-05-2015,5754,Pakistan,Pakistan,7904,Not assigned,420, $314.0 ," $1,31,880.0 ", $-   ,May
DE-2015-2238,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,21-06-2015,5754,Pakistan,Pakistan,7904,Not assigned,486, $314.0 ," $1,52,604.0 ", $-   ,Jun
DE-2015-2239,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,11-05-2015,5754,Pakistan,Pakistan,7904,Not assigned,412, $314.0 ," $1,29,368.0 ", $-   ,May
DE-2015-2240,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,17-09-2015,5754,Pakistan,Pakistan,7904,Assigned,245, $314.0 ," $76,930.0 "," $2,613.3 ",Sep
DE-2015-2241,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,10-09-2015,5754,Pakistan,Pakistan,7904,Assigned,204, $314.0 ," $64,056.0 "," $1,292.0 ",Sep
DE-2015-2242,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,17-02-2015,5754,Pakistan,Pakistan,7904,Assigned,217, $314.0 ," $68,138.0 "," $3,689.0 ",Feb
DE-2015-2243,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,25-07-2015,5754,Pakistan,Pakistan,7904,Assigned,398, $314.0 ," $1,24,972.0 "," $10,613.3 ",Jul
DE-2015-2244,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,29-11-2015,5754,Pakistan,Pakistan,7904,Assigned,335, $314.0 ," $1,05,190.0 "," $8,821.7 ",Nov
DE-2015-2245,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,11-12-2015,5754,Pakistan,Pakistan,7904,Assigned,451, $314.0 ," $1,41,614.0 "," $13,830.7 ",Dec
DE-2015-2246,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,11-07-2015,5754,Pakistan,Pakistan,7904,Assigned,348, $314.0 ," $1,09,272.0 "," $5,336.0 ",Jul
DE-2015-2247,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,30-07-2015,5754,Pakistan,Pakistan,7904,Not assigned,346, $314.0 ," $1,08,644.0 ", $-   ,Jul
DE-2015-2248,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,14-10-2015,5754,Pakistan,Pakistan,7904,Not assigned,326, $314.0 ," $1,02,364.0 ", $-   ,Oct
DE-2015-2249,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,11-03-2015,5754,Pakistan,Pakistan,7904,Assigned,411, $314.0 ," $1,29,054.0 "," $12,056.0 ",Mar
DE-2015-2250,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,15-02-2015,5754,Pakistan,Pakistan,7904,Assigned,393, $314.0 ," $1,23,402.0 "," $3,930.0 ",Feb
DE-2015-2251,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,20-02-2015,5754,Pakistan,Pakistan,7904,Assigned,38, $314.0 ," $11,932.0 ", $342.0 ,Feb
TA-2015-2252,Filgrastim,Neulasta,Amgen,Neutropenia,28-10-2015,5737,India,India,8270,Not assigned,298, $266.0 ," $79,268.0 ", $-   ,Oct
TA-2015-2253,Filgrastim,Neulasta,Amgen,Neutropenia,22-11-2015,5737,India,India,8270,Not assigned,220, $266.0 ," $58,520.0 ", $-   ,Nov
TA-2015-2254,Filgrastim,Neulasta,Amgen,Neutropenia,08-01-2015,5737,India,India,8270,Not assigned,297, $266.0 ," $79,002.0 ", $-   ,Jan
EL-2015-2255,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,29-06-2015,5737,Pakistan,Pakistan,8270,Assigned,427, $250.0 ," $1,06,750.0 "," $11,671.3 ",Jun
EL-2015-2256,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,28-01-2015,5737,Pakistan,Pakistan,8270,Assigned,244, $250.0 ," $61,000.0 "," $4,554.7 ",Jan
EL-2015-2257,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,27-03-2015,5737,Pakistan,Pakistan,8270,Assigned,363, $250.0 ," $90,750.0 "," $6,655.0 ",Mar
EL-2015-2258,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,10-04-2015,5737,Pakistan,Pakistan,8270,Assigned,181, $250.0 ," $45,250.0 "," $3,921.7 ",Apr
US-2015-2259,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,30-11-2015,5653,India,India,7933,Not assigned,75, $231.0 ," $17,325.0 ", $-   ,Nov
US-2015-2260,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,27-03-2015,5653,India,India,7933,Not assigned,475, $231.0 ," $1,09,725.0 ", $-   ,Mar
US-2015-2261,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,24-08-2015,5653,India,India,7933,Not assigned,129, $231.0 ," $29,799.0 ", $-   ,Aug
US-2015-2262,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,12-04-2015,5653,India,India,7933,Not assigned,19, $231.0 ," $4,389.0 ", $-   ,Apr
AR-2015-2263,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,18-04-2015,5653,India,India,7933,Assigned,252, $231.0 ," $58,212.0 "," $3,024.0 ",Apr
AR-2015-2264,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,04-03-2015,5653,India,India,7933,Assigned,294, $231.0 ," $67,914.0 "," $8,918.0 ",Mar
AR-2015-2265,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,14-11-2015,5653,India,India,7933,Not assigned,145, $231.0 ," $33,495.0 ", $-   ,Nov
CA-2015-2266,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-08-2015,5887,India,India,8095,Not assigned,104, $500.0 ," $52,000.0 ", $-   ,Aug
AR-2015-2267,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,25-04-2015,5653,Pakistan,Pakistan,7933,Assigned,126, $231.0 ," $29,106.0 "," $1,428.0 ",Apr
AR-2015-2268,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,07-12-2015,5653,Pakistan,Pakistan,7933,Assigned,487, $231.0 ," $1,12,497.0 "," $8,441.3 ",Dec
CA-2015-2269,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-07-2015,5887,India,India,8095,Not assigned,452, $500.0 ," $2,26,000.0 ", $-   ,Jul
AR-2015-2270,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,04-02-2015,5653,Pakistan,Pakistan,7933,Assigned,473, $231.0 ," $1,09,263.0 "," $8,356.3 ",Feb
AR-2015-2271,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,23-04-2015,5653,Pakistan,Pakistan,7933,Assigned,46, $231.0 ," $10,626.0 ", $797.3 ,Apr
DE-2015-2272,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,15-01-2015,5754,Pakistan,Pakistan,7904,Assigned,127, $314.0 ," $39,878.0 "," $2,921.0 ",Jan
DE-2015-2273,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,22-12-2015,5754,Pakistan,Pakistan,7904,Not assigned,499, $314.0 ," $1,56,686.0 ", $-   ,Dec
DE-2015-2274,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,26-08-2015,5754,Pakistan,Pakistan,7904,Not assigned,254, $314.0 ," $79,756.0 ", $-   ,Aug
DE-2015-2275,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,06-09-2015,5754,Pakistan,Pakistan,7904,Not assigned,440, $314.0 ," $1,38,160.0 ", $-   ,Sep
DE-2015-2276,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,25-07-2015,5754,Pakistan,Pakistan,7904,Not assigned,238, $314.0 ," $74,732.0 ", $-   ,Jul
DE-2015-2277,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,03-02-2015,5754,Pakistan,Pakistan,7904,Assigned,469, $314.0 ," $1,47,266.0 "," $13,132.0 ",Feb
DE-2015-2278,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,24-10-2015,5754,Pakistan,Pakistan,7904,Assigned,146, $314.0 ," $45,844.0 ", $827.3 ,Oct
DE-2015-2279,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,17-10-2015,5754,Pakistan,Pakistan,7904,Assigned,197, $314.0 ," $61,858.0 "," $1,576.0 ",Oct
TA-2015-2280,Filgrastim,Neulasta,Amgen,Neutropenia,16-10-2015,5737,Pakistan,Pakistan,8270,Assigned,226, $266.0 ," $60,116.0 "," $2,410.7 ",Oct
AR-2015-2281,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,29-06-2015,5653,Pakistan,Pakistan,7933,Assigned,242, $231.0 ," $55,902.0 "," $3,952.7 ",Jun
EL-2015-2282,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,24-11-2015,5737,Pakistan,Pakistan,8270,Assigned,183, $250.0 ," $45,750.0 "," $3,233.0 ",Nov
EL-2015-2283,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,23-03-2015,5737,Pakistan,Pakistan,8270,Assigned,80, $250.0 ," $20,000.0 "," $1,573.3 ",Mar
EL-2015-2284,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,30-07-2015,5737,Pakistan,Pakistan,8270,Assigned,68, $250.0 ," $17,000.0 "," $1,382.7 ",Jul
EL-2015-2285,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,10-10-2015,5737,Pakistan,Pakistan,8270,Assigned,73, $250.0 ," $18,250.0 ", $754.3 ,Oct
EL-2015-2286,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,21-09-2015,5737,Pakistan,Pakistan,8270,Assigned,25, $250.0 ," $6,250.0 ", $141.7 ,Sep
US-2015-2287,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,30-04-2015,5653,India,India,7933,Not assigned,114, $231.0 ," $26,334.0 ", $-   ,Apr
US-2015-2288,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,23-01-2015,5653,Pakistan,Pakistan,7933,Assigned,467, $231.0 ," $1,07,877.0 "," $12,453.3 ",Jan
US-2015-2289,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,16-11-2015,5653,Pakistan,Pakistan,7933,Assigned,441, $231.0 ," $1,01,871.0 "," $11,172.0 ",Nov
IN-2015-2290,Bevacizumab,Avastin,Genentech/Roche,Cancer,24-03-2015,5685,India,India,8209,Not assigned,1, $243.0 , $243.0 , $-   ,Mar
US-2015-2291,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,27-02-2015,5653,India,India,7933,Not assigned,484, $231.0 ," $1,11,804.0 ", $-   ,Feb
UM-2015-2292,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,17-03-2015,5704,Oman,Oman,8370,Not assigned,47, $366.0 ," $17,202.0 ", $-   ,Mar
UM-2015-2293,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,15-06-2015,5704,Bangladesh,Bangladesh,8370,Not assigned,264, $366.0 ," $96,624.0 ", $-   ,Jun
UM-2015-2294,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,29-08-2015,5704,Egypt,Egypt,8370,Assigned,53, $366.0 ," $19,398.0 ", $706.7 ,Aug
IN-2015-2295,Oxycodone,OxyContin,Generic,Pain,20-10-2015,5704,Thailand,Thailand,8370,Not assigned,485, $472.0 ," $2,28,920.0 ", $-   ,Oct
IN-2015-2296,Oxycodone,OxyContin,Generic,Pain,09-10-2015,5704,Thailand,Thailand,8370,Assigned,92, $472.0 ," $43,424.0 "," $1,502.7 ",Oct
IN-2015-2297,Oxycodone,OxyContin,Generic,Pain,23-01-2015,5704,Thailand,Thailand,8370,Assigned,101, $472.0 ," $47,672.0 "," $2,491.3 ",Jan
IN-2015-2298,Oxycodone,OxyContin,Generic,Pain,17-11-2015,5704,Thailand,Thailand,8370,Assigned,260, $472.0 ," $1,22,720.0 "," $6,760.0 ",Nov
IN-2015-2299,Oxycodone,OxyContin,Generic,Pain,01-08-2015,5704,Singapore,Singapore,8370,Not assigned,415, $472.0 ," $1,95,880.0 ", $-   ,Aug
CA-2015-2300,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-10-2015,5887,Laos,Laos,8095,Not assigned,470, $500.0 ," $2,35,000.0 ", $-   ,Oct
CA-2015-2301,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-04-2015,5887,Laos,Laos,8095,Not assigned,122, $500.0 ," $61,000.0 ", $-   ,Apr
CA-2015-2302,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-01-2015,5887,Laos,Laos,8095,Not assigned,372, $500.0 ," $1,86,000.0 ", $-   ,Jan
CA-2015-2303,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-01-2015,5887,India,India,8095,Not assigned,384, $500.0 ," $1,92,000.0 ", $-   ,Jan
CA-2015-2304,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-04-2015,5887,India,India,8095,Not assigned,138, $500.0 ," $69,000.0 ", $-   ,Apr
CA-2015-2305,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-12-2015,5887,India,India,8095,Not assigned,318, $500.0 ," $1,59,000.0 ", $-   ,Dec
CA-2015-2306,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-07-2015,5887,India,India,8095,Not assigned,4, $500.0 ," $2,000.0 ", $-   ,Jul
CA-2015-2307,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-11-2015,5887,Nepal,Nepal,8095,Assigned,166, $500.0 ," $83,000.0 "," $2,102.7 ",Nov
CA-2015-2308,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-05-2015,5887,India,India,8095,Not assigned,318, $500.0 ," $1,59,000.0 ", $-   ,May
CA-2015-2309,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-04-2015,5887,Laos,Laos,8095,Not assigned,397, $500.0 ," $1,98,500.0 ", $-   ,Apr
CA-2015-2310,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-01-2015,5887,India,India,8095,Not assigned,177, $500.0 ," $88,500.0 ", $-   ,Jan
CA-2015-2311,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-07-2015,5887,India,India,8095,Not assigned,333, $500.0 ," $1,66,500.0 ", $-   ,Jul
CA-2015-2312,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-12-2015,5887,India,India,8095,Not assigned,201, $500.0 ," $1,00,500.0 ", $-   ,Dec
CA-2015-2313,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-12-2015,5887,India,India,8095,Not assigned,363, $500.0 ," $1,81,500.0 ", $-   ,Dec
CA-2015-2314,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-03-2015,5887,India,India,8095,Not assigned,421, $500.0 ," $2,10,500.0 ", $-   ,Mar
CA-2015-2315,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-03-2015,5887,India,India,8095,Not assigned,49, $500.0 ," $24,500.0 ", $-   ,Mar
CA-2015-2316,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-12-2015,5887,Thailand,Thailand,8095,Assigned,213, $500.0 ," $1,06,500.0 "," $3,550.0 ",Dec
CA-2015-2317,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-11-2015,5887,Thailand,Thailand,8095,Assigned,472, $500.0 ," $2,36,000.0 "," $7,237.3 ",Nov
CA-2015-2318,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-12-2015,5887,India,India,8095,Not assigned,295, $500.0 ," $1,47,500.0 ", $-   ,Dec
CA-2015-2319,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-07-2015,5887,India,India,8095,Not assigned,306, $500.0 ," $1,53,000.0 ", $-   ,Jul
CA-2015-2320,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-01-2015,5887,Hong Kong,Hong Kong,8095,Not assigned,470, $500.0 ," $2,35,000.0 ", $-   ,Jan
CA-2015-2321,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-02-2015,5887,Hong Kong,Hong Kong,8095,Not assigned,388, $500.0 ," $1,94,000.0 ", $-   ,Feb
CA-2015-2322,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-08-2015,5887,India,India,8095,Not assigned,270, $500.0 ," $1,35,000.0 ", $-   ,Aug
CA-2015-2323,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-12-2015,5887,India,India,8095,Not assigned,280, $500.0 ," $1,40,000.0 ", $-   ,Dec
CA-2015-2324,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-11-2015,5887,India,India,8095,Not assigned,185, $500.0 ," $92,500.0 ", $-   ,Nov
CA-2015-2325,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-06-2015,5887,India,India,8095,Not assigned,272, $500.0 ," $1,36,000.0 ", $-   ,Jun
CA-2015-2326,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-09-2015,5887,India,India,8095,Not assigned,145, $500.0 ," $72,500.0 ", $-   ,Sep
CA-2015-2327,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-04-2015,5887,India,India,8095,Not assigned,281, $500.0 ," $1,40,500.0 ", $-   ,Apr
CA-2015-2328,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-06-2015,5887,Nigeria,Nigeria,8095,Not assigned,358, $500.0 ," $1,79,000.0 ", $-   ,Jun
CA-2015-2329,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-06-2015,5887,India,India,8095,Not assigned,277, $500.0 ," $1,38,500.0 ", $-   ,Jun
CA-2015-2330,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-03-2015,5887,India,India,8095,Not assigned,386, $500.0 ," $1,93,000.0 ", $-   ,Mar
CA-2015-2331,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-06-2015,5887,India,India,8095,Assigned,380, $500.0 ," $1,90,000.0 "," $1,266.7 ",Jun
CA-2015-2332,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-03-2015,5887,Sri Lanka,Sri Lanka,8095,Assigned,187, $500.0 ," $93,500.0 "," $2,181.7 ",Mar
CA-2015-2333,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-08-2015,5887,India,India,8095,Not assigned,416, $500.0 ," $2,08,000.0 ", $-   ,Aug
CA-2015-2334,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-11-2015,5887,Philippines,Philippines,8095,Assigned,212, $500.0 ," $1,06,000.0 "," $6,854.7 ",Nov
CA-2015-2335,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-04-2015,5887,India,India,8095,Not assigned,419, $500.0 ," $2,09,500.0 ", $-   ,Apr
CA-2015-2336,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-11-2015,5887,India,India,8095,Not assigned,385, $500.0 ," $1,92,500.0 ", $-   ,Nov
CA-2015-2337,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-03-2015,5887,India,India,8095,Not assigned,401, $500.0 ," $2,00,500.0 ", $-   ,Mar
CA-2015-2338,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-01-2015,5887,India,India,8095,Not assigned,288, $500.0 ," $1,44,000.0 ", $-   ,Jan
CA-2015-2339,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-03-2015,5887,India,India,8095,Not assigned,220, $500.0 ," $1,10,000.0 ", $-   ,Mar
CA-2015-2340,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-09-2015,5887,India,India,8095,Assigned,460, $500.0 ," $2,30,000.0 "," $10,580.0 ",Sep
CA-2015-2341,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-07-2015,5887,Philippines,Philippines,8095,Assigned,227, $500.0 ," $1,13,500.0 "," $6,053.3 ",Jul
CA-2015-2342,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-10-2015,5887,India,India,8095,Not assigned,407, $500.0 ," $2,03,500.0 ", $-   ,Oct
CA-2015-2343,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-04-2015,5887,India,India,8095,Not assigned,311, $500.0 ," $1,55,500.0 ", $-   ,Apr
CA-2015-2344,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-01-2015,5887,India,India,8095,Not assigned,294, $500.0 ," $1,47,000.0 ", $-   ,Jan
TA-2015-2345,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,22-11-2015,5704,India,India,8370,Not assigned,240, $453.0 ," $1,08,720.0 ", $-   ,Nov
CA-2015-2346,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-04-2015,5887,India,India,8095,Not assigned,459, $500.0 ," $2,29,500.0 ", $-   ,Apr
CA-2015-2347,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-04-2015,5887,India,India,8095,Not assigned,47, $500.0 ," $23,500.0 ", $-   ,Apr
CA-2015-2348,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-04-2015,5887,India,India,8095,Not assigned,274, $500.0 ," $1,37,000.0 ", $-   ,Apr
CA-2015-2349,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-05-2015,5887,India,India,8095,Not assigned,212, $500.0 ," $1,06,000.0 ", $-   ,May
CA-2015-2350,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-09-2015,5887,Hong Kong,China,8095,Not assigned,198, $500.0 ," $99,000.0 ", $-   ,Sep
CA-2015-2351,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-02-2015,5887,India,India,8095,Not assigned,498, $500.0 ," $2,49,000.0 ", $-   ,Feb
CA-2015-2352,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-08-2015,5887,India,India,8095,Not assigned,16, $500.0 ," $8,000.0 ", $-   ,Aug
CA-2015-2353,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-06-2015,5887,India,India,8095,Not assigned,450, $500.0 ," $2,25,000.0 ", $-   ,Jun
TA-2015-2354,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,18-10-2015,5704,India,India,8370,Not assigned,198, $453.0 ," $89,694.0 ", $-   ,Oct
IN-2015-2355,Oxycodone,OxyContin,Generic,Pain,13-08-2015,5704,India,India,8370,Not assigned,401, $472.0 ," $1,89,272.0 ", $-   ,Aug
CA-2015-2356,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-12-2015,5887,India,India,8095,Not assigned,80, $500.0 ," $40,000.0 ", $-   ,Dec
CA-2015-2357,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-05-2015,5887,Nepal,Nepal,8095,Assigned,300, $500.0 ," $1,50,000.0 "," $3,200.0 ",May
CA-2015-2358,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-11-2015,5887,India,India,8095,Not assigned,256, $500.0 ," $1,28,000.0 ", $-   ,Nov
CA-2015-2359,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-01-2015,5887,India,India,8095,Not assigned,56, $500.0 ," $28,000.0 ", $-   ,Jan
CA-2015-2360,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-11-2015,5887,India,India,8095,Not assigned,428, $500.0 ," $2,14,000.0 ", $-   ,Nov
CA-2015-2361,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-09-2015,5887,Nepal,Nepal,8095,Assigned,172, $500.0 ," $86,000.0 "," $5,102.7 ",Sep
CA-2015-2362,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-05-2015,5887,Nepal,Nepal,8095,Assigned,312, $500.0 ," $1,56,000.0 "," $10,192.0 ",May
CA-2015-2363,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-04-2015,5887,India,India,8095,Not assigned,360, $500.0 ," $1,80,000.0 ", $-   ,Apr
CA-2015-2364,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-12-2015,5887,Hong Kong,China,8095,Not assigned,177, $500.0 ," $88,500.0 ", $-   ,Dec
CA-2015-2365,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-01-2015,5887,India,India,8095,Not assigned,332, $500.0 ," $1,66,000.0 ", $-   ,Jan
CA-2015-2366,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-03-2015,5887,India,India,8095,Not assigned,188, $500.0 ," $94,000.0 ", $-   ,Mar
CA-2015-2367,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-02-2015,5887,India,India,8095,Not assigned,384, $500.0 ," $1,92,000.0 ", $-   ,Feb
CA-2015-2368,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-03-2015,5887,India,India,8095,Not assigned,45, $500.0 ," $22,500.0 ", $-   ,Mar
CA-2015-2369,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-09-2015,5887,Indonesia,Indonesia,8095,Assigned,353, $500.0 ," $1,76,500.0 "," $1,412.0 ",Sep
CA-2015-2370,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-10-2015,5887,India,India,8095,Not assigned,126, $500.0 ," $63,000.0 ", $-   ,Oct
CA-2015-2371,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-07-2015,5887,South Africa,South Africa,8095,Assigned,58, $500.0 ," $29,000.0 ", $348.0 ,Jul
CA-2015-2372,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-11-2015,5887,India,India,8095,Not assigned,58, $500.0 ," $29,000.0 ", $-   ,Nov
CA-2015-2373,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-09-2015,5887,Nepal,Nepal,8095,Assigned,289, $500.0 ," $1,44,500.0 "," $7,225.0 ",Sep
CA-2015-2374,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-10-2015,5887,India,India,8095,Not assigned,204, $500.0 ," $1,02,000.0 ", $-   ,Oct
CA-2015-2375,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-04-2015,5887,India,India,8095,Not assigned,269, $500.0 ," $1,34,500.0 ", $-   ,Apr
CA-2015-2376,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-10-2015,5887,India,India,8095,Not assigned,241, $500.0 ," $1,20,500.0 ", $-   ,Oct
CA-2015-2377,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-10-2015,5887,India,India,8095,Not assigned,319, $500.0 ," $1,59,500.0 ", $-   ,Oct
CA-2015-2378,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-08-2015,5887,India,India,8095,Not assigned,258, $500.0 ," $1,29,000.0 ", $-   ,Aug
CA-2015-2379,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-07-2015,5887,India,India,8095,Not assigned,111, $500.0 ," $55,500.0 ", $-   ,Jul
CA-2015-2380,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-06-2015,5887,India,India,8095,Not assigned,239, $500.0 ," $1,19,500.0 ", $-   ,Jun
CA-2015-2381,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-03-2015,5887,India,India,8095,Not assigned,58, $500.0 ," $29,000.0 ", $-   ,Mar
TA-2015-2382,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,27-04-2015,5704,India,India,8370,Not assigned,492, $453.0 ," $2,22,876.0 ", $-   ,Apr
IN-2015-2383,Oxycodone,OxyContin,Generic,Pain,22-02-2015,5704,India,India,8370,Not assigned,33, $472.0 ," $15,576.0 ", $-   ,Feb
CA-2015-2384,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-10-2015,5887,India,India,8095,Assigned,153, $500.0 ," $76,500.0 "," $2,448.0 ",Oct
CA-2015-2385,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-03-2015,5887,India,India,8095,Assigned,262, $500.0 ," $1,31,000.0 "," $3,318.7 ",Mar
CA-2015-2386,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-07-2015,5887,India,India,8095,Assigned,219, $500.0 ," $1,09,500.0 "," $1,898.0 ",Jul
CA-2015-2387,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-05-2015,5887,India,India,8095,Not assigned,21, $500.0 ," $10,500.0 ", $-   ,May
CA-2015-2388,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-08-2015,5887,Indonesia,Indonesia,8095,Assigned,495, $500.0 ," $2,47,500.0 "," $9,405.0 ",Aug
CA-2015-2389,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-10-2015,5887,India,India,8095,Not assigned,206, $500.0 ," $1,03,000.0 ", $-   ,Oct
CA-2015-2390,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-10-2015,5887,India,India,8095,Assigned,404, $500.0 ," $2,02,000.0 "," $5,925.3 ",Oct
CA-2015-2391,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-04-2015,5887,Indonesia,Indonesia,8095,Assigned,254, $500.0 ," $1,27,000.0 "," $2,201.3 ",Apr
CA-2015-2392,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-02-2015,5887,India,India,8095,Not assigned,263, $500.0 ," $1,31,500.0 ", $-   ,Feb
CA-2015-2393,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-10-2015,5887,India,India,8095,Not assigned,397, $500.0 ," $1,98,500.0 ", $-   ,Oct
CA-2015-2394,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-06-2015,5887,Kenya,Kenya,8095,Assigned,284, $500.0 ," $1,42,000.0 "," $3,597.3 ",Jun
CA-2015-2395,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-06-2015,5887,Kenya,Kenya,8095,Assigned,326, $500.0 ," $1,63,000.0 "," $5,976.7 ",Jun
CA-2015-2396,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-06-2015,5887,Egypt,Egypt,8095,Not assigned,286, $500.0 ," $1,43,000.0 ", $-   ,Jun
CA-2015-2397,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-11-2015,5887,India,India,8095,Not assigned,375, $500.0 ," $1,87,500.0 ", $-   ,Nov
CA-2015-2398,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-04-2015,5887,Thailand,Thailand,8095,Assigned,494, $500.0 ," $2,47,000.0 "," $4,940.0 ",Apr
CA-2015-2399,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-08-2015,5887,Thailand,Thailand,8095,Assigned,365, $500.0 ," $1,82,500.0 "," $11,680.0 ",Aug
CA-2015-2400,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-09-2015,5887,South Korea,South Korea,8095,Assigned,92, $500.0 ," $46,000.0 "," $1,349.3 ",Sep
CA-2015-2401,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-02-2015,5887,Thailand,Thailand,8095,Assigned,33, $500.0 ," $16,500.0 ", $913.0 ,Feb
CA-2015-2402,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-08-2015,5887,Philippines,Philippines,8095,Assigned,417, $500.0 ," $2,08,500.0 "," $10,703.0 ",Aug
CA-2015-2403,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-09-2015,5887,Philippines,Philippines,8095,Assigned,329, $500.0 ," $1,64,500.0 "," $5,154.3 ",Sep
CA-2015-2404,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-01-2015,5887,India,India,8095,Not assigned,409, $500.0 ," $2,04,500.0 ", $-   ,Jan
CA-2015-2405,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-12-2015,5887,India,India,8095,Not assigned,305, $500.0 ," $1,52,500.0 ", $-   ,Dec
CA-2015-2406,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-04-2015,5887,Thailand,Thailand,8095,Assigned,340, $500.0 ," $1,70,000.0 "," $7,026.7 ",Apr
CA-2015-2407,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-03-2015,5887,South Korea,South Korea,8095,Assigned,134, $500.0 ," $67,000.0 "," $3,394.7 ",Mar
CA-2015-2408,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-12-2015,5887,Cambodia,Cambodia,8095,Not assigned,428, $500.0 ," $2,14,000.0 ", $-   ,Dec
CA-2015-2409,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-08-2015,5887,Singapore,Singapore,8095,Not assigned,439, $500.0 ," $2,19,500.0 ", $-   ,Aug
CA-2015-2410,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-10-2015,5887,India,India,8095,Not assigned,271, $500.0 ," $1,35,500.0 ", $-   ,Oct
CA-2015-2411,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-12-2015,5887,India,India,8095,Not assigned,402, $500.0 ," $2,01,000.0 ", $-   ,Dec
CA-2015-2412,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-10-2015,5887,India,India,8095,Not assigned,135, $500.0 ," $67,500.0 ", $-   ,Oct
CA-2015-2413,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-10-2015,5887,Vietnam,Japan,8095,Assigned,425, $500.0 ," $2,12,500.0 "," $11,900.0 ",Oct
CA-2015-2414,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-07-2015,5887,Tunisia,Tunisia,8095,Not assigned,34, $500.0 ," $17,000.0 ", $-   ,Jul
CA-2015-2415,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-08-2015,5887,Philippines,Philippines,8095,Assigned,322, $500.0 ," $1,61,000.0 "," $7,620.7 ",Aug
CA-2015-2416,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-06-2015,5887,Malaysia,Malaysia,8095,Assigned,361, $500.0 ," $1,80,500.0 "," $9,025.0 ",Jun
CA-2015-2417,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-06-2015,5887,Taiwan,Taiwan,8095,Not assigned,272, $500.0 ," $1,36,000.0 ", $-   ,Jun
CA-2015-2418,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-05-2015,5887,Philippines,Philippines,8095,Not assigned,66, $500.0 ," $33,000.0 ", $-   ,May
CA-2015-2419,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-06-2015,5887,Hong Kong,Hong Kong,8095,Not assigned,9, $500.0 ," $4,500.0 ", $-   ,Jun
CA-2015-2420,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-06-2015,5887,Philippines,Philippines,8095,Not assigned,404, $500.0 ," $2,02,000.0 ", $-   ,Jun
CA-2015-2421,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-04-2015,5887,India,India,8095,Not assigned,449, $500.0 ," $2,24,500.0 ", $-   ,Apr
CA-2015-2422,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-07-2015,5887,Iran,Iran,8095,Not assigned,316, $500.0 ," $1,58,000.0 ", $-   ,Jul
CA-2015-2423,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-06-2015,5887,India,India,8095,Not assigned,475, $500.0 ," $2,37,500.0 ", $-   ,Jun
CA-2015-2424,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-08-2015,5887,Thailand,Thailand,8095,Not assigned,348, $500.0 ," $1,74,000.0 ", $-   ,Aug
CA-2015-2425,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-02-2015,5887,Taiwan,China,8095,Not assigned,254, $500.0 ," $1,27,000.0 ", $-   ,Feb
CA-2015-2426,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-09-2015,5887,India,India,8095,Not assigned,347, $500.0 ," $1,73,500.0 ", $-   ,Sep
CA-2015-2427,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-07-2015,5887,India,India,8095,Not assigned,437, $500.0 ," $2,18,500.0 ", $-   ,Jul
CA-2015-2428,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-06-2015,5887,Malaysia,Malaysia,8095,Not assigned,443, $500.0 ," $2,21,500.0 ", $-   ,Jun
CA-2015-2429,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-10-2015,5887,Philippines,Philippines,8095,Assigned,383, $500.0 ," $1,91,500.0 "," $3,319.3 ",Oct
CA-2015-2430,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-04-2015,5887,Vietnam,Japan,8095,Assigned,75, $500.0 ," $37,500.0 ", $300.0 ,Apr
CA-2015-2431,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-08-2015,5887,Hong Kong,China,8095,Not assigned,161, $500.0 ," $80,500.0 ", $-   ,Aug
CA-2015-2432,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-08-2015,5887,Vietnam,Japan,8095,Assigned,134, $500.0 ," $67,000.0 "," $3,975.3 ",Aug
CA-2015-2433,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-02-2015,5887,India,India,8095,Not assigned,291, $500.0 ," $1,45,500.0 ", $-   ,Feb
CA-2015-2434,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-02-2015,5887,India,India,8095,Not assigned,222, $500.0 ," $1,11,000.0 ", $-   ,Feb
CA-2015-2435,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-11-2015,5887,Thailand,Thailand,8095,Not assigned,287, $500.0 ," $1,43,500.0 ", $-   ,Nov
CA-2015-2436,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-12-2015,5887,Egypt,Egypt,8095,Not assigned,215, $500.0 ," $1,07,500.0 ", $-   ,Dec
CA-2015-2437,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-09-2015,5887,India,India,8095,Not assigned,360, $500.0 ," $1,80,000.0 ", $-   ,Sep
CA-2015-2438,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-10-2015,5887,Sri Lanka,Sri Lanka,8095,Assigned,63, $500.0 ," $31,500.0 "," $1,764.0 ",Oct
CA-2015-2439,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-09-2015,5887,Thailand,Thailand,8095,Assigned,67, $500.0 ," $33,500.0 "," $1,317.7 ",Sep
CA-2015-2440,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-12-2015,5887,Taiwan,China,8095,Not assigned,220, $500.0 ," $1,10,000.0 ", $-   ,Dec
CA-2015-2441,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-07-2015,5887,Taiwan,China,8095,Not assigned,256, $500.0 ," $1,28,000.0 ", $-   ,Jul
CA-2015-2442,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-10-2015,5887,India,India,8095,Not assigned,167, $500.0 ," $83,500.0 ", $-   ,Oct
CA-2015-2443,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-01-2015,5887,India,India,8095,Not assigned,310, $500.0 ," $1,55,000.0 ", $-   ,Jan
CA-2015-2444,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-04-2015,5887,India,India,8095,Not assigned,242, $500.0 ," $1,21,000.0 ", $-   ,Apr
CA-2015-2445,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-07-2015,5887,India,India,8095,Not assigned,252, $500.0 ," $1,26,000.0 ", $-   ,Jul
CA-2015-2446,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-02-2015,5887,Egypt,Egypt,8095,Not assigned,391, $500.0 ," $1,95,500.0 ", $-   ,Feb
CA-2015-2447,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-01-2015,5887,India,India,8095,Not assigned,40, $500.0 ," $20,000.0 ", $-   ,Jan
CA-2015-2448,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-11-2015,5887,Turkey,Lebanon,8095,Assigned,469, $500.0 ," $2,34,500.0 "," $6,722.3 ",Nov
CA-2015-2449,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-11-2015,5887,India,India,8095,Not assigned,1, $500.0 , $500.0 , $-   ,Nov
CA-2015-2450,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-05-2015,5887,India,India,8095,Not assigned,33, $500.0 ," $16,500.0 ", $-   ,May
CA-2015-2451,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-12-2015,5887,Philippines,Philippines,8095,Assigned,213, $500.0 ," $1,06,500.0 "," $5,325.0 ",Dec
CA-2015-2452,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-06-2015,5887,Philippines,Philippines,8095,Assigned,316, $500.0 ," $1,58,000.0 "," $5,688.0 ",Jun
CA-2015-2453,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-09-2015,5887,India,India,8095,Not assigned,110, $500.0 ," $55,000.0 ", $-   ,Sep
CA-2015-2454,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-08-2015,5887,Ireland,Netherlands,8095,Not assigned,65, $500.0 ," $32,500.0 ", $-   ,Aug
CA-2015-2455,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-02-2015,5887,India,India,8095,Assigned,73, $500.0 ," $36,500.0 ", $413.7 ,Feb
CA-2015-2456,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-05-2015,5887,Iran,Iran,8095,Not assigned,282, $500.0 ," $1,41,000.0 ", $-   ,May
CA-2015-2457,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-10-2015,5887,Indonesia,Indonesia,8095,Assigned,360, $500.0 ," $1,80,000.0 "," $11,040.0 ",Oct
CA-2015-2458,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-03-2015,5887,Taiwan,China,8095,Not assigned,291, $500.0 ," $1,45,500.0 ", $-   ,Mar
CA-2015-2459,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-11-2015,5887,Taiwan,China,8095,Not assigned,40, $500.0 ," $20,000.0 ", $-   ,Nov
CA-2015-2460,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-01-2015,5887,Indonesia,Indonesia,8095,Assigned,306, $500.0 ," $1,53,000.0 "," $6,018.0 ",Jan
CA-2015-2461,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-07-2015,5887,Indonesia,Indonesia,8095,Assigned,332, $500.0 ," $1,66,000.0 "," $10,181.3 ",Jul
IN-2015-2462,Bevacizumab,Avastin,Genentech/Roche,Cancer,16-10-2015,5685,India,India,8209,Assigned,351, $243.0 ," $85,293.0 "," $8,541.0 ",Oct
IN-2015-2463,Bevacizumab,Avastin,Genentech/Roche,Cancer,27-11-2015,5685,India,India,8209,Not assigned,343, $243.0 ," $83,349.0 ", $-   ,Nov
IN-2015-2464,Bevacizumab,Avastin,Genentech/Roche,Cancer,13-04-2015,5685,India,India,8209,Not assigned,52, $243.0 ," $12,636.0 ", $-   ,Apr
IN-2015-2465,Bevacizumab,Avastin,Genentech/Roche,Cancer,30-11-2015,5685,India,India,8209,Not assigned,237, $243.0 ," $57,591.0 ", $-   ,Nov
IN-2015-2466,Bevacizumab,Avastin,Genentech/Roche,Cancer,03-06-2015,5685,India,India,8209,Not assigned,176, $243.0 ," $42,768.0 ", $-   ,Jun
IN-2015-2467,Bevacizumab,Avastin,Genentech/Roche,Cancer,10-01-2015,5685,India,India,8209,Not assigned,362, $243.0 ," $87,966.0 ", $-   ,Jan
IN-2015-2468,Bevacizumab,Avastin,Genentech/Roche,Cancer,23-08-2015,5685,India,India,8209,Assigned,130, $243.0 ," $31,590.0 ", $953.3 ,Aug
IN-2015-2469,Bevacizumab,Avastin,Genentech/Roche,Cancer,01-12-2015,5685,Laos,Laos,8209,Not assigned,422, $243.0 ," $1,02,546.0 ", $-   ,Dec
IN-2015-2470,Bevacizumab,Avastin,Genentech/Roche,Cancer,29-04-2015,5685,Laos,Laos,8209,Not assigned,72, $243.0 ," $17,496.0 ", $-   ,Apr
IN-2015-2471,Bevacizumab,Avastin,Genentech/Roche,Cancer,06-09-2015,5685,Laos,Laos,8209,Not assigned,222, $243.0 ," $53,946.0 ", $-   ,Sep
IN-2015-2472,Bevacizumab,Avastin,Genentech/Roche,Cancer,27-03-2015,5685,Laos,Laos,8209,Not assigned,39, $243.0 ," $9,477.0 ", $-   ,Mar
IN-2015-2473,Bevacizumab,Avastin,Genentech/Roche,Cancer,17-03-2015,5685,Kenya,Kenya,8209,Assigned,97, $243.0 ," $23,571.0 ", $582.0 ,Mar
IN-2015-2474,Bevacizumab,Avastin,Genentech/Roche,Cancer,28-07-2015,5685,Nigeria,Nigeria,8209,Not assigned,298, $243.0 ," $72,414.0 ", $-   ,Jul
IN-2015-2475,Bevacizumab,Avastin,Genentech/Roche,Cancer,30-12-2015,5685,Nepal,Nepal,8209,Assigned,192, $243.0 ," $46,656.0 ", $768.0 ,Dec
IN-2015-2476,Bevacizumab,Avastin,Genentech/Roche,Cancer,10-07-2015,5685,Nepal,Nepal,8209,Assigned,116, $243.0 ," $28,188.0 ", $850.7 ,Jul
IN-2015-2477,Bevacizumab,Avastin,Genentech/Roche,Cancer,08-10-2015,5685,Thailand,Thailand,8209,Assigned,443, $243.0 ," $1,07,649.0 "," $9,303.0 ",Oct
IN-2015-2478,Bevacizumab,Avastin,Genentech/Roche,Cancer,30-08-2015,5685,Thailand,Thailand,8209,Not assigned,413, $243.0 ," $1,00,359.0 ", $-   ,Aug
IN-2015-2479,Bevacizumab,Avastin,Genentech/Roche,Cancer,01-11-2015,5685,Thailand,Thailand,8209,Assigned,313, $243.0 ," $76,059.0 "," $9,285.7 ",Nov
IN-2015-2480,Bevacizumab,Avastin,Genentech/Roche,Cancer,11-07-2015,5685,Cambodia,Cambodia,8209,Not assigned,372, $243.0 ," $90,396.0 ", $-   ,Jul
IN-2015-2481,Bevacizumab,Avastin,Genentech/Roche,Cancer,31-10-2015,5685,Egypt,Egypt,8209,Not assigned,222, $243.0 ," $53,946.0 ", $-   ,Oct
IN-2015-2482,Bevacizumab,Avastin,Genentech/Roche,Cancer,08-03-2015,5685,Japan,Japan,8209,Not assigned,123, $243.0 ," $29,889.0 ", $-   ,Mar
IN-2015-2483,Bevacizumab,Avastin,Genentech/Roche,Cancer,14-11-2015,5685,Cambodia,Cambodia,8209,Not assigned,394, $243.0 ," $95,742.0 ", $-   ,Nov
IN-2015-2484,Bevacizumab,Avastin,Genentech/Roche,Cancer,31-03-2015,5685,Taiwan,China,8209,Not assigned,189, $243.0 ," $45,927.0 ", $-   ,Mar
NE-2015-2485,Glatiramer,Copaxone,Generic,Multiple sclerosis,19-06-2015,5704,India,India,8370,Not assigned,182, $451.0 ," $82,082.0 ", $-   ,Jun
NE-2015-2486,Glatiramer,Copaxone,Generic,Multiple sclerosis,18-03-2015,5704,India,India,8370,Not assigned,9, $451.0 ," $4,059.0 ", $-   ,Mar
NE-2015-2487,Glatiramer,Copaxone,Generic,Multiple sclerosis,01-12-2015,5704,India,India,8370,Not assigned,129, $451.0 ," $58,179.0 ", $-   ,Dec
NE-2015-2488,Glatiramer,Copaxone,Generic,Multiple sclerosis,28-02-2015,5704,Kenya,Kenya,8370,Assigned,127, $451.0 ," $57,277.0 "," $3,598.3 ",Feb
NE-2015-2489,Glatiramer,Copaxone,Generic,Multiple sclerosis,22-02-2015,5704,Yemen,Yemen,8370,Not assigned,58, $451.0 ," $26,158.0 ", $-   ,Feb
NE-2015-2490,Glatiramer,Copaxone,Generic,Multiple sclerosis,27-04-2015,5704,Yemen,Yemen,8370,Not assigned,44, $451.0 ," $19,844.0 ", $-   ,Apr
NE-2015-2491,Glatiramer,Copaxone,Generic,Multiple sclerosis,07-05-2015,5704,Kenya,Kenya,8370,Assigned,167, $451.0 ," $75,317.0 ", $890.7 ,May
NE-2015-2492,Glatiramer,Copaxone,Generic,Multiple sclerosis,23-12-2015,5704,Nepal,Nepal,8370,Assigned,314, $451.0 ," $1,41,614.0 "," $2,616.7 ",Dec
NE-2015-2493,Glatiramer,Copaxone,Generic,Multiple sclerosis,14-02-2015,5704,Nepal,Nepal,8370,Assigned,44, $451.0 ," $19,844.0 ", $396.0 ,Feb
NE-2015-2494,Glatiramer,Copaxone,Generic,Multiple sclerosis,24-01-2015,5704,Nepal,Nepal,8370,Assigned,226, $451.0 ," $1,01,926.0 "," $7,006.0 ",Jan
NE-2015-2495,Glatiramer,Copaxone,Generic,Multiple sclerosis,05-07-2015,5704,Malaysia,Malaysia,8370,Assigned,10, $451.0 ," $4,510.0 ", $83.3 ,Jul
NE-2015-2496,Glatiramer,Copaxone,Generic,Multiple sclerosis,09-03-2015,5704,Philippines,Philippines,8370,Assigned,105, $451.0 ," $47,355.0 "," $2,345.0 ",Mar
NE-2015-2497,Glatiramer,Copaxone,Generic,Multiple sclerosis,02-04-2015,5704,Thailand,Thailand,8370,Assigned,344, $451.0 ," $1,55,144.0 "," $6,077.3 ",Apr
NE-2015-2498,Glatiramer,Copaxone,Generic,Multiple sclerosis,25-05-2015,5704,Malaysia,Malaysia,8370,Assigned,311, $451.0 ," $1,40,261.0 "," $9,641.0 ",May
NE-2015-2499,Glatiramer,Copaxone,Generic,Multiple sclerosis,09-10-2015,5704,Malaysia,Malaysia,8370,Assigned,389, $451.0 ," $1,75,439.0 "," $8,428.3 ",Oct
NE-2015-2500,Glatiramer,Copaxone,Generic,Multiple sclerosis,21-07-2015,5704,Malaysia,Malaysia,8370,Assigned,7, $451.0 ," $3,157.0 ", $53.7 ,Jul
NE-2015-2501,Glatiramer,Copaxone,Generic,Multiple sclerosis,02-03-2015,5704,Malaysia,Malaysia,8370,Assigned,53, $451.0 ," $23,903.0 "," $1,431.0 ",Mar
NE-2015-2502,Glatiramer,Copaxone,Generic,Multiple sclerosis,22-09-2015,5704,Malaysia,Malaysia,8370,Assigned,287, $451.0 ," $1,29,437.0 "," $2,774.3 ",Sep
NE-2015-2503,Glatiramer,Copaxone,Generic,Multiple sclerosis,17-10-2015,5704,Netherlands,Netherlands,8370,Not assigned,268, $451.0 ," $1,20,868.0 ", $-   ,Oct
VA-2015-2504,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,24-12-2015,5938,India,India,8068,Not assigned,351, $310.0 ," $1,08,810.0 ", $-   ,Dec
VA-2015-2505,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,15-02-2015,5938,India,India,8068,Not assigned,147, $310.0 ," $45,570.0 ", $-   ,Feb
VA-2015-2506,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,23-05-2015,5938,Bangladesh,Bangladesh,8068,Assigned,414, $310.0 ," $1,28,340.0 "," $12,972.0 ",May
VA-2015-2507,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,08-05-2015,5938,Tunisia,Tunisia,8068,Not assigned,423, $310.0 ," $1,31,130.0 ", $-   ,May
VA-2015-2508,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,05-03-2015,5938,Tunisia,Tunisia,8068,Not assigned,416, $310.0 ," $1,28,960.0 ", $-   ,Mar
RA-2015-2509,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,13-03-2015,5819,India,India,8119,Not assigned,167, $364.0 ," $60,788.0 ", $-   ,Mar
RA-2015-2510,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,28-08-2015,5819,India,India,8119,Not assigned,131, $364.0 ," $47,684.0 ", $-   ,Aug
RA-2015-2511,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,15-01-2015,5819,India,India,8119,Assigned,244, $364.0 ," $88,816.0 "," $5,856.0 ",Jan
RA-2015-2512,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,17-05-2015,5819,India,India,8119,Not assigned,332, $364.0 ," $1,20,848.0 ", $-   ,May
RA-2015-2513,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,13-05-2015,5819,Thailand,Thailand,8119,Not assigned,446, $364.0 ," $1,62,344.0 ", $-   ,May
RA-2015-2514,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,23-10-2015,5819,Nepal,Nepal,8119,Assigned,448, $364.0 ," $1,63,072.0 "," $9,557.3 ",Oct
RA-2015-2515,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,21-09-2015,5819,Hong Kong,China,8119,Not assigned,169, $364.0 ," $61,516.0 ", $-   ,Sep
RA-2015-2516,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,04-04-2015,5819,Hong Kong,China,8119,Not assigned,410, $364.0 ," $1,49,240.0 ", $-   ,Apr
AR-2015-2517,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,29-01-2015,5653,India,India,7933,Not assigned,275, $231.0 ," $63,525.0 ", $-   ,Jan
AR-2015-2518,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,17-05-2015,5653,India,India,7933,Not assigned,444, $231.0 ," $1,02,564.0 ", $-   ,May
AR-2015-2519,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,05-09-2015,5653,India,India,7933,Not assigned,314, $231.0 ," $72,534.0 ", $-   ,Sep
AR-2015-2520,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,25-05-2015,5653,India,India,7933,Not assigned,462, $231.0 ," $1,06,722.0 ", $-   ,May
AR-2015-2521,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,15-06-2015,5653,India,India,7933,Not assigned,211, $231.0 ," $48,741.0 ", $-   ,Jun
AR-2015-2522,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,04-02-2015,5653,India,India,7933,Not assigned,336, $231.0 ," $77,616.0 ", $-   ,Feb
AR-2015-2523,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,08-02-2015,5653,India,India,7933,Not assigned,363, $231.0 ," $83,853.0 ", $-   ,Feb
AR-2015-2524,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,17-01-2015,5653,India,India,7933,Assigned,101, $231.0 ," $23,331.0 "," $2,154.7 ",Jan
AR-2015-2525,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,16-01-2015,5653,India,India,7933,Assigned,288, $231.0 ," $66,528.0 "," $6,144.0 ",Jan
AR-2015-2526,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,05-05-2015,5653,India,India,7933,Not assigned,473, $231.0 ," $1,09,263.0 ", $-   ,May
AR-2015-2527,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,06-11-2015,5653,India,India,7933,Not assigned,394, $231.0 ," $91,014.0 ", $-   ,Nov
AR-2015-2528,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,28-08-2015,5653,India,India,7933,Not assigned,316, $231.0 ," $72,996.0 ", $-   ,Aug
AR-2015-2529,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,24-01-2015,5653,India,India,7933,Not assigned,367, $231.0 ," $84,777.0 ", $-   ,Jan
AR-2015-2530,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,04-12-2015,5653,India,India,7933,Not assigned,128, $231.0 ," $29,568.0 ", $-   ,Dec
AR-2015-2531,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,13-11-2015,5653,Egypt,Egypt,7933,Not assigned,327, $231.0 ," $75,537.0 ", $-   ,Nov
AR-2015-2532,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,03-01-2015,5653,Thailand,Thailand,7933,Not assigned,295, $231.0 ," $68,145.0 ", $-   ,Jan
AR-2015-2533,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,06-12-2015,5653,Thailand,Thailand,7933,Not assigned,162, $231.0 ," $37,422.0 ", $-   ,Dec
AR-2015-2534,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,22-10-2015,5653,Egypt,Egypt,7933,Not assigned,30, $231.0 ," $6,930.0 ", $-   ,Oct
AR-2015-2535,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,05-12-2015,5653,Vietnam,Netherlands,7933,Assigned,324, $231.0 ," $74,844.0 "," $2,052.0 ",Dec
AR-2015-2536,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,08-04-2015,5653,Indonesia,Indonesia,7933,Assigned,375, $231.0 ," $86,625.0 "," $5,125.0 ",Apr
AR-2015-2537,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,28-08-2015,5653,Kenya,Kenya,7933,Assigned,496, $231.0 ," $1,14,576.0 "," $12,896.0 ",Aug
AR-2015-2538,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,14-07-2015,5653,Egypt,Egypt,7933,Not assigned,46, $231.0 ," $10,626.0 ", $-   ,Jul
AR-2015-2539,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,23-02-2015,5653,Indonesia,Indonesia,7933,Assigned,333, $231.0 ," $76,923.0 "," $7,215.0 ",Feb
DE-2015-2540,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,20-04-2015,5754,India,India,7904,Not assigned,242, $314.0 ," $75,988.0 ", $-   ,Apr
DE-2015-2541,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,27-10-2015,5754,India,India,7904,Not assigned,179, $314.0 ," $56,206.0 ", $-   ,Oct
DE-2015-2542,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,10-01-2015,5754,India,India,7904,Not assigned,42, $314.0 ," $13,188.0 ", $-   ,Jan
DE-2015-2543,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,04-01-2015,5754,India,India,7904,Not assigned,74, $314.0 ," $23,236.0 ", $-   ,Jan
DE-2015-2544,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,24-06-2015,5754,India,India,7904,Not assigned,464, $314.0 ," $1,45,696.0 ", $-   ,Jun
DE-2015-2545,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,13-11-2015,5754,India,India,7904,Assigned,470, $314.0 ," $1,47,580.0 "," $11,280.0 ",Nov
DE-2015-2546,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,16-01-2015,5754,India,India,7904,Assigned,331, $314.0 ," $1,03,934.0 "," $4,413.3 ",Jan
DE-2015-2547,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,19-03-2015,5754,India,India,7904,Assigned,349, $314.0 ," $1,09,586.0 "," $5,933.0 ",Mar
DE-2015-2548,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,26-08-2015,5754,India,India,7904,Assigned,235, $314.0 ," $73,790.0 "," $1,018.3 ",Aug
DE-2015-2549,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,21-04-2015,5754,India,India,7904,Not assigned,288, $314.0 ," $90,432.0 ", $-   ,Apr
DE-2015-2550,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,11-03-2015,5754,India,India,7904,Not assigned,108, $314.0 ," $33,912.0 ", $-   ,Mar
DE-2015-2551,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,02-12-2015,5754,India,India,7904,Not assigned,496, $314.0 ," $1,55,744.0 ", $-   ,Dec
DE-2015-2552,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,25-04-2015,5754,Egypt,Egypt,7904,Not assigned,294, $314.0 ," $92,316.0 ", $-   ,Apr
DE-2015-2553,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,15-02-2015,5754,Vietnam,Japan,7904,Assigned,219, $314.0 ," $68,766.0 "," $4,161.0 ",Feb
DE-2015-2554,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,08-02-2015,5754,Egypt,Egypt,7904,Not assigned,84, $314.0 ," $26,376.0 ", $-   ,Feb
DE-2015-2555,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,08-12-2015,5754,Egypt,Egypt,7904,Not assigned,48, $314.0 ," $15,072.0 ", $-   ,Dec
DE-2015-2556,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,08-12-2015,5754,Egypt,Egypt,7904,Not assigned,115, $314.0 ," $36,110.0 ", $-   ,Dec
DE-2015-2557,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,27-09-2015,5754,Egypt,Egypt,7904,Not assigned,140, $314.0 ," $43,960.0 ", $-   ,Sep
DE-2015-2558,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,17-09-2015,5754,Egypt,Egypt,7904,Not assigned,243, $314.0 ," $76,302.0 ", $-   ,Sep
DE-2015-2559,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,05-08-2015,5754,Vietnam,Netherlands,7904,Assigned,363, $314.0 ," $1,13,982.0 "," $3,025.0 ",Aug
DE-2015-2560,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,15-09-2015,5754,Vietnam,Netherlands,7904,Assigned,357, $314.0 ," $1,12,098.0 "," $6,069.0 ",Sep
EL-2015-2561,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,27-07-2015,5737,Syria,Lebanon,8270,Assigned,12, $250.0 ," $3,000.0 ", $388.0 ,Jul
EL-2015-2562,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,03-02-2015,5737,Singapore,Singapore,8270,Not assigned,96, $250.0 ," $24,000.0 ", $-   ,Feb
EL-2015-2563,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,10-04-2015,5737,Vietnam,Netherlands,8270,Assigned,80, $250.0 ," $20,000.0 ", $746.7 ,Apr
EL-2015-2564,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,20-12-2015,5737,Philippines,Philippines,8270,Assigned,50, $250.0 ," $12,500.0 ", $916.7 ,Dec
EL-2015-2565,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,23-01-2015,5737,Philippines,Philippines,8270,Assigned,318, $250.0 ," $79,500.0 "," $9,328.0 ",Jan
EL-2015-2566,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,05-10-2015,5737,Philippines,Philippines,8270,Assigned,128, $250.0 ," $32,000.0 "," $1,834.7 ",Oct
EL-2015-2567,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,11-12-2015,5737,Vietnam,Japan,8270,Assigned,104, $250.0 ," $26,000.0 "," $1,248.0 ",Dec
UM-2015-2568,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,28-01-2015,5704,India,India,8370,Not assigned,324, $366.0 ," $1,18,584.0 ", $-   ,Jan
UM-2015-2569,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,25-02-2015,5704,India,India,8370,Not assigned,96, $366.0 ," $35,136.0 ", $-   ,Feb
UM-2015-2570,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,27-06-2015,5704,India,India,8370,Not assigned,274, $366.0 ," $1,00,284.0 ", $-   ,Jun
UM-2015-2571,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,21-03-2015,5704,India,India,8370,Not assigned,116, $366.0 ," $42,456.0 ", $-   ,Mar
UM-2015-2572,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,02-09-2015,5704,India,India,8370,Not assigned,251, $366.0 ," $91,866.0 ", $-   ,Sep
UM-2015-2573,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,12-06-2015,5704,India,India,8370,Not assigned,418, $366.0 ," $1,52,988.0 ", $-   ,Jun
UM-2015-2574,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,03-10-2015,5704,Malaysia,Malaysia,8370,Assigned,410, $366.0 ," $1,50,060.0 "," $3,143.3 ",Oct
UM-2015-2575,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,26-08-2015,5704,Sri Lanka,Sri Lanka,8370,Assigned,428, $366.0 ," $1,56,648.0 "," $3,281.3 ",Aug
UM-2015-2576,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,21-03-2015,5704,Saudi Arabia,Saudi Arabia,8370,Not assigned,450, $366.0 ," $1,64,700.0 ", $-   ,Mar
UM-2015-2577,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,26-06-2015,5704,Slovenia,Slovenia,8370,Not assigned,141, $366.0 ," $51,606.0 ", $-   ,Jun
UM-2015-2578,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,03-07-2015,5704,Algeria,Algeria,8370,Not assigned,9, $366.0 ," $3,294.0 ", $-   ,Jul
UM-2015-2579,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,30-09-2015,5704,Algeria,Algeria,8370,Not assigned,429, $366.0 ," $1,57,014.0 ", $-   ,Sep
UM-2015-2580,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,04-08-2015,5704,Argentina,Argentina,8370,Not assigned,284, $366.0 ," $1,03,944.0 ", $-   ,Aug
UM-2015-2581,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,11-05-2015,5704,Philippines,Philippines,8370,Assigned,171, $366.0 ," $62,586.0 "," $4,047.0 ",May
UM-2015-2582,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,14-03-2015,5704,USA,Mexico,8370,Not assigned,153, $366.0 ," $55,998.0 ", $-   ,Mar
UM-2015-2583,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,02-04-2015,5704,Turkey,Netherlands,8370,Not assigned,97, $366.0 ," $35,502.0 ", $-   ,Apr
UM-2015-2584,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,11-07-2015,5704,Spain,Netherlands,8370,Not assigned,478, $366.0 ," $1,74,948.0 ", $-   ,Jul
UM-2015-2585,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,03-09-2015,5704,India,India,8370,Not assigned,277, $366.0 ," $1,01,382.0 ", $-   ,Sep
UM-2015-2586,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,09-07-2015,5704,India,India,8370,Not assigned,160, $366.0 ," $58,560.0 ", $-   ,Jul
UM-2015-2587,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,09-06-2015,5704,India,India,8370,Not assigned,229, $366.0 ," $83,814.0 ", $-   ,Jun
UM-2015-2588,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,16-11-2015,5704,India,India,8370,Not assigned,35, $366.0 ," $12,810.0 ", $-   ,Nov
UM-2015-2589,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,11-07-2015,5704,India,India,8370,Not assigned,243, $366.0 ," $88,938.0 ", $-   ,Jul
UM-2015-2590,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,11-07-2015,5704,India,India,8370,Not assigned,138, $366.0 ," $50,508.0 ", $-   ,Jul
UM-2015-2591,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,24-11-2015,5704,India,India,8370,Not assigned,320, $366.0 ," $1,17,120.0 ", $-   ,Nov
UM-2015-2592,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,16-02-2015,5704,India,India,8370,Not assigned,36, $366.0 ," $13,176.0 ", $-   ,Feb
UM-2015-2593,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,26-11-2015,5704,India,India,8370,Not assigned,405, $366.0 ," $1,48,230.0 ", $-   ,Nov
UM-2015-2594,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,24-06-2015,5704,India,India,8370,Not assigned,49, $366.0 ," $17,934.0 ", $-   ,Jun
UM-2015-2595,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,23-12-2015,5704,India,India,8370,Not assigned,465, $366.0 ," $1,70,190.0 ", $-   ,Dec
UM-2015-2596,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,04-08-2015,5704,India,India,8370,Not assigned,211, $366.0 ," $77,226.0 ", $-   ,Aug
UM-2015-2597,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,04-05-2015,5704,India,India,8370,Not assigned,269, $366.0 ," $98,454.0 ", $-   ,May
UM-2015-2598,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,09-09-2015,5704,India,India,8370,Not assigned,457, $366.0 ," $1,67,262.0 ", $-   ,Sep
UM-2015-2599,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,08-05-2015,5704,India,India,8370,Not assigned,361, $366.0 ," $1,32,126.0 ", $-   ,May
UM-2015-2600,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,05-10-2015,5704,India,India,8370,Not assigned,330, $366.0 ," $1,20,780.0 ", $-   ,Oct
UM-2015-2601,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,19-01-2015,5704,India,India,8370,Not assigned,468, $366.0 ," $1,71,288.0 ", $-   ,Jan
UM-2015-2602,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,07-05-2015,5704,India,India,8370,Not assigned,457, $366.0 ," $1,67,262.0 ", $-   ,May
UM-2015-2603,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,28-05-2015,5704,India,India,8370,Not assigned,71, $366.0 ," $25,986.0 ", $-   ,May
UM-2015-2604,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,23-09-2015,5704,India,India,8370,Not assigned,305, $366.0 ," $1,11,630.0 ", $-   ,Sep
UM-2015-2605,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,14-02-2015,5704,India,India,8370,Not assigned,152, $366.0 ," $55,632.0 ", $-   ,Feb
UM-2015-2606,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,01-04-2015,5704,India,India,8370,Not assigned,68, $366.0 ," $24,888.0 ", $-   ,Apr
UM-2015-2607,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,04-08-2015,5704,India,India,8370,Not assigned,76, $366.0 ," $27,816.0 ", $-   ,Aug
UM-2015-2608,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,05-12-2015,5704,India,India,8370,Not assigned,183, $366.0 ," $66,978.0 ", $-   ,Dec
UM-2015-2609,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,07-03-2015,5704,India,India,8370,Not assigned,129, $366.0 ," $47,214.0 ", $-   ,Mar
UM-2015-2610,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,05-03-2015,5704,India,India,8370,Not assigned,399, $366.0 ," $1,46,034.0 ", $-   ,Mar
UM-2015-2611,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,10-06-2015,5704,India,India,8370,Not assigned,497, $366.0 ," $1,81,902.0 ", $-   ,Jun
UM-2015-2612,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,20-06-2015,5704,India,India,8370,Not assigned,121, $366.0 ," $44,286.0 ", $-   ,Jun
UM-2015-2613,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,29-01-2015,5704,India,India,8370,Not assigned,275, $366.0 ," $1,00,650.0 ", $-   ,Jan
US-2015-2614,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,22-12-2015,5653,Bangladesh,Bangladesh,7933,Assigned,166, $231.0 ," $38,346.0 "," $3,209.3 ",Dec
US-2015-2615,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,28-11-2015,5653,Bangladesh,Bangladesh,7933,Assigned,140, $231.0 ," $32,340.0 "," $4,433.3 ",Nov
US-2015-2616,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,27-11-2015,5653,Bangladesh,Bangladesh,7933,Assigned,241, $231.0 ," $55,671.0 "," $4,016.7 ",Nov
US-2015-2617,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,21-07-2015,5653,Bangladesh,Bangladesh,7933,Assigned,11, $231.0 ," $2,541.0 ", $165.0 ,Jul
US-2015-2618,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,12-07-2015,5653,Syria,Lebanon,7933,Assigned,465, $231.0 ," $1,07,415.0 "," $4,650.0 ",Jul
US-2015-2619,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,08-09-2015,5653,Malaysia,Malaysia,7933,Not assigned,87, $231.0 ," $20,097.0 ", $-   ,Sep
US-2015-2620,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,25-01-2015,5653,Pakistan,Pakistan,7933,Assigned,119, $231.0 ," $27,489.0 "," $3,292.3 ",Jan
US-2015-2621,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,06-02-2015,5653,Syria,Lebanon,7933,Assigned,209, $231.0 ," $48,279.0 "," $5,852.0 ",Feb
US-2015-2622,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,19-12-2015,5653,Saudi Arabia,Saudi Arabia,7933,Not assigned,382, $231.0 ," $88,242.0 ", $-   ,Dec
US-2015-2623,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,01-01-2015,5653,Malaysia,Malaysia,7933,Assigned,236, $231.0 ," $54,516.0 "," $2,832.0 ",Jan
TA-2015-2624,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,20-02-2015,5704,India,India,8370,Not assigned,70, $453.0 ," $31,710.0 ", $-   ,Feb
TA-2015-2625,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,26-01-2015,5704,India,India,8370,Not assigned,174, $453.0 ," $78,822.0 ", $-   ,Jan
IN-2015-2626,Oxycodone,OxyContin,Generic,Pain,13-02-2015,5704,Thailand,Thailand,8370,Not assigned,412, $472.0 ," $1,94,464.0 ", $-   ,Feb
IN-2015-2627,Oxycodone,OxyContin,Generic,Pain,11-04-2015,5704,Egypt,Egypt,8370,Not assigned,134, $472.0 ," $63,248.0 ", $-   ,Apr
IN-2015-2628,Oxycodone,OxyContin,Generic,Pain,06-02-2015,5704,Egypt,Egypt,8370,Not assigned,55, $472.0 ," $25,960.0 ", $-   ,Feb
IN-2015-2629,Oxycodone,OxyContin,Generic,Pain,10-04-2015,5704,Egypt,Egypt,8370,Not assigned,126, $472.0 ," $59,472.0 ", $-   ,Apr
IN-2015-2630,Oxycodone,OxyContin,Generic,Pain,05-08-2015,5704,Singapore,Singapore,8370,Not assigned,195, $472.0 ," $92,040.0 ", $-   ,Aug
IN-2015-2631,Oxycodone,OxyContin,Generic,Pain,16-02-2015,5704,Thailand,Thailand,8370,Not assigned,66, $472.0 ," $31,152.0 ", $-   ,Feb
CA-2015-2632,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-03-2015,5887,Netherlands,Netherlands,8095,Not assigned,50, $500.0 ," $25,000.0 ", $-   ,Mar
CA-2015-2633,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-10-2015,5887,India,India,8095,Not assigned,246, $500.0 ," $1,23,000.0 ", $-   ,Oct
CA-2015-2634,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-12-2015,5887,India,India,8095,Not assigned,233, $500.0 ," $1,16,500.0 ", $-   ,Dec
CA-2015-2635,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-03-2015,5887,India,India,8095,Not assigned,257, $500.0 ," $1,28,500.0 ", $-   ,Mar
CA-2015-2636,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-05-2015,5887,India,India,8095,Not assigned,225, $500.0 ," $1,12,500.0 ", $-   ,May
CA-2015-2637,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-07-2015,5887,India,India,8095,Not assigned,188, $500.0 ," $94,000.0 ", $-   ,Jul
CA-2015-2638,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-06-2015,5887,India,India,8095,Not assigned,345, $500.0 ," $1,72,500.0 ", $-   ,Jun
CA-2015-2639,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-07-2015,5887,India,India,8095,Not assigned,51, $500.0 ," $25,500.0 ", $-   ,Jul
CA-2015-2640,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-01-2015,5887,India,India,8095,Not assigned,406, $500.0 ," $2,03,000.0 ", $-   ,Jan
CA-2015-2641,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-01-2015,5887,India,India,8095,Not assigned,265, $500.0 ," $1,32,500.0 ", $-   ,Jan
CA-2015-2642,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-06-2015,5887,India,India,8095,Not assigned,91, $500.0 ," $45,500.0 ", $-   ,Jun
CA-2015-2643,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-09-2015,5887,India,India,8095,Not assigned,434, $500.0 ," $2,17,000.0 ", $-   ,Sep
CA-2015-2644,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-01-2015,5887,India,India,8095,Not assigned,88, $500.0 ," $44,000.0 ", $-   ,Jan
CA-2015-2645,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-07-2015,5887,India,India,8095,Not assigned,258, $500.0 ," $1,29,000.0 ", $-   ,Jul
CA-2015-2646,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-07-2015,5887,India,India,8095,Not assigned,270, $500.0 ," $1,35,000.0 ", $-   ,Jul
CA-2015-2647,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-05-2015,5887,India,India,8095,Not assigned,451, $500.0 ," $2,25,500.0 ", $-   ,May
CA-2015-2648,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-07-2015,5887,India,India,8095,Assigned,173, $500.0 ," $86,500.0 "," $1,095.7 ",Jul
CA-2015-2649,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-03-2015,5887,India,India,8095,Assigned,354, $500.0 ," $1,77,000.0 "," $2,714.0 ",Mar
CA-2015-2650,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-01-2015,5887,India,India,8095,Not assigned,363, $500.0 ," $1,81,500.0 ", $-   ,Jan
CA-2015-2651,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-12-2015,5887,India,India,8095,Assigned,367, $500.0 ," $1,83,500.0 "," $12,111.0 ",Dec
CA-2015-2652,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-10-2015,5887,India,India,8095,Not assigned,295, $500.0 ," $1,47,500.0 ", $-   ,Oct
CA-2015-2653,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-10-2015,5887,India,India,8095,Not assigned,362, $500.0 ," $1,81,000.0 ", $-   ,Oct
CA-2015-2654,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-06-2015,5887,India,India,8095,Not assigned,7, $500.0 ," $3,500.0 ", $-   ,Jun
CA-2015-2655,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-11-2015,5887,India,India,8095,Not assigned,144, $500.0 ," $72,000.0 ", $-   ,Nov
CA-2015-2656,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-11-2015,5887,India,India,8095,Not assigned,246, $500.0 ," $1,23,000.0 ", $-   ,Nov
CA-2015-2657,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-09-2015,5887,India,India,8095,Not assigned,376, $500.0 ," $1,88,000.0 ", $-   ,Sep
CA-2015-2658,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-05-2015,5887,India,India,8095,Not assigned,73, $500.0 ," $36,500.0 ", $-   ,May
CA-2015-2659,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-03-2015,5887,India,India,8095,Not assigned,272, $500.0 ," $1,36,000.0 ", $-   ,Mar
CA-2015-2660,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-02-2015,5887,India,India,8095,Not assigned,36, $500.0 ," $18,000.0 ", $-   ,Feb
CA-2015-2661,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-12-2015,5887,India,India,8095,Not assigned,336, $500.0 ," $1,68,000.0 ", $-   ,Dec
CA-2015-2662,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-01-2015,5887,India,India,8095,Not assigned,170, $500.0 ," $85,000.0 ", $-   ,Jan
CA-2015-2663,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-12-2015,5887,India,India,8095,Not assigned,137, $500.0 ," $68,500.0 ", $-   ,Dec
CA-2015-2664,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-09-2015,5887,India,India,8095,Not assigned,492, $500.0 ," $2,46,000.0 ", $-   ,Sep
CA-2015-2665,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-07-2015,5887,India,India,8095,Not assigned,24, $500.0 ," $12,000.0 ", $-   ,Jul
CA-2015-2666,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-03-2015,5887,India,India,8095,Not assigned,17, $500.0 ," $8,500.0 ", $-   ,Mar
CA-2015-2667,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-12-2015,5887,India,India,8095,Not assigned,78, $500.0 ," $39,000.0 ", $-   ,Dec
CA-2015-2668,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-09-2015,5887,India,India,8095,Not assigned,260, $500.0 ," $1,30,000.0 ", $-   ,Sep
CA-2015-2669,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-06-2015,5887,India,India,8095,Not assigned,435, $500.0 ," $2,17,500.0 ", $-   ,Jun
CA-2015-2670,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-09-2015,5887,India,India,8095,Not assigned,282, $500.0 ," $1,41,000.0 ", $-   ,Sep
CA-2015-2671,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-04-2015,5887,India,India,8095,Not assigned,11, $500.0 ," $5,500.0 ", $-   ,Apr
CA-2015-2672,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-03-2015,5887,India,India,8095,Assigned,347, $500.0 ," $1,73,500.0 "," $10,294.3 ",Mar
CA-2015-2673,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-10-2015,5887,India,India,8095,Not assigned,44, $500.0 ," $22,000.0 ", $-   ,Oct
CA-2015-2674,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-11-2015,5887,India,India,8095,Not assigned,232, $500.0 ," $1,16,000.0 ", $-   ,Nov
CA-2015-2675,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-03-2015,5887,India,India,8095,Not assigned,293, $500.0 ," $1,46,500.0 ", $-   ,Mar
CA-2015-2676,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-08-2015,5887,India,India,8095,Not assigned,288, $500.0 ," $1,44,000.0 ", $-   ,Aug
CA-2015-2677,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-04-2015,5887,India,India,8095,Not assigned,224, $500.0 ," $1,12,000.0 ", $-   ,Apr
CA-2015-2678,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-07-2015,5887,India,India,8095,Not assigned,427, $500.0 ," $2,13,500.0 ", $-   ,Jul
CA-2015-2679,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-08-2015,5887,India,India,8095,Not assigned,338, $500.0 ," $1,69,000.0 ", $-   ,Aug
CA-2015-2680,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-11-2015,5887,India,India,8095,Not assigned,9, $500.0 ," $4,500.0 ", $-   ,Nov
CA-2015-2681,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-12-2015,5887,India,India,8095,Assigned,247, $500.0 ," $1,23,500.0 "," $3,458.0 ",Dec
CA-2015-2682,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-12-2015,5887,India,India,8095,Assigned,135, $500.0 ," $67,500.0 "," $2,385.0 ",Dec
TA-2015-2683,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,08-12-2015,5704,India,India,8370,Not assigned,453, $453.0 ," $2,05,209.0 ", $-   ,Dec
CA-2015-2684,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-04-2015,5887,India,India,8095,Not assigned,462, $500.0 ," $2,31,000.0 ", $-   ,Apr
CA-2015-2685,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-10-2015,5887,India,India,8095,Assigned,328, $500.0 ," $1,64,000.0 "," $2,624.0 ",Oct
CA-2015-2686,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-06-2015,5887,India,India,8095,Not assigned,330, $500.0 ," $1,65,000.0 ", $-   ,Jun
CA-2015-2687,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-02-2015,5887,India,India,8095,Not assigned,94, $500.0 ," $47,000.0 ", $-   ,Feb
CA-2015-2688,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-04-2015,5887,India,India,8095,Not assigned,216, $500.0 ," $1,08,000.0 ", $-   ,Apr
CA-2015-2689,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-12-2015,5887,India,India,8095,Not assigned,234, $500.0 ," $1,17,000.0 ", $-   ,Dec
CA-2015-2690,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-06-2015,5887,India,India,8095,Not assigned,123, $500.0 ," $61,500.0 ", $-   ,Jun
CA-2015-2691,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-11-2015,5887,India,India,8095,Not assigned,163, $500.0 ," $81,500.0 ", $-   ,Nov
CA-2015-2692,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-04-2015,5887,India,India,8095,Not assigned,386, $500.0 ," $1,93,000.0 ", $-   ,Apr
CA-2015-2693,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-10-2015,5887,India,India,8095,Assigned,154, $500.0 ," $77,000.0 "," $2,515.3 ",Oct
CA-2015-2694,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-05-2015,5887,India,India,8095,Assigned,347, $500.0 ," $1,73,500.0 "," $9,484.7 ",May
CA-2015-2695,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-03-2015,5887,India,India,8095,Not assigned,352, $500.0 ," $1,76,000.0 ", $-   ,Mar
CA-2015-2696,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-08-2015,5887,India,India,8095,Not assigned,303, $500.0 ," $1,51,500.0 ", $-   ,Aug
CA-2015-2697,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-11-2015,5887,India,India,8095,Not assigned,172, $500.0 ," $86,000.0 ", $-   ,Nov
CA-2015-2698,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-12-2015,5887,India,India,8095,Not assigned,365, $500.0 ," $1,82,500.0 ", $-   ,Dec
CA-2015-2699,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-04-2015,5887,India,India,8095,Not assigned,384, $500.0 ," $1,92,000.0 ", $-   ,Apr
CA-2015-2700,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-08-2015,5887,India,India,8095,Not assigned,200, $500.0 ," $1,00,000.0 ", $-   ,Aug
CA-2015-2701,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-03-2015,5887,India,India,8095,Not assigned,220, $500.0 ," $1,10,000.0 ", $-   ,Mar
CA-2015-2702,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-07-2015,5887,India,India,8095,Not assigned,468, $500.0 ," $2,34,000.0 ", $-   ,Jul
CA-2015-2703,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-11-2015,5887,India,India,8095,Not assigned,151, $500.0 ," $75,500.0 ", $-   ,Nov
CA-2015-2704,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-07-2015,5887,India,India,8095,Not assigned,410, $500.0 ," $2,05,000.0 ", $-   ,Jul
CA-2015-2705,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-08-2015,5887,India,India,8095,Assigned,428, $500.0 ," $2,14,000.0 "," $3,994.7 ",Aug
CA-2015-2706,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-07-2015,5887,India,India,8095,Not assigned,153, $500.0 ," $76,500.0 ", $-   ,Jul
CA-2015-2707,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-12-2015,5887,India,India,8095,Not assigned,269, $500.0 ," $1,34,500.0 ", $-   ,Dec
CA-2015-2708,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-10-2015,5887,India,India,8095,Not assigned,137, $500.0 ," $68,500.0 ", $-   ,Oct
CA-2015-2709,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-05-2015,5887,India,India,8095,Not assigned,254, $500.0 ," $1,27,000.0 ", $-   ,May
CA-2015-2710,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-09-2015,5887,India,India,8095,Not assigned,161, $500.0 ," $80,500.0 ", $-   ,Sep
CA-2015-2711,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-05-2015,5887,India,India,8095,Not assigned,373, $500.0 ," $1,86,500.0 ", $-   ,May
VA-2015-2712,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,29-12-2015,5938,Ireland,Netherlands,8068,Not assigned,129, $310.0 ," $39,990.0 ", $-   ,Dec
CA-2015-2713,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-10-2015,5887,India,India,8095,Not assigned,59, $500.0 ," $29,500.0 ", $-   ,Oct
CA-2015-2714,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-05-2015,5887,India,India,8095,Not assigned,209, $500.0 ," $1,04,500.0 ", $-   ,May
CA-2015-2715,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-05-2015,5887,India,India,8095,Not assigned,364, $500.0 ," $1,82,000.0 ", $-   ,May
CA-2015-2716,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-07-2015,5887,India,India,8095,Not assigned,269, $500.0 ," $1,34,500.0 ", $-   ,Jul
CA-2015-2717,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-01-2015,5887,India,India,8095,Not assigned,211, $500.0 ," $1,05,500.0 ", $-   ,Jan
CA-2015-2718,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-07-2015,5887,India,India,8095,Not assigned,42, $500.0 ," $21,000.0 ", $-   ,Jul
CA-2015-2719,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-07-2015,5887,India,India,8095,Not assigned,101, $500.0 ," $50,500.0 ", $-   ,Jul
CA-2015-2720,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-09-2015,5887,India,India,8095,Not assigned,495, $500.0 ," $2,47,500.0 ", $-   ,Sep
CA-2015-2721,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-09-2015,5887,India,India,8095,Not assigned,472, $500.0 ," $2,36,000.0 ", $-   ,Sep
CA-2015-2722,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-12-2015,5887,India,India,8095,Not assigned,426, $500.0 ," $2,13,000.0 ", $-   ,Dec
CA-2015-2723,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-06-2015,5887,India,India,8095,Not assigned,236, $500.0 ," $1,18,000.0 ", $-   ,Jun
CA-2015-2724,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-07-2015,5887,India,India,8095,Not assigned,372, $500.0 ," $1,86,000.0 ", $-   ,Jul
CA-2015-2725,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-01-2015,5887,India,India,8095,Assigned,499, $500.0 ," $2,49,500.0 "," $11,643.3 ",Jan
CA-2015-2726,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-11-2015,5887,India,India,8095,Not assigned,232, $500.0 ," $1,16,000.0 ", $-   ,Nov
CA-2015-2727,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-03-2015,5887,India,India,8095,Not assigned,26, $500.0 ," $13,000.0 ", $-   ,Mar
CA-2015-2728,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-01-2015,5887,India,India,8095,Not assigned,460, $500.0 ," $2,30,000.0 ", $-   ,Jan
CA-2015-2729,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-12-2015,5887,India,India,8095,Assigned,185, $500.0 ," $92,500.0 ", $801.7 ,Dec
CA-2015-2730,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-01-2015,5887,India,India,8095,Not assigned,237, $500.0 ," $1,18,500.0 ", $-   ,Jan
CA-2015-2731,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-07-2015,5887,India,India,8095,Not assigned,311, $500.0 ," $1,55,500.0 ", $-   ,Jul
CA-2015-2732,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-06-2015,5887,India,India,8095,Not assigned,337, $500.0 ," $1,68,500.0 ", $-   ,Jun
CA-2015-2733,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-03-2015,5887,Nepal,Nepal,8095,Assigned,284, $500.0 ," $1,42,000.0 "," $8,614.7 ",Mar
IN-2015-2734,Bevacizumab,Avastin,Genentech/Roche,Cancer,11-01-2015,5685,Nepal,Nepal,8209,Assigned,237, $243.0 ," $57,591.0 "," $1,106.0 ",Jan
CA-2015-2735,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-12-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,315, $500.0 ," $1,57,500.0 ", $-   ,Dec
NE-2015-2736,Glatiramer,Copaxone,Generic,Multiple sclerosis,14-02-2015,5704,Nepal,Nepal,8370,Assigned,458, $451.0 ," $2,06,558.0 "," $14,045.3 ",Feb
CA-2015-2737,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-11-2015,5887,South Africa,South Africa,8095,Assigned,428, $500.0 ," $2,14,000.0 "," $7,561.3 ",Nov
CA-2015-2738,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-08-2015,5887,Kenya,Kenya,8095,Assigned,217, $500.0 ," $1,08,500.0 "," $4,701.7 ",Aug
IN-2015-2739,Bevacizumab,Avastin,Genentech/Roche,Cancer,03-04-2015,5685,Kenya,Kenya,8209,Assigned,13, $243.0 ," $3,159.0 ", $225.3 ,Apr
CA-2015-2740,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-05-2015,5887,Vietnam,Japan,8095,Assigned,227, $500.0 ," $1,13,500.0 "," $4,010.3 ",May
UM-2015-2741,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,24-05-2015,5704,Vietnam,Japan,8370,Assigned,127, $366.0 ," $46,482.0 "," $3,894.7 ",May
CA-2015-2742,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-10-2015,5887,India,India,8095,Not assigned,242, $500.0 ," $1,21,000.0 ", $-   ,Oct
CA-2015-2743,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-10-2015,5887,Vietnam,Japan,8095,Assigned,407, $500.0 ," $2,03,500.0 "," $3,391.7 ",Oct
CA-2015-2744,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-05-2015,5887,Indonesia,Indonesia,8095,Assigned,186, $500.0 ," $93,000.0 "," $1,116.0 ",May
CA-2015-2745,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-08-2015,5887,Vietnam,Japan,8095,Assigned,262, $500.0 ," $1,31,000.0 "," $4,803.3 ",Aug
CA-2015-2746,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-03-2015,5887,Utd.Arab Emir.,Utd.Arab Emir.,8095,Not assigned,325, $500.0 ," $1,62,500.0 ", $-   ,Mar
RA-2015-2747,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,28-09-2015,5819,Thailand,Thailand,8119,Assigned,420, $364.0 ," $1,52,880.0 "," $11,480.0 ",Sep
CA-2015-2748,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-01-2015,5887,Thailand,Thailand,8095,Not assigned,318, $500.0 ," $1,59,000.0 ", $-   ,Jan
CA-2015-2749,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-05-2015,5887,Thailand,Thailand,8095,Not assigned,137, $500.0 ," $68,500.0 ", $-   ,May
CA-2015-2750,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-02-2015,5887,Iran,Iran,8095,Not assigned,116, $500.0 ," $58,000.0 ", $-   ,Feb
CA-2015-2751,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-03-2015,5887,Iran,Iran,8095,Not assigned,375, $500.0 ," $1,87,500.0 ", $-   ,Mar
CA-2015-2752,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-11-2015,5887,Lebanon,Lebanon,8095,Not assigned,101, $500.0 ," $50,500.0 ", $-   ,Nov
CA-2015-2753,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-05-2015,5887,Lebanon,Lebanon,8095,Not assigned,364, $500.0 ," $1,82,000.0 ", $-   ,May
CA-2015-2754,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-09-2015,5887,Nepal,Nepal,8095,Assigned,113, $500.0 ," $56,500.0 "," $2,787.3 ",Sep
CA-2015-2755,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-06-2015,5887,Nepal,Nepal,8095,Assigned,87, $500.0 ," $43,500.0 ", $928.0 ,Jun
CA-2015-2756,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-04-2015,5887,Thailand,Thailand,8095,Not assigned,398, $500.0 ," $1,99,000.0 ", $-   ,Apr
CA-2015-2757,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-10-2015,5887,Thailand,Thailand,8095,Not assigned,275, $500.0 ," $1,37,500.0 ", $-   ,Oct
CA-2015-2758,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-05-2015,5887,Thailand,Thailand,8095,Not assigned,385, $500.0 ," $1,92,500.0 ", $-   ,May
CA-2015-2759,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-07-2015,5887,Lebanon,Lebanon,8095,Not assigned,397, $500.0 ," $1,98,500.0 ", $-   ,Jul
CA-2015-2760,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-12-2015,5887,Lebanon,Lebanon,8095,Not assigned,273, $500.0 ," $1,36,500.0 ", $-   ,Dec
RA-2015-2761,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,19-01-2015,5819,Thailand,Thailand,8119,Assigned,211, $364.0 ," $76,804.0 "," $1,758.3 ",Jan
CA-2015-2762,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-02-2015,5887,Sudan,Utd.Arab Emir.,8095,Assigned,490, $500.0 ," $2,45,000.0 "," $13,556.7 ",Feb
CA-2015-2763,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-08-2015,5887,Nepal,Nepal,8095,Assigned,188, $500.0 ," $94,000.0 "," $4,324.0 ",Aug
CA-2015-2764,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-04-2015,5887,Thailand,Thailand,8095,Assigned,186, $500.0 ," $93,000.0 "," $5,208.0 ",Apr
CA-2015-2765,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-04-2015,5887,Sri Lanka,Sri Lanka,8095,Assigned,236, $500.0 ," $1,18,000.0 "," $3,461.3 ",Apr
CA-2015-2766,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-08-2015,5887,Thailand,Thailand,8095,Assigned,122, $500.0 ," $61,000.0 "," $1,382.7 ",Aug
CA-2015-2767,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-03-2015,5887,Thailand,Thailand,8095,Assigned,197, $500.0 ," $98,500.0 "," $1,444.7 ",Mar
UM-2015-2768,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,02-08-2015,5704,Syria,Lebanon,8370,Assigned,109, $366.0 ," $39,894.0 "," $3,233.7 ",Aug
CA-2015-2769,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-12-2015,5887,India,India,8095,Not assigned,229, $500.0 ," $1,14,500.0 ", $-   ,Dec
CA-2015-2770,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-01-2015,5887,Malaysia,Malaysia,8095,Assigned,153, $500.0 ," $76,500.0 "," $3,825.0 ",Jan
CA-2015-2771,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-06-2015,5887,Malaysia,Malaysia,8095,Assigned,59, $500.0 ," $29,500.0 ", $963.7 ,Jun
CA-2015-2772,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-02-2015,5887,Vietnam,Vietnam,8095,Assigned,181, $500.0 ," $90,500.0 "," $1,810.0 ",Feb
CA-2015-2773,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-08-2015,5887,Hong Kong,China,8095,Not assigned,404, $500.0 ," $2,02,000.0 ", $-   ,Aug
CA-2015-2774,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-08-2015,5887,Cambodia,Cambodia,8095,Assigned,487, $500.0 ," $2,43,500.0 "," $6,006.3 ",Aug
IN-2015-2775,Bevacizumab,Avastin,Genentech/Roche,Cancer,10-10-2015,5685,Cambodia,Cambodia,8209,Assigned,346, $243.0 ," $84,078.0 "," $10,841.3 ",Oct
CA-2015-2776,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-08-2015,5887,Thailand,Thailand,8095,Assigned,172, $500.0 ," $86,000.0 "," $4,816.0 ",Aug
CA-2015-2777,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-10-2015,5887,Thailand,Thailand,8095,Assigned,123, $500.0 ," $61,500.0 "," $3,854.0 ",Oct
CA-2015-2778,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-07-2015,5887,Indonesia,Indonesia,8095,Assigned,400, $500.0 ," $2,00,000.0 "," $9,200.0 ",Jul
CA-2015-2779,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-04-2015,5887,Indonesia,Indonesia,8095,Assigned,115, $500.0 ," $57,500.0 "," $2,453.3 ",Apr
CA-2015-2780,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-03-2015,5887,Singapore,Singapore,8095,Not assigned,454, $500.0 ," $2,27,000.0 ", $-   ,Mar
CA-2015-2781,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-06-2015,5887,Thailand,Thailand,8095,Not assigned,321, $500.0 ," $1,60,500.0 ", $-   ,Jun
CA-2015-2782,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-11-2015,5887,Thailand,Thailand,8095,Not assigned,337, $500.0 ," $1,68,500.0 ", $-   ,Nov
CA-2015-2783,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-04-2015,5887,Kenya,Kenya,8095,Assigned,136, $500.0 ," $68,000.0 "," $1,722.7 ",Apr
CA-2015-2784,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-01-2015,5887,Philippines,Philippines,8095,Assigned,136, $500.0 ," $68,000.0 ", $725.3 ,Jan
CA-2015-2785,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-02-2015,5887,Philippines,Philippines,8095,Assigned,322, $500.0 ," $1,61,000.0 "," $4,508.0 ",Feb
CA-2015-2786,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-10-2015,5887,Egypt,Egypt,8095,Assigned,378, $500.0 ," $1,89,000.0 "," $7,938.0 ",Oct
CA-2015-2787,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-12-2015,5887,Egypt,Egypt,8095,Assigned,354, $500.0 ," $1,77,000.0 "," $4,838.0 ",Dec
CA-2015-2788,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-06-2015,5887,Egypt,Egypt,8095,Assigned,39, $500.0 ," $19,500.0 "," $1,196.0 ",Jun
CA-2015-2789,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-03-2015,5887,Egypt,Egypt,8095,Assigned,461, $500.0 ," $2,30,500.0 "," $12,293.3 ",Mar
CA-2015-2790,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-05-2015,5887,Philippines,Philippines,8095,Assigned,388, $500.0 ," $1,94,000.0 "," $8,018.7 ",May
CA-2015-2791,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-10-2015,5887,Oman,Oman,8095,Not assigned,64, $500.0 ," $32,000.0 ", $-   ,Oct
CA-2015-2792,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-12-2015,5887,Oman,Oman,8095,Not assigned,34, $500.0 ," $17,000.0 ", $-   ,Dec
CA-2015-2793,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-05-2015,5887,India,India,8095,Not assigned,52, $500.0 ," $26,000.0 ", $-   ,May
CA-2015-2794,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-08-2015,5887,Thailand,Thailand,8095,Assigned,375, $500.0 ," $1,87,500.0 "," $10,500.0 ",Aug
CA-2015-2795,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-06-2015,5887,Lebanon,Lebanon,8095,Assigned,33, $500.0 ," $16,500.0 ", $473.0 ,Jun
VA-2015-2796,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,10-09-2015,5938,Bangladesh,Bangladesh,8068,Assigned,173, $310.0 ," $53,630.0 "," $5,074.7 ",Sep
CA-2015-2797,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-10-2015,5887,Taiwan,China,8095,Not assigned,156, $500.0 ," $78,000.0 ", $-   ,Oct
CA-2015-2798,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-07-2015,5887,Taiwan,China,8095,Not assigned,183, $500.0 ," $91,500.0 ", $-   ,Jul
VA-2015-2799,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,20-12-2015,5938,Egypt,Egypt,8068,Not assigned,11, $310.0 ," $3,410.0 ", $-   ,Dec
VA-2015-2800,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,21-07-2015,5938,Egypt,Egypt,8068,Not assigned,360, $310.0 ," $1,11,600.0 ", $-   ,Jul
TA-2015-2801,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,05-04-2015,5704,Netherlands,Netherlands,8370,Not assigned,37, $453.0 ," $16,761.0 ", $-   ,Apr
TA-2015-2802,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,15-05-2015,5704,Netherlands,Netherlands,8370,Not assigned,328, $453.0 ," $1,48,584.0 ", $-   ,May
TA-2015-2803,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,26-11-2015,5704,Netherlands,Netherlands,8370,Not assigned,412, $453.0 ," $1,86,636.0 ", $-   ,Nov
TA-2015-2804,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,13-02-2015,5704,Netherlands,Netherlands,8370,Not assigned,335, $453.0 ," $1,51,755.0 ", $-   ,Feb
TA-2015-2805,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,17-05-2015,5704,Netherlands,Netherlands,8370,Not assigned,345, $453.0 ," $1,56,285.0 ", $-   ,May
CA-2015-2806,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-10-2015,5887,Vietnam,Japan,8095,Assigned,148, $500.0 ," $74,000.0 "," $4,390.7 ",Oct
IN-2015-2807,Bevacizumab,Avastin,Genentech/Roche,Cancer,01-09-2015,5685,India,India,8209,Assigned,127, $243.0 ," $30,861.0 "," $2,116.7 ",Sep
IN-2015-2808,Bevacizumab,Avastin,Genentech/Roche,Cancer,22-02-2015,5685,India,India,8209,Not assigned,214, $243.0 ," $52,002.0 ", $-   ,Feb
IN-2015-2809,Bevacizumab,Avastin,Genentech/Roche,Cancer,04-02-2015,5685,India,India,8209,Not assigned,172, $243.0 ," $41,796.0 ", $-   ,Feb
IN-2015-2810,Bevacizumab,Avastin,Genentech/Roche,Cancer,02-03-2015,5685,India,India,8209,Not assigned,445, $243.0 ," $1,08,135.0 ", $-   ,Mar
IN-2015-2811,Bevacizumab,Avastin,Genentech/Roche,Cancer,25-06-2015,5685,India,India,8209,Not assigned,257, $243.0 ," $62,451.0 ", $-   ,Jun
IN-2015-2812,Bevacizumab,Avastin,Genentech/Roche,Cancer,08-10-2015,5685,India,India,8209,Not assigned,278, $243.0 ," $67,554.0 ", $-   ,Oct
CA-2015-2813,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-06-2015,5887,Hong Kong,China,8095,Not assigned,259, $500.0 ," $1,29,500.0 ", $-   ,Jun
IN-2015-2814,Bevacizumab,Avastin,Genentech/Roche,Cancer,17-08-2015,5685,Nepal,Nepal,8209,Assigned,285, $243.0 ," $69,255.0 "," $4,845.0 ",Aug
IN-2015-2815,Bevacizumab,Avastin,Genentech/Roche,Cancer,23-07-2015,5685,Nepal,Nepal,8209,Assigned,393, $243.0 ," $95,499.0 "," $6,026.0 ",Jul
IN-2015-2816,Bevacizumab,Avastin,Genentech/Roche,Cancer,17-02-2015,5685,Sudan,Utd.Arab Emir.,8209,Assigned,416, $243.0 ," $1,01,088.0 "," $3,882.7 ",Feb
IN-2015-2817,Bevacizumab,Avastin,Genentech/Roche,Cancer,06-01-2015,5685,India,India,8209,Not assigned,457, $243.0 ," $1,11,051.0 ", $-   ,Jan
CA-2015-2818,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-12-2015,5887,Vietnam,Japan,8095,Assigned,473, $500.0 ," $2,36,500.0 "," $2,995.7 ",Dec
IN-2015-2819,Bevacizumab,Avastin,Genentech/Roche,Cancer,10-11-2015,5685,Thailand,Thailand,8209,Assigned,172, $243.0 ," $41,796.0 "," $2,350.7 ",Nov
IN-2015-2820,Bevacizumab,Avastin,Genentech/Roche,Cancer,01-03-2015,5685,Turkey,Turkey,8209,Not assigned,447, $243.0 ," $1,08,621.0 ", $-   ,Mar
IN-2015-2821,Bevacizumab,Avastin,Genentech/Roche,Cancer,23-05-2015,5685,Egypt,Egypt,8209,Not assigned,128, $243.0 ," $31,104.0 ", $-   ,May
CA-2015-2822,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-01-2015,5887,Egypt,Egypt,8095,Not assigned,130, $500.0 ," $65,000.0 ", $-   ,Jan
IN-2015-2823,Bevacizumab,Avastin,Genentech/Roche,Cancer,20-07-2015,5685,Thailand,Thailand,8209,Assigned,345, $243.0 ," $83,835.0 "," $10,810.0 ",Jul
IN-2015-2824,Bevacizumab,Avastin,Genentech/Roche,Cancer,08-01-2015,5685,Thailand,Thailand,8209,Assigned,307, $243.0 ," $74,601.0 "," $5,116.7 ",Jan
IN-2015-2825,Bevacizumab,Avastin,Genentech/Roche,Cancer,20-06-2015,5685,Netherlands,Netherlands,8209,Not assigned,374, $243.0 ," $90,882.0 ", $-   ,Jun
IN-2015-2826,Bevacizumab,Avastin,Genentech/Roche,Cancer,31-05-2015,5685,Taiwan,China,8209,Not assigned,395, $243.0 ," $95,985.0 ", $-   ,May
NE-2015-2827,Glatiramer,Copaxone,Generic,Multiple sclerosis,10-02-2015,5704,India,India,8370,Assigned,311, $451.0 ," $1,40,261.0 "," $6,116.3 ",Feb
NE-2015-2828,Glatiramer,Copaxone,Generic,Multiple sclerosis,14-03-2015,5704,India,India,8370,Not assigned,259, $451.0 ," $1,16,809.0 ", $-   ,Mar
NE-2015-2829,Glatiramer,Copaxone,Generic,Multiple sclerosis,02-05-2015,5704,India,India,8370,Not assigned,428, $451.0 ," $1,93,028.0 ", $-   ,May
NE-2015-2830,Glatiramer,Copaxone,Generic,Multiple sclerosis,28-12-2015,5704,India,India,8370,Not assigned,419, $451.0 ," $1,88,969.0 ", $-   ,Dec
NE-2015-2831,Glatiramer,Copaxone,Generic,Multiple sclerosis,21-03-2015,5704,Yemen,Yemen,8370,Not assigned,418, $451.0 ," $1,88,518.0 ", $-   ,Mar
NE-2015-2832,Glatiramer,Copaxone,Generic,Multiple sclerosis,03-09-2015,5704,Kenya,Kenya,8370,Assigned,345, $451.0 ," $1,55,595.0 "," $6,785.0 ",Sep
NE-2015-2833,Glatiramer,Copaxone,Generic,Multiple sclerosis,03-07-2015,5704,Sri Lanka,Sri Lanka,8370,Assigned,90, $451.0 ," $40,590.0 "," $2,190.0 ",Jul
NE-2015-2834,Glatiramer,Copaxone,Generic,Multiple sclerosis,13-12-2015,5704,Canada,Canada,8370,Not assigned,160, $451.0 ," $72,160.0 ", $-   ,Dec
NE-2015-2835,Glatiramer,Copaxone,Generic,Multiple sclerosis,11-10-2015,5704,Kenya,Kenya,8370,Assigned,268, $451.0 ," $1,20,868.0 "," $1,518.7 ",Oct
NE-2015-2836,Glatiramer,Copaxone,Generic,Multiple sclerosis,29-11-2015,5704,Malaysia,Malaysia,8370,Assigned,427, $451.0 ," $1,92,577.0 "," $6,832.0 ",Nov
NE-2015-2837,Glatiramer,Copaxone,Generic,Multiple sclerosis,25-08-2015,5704,Nepal,Nepal,8370,Assigned,85, $451.0 ," $38,335.0 "," $2,606.7 ",Aug
NE-2015-2838,Glatiramer,Copaxone,Generic,Multiple sclerosis,14-02-2015,5704,Nepal,Nepal,8370,Assigned,24, $451.0 ," $10,824.0 ", $112.0 ,Feb
NE-2015-2839,Glatiramer,Copaxone,Generic,Multiple sclerosis,04-12-2015,5704,Nepal,Nepal,8370,Assigned,237, $451.0 ," $1,06,887.0 "," $6,636.0 ",Dec
NE-2015-2840,Glatiramer,Copaxone,Generic,Multiple sclerosis,31-03-2015,5704,Sudan,Utd.Arab Emir.,8370,Assigned,272, $451.0 ," $1,22,672.0 "," $5,077.3 ",Mar
NE-2015-2841,Glatiramer,Copaxone,Generic,Multiple sclerosis,12-07-2015,5704,Malaysia,Malaysia,8370,Assigned,83, $451.0 ," $37,433.0 "," $2,185.7 ",Jul
NE-2015-2842,Glatiramer,Copaxone,Generic,Multiple sclerosis,24-12-2015,5704,Sri Lanka,Sri Lanka,8370,Assigned,369, $451.0 ," $1,66,419.0 "," $1,476.0 ",Dec
NE-2015-2843,Glatiramer,Copaxone,Generic,Multiple sclerosis,16-06-2015,5704,Malaysia,Malaysia,8370,Assigned,259, $451.0 ," $1,16,809.0 "," $6,388.7 ",Jun
NE-2015-2844,Glatiramer,Copaxone,Generic,Multiple sclerosis,10-03-2015,5704,Philippines,Philippines,8370,Assigned,453, $451.0 ," $2,04,303.0 "," $4,983.0 ",Mar
NE-2015-2845,Glatiramer,Copaxone,Generic,Multiple sclerosis,08-11-2015,5704,Turkey,Turkey,8370,Not assigned,1, $451.0 , $451.0 , $-   ,Nov
NE-2015-2846,Glatiramer,Copaxone,Generic,Multiple sclerosis,12-09-2015,5704,Oman,Oman,8370,Not assigned,302, $451.0 ," $1,36,202.0 ", $-   ,Sep
NE-2015-2847,Glatiramer,Copaxone,Generic,Multiple sclerosis,27-03-2015,5704,Oman,Oman,8370,Not assigned,149, $451.0 ," $67,199.0 ", $-   ,Mar
CA-2015-2848,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-12-2015,5887,India,India,8095,Not assigned,447, $500.0 ," $2,23,500.0 ", $-   ,Dec
NE-2015-2849,Glatiramer,Copaxone,Generic,Multiple sclerosis,11-10-2015,5704,Germany,Netherlands,8370,Not assigned,178, $451.0 ," $80,278.0 ", $-   ,Oct
NE-2015-2850,Glatiramer,Copaxone,Generic,Multiple sclerosis,01-07-2015,5704,Netherlands,Netherlands,8370,Not assigned,299, $451.0 ," $1,34,849.0 ", $-   ,Jul
NE-2015-2851,Glatiramer,Copaxone,Generic,Multiple sclerosis,05-08-2015,5704,Netherlands,Netherlands,8370,Not assigned,286, $451.0 ," $1,28,986.0 ", $-   ,Aug
NE-2015-2852,Glatiramer,Copaxone,Generic,Multiple sclerosis,27-04-2015,5704,Netherlands,Netherlands,8370,Not assigned,218, $451.0 ," $98,318.0 ", $-   ,Apr
NE-2015-2853,Glatiramer,Copaxone,Generic,Multiple sclerosis,25-12-2015,5704,Netherlands,Netherlands,8370,Not assigned,301, $451.0 ," $1,35,751.0 ", $-   ,Dec
NE-2015-2854,Glatiramer,Copaxone,Generic,Multiple sclerosis,16-06-2015,5704,Mexico,Mexico,8370,Not assigned,249, $451.0 ," $1,12,299.0 ", $-   ,Jun
VA-2015-2855,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,02-09-2015,5938,India,India,8068,Not assigned,346, $310.0 ," $1,07,260.0 ", $-   ,Sep
VA-2015-2856,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,17-07-2015,5938,India,India,8068,Not assigned,175, $310.0 ," $54,250.0 ", $-   ,Jul
CA-2015-2857,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-05-2015,5887,Indonesia,Indonesia,8095,Assigned,60, $500.0 ," $30,000.0 "," $1,120.0 ",May
VA-2015-2858,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,21-08-2015,5938,Nepal,Nepal,8068,Assigned,233, $310.0 ," $72,230.0 "," $7,689.0 ",Aug
CA-2015-2859,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-01-2015,5887,Indonesia,Indonesia,8095,Assigned,497, $500.0 ," $2,48,500.0 "," $14,413.0 ",Jan
VA-2015-2860,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,04-02-2015,5938,United Kingdom,United Kingdom,8068,Not assigned,29, $310.0 ," $8,990.0 ", $-   ,Feb
VA-2015-2861,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,26-11-2015,5938,United Kingdom,United Kingdom,8068,Not assigned,129, $310.0 ," $39,990.0 ", $-   ,Nov
CA-2015-2862,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-01-2015,5887,Indonesia,Indonesia,8095,Assigned,165, $500.0 ," $82,500.0 "," $3,795.0 ",Jan
CA-2015-2863,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-10-2015,5887,Indonesia,Indonesia,8095,Assigned,456, $500.0 ," $2,28,000.0 "," $6,840.0 ",Oct
RA-2015-2864,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,21-10-2015,5819,India,India,8119,Assigned,63, $364.0 ," $22,932.0 "," $1,638.0 ",Oct
RA-2015-2865,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,21-03-2015,5819,India,India,8119,Not assigned,47, $364.0 ," $17,108.0 ", $-   ,Mar
RA-2015-2866,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,08-12-2015,5819,India,India,8119,Assigned,290, $364.0 ," $1,05,560.0 "," $8,216.7 ",Dec
RA-2015-2867,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,07-07-2015,5819,India,India,8119,Not assigned,272, $364.0 ," $99,008.0 ", $-   ,Jul
RA-2015-2868,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,14-12-2015,5819,India,India,8119,Assigned,455, $364.0 ," $1,65,620.0 "," $14,256.7 ",Dec
RA-2015-2869,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,19-03-2015,5819,India,India,8119,Not assigned,404, $364.0 ," $1,47,056.0 ", $-   ,Mar
RA-2015-2870,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,21-11-2015,5819,India,India,8119,Not assigned,402, $364.0 ," $1,46,328.0 ", $-   ,Nov
RA-2015-2871,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,15-06-2015,5819,India,India,8119,Not assigned,360, $364.0 ," $1,31,040.0 ", $-   ,Jun
CA-2015-2872,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-08-2015,5887,South Korea,South Korea,8095,Assigned,208, $500.0 ," $1,04,000.0 "," $2,080.0 ",Aug
CA-2015-2873,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-01-2015,5887,Vietnam,Japan,8095,Assigned,370, $500.0 ," $1,85,000.0 "," $6,660.0 ",Jan
AR-2015-2874,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,06-11-2015,5653,India,India,7933,Not assigned,377, $231.0 ," $87,087.0 ", $-   ,Nov
AR-2015-2875,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,22-04-2015,5653,India,India,7933,Not assigned,490, $231.0 ," $1,13,190.0 ", $-   ,Apr
AR-2015-2876,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,03-05-2015,5653,India,India,7933,Not assigned,296, $231.0 ," $68,376.0 ", $-   ,May
AR-2015-2877,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,15-03-2015,5653,India,India,7933,Assigned,116, $231.0 ," $26,796.0 "," $2,938.7 ",Mar
AR-2015-2878,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,22-10-2015,5653,India,India,7933,Assigned,189, $231.0 ," $43,659.0 "," $6,300.0 ",Oct
AR-2015-2879,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,26-11-2015,5653,India,India,7933,Assigned,474, $231.0 ," $1,09,494.0 "," $5,530.0 ",Nov
AR-2015-2880,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,09-06-2015,5653,India,India,7933,Assigned,29, $231.0 ," $6,699.0 ", $415.7 ,Jun
AR-2015-2881,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,22-11-2015,5653,India,India,7933,Assigned,52, $231.0 ," $12,012.0 "," $1,265.3 ",Nov
AR-2015-2882,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,06-09-2015,5653,India,India,7933,Not assigned,274, $231.0 ," $63,294.0 ", $-   ,Sep
AR-2015-2883,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,14-01-2015,5653,India,India,7933,Not assigned,7, $231.0 ," $1,617.0 ", $-   ,Jan
AR-2015-2884,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,13-06-2015,5653,India,India,7933,Not assigned,458, $231.0 ," $1,05,798.0 ", $-   ,Jun
AR-2015-2885,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,01-08-2015,5653,India,India,7933,Not assigned,459, $231.0 ," $1,06,029.0 ", $-   ,Aug
AR-2015-2886,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,26-12-2015,5653,India,India,7933,Assigned,76, $231.0 ," $17,556.0 ", $278.7 ,Dec
AR-2015-2887,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,20-06-2015,5653,Egypt,Egypt,7933,Not assigned,229, $231.0 ," $52,899.0 ", $-   ,Jun
AR-2015-2888,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,10-01-2015,5653,Vietnam,Netherlands,7933,Assigned,215, $231.0 ," $49,665.0 "," $5,375.0 ",Jan
AR-2015-2889,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,05-03-2015,5653,Vietnam,Netherlands,7933,Assigned,303, $231.0 ," $69,993.0 "," $3,939.0 ",Mar
AR-2015-2890,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,28-04-2015,5653,Japan,Singapore,7933,Not assigned,459, $231.0 ," $1,06,029.0 ", $-   ,Apr
AR-2015-2891,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,14-04-2015,5653,Egypt,Egypt,7933,Not assigned,339, $231.0 ," $78,309.0 ", $-   ,Apr
AR-2015-2892,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,22-10-2015,5653,Vietnam,Netherlands,7933,Assigned,493, $231.0 ," $1,13,883.0 "," $13,311.0 ",Oct
AR-2015-2893,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,19-08-2015,5653,Kenya,Kenya,7933,Assigned,312, $231.0 ," $72,072.0 "," $4,368.0 ",Aug
AR-2015-2894,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,27-06-2015,5653,Vietnam,Netherlands,7933,Assigned,216, $231.0 ," $49,896.0 ", $792.0 ,Jun
AR-2015-2895,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,28-07-2015,5653,Thailand,Thailand,7933,Assigned,345, $231.0 ," $79,695.0 "," $8,165.0 ",Jul
AR-2015-2896,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,06-05-2015,5653,Vietnam,Japan,7933,Assigned,172, $231.0 ," $39,732.0 "," $1,032.0 ",May
AR-2015-2897,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,16-02-2015,5653,Vietnam,Netherlands,7933,Assigned,83, $231.0 ," $19,173.0 ", $332.0 ,Feb
AR-2015-2898,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,20-03-2015,5653,Vietnam,Netherlands,7933,Assigned,287, $231.0 ," $66,297.0 "," $6,122.7 ",Mar
AR-2015-2899,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,12-11-2015,5653,Vietnam,Netherlands,7933,Assigned,487, $231.0 ," $1,12,497.0 "," $2,110.3 ",Nov
AR-2015-2900,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,17-07-2015,5653,Vietnam,Netherlands,7933,Assigned,338, $231.0 ," $78,078.0 "," $6,760.0 ",Jul
AR-2015-2901,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,03-11-2015,5653,Cambodia,Cambodia,7933,Assigned,252, $231.0 ," $58,212.0 ", $840.0 ,Nov
AR-2015-2902,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,21-11-2015,5653,Malaysia,Malaysia,7933,Assigned,281, $231.0 ," $64,911.0 "," $2,716.3 ",Nov
AR-2015-2903,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,15-04-2015,5653,Malaysia,Malaysia,7933,Not assigned,16, $231.0 ," $3,696.0 ", $-   ,Apr
AR-2015-2904,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,30-09-2015,5653,Vietnam,Japan,7933,Assigned,53, $231.0 ," $12,243.0 ", $759.7 ,Sep
AR-2015-2905,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,10-02-2015,5653,Vietnam,Vietnam,7933,Assigned,315, $231.0 ," $72,765.0 "," $8,820.0 ",Feb
AR-2015-2906,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,08-06-2015,5653,Thailand,Thailand,7933,Assigned,380, $231.0 ," $87,780.0 "," $4,560.0 ",Jun
AR-2015-2907,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,08-08-2015,5653,Philippines,Philippines,7933,Assigned,148, $231.0 ," $34,188.0 "," $3,058.7 ",Aug
DE-2015-2908,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,15-08-2015,5754,India,India,7904,Not assigned,217, $314.0 ," $68,138.0 ", $-   ,Aug
DE-2015-2909,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,08-04-2015,5754,India,India,7904,Assigned,273, $314.0 ," $85,722.0 "," $8,099.0 ",Apr
DE-2015-2910,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,22-05-2015,5754,India,India,7904,Not assigned,295, $314.0 ," $92,630.0 ", $-   ,May
DE-2015-2911,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,02-01-2015,5754,India,India,7904,Assigned,3, $314.0 , $942.0 , $28.0 ,Jan
DE-2015-2912,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,02-02-2015,5754,India,India,7904,Assigned,219, $314.0 ," $68,766.0 "," $1,460.0 ",Feb
DE-2015-2913,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,23-01-2015,5754,India,India,7904,Not assigned,388, $314.0 ," $1,21,832.0 ", $-   ,Jan
DE-2015-2914,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,05-12-2015,5754,India,India,7904,Not assigned,279, $314.0 ," $87,606.0 ", $-   ,Dec
DE-2015-2915,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,18-03-2015,5754,India,India,7904,Not assigned,415, $314.0 ," $1,30,310.0 ", $-   ,Mar
DE-2015-2916,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,18-03-2015,5754,India,India,7904,Not assigned,382, $314.0 ," $1,19,948.0 ", $-   ,Mar
DE-2015-2917,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,13-12-2015,5754,India,India,7904,Not assigned,280, $314.0 ," $87,920.0 ", $-   ,Dec
DE-2015-2918,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,08-11-2015,5754,India,India,7904,Assigned,180, $314.0 ," $56,520.0 "," $2,760.0 ",Nov
DE-2015-2919,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,07-03-2015,5754,India,India,7904,Not assigned,19, $314.0 ," $5,966.0 ", $-   ,Mar
DE-2015-2920,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,20-01-2015,5754,India,India,7904,Assigned,44, $314.0 ," $13,816.0 ", $601.3 ,Jan
DE-2015-2921,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,27-03-2015,5754,India,India,7904,Assigned,369, $314.0 ," $1,15,866.0 "," $9,963.0 ",Mar
DE-2015-2922,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,21-05-2015,5754,India,India,7904,Not assigned,136, $314.0 ," $42,704.0 ", $-   ,May
DE-2015-2923,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,27-04-2015,5754,India,India,7904,Not assigned,156, $314.0 ," $48,984.0 ", $-   ,Apr
DE-2015-2924,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,17-06-2015,5754,Vietnam,Japan,7904,Assigned,72, $314.0 ," $22,608.0 "," $1,512.0 ",Jun
DE-2015-2925,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,14-02-2015,5754,Vietnam,Netherlands,7904,Assigned,188, $314.0 ," $59,032.0 "," $1,754.7 ",Feb
DE-2015-2926,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,06-06-2015,5754,Vietnam,Netherlands,7904,Assigned,129, $314.0 ," $40,506.0 "," $2,967.0 ",Jun
DE-2015-2927,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,16-11-2015,5754,Egypt,Egypt,7904,Not assigned,311, $314.0 ," $97,654.0 ", $-   ,Nov
DE-2015-2928,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,22-09-2015,5754,Egypt,Egypt,7904,Not assigned,306, $314.0 ," $96,084.0 ", $-   ,Sep
DE-2015-2929,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,11-10-2015,5754,Vietnam,Netherlands,7904,Assigned,273, $314.0 ," $85,722.0 "," $6,370.0 ",Oct
DE-2015-2930,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,11-04-2015,5754,Egypt,Egypt,7904,Not assigned,287, $314.0 ," $90,118.0 ", $-   ,Apr
DE-2015-2931,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,22-02-2015,5754,Vietnam,Netherlands,7904,Assigned,130, $314.0 ," $40,820.0 ", $606.7 ,Feb
DE-2015-2932,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,03-06-2015,5754,Egypt,Egypt,7904,Not assigned,255, $314.0 ," $80,070.0 ", $-   ,Jun
DE-2015-2933,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,07-08-2015,5754,Nepal,Nepal,7904,Assigned,169, $314.0 ," $53,066.0 "," $1,633.7 ",Aug
DE-2015-2934,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,09-10-2015,5754,Nepal,Nepal,7904,Assigned,457, $314.0 ," $1,43,498.0 "," $9,749.3 ",Oct
DE-2015-2935,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,10-10-2015,5754,Vietnam,Japan,7904,Assigned,50, $314.0 ," $15,700.0 ", $750.0 ,Oct
DE-2015-2936,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,10-07-2015,5754,Vietnam,Japan,7904,Assigned,99, $314.0 ," $31,086.0 ", $429.0 ,Jul
DE-2015-2937,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,14-09-2015,5754,Vietnam,Netherlands,7904,Assigned,370, $314.0 ," $1,16,180.0 "," $3,576.7 ",Sep
DE-2015-2938,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,20-09-2015,5754,Indonesia,Indonesia,7904,Assigned,270, $314.0 ," $84,780.0 "," $4,140.0 ",Sep
DE-2015-2939,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,18-09-2015,5754,Indonesia,Indonesia,7904,Assigned,475, $314.0 ," $1,49,150.0 "," $4,275.0 ",Sep
DE-2015-2940,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,01-09-2015,5754,Syria,Lebanon,7904,Assigned,91, $314.0 ," $28,574.0 "," $2,790.7 ",Sep
TA-2015-2941,Filgrastim,Neulasta,Amgen,Neutropenia,19-04-2015,5737,Bangladesh,Bangladesh,8270,Not assigned,468, $266.0 ," $1,24,488.0 ", $-   ,Apr
TA-2015-2942,Filgrastim,Neulasta,Amgen,Neutropenia,18-01-2015,5737,Bangladesh,Bangladesh,8270,Not assigned,252, $266.0 ," $67,032.0 ", $-   ,Jan
AR-2015-2943,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,20-12-2015,5653,Vietnam,Japan,7933,Assigned,430, $231.0 ," $99,330.0 "," $4,156.7 ",Dec
AR-2015-2944,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,20-05-2015,5653,Vietnam,Japan,7933,Assigned,109, $231.0 ," $25,179.0 "," $2,616.0 ",May
EL-2015-2945,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,10-04-2015,5737,Vietnam,Japan,8270,Assigned,282, $250.0 ," $70,500.0 "," $2,820.0 ",Apr
EL-2015-2946,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,24-06-2015,5737,Philippines,Philippines,8270,Assigned,73, $250.0 ," $18,250.0 "," $2,068.3 ",Jun
EL-2015-2947,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,07-02-2015,5737,Malaysia,Malaysia,8270,Assigned,356, $250.0 ," $89,000.0 "," $11,392.0 ",Feb
UM-2015-2948,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,19-05-2015,5704,India,India,8370,Not assigned,322, $366.0 ," $1,17,852.0 ", $-   ,May
UM-2015-2949,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,22-02-2015,5704,India,India,8370,Assigned,311, $366.0 ," $1,13,826.0 "," $9,433.7 ",Feb
UM-2015-2950,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,09-03-2015,5704,India,India,8370,Not assigned,361, $366.0 ," $1,32,126.0 ", $-   ,Mar
UM-2015-2951,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,28-10-2015,5704,India,India,8370,Not assigned,121, $366.0 ," $44,286.0 ", $-   ,Oct
UM-2015-2952,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,16-08-2015,5704,India,India,8370,Not assigned,447, $366.0 ," $1,63,602.0 ", $-   ,Aug
UM-2015-2953,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,02-02-2015,5704,India,India,8370,Not assigned,456, $366.0 ," $1,66,896.0 ", $-   ,Feb
UM-2015-2954,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,16-02-2015,5704,India,India,8370,Not assigned,338, $366.0 ," $1,23,708.0 ", $-   ,Feb
UM-2015-2955,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,13-11-2015,5704,India,India,8370,Not assigned,411, $366.0 ," $1,50,426.0 ", $-   ,Nov
UM-2015-2956,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,08-01-2015,5704,India,India,8370,Not assigned,327, $366.0 ," $1,19,682.0 ", $-   ,Jan
UM-2015-2957,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,11-12-2015,5704,India,India,8370,Not assigned,316, $366.0 ," $1,15,656.0 ", $-   ,Dec
UM-2015-2958,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,08-11-2015,5704,India,India,8370,Not assigned,306, $366.0 ," $1,11,996.0 ", $-   ,Nov
UM-2015-2959,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,16-04-2015,5704,India,India,8370,Not assigned,456, $366.0 ," $1,66,896.0 ", $-   ,Apr
UM-2015-2960,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,22-09-2015,5704,Thailand,Thailand,8370,Assigned,335, $366.0 ," $1,22,610.0 "," $2,121.7 ",Sep
CA-2015-2961,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-10-2015,5887,Egypt,Egypt,8095,Not assigned,434, $500.0 ," $2,17,000.0 ", $-   ,Oct
UM-2015-2962,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,29-08-2015,5704,Tunisia,Tunisia,8370,Not assigned,370, $366.0 ," $1,35,420.0 ", $-   ,Aug
UM-2015-2963,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,11-02-2015,5704,Malaysia,Malaysia,8370,Assigned,419, $366.0 ," $1,53,354.0 "," $1,955.3 ",Feb
CA-2015-2964,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-05-2015,5887,Indonesia,Indonesia,8095,Assigned,350, $500.0 ," $1,75,000.0 "," $10,033.3 ",May
UM-2015-2965,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,11-11-2015,5704,India,India,8370,Not assigned,3, $366.0 ," $1,098.0 ", $-   ,Nov
UM-2015-2966,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,23-02-2015,5704,India,India,8370,Not assigned,457, $366.0 ," $1,67,262.0 ", $-   ,Feb
UM-2015-2967,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,08-03-2015,5704,India,India,8370,Not assigned,303, $366.0 ," $1,10,898.0 ", $-   ,Mar
UM-2015-2968,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,08-05-2015,5704,India,India,8370,Not assigned,280, $366.0 ," $1,02,480.0 ", $-   ,May
UM-2015-2969,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,07-03-2015,5704,India,India,8370,Not assigned,73, $366.0 ," $26,718.0 ", $-   ,Mar
UM-2015-2970,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,07-11-2015,5704,India,India,8370,Not assigned,260, $366.0 ," $95,160.0 ", $-   ,Nov
UM-2015-2971,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,23-05-2015,5704,India,India,8370,Not assigned,295, $366.0 ," $1,07,970.0 ", $-   ,May
UM-2015-2972,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,08-01-2015,5704,India,India,8370,Not assigned,457, $366.0 ," $1,67,262.0 ", $-   ,Jan
UM-2015-2973,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,28-12-2015,5704,India,India,8370,Not assigned,121, $366.0 ," $44,286.0 ", $-   ,Dec
UM-2015-2974,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,11-05-2015,5704,India,India,8370,Not assigned,21, $366.0 ," $7,686.0 ", $-   ,May
UM-2015-2975,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,11-10-2015,5704,India,India,8370,Not assigned,304, $366.0 ," $1,11,264.0 ", $-   ,Oct
UM-2015-2976,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,17-03-2015,5704,India,India,8370,Not assigned,452, $366.0 ," $1,65,432.0 ", $-   ,Mar
UM-2015-2977,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,14-08-2015,5704,India,India,8370,Not assigned,294, $366.0 ," $1,07,604.0 ", $-   ,Aug
UM-2015-2978,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,08-05-2015,5704,India,India,8370,Not assigned,252, $366.0 ," $92,232.0 ", $-   ,May
UM-2015-2979,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,24-09-2015,5704,India,India,8370,Not assigned,313, $366.0 ," $1,14,558.0 ", $-   ,Sep
UM-2015-2980,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,14-05-2015,5704,India,India,8370,Not assigned,215, $366.0 ," $78,690.0 ", $-   ,May
UM-2015-2981,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,16-07-2015,5704,India,India,8370,Not assigned,168, $366.0 ," $61,488.0 ", $-   ,Jul
UM-2015-2982,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,27-11-2015,5704,India,India,8370,Not assigned,133, $366.0 ," $48,678.0 ", $-   ,Nov
UM-2015-2983,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,13-04-2015,5704,India,India,8370,Not assigned,189, $366.0 ," $69,174.0 ", $-   ,Apr
UM-2015-2984,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,28-07-2015,5704,India,India,8370,Not assigned,80, $366.0 ," $29,280.0 ", $-   ,Jul
UM-2015-2985,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,19-04-2015,5704,India,India,8370,Not assigned,149, $366.0 ," $54,534.0 ", $-   ,Apr
UM-2015-2986,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,18-12-2015,5704,India,India,8370,Not assigned,373, $366.0 ," $1,36,518.0 ", $-   ,Dec
UM-2015-2987,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,11-10-2015,5704,India,India,8370,Not assigned,403, $366.0 ," $1,47,498.0 ", $-   ,Oct
UM-2015-2988,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,18-05-2015,5704,India,India,8370,Not assigned,168, $366.0 ," $61,488.0 ", $-   ,May
UM-2015-2989,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,16-09-2015,5704,India,India,8370,Not assigned,120, $366.0 ," $43,920.0 ", $-   ,Sep
UM-2015-2990,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,27-07-2015,5704,India,India,8370,Not assigned,334, $366.0 ," $1,22,244.0 ", $-   ,Jul
UM-2015-2991,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,21-04-2015,5704,India,India,8370,Not assigned,475, $366.0 ," $1,73,850.0 ", $-   ,Apr
UM-2015-2992,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,21-05-2015,5704,India,India,8370,Not assigned,236, $366.0 ," $86,376.0 ", $-   ,May
UM-2015-2993,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,17-11-2015,5704,Nepal,Nepal,8370,Assigned,370, $366.0 ," $1,35,420.0 "," $8,880.0 ",Nov
UM-2015-2994,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,08-07-2015,5704,Paraguay,Mexico,8370,Not assigned,268, $366.0 ," $98,088.0 ", $-   ,Jul
US-2015-2995,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,29-07-2015,5653,Pakistan,Pakistan,7933,Assigned,122, $231.0 ," $28,182.0 "," $1,220.0 ",Jul
US-2015-2996,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,03-02-2015,5653,Bangladesh,Bangladesh,7933,Assigned,153, $231.0 ," $35,343.0 "," $3,825.0 ",Feb
US-2015-2997,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,17-01-2015,5653,Bangladesh,Bangladesh,7933,Assigned,498, $231.0 ," $1,15,038.0 "," $9,960.0 ",Jan
US-2015-2998,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,09-03-2015,5653,South Africa,South Africa,7933,Assigned,36, $231.0 ," $8,316.0 ", $612.0 ,Mar
US-2015-2999,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,28-07-2015,5653,South Africa,South Africa,7933,Assigned,293, $231.0 ," $67,683.0 "," $5,371.7 ",Jul
US-2015-3000,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,09-09-2015,5653,Kenya,Kenya,7933,Assigned,472, $231.0 ," $1,09,032.0 "," $11,328.0 ",Sep
US-2015-3001,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,13-08-2015,5653,Syria,Lebanon,7933,Assigned,239, $231.0 ," $55,209.0 "," $2,708.7 ",Aug
US-2015-3002,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,19-11-2015,5653,Australia,Australia,7933,Not assigned,377, $231.0 ," $87,087.0 ", $-   ,Nov
US-2015-3003,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,24-03-2015,5653,Malaysia,Malaysia,7933,Assigned,277, $231.0 ," $63,987.0 "," $4,616.7 ",Mar
TA-2015-3004,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,12-12-2015,5704,India,India,8370,Not assigned,185, $453.0 ," $83,805.0 ", $-   ,Dec
TA-2015-3005,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,15-03-2015,5704,India,India,8370,Not assigned,113, $453.0 ," $51,189.0 ", $-   ,Mar
TA-2015-3006,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,18-01-2015,5704,India,India,8370,Not assigned,158, $453.0 ," $71,574.0 ", $-   ,Jan
TA-2015-3007,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,19-12-2015,5704,India,India,8370,Not assigned,311, $453.0 ," $1,40,883.0 ", $-   ,Dec
TA-2015-3008,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,12-04-2015,5704,India,India,8370,Not assigned,69, $453.0 ," $31,257.0 ", $-   ,Apr
TA-2015-3009,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,19-03-2015,5704,India,India,8370,Not assigned,252, $453.0 ," $1,14,156.0 ", $-   ,Mar
UM-2015-3010,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,09-03-2015,5704,India,India,8370,Not assigned,290, $366.0 ," $1,06,140.0 ", $-   ,Mar
UM-2015-3011,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,25-08-2015,5704,India,India,8370,Not assigned,181, $366.0 ," $66,246.0 ", $-   ,Aug
UM-2015-3012,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,19-02-2015,5704,India,India,8370,Not assigned,343, $366.0 ," $1,25,538.0 ", $-   ,Feb
IN-2015-3013,Oxycodone,OxyContin,Generic,Pain,11-01-2015,5704,India,India,8370,Assigned,357, $472.0 ," $1,68,504.0 "," $9,639.0 ",Jan
IN-2015-3014,Oxycodone,OxyContin,Generic,Pain,04-08-2015,5704,India,India,8370,Assigned,153, $472.0 ," $72,216.0 "," $4,998.0 ",Aug
DE-2015-3015,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,14-07-2015,5754,India,India,7904,Not assigned,166, $314.0 ," $52,124.0 ", $-   ,Jul
DE-2015-3016,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,27-07-2015,5754,Pakistan,Pakistan,7904,Assigned,64, $314.0 ," $20,096.0 ", $789.3 ,Jul
DE-2015-3017,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,13-07-2015,5754,Pakistan,Pakistan,7904,Not assigned,159, $314.0 ," $49,926.0 ", $-   ,Jul
DE-2015-3018,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,08-10-2015,5754,Pakistan,Pakistan,7904,Not assigned,104, $314.0 ," $32,656.0 ", $-   ,Oct
TA-2015-3019,Filgrastim,Neulasta,Amgen,Neutropenia,01-01-2015,5737,India,India,8270,Not assigned,491, $266.0 ," $1,30,606.0 ", $-   ,Jan
US-2015-3020,Insulin glargine,Lantus,Sanofi-Aventis,Diabetes mellitus type 1 and 2,01-06-2015,5653,South Africa,India,7933,Not assigned,156, $231.0 ," $36,036.0 ", $-   ,Jun
FY-2015-3021,Aripiprazole,Abilify,Generic,Psychosis; depression,07-03-2015,5704,Netherlands,Netherlands,8370,Not assigned,107, $204.0 ," $21,828.0 ", $-   ,Mar
IN-2015-3022,Oxycodone,OxyContin,Generic,Pain,03-04-2015,5704,Vietnam,Netherlands,8370,Assigned,223, $472.0 ," $1,05,256.0 "," $6,169.7 ",Apr
IN-2015-3023,Oxycodone,OxyContin,Generic,Pain,04-11-2015,5704,Singapore,Singapore,8370,Not assigned,324, $472.0 ," $1,52,928.0 ", $-   ,Nov
IN-2015-3024,Oxycodone,OxyContin,Generic,Pain,04-01-2015,5704,Vietnam,Netherlands,8370,Assigned,253, $472.0 ," $1,19,416.0 "," $3,626.3 ",Jan
IN-2015-3025,Oxycodone,OxyContin,Generic,Pain,03-04-2015,5704,Australia,Australia,8370,Not assigned,25, $472.0 ," $11,800.0 ", $-   ,Apr
CA-2015-3026,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-12-2015,5887,India,India,8095,Not assigned,27, $500.0 ," $13,500.0 ", $-   ,Dec
CA-2015-3027,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-04-2015,5887,India,India,8095,Not assigned,273, $500.0 ," $1,36,500.0 ", $-   ,Apr
CA-2015-3028,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-03-2015,5887,India,India,8095,Not assigned,61, $500.0 ," $30,500.0 ", $-   ,Mar
CA-2015-3029,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-04-2015,5887,India,India,8095,Not assigned,146, $500.0 ," $73,000.0 ", $-   ,Apr
CA-2015-3030,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-12-2015,5887,India,India,8095,Not assigned,288, $500.0 ," $1,44,000.0 ", $-   ,Dec
CA-2015-3031,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-06-2015,5887,India,India,8095,Not assigned,231, $500.0 ," $1,15,500.0 ", $-   ,Jun
CA-2015-3032,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-01-2015,5887,India,India,8095,Not assigned,376, $500.0 ," $1,88,000.0 ", $-   ,Jan
CA-2015-3033,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-02-2015,5887,India,India,8095,Not assigned,198, $500.0 ," $99,000.0 ", $-   ,Feb
CA-2015-3034,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-04-2015,5887,India,India,8095,Not assigned,337, $500.0 ," $1,68,500.0 ", $-   ,Apr
CA-2015-3035,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-04-2015,5887,India,India,8095,Not assigned,337, $500.0 ," $1,68,500.0 ", $-   ,Apr
CA-2015-3036,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-05-2015,5887,India,India,8095,Assigned,182, $500.0 ," $91,000.0 "," $3,640.0 ",May
CA-2015-3037,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-12-2015,5887,India,India,8095,Not assigned,453, $500.0 ," $2,26,500.0 ", $-   ,Dec
CA-2015-3038,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-09-2015,5887,India,India,8095,Not assigned,465, $500.0 ," $2,32,500.0 ", $-   ,Sep
CA-2015-3039,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-10-2015,5887,India,India,8095,Not assigned,18, $500.0 ," $9,000.0 ", $-   ,Oct
CA-2015-3040,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-10-2015,5887,India,India,8095,Not assigned,117, $500.0 ," $58,500.0 ", $-   ,Oct
CA-2015-3041,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-09-2015,5887,India,India,8095,Not assigned,278, $500.0 ," $1,39,000.0 ", $-   ,Sep
CA-2015-3042,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-12-2015,5887,India,India,8095,Assigned,488, $500.0 ," $2,44,000.0 "," $6,018.7 ",Dec
CA-2015-3043,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-10-2015,5887,India,India,8095,Not assigned,305, $500.0 ," $1,52,500.0 ", $-   ,Oct
CA-2015-3044,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-10-2015,5887,India,India,8095,Not assigned,228, $500.0 ," $1,14,000.0 ", $-   ,Oct
CA-2015-3045,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-03-2015,5887,India,India,8095,Assigned,41, $500.0 ," $20,500.0 "," $1,093.3 ",Mar
CA-2015-3046,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-07-2015,5887,India,India,8095,Not assigned,450, $500.0 ," $2,25,000.0 ", $-   ,Jul
CA-2015-3047,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-08-2015,5887,India,India,8095,Not assigned,412, $500.0 ," $2,06,000.0 ", $-   ,Aug
CA-2015-3048,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-06-2015,5887,India,India,8095,Not assigned,100, $500.0 ," $50,000.0 ", $-   ,Jun
CA-2015-3049,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-07-2015,5887,India,India,8095,Assigned,336, $500.0 ," $1,68,000.0 "," $4,032.0 ",Jul
CA-2015-3050,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-09-2015,5887,India,India,8095,Assigned,140, $500.0 ," $70,000.0 "," $2,893.3 ",Sep
CA-2015-3051,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-02-2015,5887,India,India,8095,Not assigned,298, $500.0 ," $1,49,000.0 ", $-   ,Feb
CA-2015-3052,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-01-2015,5887,India,India,8095,Not assigned,87, $500.0 ," $43,500.0 ", $-   ,Jan
CA-2015-3053,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-09-2015,5887,India,India,8095,Assigned,358, $500.0 ," $1,79,000.0 "," $8,592.0 ",Sep
CA-2015-3054,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-10-2015,5887,India,India,8095,Assigned,136, $500.0 ," $68,000.0 "," $3,400.0 ",Oct
CA-2015-3055,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-06-2015,5887,India,India,8095,Not assigned,259, $500.0 ," $1,29,500.0 ", $-   ,Jun
CA-2015-3056,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-01-2015,5887,India,India,8095,Assigned,108, $500.0 ," $54,000.0 ", $864.0 ,Jan
CA-2015-3057,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-06-2015,5887,India,India,8095,Not assigned,216, $500.0 ," $1,08,000.0 ", $-   ,Jun
CA-2015-3058,Pregabalin,Lyrica,Pfizer,Neuropathic pain,20-07-2015,5887,India,India,8095,Assigned,411, $500.0 ," $2,05,500.0 "," $7,672.0 ",Jul
CA-2015-3059,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-11-2015,5887,India,India,8095,Assigned,70, $500.0 ," $35,000.0 ", $466.7 ,Nov
CA-2015-3060,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-02-2015,5887,India,India,8095,Not assigned,261, $500.0 ," $1,30,500.0 ", $-   ,Feb
CA-2015-3061,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-07-2015,5887,India,India,8095,Not assigned,468, $500.0 ," $2,34,000.0 ", $-   ,Jul
CA-2015-3062,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-01-2015,5887,India,India,8095,Not assigned,28, $500.0 ," $14,000.0 ", $-   ,Jan
CA-2015-3063,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-06-2015,5887,India,India,8095,Not assigned,327, $500.0 ," $1,63,500.0 ", $-   ,Jun
CA-2015-3064,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-10-2015,5887,India,India,8095,Assigned,475, $500.0 ," $2,37,500.0 "," $11,716.7 ",Oct
CA-2015-3065,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-02-2015,5887,India,India,8095,Assigned,490, $500.0 ," $2,45,000.0 "," $2,940.0 ",Feb
CA-2015-3066,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-03-2015,5887,India,India,8095,Assigned,19, $500.0 ," $9,500.0 ", $367.3 ,Mar
TA-2015-3067,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,10-06-2015,5704,India,India,8370,Not assigned,485, $453.0 ," $2,19,705.0 ", $-   ,Jun
CA-2015-3068,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-03-2015,5887,India,India,8095,Not assigned,92, $500.0 ," $46,000.0 ", $-   ,Mar
CA-2015-3069,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-02-2015,5887,India,India,8095,Not assigned,345, $500.0 ," $1,72,500.0 ", $-   ,Feb
CA-2015-3070,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-01-2015,5887,India,India,8095,Not assigned,204, $500.0 ," $1,02,000.0 ", $-   ,Jan
TA-2015-3071,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,30-08-2015,5704,India,India,8370,Not assigned,24, $453.0 ," $10,872.0 ", $-   ,Aug
CA-2015-3072,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-06-2015,5887,India,India,8095,Not assigned,44, $500.0 ," $22,000.0 ", $-   ,Jun
CA-2015-3073,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-03-2015,5887,India,India,8095,Not assigned,491, $500.0 ," $2,45,500.0 ", $-   ,Mar
CA-2015-3074,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-07-2015,5887,India,India,8095,Not assigned,466, $500.0 ," $2,33,000.0 ", $-   ,Jul
CA-2015-3075,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-02-2015,5887,India,India,8095,Not assigned,241, $500.0 ," $1,20,500.0 ", $-   ,Feb
CA-2015-3076,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-06-2015,5887,India,India,8095,Not assigned,341, $500.0 ," $1,70,500.0 ", $-   ,Jun
CA-2015-3077,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-05-2015,5887,India,India,8095,Not assigned,341, $500.0 ," $1,70,500.0 ", $-   ,May
CA-2015-3078,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-05-2015,5887,India,India,8095,Not assigned,232, $500.0 ," $1,16,000.0 ", $-   ,May
CA-2015-3079,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-02-2015,5887,India,India,8095,Not assigned,140, $500.0 ," $70,000.0 ", $-   ,Feb
CA-2015-3080,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-04-2015,5887,India,India,8095,Not assigned,206, $500.0 ," $1,03,000.0 ", $-   ,Apr
CA-2015-3081,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-01-2015,5887,India,India,8095,Not assigned,358, $500.0 ," $1,79,000.0 ", $-   ,Jan
CA-2015-3082,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-08-2015,5887,India,India,8095,Not assigned,246, $500.0 ," $1,23,000.0 ", $-   ,Aug
CA-2015-3083,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-03-2015,5887,India,India,8095,Not assigned,86, $500.0 ," $43,000.0 ", $-   ,Mar
CA-2015-3084,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-07-2015,5887,India,India,8095,Not assigned,494, $500.0 ," $2,47,000.0 ", $-   ,Jul
CA-2015-3085,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-06-2015,5887,India,India,8095,Not assigned,226, $500.0 ," $1,13,000.0 ", $-   ,Jun
CA-2015-3086,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-05-2015,5887,India,India,8095,Assigned,290, $500.0 ," $1,45,000.0 "," $6,766.7 ",May
CA-2015-3087,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-01-2015,5887,India,India,8095,Assigned,487, $500.0 ," $2,43,500.0 "," $4,545.3 ",Jan
CA-2015-3088,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-01-2015,5887,India,India,8095,Not assigned,56, $500.0 ," $28,000.0 ", $-   ,Jan
CA-2015-3089,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-11-2015,5887,India,India,8095,Not assigned,311, $500.0 ," $1,55,500.0 ", $-   ,Nov
CA-2015-3090,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-02-2015,5887,India,India,8095,Not assigned,311, $500.0 ," $1,55,500.0 ", $-   ,Feb
CA-2015-3091,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-01-2015,5887,India,India,8095,Not assigned,498, $500.0 ," $2,49,000.0 ", $-   ,Jan
CA-2015-3092,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-03-2015,5887,India,India,8095,Not assigned,221, $500.0 ," $1,10,500.0 ", $-   ,Mar
CA-2015-3093,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-11-2015,5887,India,India,8095,Not assigned,69, $500.0 ," $34,500.0 ", $-   ,Nov
CA-2015-3094,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-02-2015,5887,India,India,8095,Not assigned,216, $500.0 ," $1,08,000.0 ", $-   ,Feb
CA-2015-3095,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-11-2015,5887,India,India,8095,Not assigned,227, $500.0 ," $1,13,500.0 ", $-   ,Nov
CA-2015-3096,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-05-2015,5887,India,India,8095,Not assigned,172, $500.0 ," $86,000.0 ", $-   ,May
CA-2015-3097,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-11-2015,5887,India,India,8095,Not assigned,145, $500.0 ," $72,500.0 ", $-   ,Nov
CA-2015-3098,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-05-2015,5887,India,India,8095,Not assigned,213, $500.0 ," $1,06,500.0 ", $-   ,May
CA-2015-3099,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-03-2015,5887,India,India,8095,Not assigned,241, $500.0 ," $1,20,500.0 ", $-   ,Mar
CA-2015-3100,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-07-2015,5887,India,India,8095,Not assigned,381, $500.0 ," $1,90,500.0 ", $-   ,Jul
CA-2015-3101,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-05-2015,5887,India,India,8095,Not assigned,421, $500.0 ," $2,10,500.0 ", $-   ,May
CA-2015-3102,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-07-2015,5887,India,India,8095,Not assigned,322, $500.0 ," $1,61,000.0 ", $-   ,Jul
CA-2015-3103,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-04-2015,5887,India,India,8095,Assigned,23, $500.0 ," $11,500.0 ", $199.3 ,Apr
CA-2015-3104,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-10-2015,5887,India,India,8095,Assigned,466, $500.0 ," $2,33,000.0 "," $3,106.7 ",Oct
CA-2015-3105,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-03-2015,5887,India,India,8095,Not assigned,29, $500.0 ," $14,500.0 ", $-   ,Mar
CA-2015-3106,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-11-2015,5887,India,India,8095,Not assigned,23, $500.0 ," $11,500.0 ", $-   ,Nov
CA-2015-3107,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-06-2015,5887,India,India,8095,Not assigned,27, $500.0 ," $13,500.0 ", $-   ,Jun
CA-2015-3108,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-12-2015,5887,India,India,8095,Not assigned,172, $500.0 ," $86,000.0 ", $-   ,Dec
CA-2015-3109,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-08-2015,5887,India,India,8095,Not assigned,104, $500.0 ," $52,000.0 ", $-   ,Aug
CA-2015-3110,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-09-2015,5887,India,India,8095,Not assigned,90, $500.0 ," $45,000.0 ", $-   ,Sep
CA-2015-3111,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-06-2015,5887,Philippines,Philippines,8095,Assigned,437, $500.0 ," $2,18,500.0 "," $6,555.0 ",Jun
CA-2015-3112,Pregabalin,Lyrica,Pfizer,Neuropathic pain,17-02-2015,5887,Kenya,Kenya,8095,Assigned,153, $500.0 ," $76,500.0 "," $2,703.0 ",Feb
CA-2015-3113,Pregabalin,Lyrica,Pfizer,Neuropathic pain,30-11-2015,5887,Kenya,Kenya,8095,Assigned,37, $500.0 ," $18,500.0 ", $925.0 ,Nov
CA-2015-3114,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-08-2015,5887,Kenya,Kenya,8095,Assigned,49, $500.0 ," $24,500.0 ", $996.3 ,Aug
CA-2015-3115,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-03-2015,5887,Egypt,Egypt,8095,Not assigned,464, $500.0 ," $2,32,000.0 ", $-   ,Mar
CA-2015-3116,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-01-2015,5887,Egypt,Egypt,8095,Not assigned,109, $500.0 ," $54,500.0 ", $-   ,Jan
CA-2015-3117,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-12-2015,5887,Egypt,Egypt,8095,Assigned,169, $500.0 ," $84,500.0 "," $1,859.0 ",Dec
CA-2015-3118,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-10-2015,5887,Egypt,Egypt,8095,Assigned,125, $500.0 ," $62,500.0 ", $791.7 ,Oct
CA-2015-3119,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-10-2015,5887,Thailand,Thailand,8095,Not assigned,429, $500.0 ," $2,14,500.0 ", $-   ,Oct
CA-2015-3120,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-08-2015,5887,Nepal,Nepal,8095,Assigned,84, $500.0 ," $42,000.0 "," $1,064.0 ",Aug
CA-2015-3121,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-05-2015,5887,Nepal,Nepal,8095,Assigned,69, $500.0 ," $34,500.0 "," $2,001.0 ",May
CA-2015-3122,Pregabalin,Lyrica,Pfizer,Neuropathic pain,09-07-2015,5887,Sri Lanka,Sri Lanka,8095,Assigned,237, $500.0 ," $1,18,500.0 "," $7,742.0 ",Jul
CA-2015-3123,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-05-2015,5887,Philippines,Philippines,8095,Assigned,191, $500.0 ," $95,500.0 "," $4,520.3 ",May
CA-2015-3124,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-01-2015,5887,Vietnam,Vietnam,8095,Assigned,158, $500.0 ," $79,000.0 ", $842.7 ,Jan
CA-2015-3125,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-08-2015,5887,Germany,Germany,8095,Not assigned,47, $500.0 ," $23,500.0 ", $-   ,Aug
CA-2015-3126,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-04-2015,5887,Germany,Germany,8095,Not assigned,84, $500.0 ," $42,000.0 ", $-   ,Apr
CA-2015-3127,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-06-2015,5887,Malaysia,Malaysia,8095,Not assigned,430, $500.0 ," $2,15,000.0 ", $-   ,Jun
CA-2015-3128,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-01-2015,5887,Sri Lanka,Sri Lanka,8095,Assigned,451, $500.0 ," $2,25,500.0 "," $11,575.7 ",Jan
CA-2015-3129,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-01-2015,5887,Egypt,Egypt,8095,Not assigned,391, $500.0 ," $1,95,500.0 ", $-   ,Jan
CA-2015-3130,Pregabalin,Lyrica,Pfizer,Neuropathic pain,31-12-2015,5887,Egypt,Egypt,8095,Not assigned,275, $500.0 ," $1,37,500.0 ", $-   ,Dec
CA-2015-3131,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-03-2015,5887,Vietnam,Netherlands,8095,Assigned,231, $500.0 ," $1,15,500.0 "," $4,928.0 ",Mar
CA-2015-3132,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-06-2015,5887,Singapore,Singapore,8095,Not assigned,202, $500.0 ," $1,01,000.0 ", $-   ,Jun
CA-2015-3133,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-04-2015,5887,Syria,Lebanon,8095,Assigned,89, $500.0 ," $44,500.0 ", $593.3 ,Apr
CA-2015-3134,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-10-2015,5887,Philippines,Philippines,8095,Assigned,269, $500.0 ," $1,34,500.0 "," $2,510.7 ",Oct
CA-2015-3135,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-05-2015,5887,Philippines,Philippines,8095,Assigned,24, $500.0 ," $12,000.0 ", $560.0 ,May
CA-2015-3136,Pregabalin,Lyrica,Pfizer,Neuropathic pain,01-11-2015,5887,Singapore,Singapore,8095,Not assigned,254, $500.0 ," $1,27,000.0 ", $-   ,Nov
CA-2015-3137,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-06-2015,5887,Hong Kong,China,8095,Not assigned,467, $500.0 ," $2,33,500.0 ", $-   ,Jun
CA-2015-3138,Pregabalin,Lyrica,Pfizer,Neuropathic pain,24-09-2015,5887,Russian Fed.,Netherlands,8095,Not assigned,57, $500.0 ," $28,500.0 ", $-   ,Sep
CA-2015-3139,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-06-2015,5887,Taiwan,China,8095,Not assigned,323, $500.0 ," $1,61,500.0 ", $-   ,Jun
CA-2015-3140,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-12-2015,5887,Netherlands,Netherlands,8095,Not assigned,497, $500.0 ," $2,48,500.0 ", $-   ,Dec
CA-2015-3141,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-02-2015,5887,Taiwan,China,8095,Not assigned,216, $500.0 ," $1,08,000.0 ", $-   ,Feb
CA-2015-3142,Pregabalin,Lyrica,Pfizer,Neuropathic pain,22-06-2015,5887,Taiwan,China,8095,Not assigned,8, $500.0 ," $4,000.0 ", $-   ,Jun
IN-2015-3143,Bevacizumab,Avastin,Genentech/Roche,Cancer,07-09-2015,5685,India,India,8209,Not assigned,77, $243.0 ," $18,711.0 ", $-   ,Sep
IN-2015-3144,Bevacizumab,Avastin,Genentech/Roche,Cancer,22-08-2015,5685,India,India,8209,Not assigned,275, $243.0 ," $66,825.0 ", $-   ,Aug
IN-2015-3145,Bevacizumab,Avastin,Genentech/Roche,Cancer,21-06-2015,5685,India,India,8209,Not assigned,447, $243.0 ," $1,08,621.0 ", $-   ,Jun
IN-2015-3146,Bevacizumab,Avastin,Genentech/Roche,Cancer,13-06-2015,5685,India,India,8209,Not assigned,49, $243.0 ," $11,907.0 ", $-   ,Jun
IN-2015-3147,Bevacizumab,Avastin,Genentech/Roche,Cancer,02-06-2015,5685,India,India,8209,Not assigned,205, $243.0 ," $49,815.0 ", $-   ,Jun
IN-2015-3148,Bevacizumab,Avastin,Genentech/Roche,Cancer,30-05-2015,5685,India,India,8209,Assigned,486, $243.0 ," $1,18,098.0 "," $9,558.0 ",May
IN-2015-3149,Bevacizumab,Avastin,Genentech/Roche,Cancer,17-12-2015,5685,Iran,Iran,8209,Not assigned,24, $243.0 ," $5,832.0 ", $-   ,Dec
IN-2015-3150,Bevacizumab,Avastin,Genentech/Roche,Cancer,17-06-2015,5685,Kenya,Kenya,8209,Assigned,304, $243.0 ," $73,872.0 "," $5,776.0 ",Jun
IN-2015-3151,Bevacizumab,Avastin,Genentech/Roche,Cancer,20-03-2015,5685,Kenya,Kenya,8209,Assigned,390, $243.0 ," $94,770.0 "," $7,150.0 ",Mar
IN-2015-3152,Bevacizumab,Avastin,Genentech/Roche,Cancer,09-11-2015,5685,Kenya,Kenya,8209,Assigned,306, $243.0 ," $74,358.0 "," $5,916.0 ",Nov
IN-2015-3153,Bevacizumab,Avastin,Genentech/Roche,Cancer,18-08-2015,5685,Malaysia,Malaysia,8209,Not assigned,476, $243.0 ," $1,15,668.0 ", $-   ,Aug
IN-2015-3154,Bevacizumab,Avastin,Genentech/Roche,Cancer,12-08-2015,5685,Thailand,Thailand,8209,Assigned,313, $243.0 ," $76,059.0 "," $3,443.0 ",Aug
IN-2015-3155,Bevacizumab,Avastin,Genentech/Roche,Cancer,24-08-2015,5685,Syria,Lebanon,8209,Assigned,344, $243.0 ," $83,592.0 "," $10,664.0 ",Aug
IN-2015-3156,Bevacizumab,Avastin,Genentech/Roche,Cancer,02-10-2015,5685,Thailand,Thailand,8209,Assigned,487, $243.0 ," $1,18,341.0 "," $11,363.3 ",Oct
IN-2015-3157,Bevacizumab,Avastin,Genentech/Roche,Cancer,18-04-2015,5685,Thailand,Thailand,8209,Assigned,490, $243.0 ," $1,19,070.0 "," $8,656.7 ",Apr
IN-2015-3158,Bevacizumab,Avastin,Genentech/Roche,Cancer,06-12-2015,5685,Thailand,Thailand,8209,Assigned,355, $243.0 ," $86,265.0 "," $4,141.7 ",Dec
IN-2015-3159,Bevacizumab,Avastin,Genentech/Roche,Cancer,16-05-2015,5685,Netherlands,Netherlands,8209,Not assigned,484, $243.0 ," $1,17,612.0 ", $-   ,May
IN-2015-3160,Bevacizumab,Avastin,Genentech/Roche,Cancer,07-05-2015,5685,Netherlands,Netherlands,8209,Not assigned,299, $243.0 ," $72,657.0 ", $-   ,May
RA-2015-3161,Adalimumab,Humira,AbbVie,Crohn's disease; Rheumatoid arthritis,25-07-2015,5574,Lebanon,Lebanon,7942,Not assigned,372, $349.0 ," $1,29,828.0 ", $-   ,Jul
NE-2015-3162,Glatiramer,Copaxone,Generic,Multiple sclerosis,16-04-2015,5704,India,India,8370,Not assigned,299, $451.0 ," $1,34,849.0 ", $-   ,Apr
NE-2015-3163,Glatiramer,Copaxone,Generic,Multiple sclerosis,25-06-2015,5704,India,India,8370,Not assigned,120, $451.0 ," $54,120.0 ", $-   ,Jun
NE-2015-3164,Glatiramer,Copaxone,Generic,Multiple sclerosis,01-05-2015,5704,India,India,8370,Not assigned,330, $451.0 ," $1,48,830.0 ", $-   ,May
NE-2015-3165,Glatiramer,Copaxone,Generic,Multiple sclerosis,03-05-2015,5704,India,India,8370,Not assigned,267, $451.0 ," $1,20,417.0 ", $-   ,May
NE-2015-3166,Glatiramer,Copaxone,Generic,Multiple sclerosis,11-10-2015,5704,India,India,8370,Not assigned,498, $451.0 ," $2,24,598.0 ", $-   ,Oct
NE-2015-3167,Glatiramer,Copaxone,Generic,Multiple sclerosis,18-11-2015,5704,India,India,8370,Not assigned,268, $451.0 ," $1,20,868.0 ", $-   ,Nov
NE-2015-3168,Glatiramer,Copaxone,Generic,Multiple sclerosis,04-06-2015,5704,India,India,8370,Not assigned,435, $451.0 ," $1,96,185.0 ", $-   ,Jun
NE-2015-3169,Glatiramer,Copaxone,Generic,Multiple sclerosis,02-09-2015,5704,India,India,8370,Not assigned,176, $451.0 ," $79,376.0 ", $-   ,Sep
NE-2015-3170,Glatiramer,Copaxone,Generic,Multiple sclerosis,15-09-2015,5704,Iran,Iran,8370,Not assigned,449, $451.0 ," $2,02,499.0 ", $-   ,Sep
NE-2015-3171,Glatiramer,Copaxone,Generic,Multiple sclerosis,12-06-2015,5704,Kenya,Kenya,8370,Assigned,289, $451.0 ," $1,30,339.0 "," $6,454.3 ",Jun
NE-2015-3172,Glatiramer,Copaxone,Generic,Multiple sclerosis,22-04-2015,5704,Malaysia,Malaysia,8370,Assigned,123, $451.0 ," $55,473.0 ", $820.0 ,Apr
NE-2015-3173,Glatiramer,Copaxone,Generic,Multiple sclerosis,07-04-2015,5704,Nepal,Nepal,8370,Assigned,73, $451.0 ," $32,923.0 "," $1,825.0 ",Apr
NE-2015-3174,Glatiramer,Copaxone,Generic,Multiple sclerosis,20-11-2015,5704,Kenya,Kenya,8370,Assigned,136, $451.0 ," $61,336.0 "," $2,402.7 ",Nov
NE-2015-3175,Glatiramer,Copaxone,Generic,Multiple sclerosis,06-04-2015,5704,Thailand,Thailand,8370,Assigned,263, $451.0 ," $1,18,613.0 "," $2,980.7 ",Apr
NE-2015-3176,Glatiramer,Copaxone,Generic,Multiple sclerosis,21-08-2015,5704,Thailand,Thailand,8370,Assigned,60, $451.0 ," $27,060.0 ", $680.0 ,Aug
NE-2015-3177,Glatiramer,Copaxone,Generic,Multiple sclerosis,16-09-2015,5704,Thailand,Thailand,8370,Assigned,114, $451.0 ," $51,414.0 ", $988.0 ,Sep
NE-2015-3178,Glatiramer,Copaxone,Generic,Multiple sclerosis,14-11-2015,5704,Philippines,Philippines,8370,Assigned,216, $451.0 ," $97,416.0 "," $1,800.0 ",Nov
VA-2015-3179,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,28-01-2015,5938,India,India,8068,Not assigned,302, $310.0 ," $93,620.0 ", $-   ,Jan
VA-2015-3180,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,18-07-2015,5938,India,India,8068,Not assigned,100, $310.0 ," $31,000.0 ", $-   ,Jul
VA-2015-3181,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,22-03-2015,5938,India,India,8068,Not assigned,219, $310.0 ," $67,890.0 ", $-   ,Mar
VA-2015-3182,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,09-05-2015,5938,India,India,8068,Not assigned,205, $310.0 ," $63,550.0 ", $-   ,May
VA-2015-3183,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,21-10-2015,5938,India,India,8068,Not assigned,472, $310.0 ," $1,46,320.0 ", $-   ,Oct
VA-2015-3184,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,22-11-2015,5938,India,India,8068,Not assigned,474, $310.0 ," $1,46,940.0 ", $-   ,Nov
VA-2015-3185,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,12-09-2015,5938,India,India,8068,Not assigned,342, $310.0 ," $1,06,020.0 ", $-   ,Sep
VA-2015-3186,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,06-07-2015,5938,Egypt,Egypt,8068,Not assigned,25, $310.0 ," $7,750.0 ", $-   ,Jul
VA-2015-3187,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,18-10-2015,5938,Egypt,Egypt,8068,Not assigned,319, $310.0 ," $98,890.0 ", $-   ,Oct
VA-2015-3188,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,23-08-2015,5938,Egypt,Egypt,8068,Assigned,364, $310.0 ," $1,12,840.0 "," $8,129.3 ",Aug
VA-2015-3189,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,14-10-2015,5938,Morocco,Netherlands,8068,Not assigned,282, $310.0 ," $87,420.0 ", $-   ,Oct
VA-2015-3190,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,23-03-2015,5938,Morocco,Netherlands,8068,Not assigned,218, $310.0 ," $67,580.0 ", $-   ,Mar
RA-2015-3191,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,16-09-2015,5819,India,India,8119,Assigned,124, $364.0 ," $45,136.0 "," $1,860.0 ",Sep
RA-2015-3192,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,07-02-2015,5819,India,India,8119,Assigned,270, $364.0 ," $98,280.0 "," $2,250.0 ",Feb
RA-2015-3193,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,12-09-2015,5819,India,India,8119,Assigned,171, $364.0 ," $62,244.0 "," $4,731.0 ",Sep
RA-2015-3194,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,20-12-2015,5819,India,India,8119,Not assigned,235, $364.0 ," $85,540.0 ", $-   ,Dec
RA-2015-3195,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,17-03-2015,5819,India,India,8119,Not assigned,415, $364.0 ," $1,51,060.0 ", $-   ,Mar
RA-2015-3196,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,18-04-2015,5819,India,India,8119,Not assigned,300, $364.0 ," $1,09,200.0 ", $-   ,Apr
RA-2015-3197,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,12-11-2015,5819,Thailand,Thailand,8119,Assigned,475, $364.0 ," $1,72,900.0 "," $11,241.7 ",Nov
RA-2015-3198,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,27-12-2015,5819,Thailand,Thailand,8119,Assigned,180, $364.0 ," $65,520.0 "," $1,560.0 ",Dec
RA-2015-3199,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,27-08-2015,5819,Hong Kong,China,8119,Not assigned,60, $364.0 ," $21,840.0 ", $-   ,Aug
RA-2015-3200,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,28-10-2015,5819,Hong Kong,China,8119,Not assigned,187, $364.0 ," $68,068.0 ", $-   ,Oct
RA-2015-3201,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,07-04-2015,5819,Hong Kong,China,8119,Not assigned,77, $364.0 ," $28,028.0 ", $-   ,Apr
LA-2015-3202,Emtricitabine/tenofovir/efavirenz,Atripla,"Gilead Sciences, Inc.",HIV infection,14-01-2015,5566,Romania,Netherlands,8128,Not assigned,418, $269.0 ," $1,12,442.0 ", $-   ,Jan
AR-2015-3203,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,01-12-2015,5653,India,India,7933,Not assigned,41, $231.0 ," $9,471.0 ", $-   ,Dec
AR-2015-3204,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,19-08-2015,5653,India,India,7933,Not assigned,185, $231.0 ," $42,735.0 ", $-   ,Aug
AR-2015-3205,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,24-04-2015,5653,Vietnam,Netherlands,7933,Assigned,21, $231.0 ," $4,851.0 ", $84.0 ,Apr
AR-2015-3206,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,01-10-2015,5653,Vietnam,Netherlands,7933,Assigned,182, $231.0 ," $42,042.0 "," $3,276.0 ",Oct
AR-2015-3207,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,02-12-2015,5653,Vietnam,Japan,7933,Assigned,300, $231.0 ," $69,300.0 "," $8,600.0 ",Dec
AR-2015-3208,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,23-02-2015,5653,Vietnam,Netherlands,7933,Assigned,348, $231.0 ," $80,388.0 "," $2,204.0 ",Feb
AR-2015-3209,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,05-05-2015,5653,Vietnam,Japan,7933,Assigned,410, $231.0 ," $94,710.0 "," $1,913.3 ",May
AR-2015-3210,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,17-08-2015,5653,Sudan,Utd.Arab Emir.,7933,Assigned,208, $231.0 ," $48,048.0 "," $2,010.7 ",Aug
AR-2015-3211,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,12-01-2015,5653,Pakistan,Pakistan,7933,Assigned,180, $231.0 ," $41,580.0 "," $5,700.0 ",Jan
AR-2015-3212,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,04-06-2015,5653,Pakistan,Pakistan,7933,Assigned,158, $231.0 ," $36,498.0 "," $3,686.7 ",Jun
AR-2015-3213,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,03-11-2015,5653,Malaysia,Malaysia,7933,Assigned,214, $231.0 ," $49,434.0 "," $5,564.0 ",Nov
AR-2015-3214,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,01-12-2015,5653,Malaysia,Malaysia,7933,Assigned,210, $231.0 ," $48,510.0 "," $2,030.0 ",Dec
AR-2015-3215,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,31-01-2015,5653,Vietnam,Vietnam,7933,Assigned,209, $231.0 ," $48,279.0 "," $5,991.3 ",Jan
AR-2015-3216,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,01-08-2015,5653,Philippines,Philippines,7933,Assigned,43, $231.0 ," $9,933.0 ", $917.3 ,Aug
AR-2015-3217,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,26-03-2015,5653,Philippines,Philippines,7933,Assigned,379, $231.0 ," $87,549.0 "," $12,507.0 ",Mar
AR-2015-3218,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,13-06-2015,5653,Thailand,Thailand,7933,Assigned,59, $231.0 ," $13,629.0 ", $491.7 ,Jun
AR-2015-3219,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,02-07-2015,5653,Thailand,Thailand,7933,Assigned,478, $231.0 ," $1,10,418.0 "," $14,499.3 ",Jul
AR-2015-3220,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,28-08-2015,5653,Singapore,Singapore,7933,Not assigned,271, $231.0 ," $62,601.0 ", $-   ,Aug
AR-2015-3221,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,04-08-2015,5653,India,India,7933,Assigned,425, $231.0 ," $98,175.0 "," $4,108.3 ",Aug
AR-2015-3222,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,09-03-2015,5653,India,India,7933,Assigned,322, $231.0 ," $74,382.0 "," $5,152.0 ",Mar
DE-2015-3223,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,03-08-2015,5754,Vietnam,Netherlands,7904,Assigned,397, $314.0 ," $1,24,658.0 "," $9,131.0 ",Aug
DE-2015-3224,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,03-09-2015,5754,Bangladesh,Bangladesh,7904,Assigned,16, $314.0 ," $5,024.0 ", $517.3 ,Sep
DE-2015-3225,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,24-05-2015,5754,Nepal,Nepal,7904,Assigned,69, $314.0 ," $21,666.0 ", $391.0 ,May
DE-2015-3226,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,31-01-2015,5754,Nepal,Nepal,7904,Assigned,301, $314.0 ," $94,514.0 "," $2,107.0 ",Jan
DE-2015-3227,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,30-11-2015,5754,Bangladesh,Bangladesh,7904,Assigned,265, $314.0 ," $83,210.0 "," $7,596.7 ",Nov
DE-2015-3228,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,25-02-2015,5754,Pakistan,Pakistan,7904,Not assigned,119, $314.0 ," $37,366.0 ", $-   ,Feb
DE-2015-3229,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,01-04-2015,5754,Pakistan,Pakistan,7904,Not assigned,359, $314.0 ," $1,12,726.0 ", $-   ,Apr
DE-2015-3230,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,01-09-2015,5754,Pakistan,Pakistan,7904,Assigned,211, $314.0 ," $66,254.0 "," $5,908.0 ",Sep
DE-2015-3231,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,18-01-2015,5754,Pakistan,Pakistan,7904,Assigned,347, $314.0 ," $1,08,958.0 "," $1,966.3 ",Jan
DE-2015-3232,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,04-04-2015,5754,Pakistan,Pakistan,7904,Assigned,271, $314.0 ," $85,094.0 "," $2,619.7 ",Apr
DE-2015-3233,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,21-11-2015,5754,Nepal,Nepal,7904,Assigned,408, $314.0 ," $1,28,112.0 "," $12,376.0 ",Nov
DE-2015-3234,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,09-02-2015,5754,Nepal,Nepal,7904,Assigned,290, $314.0 ," $91,060.0 "," $6,380.0 ",Feb
DE-2015-3235,Infliximab,Remicade,"Centocor Ortho Biotech, Inc., Mitsubishi Tanabe Pharma",Crohn's disease; rheumatoid arthritis,10-02-2015,5754,Singapore,Singapore,7904,Not assigned,426, $314.0 ," $1,33,764.0 ", $-   ,Feb
DE-2015-3236,Fluticasone/salmeterol,"Advair Diskus, Seretide",GlaxoSmithKline,Asthma,25-01-2015,5804,Vietnam,Japan,8321,Assigned,1, $353.0 , $353.0 , $21.0 ,Jan
EL-2015-3237,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,07-05-2015,5737,Vietnam,Japan,8270,Assigned,196, $250.0 ," $49,000.0 "," $4,900.0 ",May
EL-2015-3238,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,06-03-2015,5737,Pakistan,Pakistan,8270,Assigned,372, $250.0 ," $93,000.0 "," $7,440.0 ",Mar
EL-2015-3239,Etanercept,Enbrel,Amgen,Rheumatoid arthritis,18-11-2015,5737,India,India,8270,Not assigned,252, $250.0 ," $63,000.0 ", $-   ,Nov
UM-2015-3240,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,23-01-2015,5704,India,India,8370,Assigned,282, $366.0 ," $1,03,212.0 "," $7,520.0 ",Jan
UM-2015-3241,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,27-09-2015,5704,India,India,8370,Not assigned,65, $366.0 ," $23,790.0 ", $-   ,Sep
UM-2015-3242,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,04-05-2015,5704,India,India,8370,Not assigned,495, $366.0 ," $1,81,170.0 ", $-   ,May
UM-2015-3243,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,22-11-2015,5704,India,India,8370,Not assigned,254, $366.0 ," $92,964.0 ", $-   ,Nov
UM-2015-3244,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,23-08-2015,5704,India,India,8370,Not assigned,67, $366.0 ," $24,522.0 ", $-   ,Aug
UM-2015-3245,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,14-10-2015,5704,India,India,8370,Not assigned,344, $366.0 ," $1,25,904.0 ", $-   ,Oct
UM-2015-3246,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,19-07-2015,5704,India,India,8370,Not assigned,152, $366.0 ," $55,632.0 ", $-   ,Jul
UM-2015-3247,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,17-06-2015,5704,India,India,8370,Not assigned,80, $366.0 ," $29,280.0 ", $-   ,Jun
UM-2015-3248,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,28-10-2015,5704,Vietnam,Vietnam,8370,Not assigned,19, $366.0 ," $6,954.0 ", $-   ,Oct
UM-2015-3249,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,03-04-2015,5704,Singapore,Singapore,8370,Not assigned,145, $366.0 ," $53,070.0 ", $-   ,Apr
UM-2015-3250,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,06-05-2015,5704,USA,Mexico,8370,Not assigned,117, $366.0 ," $42,822.0 ", $-   ,May
UM-2015-3251,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,23-09-2015,5704,Colombia,Mexico,8370,Not assigned,150, $366.0 ," $54,900.0 ", $-   ,Sep
UM-2015-3252,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,01-08-2015,5704,China,China,8370,Not assigned,41, $366.0 ," $15,006.0 ", $-   ,Aug
UM-2015-3253,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,30-06-2015,5704,Ecuador,Mexico,8370,Not assigned,316, $366.0 ," $1,15,656.0 ", $-   ,Jun
UM-2015-3254,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,14-10-2015,5704,Netherlands,Netherlands,8370,Not assigned,485, $366.0 ," $1,77,510.0 ", $-   ,Oct
UM-2015-3255,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,22-04-2015,5704,India,India,8370,Not assigned,312, $366.0 ," $1,14,192.0 ", $-   ,Apr
UM-2015-3256,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,05-09-2015,5704,India,India,8370,Not assigned,87, $366.0 ," $31,842.0 ", $-   ,Sep
TA-2015-3257,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,22-10-2015,5704,India,India,8370,Not assigned,244, $453.0 ," $1,10,532.0 ", $-   ,Oct
UM-2015-3258,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,01-10-2015,5704,India,India,8370,Not assigned,286, $366.0 ," $1,04,676.0 ", $-   ,Oct
UM-2015-3259,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,31-10-2015,5704,India,India,8370,Not assigned,126, $366.0 ," $46,116.0 ", $-   ,Oct
UM-2015-3260,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,08-03-2015,5704,India,India,8370,Not assigned,273, $366.0 ," $99,918.0 ", $-   ,Mar
TA-2015-3261,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,11-07-2015,5704,India,India,8370,Not assigned,68, $453.0 ," $30,804.0 ", $-   ,Jul
TA-2015-3262,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,13-10-2015,5704,India,India,8370,Not assigned,15, $453.0 ," $6,795.0 ", $-   ,Oct
TA-2015-3263,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,10-12-2015,5704,India,India,8370,Not assigned,409, $453.0 ," $1,85,277.0 ", $-   ,Dec
TA-2015-3264,Duloxetine,Cymbalta,Generic,Depression; anxiety disorders,13-06-2015,5704,India,India,8370,Not assigned,270, $453.0 ," $1,22,310.0 ", $-   ,Jun
EX-2015-3265,Celecoxib,Celebrex,Generic,Osteoarthritis; rheumatoid arthritis,07-12-2015,5704,Argentina,Mexico,8370,Not assigned,276, $286.0 ," $78,936.0 ", $-   ,Dec
EX-2015-3266,Celecoxib,Celebrex,Generic,Osteoarthritis; rheumatoid arthritis,06-12-2015,5704,Argentina,Mexico,8370,Not assigned,262, $286.0 ," $74,932.0 ", $-   ,Dec
EX-2015-3267,Celecoxib,Celebrex,Generic,Osteoarthritis; rheumatoid arthritis,09-03-2015,5704,Argentina,Mexico,8370,Not assigned,76, $286.0 ," $21,736.0 ", $-   ,Mar
EX-2015-3268,Celecoxib,Celebrex,Generic,Osteoarthritis; rheumatoid arthritis,08-02-2015,5704,Argentina,Mexico,8370,Not assigned,251, $286.0 ," $71,786.0 ", $-   ,Feb
EX-2015-3269,Celecoxib,Celebrex,Generic,Osteoarthritis; rheumatoid arthritis,01-04-2015,5704,Argentina,Mexico,8370,Not assigned,373, $286.0 ," $1,06,678.0 ", $-   ,Apr
CA-2015-3270,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-06-2015,5887,Vietnam,Vietnam,8095,Assigned,172, $500.0 ," $86,000.0 "," $2,694.7 ",Jun
UM-2015-3271,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,21-06-2015,5704,India,India,8370,Not assigned,425, $366.0 ," $1,55,550.0 ", $-   ,Jun
IN-2015-3272,Oxycodone,OxyContin,Generic,Pain,15-10-2015,5704,Egypt,Egypt,8370,Not assigned,360, $472.0 ," $1,69,920.0 ", $-   ,Oct
IN-2015-3273,Oxycodone,OxyContin,Generic,Pain,06-08-2015,5704,Egypt,Egypt,8370,Not assigned,181, $472.0 ," $85,432.0 ", $-   ,Aug
IN-2015-3274,Oxycodone,OxyContin,Generic,Pain,17-10-2015,5704,Thailand,Thailand,8370,Assigned,328, $472.0 ," $1,54,816.0 "," $6,450.7 ",Oct
CA-2015-3275,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-08-2015,5887,India,India,8095,Not assigned,31, $500.0 ," $15,500.0 ", $-   ,Aug
CA-2015-3276,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-08-2015,5887,India,India,8095,Not assigned,56, $500.0 ," $28,000.0 ", $-   ,Aug
CA-2015-3277,Pregabalin,Lyrica,Pfizer,Neuropathic pain,13-10-2015,5887,India,India,8095,Not assigned,178, $500.0 ," $89,000.0 ", $-   ,Oct
CA-2015-3278,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-06-2015,5887,India,India,8095,Not assigned,205, $500.0 ," $1,02,500.0 ", $-   ,Jun
CA-2015-3279,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-12-2015,5887,India,India,8095,Not assigned,180, $500.0 ," $90,000.0 ", $-   ,Dec
CA-2015-3280,Pregabalin,Lyrica,Pfizer,Neuropathic pain,03-01-2015,5887,India,India,8095,Not assigned,294, $500.0 ," $1,47,000.0 ", $-   ,Jan
CA-2015-3281,Pregabalin,Lyrica,Pfizer,Neuropathic pain,14-02-2015,5887,India,India,8095,Not assigned,415, $500.0 ," $2,07,500.0 ", $-   ,Feb
CA-2015-3282,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-02-2015,5887,India,India,8095,Not assigned,500, $500.0 ," $2,50,000.0 ", $-   ,Feb
CA-2015-3283,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-06-2015,5887,India,India,8095,Not assigned,148, $500.0 ," $74,000.0 ", $-   ,Jun
CA-2015-3284,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-07-2015,5887,India,India,8095,Not assigned,121, $500.0 ," $60,500.0 ", $-   ,Jul
CA-2015-3285,Pregabalin,Lyrica,Pfizer,Neuropathic pain,18-04-2015,5887,India,India,8095,Not assigned,390, $500.0 ," $1,95,000.0 ", $-   ,Apr
CA-2015-3286,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-10-2015,5887,India,India,8095,Not assigned,409, $500.0 ," $2,04,500.0 ", $-   ,Oct
CA-2015-3287,Pregabalin,Lyrica,Pfizer,Neuropathic pain,25-07-2015,5887,India,India,8095,Not assigned,399, $500.0 ," $1,99,500.0 ", $-   ,Jul
CA-2015-3288,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-05-2015,5887,India,India,8095,Not assigned,202, $500.0 ," $1,01,000.0 ", $-   ,May
CA-2015-3289,Pregabalin,Lyrica,Pfizer,Neuropathic pain,16-08-2015,5887,India,India,8095,Not assigned,252, $500.0 ," $1,26,000.0 ", $-   ,Aug
CA-2015-3290,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-03-2015,5887,India,India,8095,Not assigned,378, $500.0 ," $1,89,000.0 ", $-   ,Mar
CA-2015-3291,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-01-2015,5887,India,India,8095,Not assigned,393, $500.0 ," $1,96,500.0 ", $-   ,Jan
CA-2015-3292,Pregabalin,Lyrica,Pfizer,Neuropathic pain,04-12-2015,5887,India,India,8095,Not assigned,261, $500.0 ," $1,30,500.0 ", $-   ,Dec
CA-2015-3293,Pregabalin,Lyrica,Pfizer,Neuropathic pain,05-07-2015,5887,India,India,8095,Not assigned,272, $500.0 ," $1,36,000.0 ", $-   ,Jul
CA-2015-3294,Pregabalin,Lyrica,Pfizer,Neuropathic pain,19-01-2015,5887,India,India,8095,Assigned,263, $500.0 ," $1,31,500.0 "," $6,399.7 ",Jan
CA-2015-3295,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-03-2015,5887,India,India,8095,Not assigned,190, $500.0 ," $95,000.0 ", $-   ,Mar
CA-2015-3296,Pregabalin,Lyrica,Pfizer,Neuropathic pain,08-07-2015,5887,India,India,8095,Not assigned,2, $500.0 ," $1,000.0 ", $-   ,Jul
CA-2015-3297,Pregabalin,Lyrica,Pfizer,Neuropathic pain,23-12-2015,5887,India,India,8095,Not assigned,159, $500.0 ," $79,500.0 ", $-   ,Dec
CA-2015-3298,Pregabalin,Lyrica,Pfizer,Neuropathic pain,21-04-2015,5887,India,India,8095,Not assigned,468, $500.0 ," $2,34,000.0 ", $-   ,Apr
CA-2015-3299,Pregabalin,Lyrica,Pfizer,Neuropathic pain,26-07-2015,5887,South Korea,South Korea,8095,Assigned,350, $500.0 ," $1,75,000.0 "," $9,100.0 ",Jul
CA-2015-3300,Pregabalin,Lyrica,Pfizer,Neuropathic pain,07-01-2015,5887,Kenya,Kenya,8095,Assigned,492, $500.0 ," $2,46,000.0 "," $16,236.0 ",Jan
CA-2015-3301,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-12-2015,5887,Kenya,Kenya,8095,Assigned,105, $500.0 ," $52,500.0 "," $2,730.0 ",Dec
CA-2015-3302,Pregabalin,Lyrica,Pfizer,Neuropathic pain,15-07-2015,5887,Syria,Lebanon,8095,Assigned,351, $500.0 ," $1,75,500.0 "," $1,638.0 ",Jul
CA-2015-3303,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-09-2015,5887,Syria,Lebanon,8095,Assigned,115, $500.0 ," $57,500.0 "," $1,226.7 ",Sep
CA-2015-3304,Pregabalin,Lyrica,Pfizer,Neuropathic pain,12-08-2015,5887,Malaysia,Malaysia,8095,Assigned,313, $500.0 ," $1,56,500.0 "," $1,565.0 ",Aug
CA-2015-3305,Pregabalin,Lyrica,Pfizer,Neuropathic pain,11-08-2015,5887,Egypt,Egypt,8095,Not assigned,468, $500.0 ," $2,34,000.0 ", $-   ,Aug
CA-2015-3306,Pregabalin,Lyrica,Pfizer,Neuropathic pain,27-02-2015,5887,Vietnam,Japan,8095,Assigned,197, $500.0 ," $98,500.0 "," $6,369.7 ",Feb
CA-2015-3307,Pregabalin,Lyrica,Pfizer,Neuropathic pain,28-09-2015,5887,Singapore,Singapore,8095,Not assigned,10, $500.0 ," $5,000.0 ", $-   ,Sep
CA-2015-3308,Pregabalin,Lyrica,Pfizer,Neuropathic pain,02-08-2015,5887,Vietnam,Japan,8095,Assigned,356, $500.0 ," $1,78,000.0 "," $8,662.7 ",Aug
CA-2015-3309,Pregabalin,Lyrica,Pfizer,Neuropathic pain,29-05-2015,5887,Vietnam,Vietnam,8095,Assigned,129, $500.0 ," $64,500.0 "," $1,204.0 ",May
CA-2015-3310,Pregabalin,Lyrica,Pfizer,Neuropathic pain,10-08-2015,5887,Indonesia,Indonesia,8095,Assigned,402, $500.0 ," $2,01,000.0 "," $8,442.0 ",Aug
CA-2015-3311,Pregabalin,Lyrica,Pfizer,Neuropathic pain,06-08-2015,5887,Hong Kong,China,8095,Not assigned,264, $500.0 ," $1,32,000.0 ", $-   ,Aug
IN-2015-3312,Bevacizumab,Avastin,Genentech/Roche,Cancer,22-09-2015,5685,Kenya,Kenya,8209,Assigned,76, $243.0 ," $18,468.0 "," $1,241.3 ",Sep
IN-2015-3313,Bevacizumab,Avastin,Genentech/Roche,Cancer,15-10-2015,5685,Ethiopia,Ethiopia,8209,Assigned,283, $243.0 ," $68,769.0 "," $2,641.3 ",Oct
IN-2015-3314,Bevacizumab,Avastin,Genentech/Roche,Cancer,15-04-2015,5685,Netherlands,Netherlands,8209,Assigned,422, $243.0 ," $1,02,546.0 "," $8,440.0 ",Apr
IN-2015-3315,Bevacizumab,Avastin,Genentech/Roche,Cancer,18-08-2015,5685,Netherlands,Netherlands,8209,Assigned,344, $243.0 ," $83,592.0 "," $9,517.3 ",Aug
IN-2015-3316,Bevacizumab,Avastin,Genentech/Roche,Cancer,31-10-2015,5685,Thailand,Thailand,8209,Assigned,190, $243.0 ," $46,170.0 "," $1,140.0 ",Oct
NE-2015-3317,Glatiramer,Copaxone,Generic,Multiple sclerosis,29-11-2015,5704,India,India,8370,Not assigned,109, $451.0 ," $49,159.0 ", $-   ,Nov
NE-2015-3318,Glatiramer,Copaxone,Generic,Multiple sclerosis,15-02-2015,5704,Ethiopia,Ethiopia,8370,Assigned,112, $451.0 ," $50,512.0 "," $2,725.3 ",Feb
NE-2015-3319,Glatiramer,Copaxone,Generic,Multiple sclerosis,17-08-2015,5704,Netherlands,Netherlands,8370,Not assigned,381, $451.0 ," $1,71,831.0 ", $-   ,Aug
NE-2015-3320,Glatiramer,Copaxone,Generic,Multiple sclerosis,31-07-2015,5704,Netherlands,Netherlands,8370,Not assigned,66, $451.0 ," $29,766.0 ", $-   ,Jul
VA-2015-3321,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,30-10-2015,5938,Bangladesh,Bangladesh,8068,Assigned,142, $310.0 ," $44,020.0 "," $1,278.0 ",Oct
VA-2015-3322,Tiotropium bromide,Spiriva,Boehringer Ingelheim,Chronic obstructive pulmonary disease,03-08-2015,5938,Syria,Lebanon,8068,Assigned,157, $310.0 ," $48,670.0 "," $3,768.0 ",Aug
RA-2015-3323,Rituximab,"Rituxan, MabThera","Biogen Idec, Chugai Pharmaceutical, Genentech/Roche",Non-Hodgkin’s lymphoma; rheumatoid arthritis,03-08-2015,5819,India,India,8119,Not assigned,41, $364.0 ," $14,924.0 ", $-   ,Aug
AR-2015-3324,Insulin glargine,Lantus Solostar,Sanofi-Aventis,Diabetes mellitus type 1 and 2,18-12-2015,5653,India,India,7933,Not assigned,42, $231.0 ," $9,702.0 ", $-   ,Dec
UM-2015-3325,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,15-08-2015,5704,India,India,8370,Not assigned,323, $366.0 ," $1,18,218.0 ", $-   ,Aug
UM-2015-3326,Esomeprazole,Nexium,Generic,Gastrointestinal disorders,29-10-2015,5704,India,India,8370,Not assigned,421, $366.0 ," $1,54,086.0 ", $-   ,Oct
